Generated by All in One SEO v4.9.2, this is an llms.txt file, used by LLMs to index the site.

# Healthmonix

Transforming Data Into Knowledge -> Knowledge Into Transformation

## Sitemaps

- [XML Sitemap](https://healthmonix.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Healthmonix unveils Prism: The future-ready platform for seamless quality reporting and interoperability ](https://healthmonix.com/2025/10/28/healthmonix-prism-quality-reporting-software-release/) - Malvern, Pa., October 2025 — Healthmonix, a recognized leader in healthcare performance and quality solutions, is excited to announce the launch of Prism, a transformative platform purpose-built for the next chapter in healthcare quality reporting and interoperability. As CMS phases out traditional MIPS and introduces new models like MIPS Value Pathways (MVPs), TEAM, and ASM,
- [Healthmonix’s EACCR designated as a 2025 Qualified Clinical Data Registry by CMS](https://healthmonix.com/2025/01/27/healthmonixs-eaccr-designated-as-a-2025-qualified-clinical-data-registry-by-cms/) - Malvern, Pa. (Jan. 27, 2025) — Healthmonix is proud to announce that the Emergency and Acute Care Clinical Registry (EACCR) has been approved as a Qualified Clinical Data Registry (QCDR) by the Centers for Medicare & Medicaid Services (CMS) for the 2025 reporting year. This is the fifth straight year Healthmonix has earned this designation
- [Healthmonix unveils 2025 Mental and Behavioral Health Registry (MBHR) with key measures to enhance care delivery](https://healthmonix.com/2025/01/20/healthmonix-unveils-2025-mental-and-behavioral-health-registry-mbhr-with-key-measures-to-enhance-care-delivery/) - Malvern, Pa. (Jan. 20, 2025) — Healthmonix is proud to announce the release of the 2025 Mental and Behavioral Health Registry (MBHR), a specialized Qualified Clinical Data Registry (QCDR) developed with the American Psychological Association to improve care for individuals with mental and behavioral health conditions. This registry provides healthcare providers with essential tools to track, report, and
- [Healthmonix launches 2025 MIPSpro Enterprise QCDR, expanding support for key healthcare specialties](https://healthmonix.com/2025/01/13/healthmonix-launches-2025-mipspro-enterprise-qcdr-expanding-support-for-key-healthcare-specialties/) - Malvern, Pa. (Jan. 13, 2025) — Healthmonix is proud to announce the release of the 2025 MIPSpro Enterprise Qualified Clinical Data Registry (QCDR). We’ve updated this cutting-edge registry to provide comprehensive support for a wide range of healthcare specialties, helping providers improve care quality, achieve regulatory compliance, and drive better patient outcomes across various clinical settings. The 2025

## Pages

- [Homepage](https://healthmonix.com/) - [carousel_slide id="41749"] Our Focus Healthmonix Prism Prism is a unified ecosystem purpose-built for today's healthcare - enabling agility, transparency, and better outcomes across CMS and payer programs. Your data, fully leveraged Unify clinical, claims, and operations data to cut spending, lift reimbursements, and improve performance — without more busywork. Healthmonix is a healthcare analytics company
- [Acknowledgment of Terms of Service](https://healthmonix.com/legal/) - By signing the Company’s Order Form, Customer affirmatively consents to the Terms of Service, which is comprised of the following documents, including but not limited to: General Terms and Conditions Business Associate Agreement Data Use Agreement MIPS Services Schedule Cost Services Schedule These documents collectively form the Terms of Service, which govern the use of
- [Careers](https://healthmonix.com/healthmonix-careers/) - It all starts with our team At Healthmonix, our team means everything to us. We care about how we work together as much as we care about building and delivering state-of-the-art software for our customers. We’re invested in your career development and happiness, as your contributions will help medical professionals and health systems across the
- [Data integration](https://healthmonix.com/dataintegration/) - Simplify combining and uploading data from multiple sources You store patient and visit information in varied places – EHRs, practice management systems, and revenue cycle management programs. Gaining a comprehensive view of that fragmented data is difficult. Make the most of your data Healthmonix works with everything from basic spreadsheets to industry-leading EHRs like Epic
- [Prism pricing](https://healthmonix.com/prism-pricing/) - Prism pricing Find your perfect plan Single option Track traditional MIPS or 1 MIPS Value Pathway (MVP) as a group or as individuals. Pricing starts at $389* per provider per year Multi option Want to track traditional MIPS and a MIPS Value Pathway (MVP)? Need to add an ACO or subgroup? Contact our Sales team
- [Health Connect](https://healthmonix.com/health-connect/) - Unleash your data with a powerful data warehouse HealthConnect consolidates all the inputs and outputs from our quality measure calculation engine. It encompasses: Patient demographic data across all your data sources Quality data that hasn’t been accessible until now Definitions of quality measures Detailed visit-by-visit results from our proprietary best-in-class measures engine Explore advanced services
- [Customer Support](https://healthmonix.com/customer-support/) - Customer Support is available Monday-Friday, 8 a.m.-5:30 p.m. Submit a support ticket Contact our support team support@healthmonix.com610-590-9081 Healthmonix Help Center What we offer Standard support Additional support options Customer Support Specialist hours Need support beyond our standard options? Take reporting to the next level with 1-on-1 personalized assistance and get the recommendations you need to
- [Training resources](https://healthmonix.com/mips-education/) - Policy guides ACOs should prepare for the significant changes in 2025 quality reporting requirements, driven by CMS's transition from manual to electronic clinical quality measures (eCQMs) under the Medicare Shared Savings Program (MSSP). With increased complexity, expanded reporting populations, and higher compliance expectations, ACOs must adapt quickly to avoid financial and operational setbacks. The article
- [Team](https://healthmonix.com/team-program/) - Boost your analytics to achieve clinical, quality, and financial goals Hospitals and health systems entering the TEAM program face a new challenge: mandatoryaccountability for bundled surgical episode costs. To succeed, organizations need more than rawnumbers. They need: Opportunity analysis Performance monitoring What if analyses Reconciliation validation Actionable insights Healthmonix’s TEAM solutions provide you with the
- [Contact us](https://healthmonix.com/contact-us/) - Get in touch and we’ll answer your questions. Our office 72 E Swedesford Road Suite 110 Malvern, PA 19355 contact@healthmonix.com Main number: 610-545-5511 New sales only: 610-550-8697 Returning customers: 724-542-8985 Customer Support: 610-590-9081
- [Prism](https://healthmonix.com/prism/) - Prism One unified platform. Built-in intelligence. Future-ready. The new standard for quality reporting The healthcare quality reporting landscape is transforming. The shift to MIPS Value Pathways (MVPs), the rise of subgroups, new CMS advanced payment models such as TEAM and ASM, the push toward interoperability, and the looming sunset of traditional MIPS all demand agility,
- [MIPS Improvement Activities](https://healthmonix.com/mips-measures/mips-improvement-activities/) - Activities 2025 improvement activities Improvement activity weighting has been removed starting with the 2025 performance year. Participation requirements are as follows: MVP participants must attest to 1 activity. Small practices and clinicians, groups, and virtual groups with rural, non-patient facing, or health professional shortage area special statuses must attest to 1 activity for Traditional MIPS.
- [2024 MIPS Promoting Interoperability measures](https://healthmonix.com/mips-measures/mips-promoting-interoperability-measures/) - These are the key points to remember when reporting PI: The performance period. The duration for the PI performance period will extend from at least 90 consecutive days to at least 180 consecutive days within the calendar year. This ensures that the PI performance category continues to align with the Medicare Promoting Interoperability Program for
- [MIPSpro Pricing](https://healthmonix.com/mipspro-pricing/) - Find your perfect plan 2025 2026 *$300 implementation fee applied to first license Available add-ons Contact our Sales team to enhance your MIPSpro experience with additional services. Not sure what plan is right for you? Become a partner Do you want to empower your customers and members to excel in quality reporting that drives higher
- [2024 MIPS specialty measure sets and guides](https://healthmonix.com/cms-mips-specialty-measure-sets/) - Looking to report specialty measure sets? Start by finding your specialty below and download the guide for reporting. These guides provide direction and guidance on QPP reporting from CMS for reporting for your specialty, along with improvement activities, quality measures in Traditional MIPS, and MIPS Value Pathways (MVPs) that are most applicable to the specialty.
- [Sections](https://healthmonix.com/sections/) - Our Focus Healthmonix Prism: Prism is the unified ecosystem built for exactly this moment — centralizing your data, streamlining your workflows, and adapting in real time to evolving CMS, payer, and interoperability standards.
- [2024 MIPS Cost measures](https://healthmonix.com/mips-measures/mips-cost-performance-category/) - Our system captures essential measures from claims data, including episode-based measures, acute-episode measures, chronic care episode measures., and population-based cost measures. Track your MIPS Cost category performance over a full calendar year with our system's total category score calculation, which averages the score of all applicable measures. Stay ahead of the curve with quarterly performance
- [MIPS quality measures](https://healthmonix.com/mips-measures/mips-quality-measures/)
- [MVP: Improving Care for Lower Extremity Joint Repair MVP ID: G0058 2025](https://healthmonix.com/improving-care-for-lower-extremity-joint-repair-mvp-id-g0058-2025/) - Most applicable medical specialty: Orthopedic surgery The Improving Care for Lower Extremity Joint Repair MVP focuses on the clinical theme of providing fundamental treatment and management of patients with osteoarthritis and lower extremity surgical repair, such as fracture and total joint replacement, to ensure appropriate care and reduce costs. To fulfill quality requirements: You must
- [Migration: MIPS Eligibility Status Lookup](https://healthmonix.com/mips-eligibility-status-lookup-for-clinicians/) - MIPS eligibility lookup Enter up to 100 relevant 10-digit National Provider Identifier (NPI) numbers to view their Quality Payment Program participation status for the selected performance year. QPP Participation Status for eligible clinicians includes MIPS eligibility as well as APM participation. Please note this tool is a technical resource and doesn't officially determine eligibility for
- [MVP: Value in Primary 2025](https://healthmonix.com/mvp-value-in-primary-2025/) - Most applicable medical specialty: Preventive medicine, internal medicine, family medicine, geriatrics The Value in Primary Care MVP focuses on the clinical theme of promoting quality care for patients in order to reduce the risk of diseases, disabilities, and death. To fulfill quality requirements: You must select 4 quality measures from the list below At least 1
- [MVP: Surgical Care - 2025](https://healthmonix.com/mvp-surgical-care/) - Most applicable medical specialty(s): General surgery, neurosurgery, cardiothoracic surgery, anesthesiologists, nonphysician practitioners, certified registered nurse anesthetists, nurse practitioner, physician assistants The Surgical Care MVP focuses on the clinical theme of surgery. To fulfill quality requirements: You must select 4 quality measures from the list below(exception for clinicians in a small practice - see # 3
- [MVP: Rehabilitative Support for Musculoskeletal Care 2025](https://healthmonix.com/mvp-rehabilitative-support-for-musculoskeletal-care-2025/) - Most applicable medical specialty: Chiropractic medicine, physiatry, physical therapy, occupational therapy The Rehabilitative Support for Musculoskeletal Care MVP focuses on the clinical theme of promoting quality care for patients. To fulfill quality requirements: You must select 4 quality measures from the list below (exception for clinicians in a small practice - see #4 below) At least
- [MVP: Quality Care in Mental Health and Substance Use Disorders 2025](https://healthmonix.com/mvp-quality-care-in-mental-health-and-substance-use-disorders-2025/) - Most applicable medical specialty(s):Mental health, behavioral health, psychiatry The Quality Care in Mental Health and Substance Use Disorders MVP focuses on the clinical theme of promoting prevention of and quality care in behavioral health, including mental health and substance use disorders (SUD). To fulfill quality requirements: You must select 4 quality measures from the list
- [MVP: Quality Care for Patients with Neurological Conditions 2025](https://healthmonix.com/quality-care-for-patients-with-neurological-conditions/) - Most applicable medical specialty: Neurology The Quality Care for Patients with Neurological Conditions MVP focuses on the clinical theme of promoting quality care for patients suffering from neurological conditions. TTo fulfill quality requirements: You must select 4 quality measures from the list below (exception for clinicians in a small practice - see #4 below) At least
- [MVP: Quality Care for the Treatment of Ear, Nose, and Throat Disorders 2025](https://healthmonix.com/mvp-quality-care-for-the-treatment-of-ear-nose-and-throat-disorders-2025/) - Most applicable medical specialty: Otolaryngology, audiologists, nurse practitioners, physician assistants The Quality Care for the Treatment of Ear, Nose, and Throat Disorders MVP focuses on the clinical theme of providing care for patients experiencing some of the most common otolaryngology conditions such as, but not limited to: otologic conditions, chronic rhinosinusitis (CRS), age-related hearing loss (ARHL)
- [MVP: Pulmonology Care - 2025](https://healthmonix.com/mvp-pulmonology-care/) - Most applicable medical specialty(s): Pulmonology, sleep medicine, nonphysician practitioners, nurse practitioner, physician assistants The Pulmonology Care MVP focuses on assessing optimal care for patients treated for a broad range of pulmonology conditions including COPD, asthma, sleep apnea, and general pulmonology. TTo fulfill quality requirements: You must select 4 quality measures from the list below (exception
- [MVP: Prevention and Treatment of Infectious Disorders Including Hepatitis C and HIV 2025](https://healthmonix.com/mvp-prevention-and-treatment-of-infectious-disorders-including-hepatitis-c-and-hiv-2025/) - Most applicable medical specialty: Infectious disease, immunology The Prevention and Treatment of Infectious Disorders Including Hepatitis C and HIV MVP focuses on the clinical theme of promoting quality care for patients suffering from infectious disorders. To fulfill quality requirements: You must select 4 quality measures from the list below (exception for clinicians in a small practice
- [MVP: Optimal Care for Patients with Urologic Conditions - 2025](https://healthmonix.com/optimal-care-for-patients-with-urologic-conditions/) - Most applicable medical specialty(s): Urology, general urologists, urology oncologists, urology care for women, non-physician practitioners, nurse practitioners, physician assistants The Optimal Care for Patients with Urologic Conditions MVP focuses on assessing optimal care for patients treated for a broad range of urologic conditions, including kidney stones, urinary incontinence, bladder cancer, and prostate cancer. To fulfill
- [MVP: Gastroenterology Care - 2025](https://healthmonix.com/mvp-gastroenterology-care/) - Most applicable medical specialty(s):Gastroenterology, non-physician practitioners, murse practitioner, physician assistants The Gastroenterology Care MVP focuses on the clinical theme of providing treatment and management of the digestive system and the liver. To fulfill quality requirements: You must select 4 quality measures from the list below (exception for clinicians in a small practice - see #
- [MVP: Dermatological Care 2025](https://healthmonix.com/dermatological-care/) - Most applicable medical specialty(s):Dermatology, non-physician practitioners, nurse practitioner, physician assistants The Dermatological Care MVP focuses on the clinical theme of providing treatment and management of dermatologic care. To fulfill quality requirements: You must select 4 quality measures from the list below(exception for clinicians in a small practice - see # 3 below) At least 1
- [MVP: Complete Ophthalmologic Care - 2025](https://healthmonix.com/mvp-complete-ophthalmologic-care/) - Most applicable medical specialty(s): Ophthalmology, Optometry The Complete Ophthalmologic Care MVP assesses meaningful outcomes in cataract, glaucoma, retinal detachment, and broadly applicable ocular care. To fulfill quality requirements: You must select 4 quality measures from the list below(exception for clinicians in a small practice - see # 3 below) At least 1 measure must be
- [Advancing Cancer Care MVP ID: M0001 2025](https://healthmonix.com/advancing-cancer-care-mvp-id-m0001-2025/) - Most applicable medical specialties: Oncology, hematology The Advancing Cancer Care MVP focuses on the clinical theme of providing fundamental treatment and management of cancer care. The measures assess three critical areas: the patient experience of care, end of life care, and appropriate diagnostics along with possible treatment options for different cancer diagnoses. To fulfill quality
- [ACOs](https://healthmonix.com/acos/) - Empower your ACO with simplified quality tracking and cost insights Navigating the intricate and ever-evolving landscape of Medicare quality measure requirements, ACOs continually work to deliver cost-effective, high-quality care while meeting regulatory reporting benchmarks. Collaborating with Healthmonix can empower your organization to champion value-based care by minimizing the reporting burden on your staff and providers
- [Healthmonix  MIPSpro Enterprise QCDR Measures](https://healthmonix.com/mipspro-enterprise-qcdr-measures/) - A Qualified Clinical Data Registry (QCDR) is a CMS-approved reporting option that allows providers to submit both MIPS and custom specialty-specific quality measures. Why Choose a QCDR? Report on measures that better reflect your specialty Improve your MIPS score with more relevant data Increase provider engagement through more clinically meaningful measures Streamline reporting with CQM,
- [MVP: Patient Safety and Support of Positive Experiences with Anesthesia 2025](https://healthmonix.com/mvp-patient-safety-and-support-of-positive-experiences-with-anesthesia-2025/) - Most applicable medical specialty: Anesthesiology The Patient Safety and Support of Positive Experiences with Anesthesia MVP focuses on increasing quality of anesthesia care, improving postoperative outcomes, promoting patient safety, and enhancing satisfaction for patients receiving anesthesia. The measures are used for a variety of surgical procedures that anesthesiologists deliver care for, and are broadly applicable to
- [MVP: Optimal Care for Kidney Health 2025](https://healthmonix.com/mvp-optimal-care-for-kidney-health-2025/) - Most applicable medical specialty: Nephrology The Optimal Care for Kidney Health MVP focuses on the clinical theme of providing fundamental treatmentand management of costly clinical conditions that contribute to, or may result from, kidney disease. To fulfill quality requirements: You must select 4 quality measures from the list below (exception for clinicians in a small practice
- [MVP: Focusing on Women's Health 2025](https://healthmonix.com/mvp-focusing-on-womens-health-2025/) - Most applicable medical specialty: Gynecology, obstetrics, urogynecology, nonphysician practitioners, certified nurse mid-wives, nurse practitioners, physician assistants Focusing on Women’s Health MVP focuses on the clinical theme of providing treatment and management of women’s health. To fulfill quality requirements: You must select 4 quality measures from the list below At least 1 measure must be an outcome
- [MVP: Coordinating Stroke Care to Promote Prevention and Cultivate Positive Outcomes MVP ID: G0054 - 2025](https://healthmonix.com/coordinating-stroke-care-to-promote-prevention-and-cultivate-positive-outcomes-mvp-id-g0054-2025/) - Most applicable medical specialties: Neurology, neurosurgical, vascular surgery The Coordinating Stroke Care to Promote Prevention and Cultivate Positive Outcomes MVP focuses on the clinical theme of providing fundamental prevention and treatment of those patients at risk for or that have had a stroke. To fulfill quality requirements: You must select 4 quality measures from the
- [MVP: Advancing Rheumatology Patient Care  MVP ID: G0053 - 2025](https://healthmonix.com/advancing-rheumatology-patient-care-mvp-id-g0053-2025/) - Most applicable medical specialty: Rheumatology The Advancing Rheumatology Patient Care MVP focuses on the clinical theme of providing fundamental treatment and management of rheumatological conditions. To fulfill quality requirements: You must select 4 quality measures from the list below (exception for clinicians in a small practice - see # 3 below) At least 1 measure
- [Advancing Care for Heart Disease MVP ID: G0055 2025](https://healthmonix.com/advancing-care-for-heart-disease-mvp-id-g0055-2025-2/) - Most applicable medical specialties: Cardiology, internal medicine, family medicine The Advancing Care for Heart Disease MVP focuses on the clinical theme of providing fundamental treatment and management of costly clinical conditions that contribute to, or may result from, heart disease. To fulfill quality requirements: You must select 4 quality measures from the list below(exception for
- [MVP: Adopting Best Practices and Promoting Patient Safety within Emergency Medicine 2025](https://healthmonix.com/mvp-adopting-best-practices-and-promoting-patient-safety-within-emergency-medicine/) - Most applicable medical specialty: Emergency medicine The Adopting Best Practices and Promoting Patient Safety within Emergency Medicine MVP focuses on important assessors of the care emergency clinicians provide to patients with undifferentiated high-risk conditions. By focusing on these specific measures and activities, emergency clinicians can reduce clinical variability, improve the quality of emergency care and
- [EHR integrations](https://healthmonix.com/ehr/) - We work with industry leaders Healthmonix integrates with many EHR systems.Don’t see yours listed? We likely still support it.Call our Sales team at 888-720-4100 to find out how we can integrate with your system.
- [Newsroom](https://healthmonix.com/newsroom/)
- [Newsroom](https://healthmonix.com/newsroom-old/)
- [MVP: Supportive Care for Neurodegenerative Conditions 2025](https://healthmonix.com/mvp-supportive-care-for-neurodegenerative-conditions-2025/) - Most applicable medical specialty: Neurology The Supportive Care for Neurodegenerative Conditions MVP focuses on the clinical theme of promoting quality care for patientswith cognitive-based neurological disorders such as dementia, Parkinson’s Disease (PD), and Amyotrophic Lateral Sclerosis (ALS). To fulfill quality requirements: You must select 4 quality measures from the list below(exception for clinicians in a small
- [Login](https://healthmonix.com/login/)
- [END USER LICENSE AGREEMENT (EULA)](https://healthmonix.com/end-user-license-agreement-eula/) - HEALTHMONIX END USER LICENSE AGREEMENT Please read the following END USER LICENSE AGREEMENT (the “EULA”) carefully before using the Healthmonix (“we,” “our,” or “us”) websites, located at healthmonix.com and revlytix.healthmonix.com or participating in any online features, services and/or programs offered by us (collectively, the “Web Properties”). This EULA is in effect for all of our
- [MIPS Measures](https://healthmonix.com/mips-measures/) - It all starts with selecting the right measures for your practice. We understand that selecting measures can be overwhelming, but our user-friendly search and review tools make it easy to find the measures that best fit your practice. With just a few clicks, you can filter by specialty, measure type, and more to find the
- [IA 2024 & 2025](https://healthmonix.com/test-table/) - 2025 Improvement Activities For the 2025 performance year under the Merit-based Incentive Payment System (MIPS), clinicians are required to engage in improvement activities for a minimum continuous period of 90 days within the calendar year. Depending on specific reporting requirements, participants must perform between one and four improvement activities. Data collected during the 2025 performance
- [Outcomes](https://healthmonix.com/outcomes/) - Healthmonix helps organizations thrive in value-based care With 15-plus years of experience, Healthmonix has helped thousands of providers, practices, and companies succeed in quality reporting and value-based care. Our platform gives users real-time dashboards, MIPS scoring, and performance reports, while our API feeds data back to your platform to provide a comprehensive performance view. We
- [Flatiron case study](https://healthmonix.com/flatiron-case-studys/) - Who they are Flatiron Health is a leading healthtech company dedicated to expanding the possibilities of point-of-care solutions in oncology. Hundreds of cancer centers rely on Flatiron technology and services to bring better outcomes to patients in an increasingly value-based world. Goals and challenges When the MIPS program started in 2017, Flatiron needed a way
- [Services](https://healthmonix.com/services/)
- [Patient deduplication](https://healthmonix.com/patient-deduplication-and-matching/) - Keep your patient records in sync for seamless reporting With patient information stored in multiple EHRs, it’s easy for practices and organizations to create duplicate records. Healthmonix offers 3 solutions to help you ensure your patients are accurately identified, which is a must for successful value-based care reporting. We’ll collaborate with your team to find
- [Houston Methodist Coordinated Care ACO case study](https://healthmonix.com/houston-methodist-coordinated-care-aco-case-study/) - Who they are Houston Methodist Coordinated Care ACO is a Medicare ACO with over 52,000 traditional Medicare beneficiaries. It includes over 300 primary care physicians in the Houston area. Goals and challenges With ACOs required to report to CMS starting with the 2025 performance year, HMCC wanted to have its workflows and data-gathering strategy in
- [APP Impact pricing](https://healthmonix.com/app-impact-packages/) - All-inclusive, intuitive APM Performance Pathway reporting made simple Healthmonix's APP Impact makes reporting intuitive with real-time performance dashboards, revenue impact estimates based on your current APP score, data integration options, and U.S.-based live customer support. Whether your organization is simply looking to track, report, and submit the APP measures or looking for additional ways to
- [Products](https://healthmonix.com/our-products/)
- [Physician practices](https://healthmonix.com/physician-practice/) - Excel in value-based care without burdening your staff Shifting Medicare regulations continue to challenge physician practices. Healthmonix’s combination of innovative software and quality reporting experience can empower your practice to excel in value-based care. We can also reduce the burden on your staff to follow quality-reporting requirements. Our qualified registries and tools help your team
- [Healthcare technology](https://healthmonix.com/healthcare-technology/) - Broaden your client services and unlock opportunities through collaboration With value-based care programs changing each year, your customers need agile software and services to stay current. Collaborating with Healthmonix can help your clients succeed in quality reporting while improving the efficiency of their patient care. Add analytics for further insights With MIPS Analytics, you can
- [Health systems](https://healthmonix.com/health-system/) - Achieve excellence in value-based care with reduced administrative burden As Medicare regulations continue to evolve, hospitals and health systems face some of the most challenging issues in healthcare today. With our wealth of experience and innovative solutions, Healthmonix can empower your organization to excel in value-based care while providing much-needed relief to your staff from
- [Score optimization](https://healthmonix.com/score-optimization/) - Maximize your performance with our class-leading tools With CMS policy changing between and even during performance years, you need to understand a wealth of information to succeed in MIPS and other value-based care programs. Our unmatched knowledge of current reporting requirements combined with our proprietary software give you the edge you need to optimize your
- [test-slider](https://healthmonix.com/test-slider/) - test
- [MIPS Eligibility Status Lookup for Clinicians](https://healthmonix.com/qpp-mips-eligibility/) - Enter up to 100 relevant 10-digit National Provider Identifier (NPI) numbers to view their Quality Payment Program participation status for the selected performance year.QPP participation status for eligible clinicians includes MIPS eligibility as well as APM participation. Please note that this tool is a technical resource only and doesn't officially determine eligibility for any clinician,
- [Latest MIPS Webinars](https://healthmonix.com/our-webinars/)
- [Who we help](https://healthmonix.com/who-we-help/)
- [Consulting](https://healthmonix.com/consulting-services/) - Receive expert guidance to boost your performance The shifting requirements and regulations governing value-based care programs can be tough to track. Enter our consultants. They can provide custom services and expertise to maximize your organization's value-based care performance and MIPS final score. See what purchasing consulting can do for you Do you need to understand
- [ACOs Home](https://healthmonix.com/acos-3/) - ACOs Empowering Accountable Care Our integrated approach to ACOs drives 23% higher eCQM performance, greater Medicare reimbursements and continued shared savings. ACOs have historically been successful in improving care and reducing cost. As CMS requirements for ACOs continue to evolve, requiring participation in the new APM Performance Pathway (APP), Healthmonix emerges as the most trusted
- [MVP: Optimal Care for Kidney Health](https://healthmonix.com/mvp-optimal-care-for-kidney-health/) - Most applicable medical specialty: Nephrology The Optimal Care for Kidney Health MVP focuses on the clinical theme of providing fundamental treatmentand management of costly clinical conditions that contribute to, or may result from, kidney disease. To fulfill quality requirements: You must select 4 quality measures from the list below(exception for clinicians in a small practice -
- [Improving Care for Lower Extremity Joint Repair MVP ID: G0058](https://healthmonix.com/improving-care-for-lower-extremity-joint-repair-mvp-id-g0058-2/) - Most applicable medical specialty: Orthopedic surgery The Improving Care for Lower Extremity Joint Repair MVP focuses on the clinical theme of providing fundamental treatment and management of patients with osteoarthritis and lower extremity surgical repair, such as fracture and total joint replacement, to ensure appropriate care and reduce costs. To fulfill quality requirements: You must
- [MVP: Value in Primary](https://healthmonix.com/mvp-value-in-primary/) - Most applicable medical specialty: Preventive medicine, internal medicine, family medicine, geriatrics The Value in Primary Care MVP focuses on the clinical theme of promoting quality care for patients in order to reduce the risk of diseases, disabilities, and death. To fulfill quality requirements: You must select 4 quality measures from the list below(exception for clinicians in
- [MVP: Focusing on Women's Health](https://healthmonix.com/mvp-focusing-on-womens-health/) - Most applicable medical specialty: Gynecology, obstetrics, urogynecology, nonphysician practitioners, certified nurse mid-wives, nurse practitioners, physician assistants Focusing on Women’s Health MVP focuses on the clinical theme of providing treatment and management of women’s health. To fulfill quality requirements: You must select 4 quality measures from the list below(exception for clinicians in a small practice - see
- [MVP: Adopting Best Practices and Promoting Patient Safety within Emergency Medicine](https://healthmonix.com/adopting-best-practices-mvp-id-g0057/) - Most applicable medical specialty: Emergency medicine The Adopting Best Practices and Promoting Patient Safety within Emergency Medicine MVP focuses on important assessors of the care emergency clinicians provide to patients with undifferentiated high-risk conditions. By focusing on these specific measures and activities, emergency clinicians can reduce clinical variability, improve the quality of emergency care and
- [MVP: Patient Safety and Support of Positive Experiences with Anesthesia](https://healthmonix.com/mvp-patient-safety-and-support-of-positive-experiences-with-anesthesia/) - Most applicable medical specialty: Anesthesiology The Patient Safety and Support of Positive Experiences with Anesthesia MVP focuses on increasing quality of anesthesia care, improving postoperative outcomes, promoting patient safety, and enhancing satisfaction for patients receiving anesthesia. The measures are used for a variety of surgical procedures that anesthesiologists deliver care for, and are broadly applicable to
- [MVP: Prevention and Treatment of Infectious Disorders Including Hepatitis C and HIV](https://healthmonix.com/mvp-prevention-and-treatment-of-infectious-disorders-including-hepatitis-c-and-hiv/) - Most applicable medical specialty: Infectious disease, immunology The Prevention and Treatment of Infectious Disorders Including Hepatitis C and HIV MVP focuses on the clinical theme of promoting quality care for patients suffering from infectious disorders. To fulfill quality requirements: You must select 4 quality measures from the list below(exception for clinicians in a small practice -
- [MVP: Quality Care for the Treatment of Ear, Nose, and Throat Disorders](https://healthmonix.com/mvp-quality-care-for-the-treatment-of-ear-nose-and-throat-disorders/) - Most applicable medical specialty: Otolaryngology The Quality Care for the Treatment of Ear, Nose, and Throat Disorders MVP focuses on the clinical theme of providing care for patients experiencing some of the most common otolaryngology conditions such as, but not limited to: otologic conditions, chronic rhinosinusitis (CRS), age-related hearing loss (ARHL) and otitis media. To fulfill
- [MVP: Quality Care in Mental Health and Substance Use Disorders](https://healthmonix.com/mvp-quality-care-in-mental-health-and-substance-use-disorders/) - Most applicable medical specialty: Mental health, Behavioral health, psychiatry The Quality Care in Mental Health and Substance Use Disorders MVP focuses on the clinical theme of promoting prevention of and quality care in behavioral health, including mental health and substance use disorders (SUD). To fulfill quality requirements: You must select 4 quality measures from the list
- [MVP: Rehabilitative Support for Musculoskeletal Care](https://healthmonix.com/mvp-rehabilitative-support-for-musculoskeletal-care/) - Most applicable medical specialty: Chiropractic medicine, physiatry, physical therapy, occupational therapy The Rehabilitative Support for Musculoskeletal Care MVP focuses on the clinical theme of promoting quality care for patients. To fulfill quality requirements: You must select 4 quality measures from the list below(exception for clinicians in a small practice - see # 3 below) At least
- [MVP: Supportive Care for Neurodegenerative Conditions](https://healthmonix.com/mvp-supportive-care-for-neurodegenerative-conditions/) - Most applicable medical specialty: Neurology The Supportive Care for Neurodegenerative Conditions MVP focuses on the clinical theme of promoting quality care for patientswith cognitive-based neurological disorders such as dementia, Parkinson’s Disease (PD), and Amyotrophic Lateral Sclerosis (ALS). To fulfill quality requirements: You must select 4 quality measures from the list below(exception for clinicians in a small
- [MVP: Optimal Care for Patients with Episodic Neurological Conditions](https://healthmonix.com/mvp-optimal-care-for-patients-with-episodic-neurological-conditions/) - Most applicable medical specialty: Neurology The Optimal Care for Patients with Episodic Neurological Conditions MVP focuses on the clinical theme of promoting quality care for patients suffering from episodic neurological conditions. To fulfill quality requirements: You must select 4 quality measures from the list below(exception for clinicians in a small practice - see # 3 below)
- [Advancing Rheumatology Patient Care  MVP ID: G0053](https://healthmonix.com/advancing-rheumatology-patient-care-mvp-id-g0053/) - Most applicable medical specialty: Rheumatology The Advancing Rheumatology Patient Care MVP focuses on the clinical theme of providing fundamental treatment and management of rheumatological conditions. To fulfill quality requirements: You must select 4 quality measures from the list below(exception for clinicians in a small practice - see # 3 below) At least 1 measure must
- [Advancing Care for Heart Disease MVP ID: G0055](https://healthmonix.com/advancing-care-for-heart-disease-mvp-id-g0055/) - Most applicable medical specialties: Cardiology, internal medicine, family medicine The Advancing Care for Heart Disease MVP focuses on the clinical theme of providing fundamental treatment and management of costly clinical conditions that contribute to, or may result from, heart disease. To fulfill quality requirements: You must select 4 quality measures from the list below(exception for
- [Advancing Cancer Care MVP ID: M0001](https://healthmonix.com/advancing-cancer-care-mvp-id-m0001/) - Most applicable medical specialties: Oncology, hematology The Advancing Cancer Care MVP focuses on the clinical theme of providing fundamental treatment and management of cancer care. The measures assess three critical areas: the patient experience of care, end of life care, and appropriate diagnostics along with possible treatment options for different cancer diagnoses. To fulfill quality
- [Coordinating Stroke Care to Promote Prevention and Cultivate Positive Outcomes MVP ID: G0054](https://healthmonix.com/coordinating-stroke-care-to-promote-prevention-and-cultivate-positive-outcomes-mvp-id-g0054/) - Most applicable medical specialties: Neurology, neurosurgical, vascular surgery The Coordinating Stroke Care to Promote Prevention and Cultivate Positive Outcomes MVP focuses on the clinical theme of providing fundamental prevention and treatment of those patients at risk for or that have had a stroke. To fulfill quality requirements: You must select 4 quality measures from the
- [Company](https://healthmonix.com/company/) - Our values Meet our leaders We’ve built a team with diverse and complementary backgrounds. Learn more about the leaders driving us forward. See where we’ve been — and where we’re going Our history Our future We’re at the forefront of healthcare innovation, paving the way for seamless data interoperability that transcends boundaries. Our commitment lies
- [Resources](https://healthmonix.com/resources/)
- [Main booking calendar](https://healthmonix.com/main-booking-calendar/) - We'd love to show you how you can become proactive about maximizing your quality reporting, aggregating your quality data from multiple sources, improving your cost tracking, or all of the above! Schedule a time that works for you.
- [MIPS ROI Calculator-New](https://healthmonix.com/mips-roi-calculator/) - With incentives and penalties continuing to increase, it's never been more important to understand the future impact to your Medicare reimbursement. We recognize that in the past few years, the incentive has been less than expected. However, as CMS increases the performance threshold and the measures become more difficult, the potential incentive is increasing. In
- [MIPS Cost Analytics pricing](https://healthmonix.com/mips-cost-analytics-pricing/) - Dig deeper and access patient risk scores
- [MVP: Promoting Wellness](https://healthmonix.com/mvp-promoting-wellness/) - Most applicable medical specialties: Preventive medicine, internal medicine, family medicine, geriatrics The Promoting Wellness MVP focuses on the clinical theme of promoting quality care for patients in order to reduce the risk of diseases, disabilities, and death. To fulfill quality requirements: You must select 4 quality measures from the list below(exception for clinicians in a small
- [MVP: Optimizing Chronic Disease Management](https://healthmonix.com/mvp-optimizing-chronic-disease-management/) - Most applicable medical specialties: Cardiology, internal medicine, family medicine The Optimizing Chronic Disease Management MVP focuses on the clinical theme of providing fundamental treatment and management of chronic disease such as diabetes, coronary artery disease, chronic obstructive disease, and major adult depression. To fulfill quality requirements: You must select 4 quality measures from the list below(exception
- [Healthmonix MIPS Cost Analytics Webinars and Downloads](https://healthmonix.com/mips-cost-analytics-webinars-and-downloads/)
- [APM Performance Pathway Webinars and Downloads](https://healthmonix.com/apm-performance-pathway-webinars-and-downloads/)
- [Flatiron case study](https://healthmonix.com/flatiron-case-study/) - Flatiron Health drives MIPS performance through seamless integration with MIPSpro Flatiron Health® is a healthtech company dedicated to improving cancer treatment and advancing research. As the pioneer in real-world evidence for oncology, they provide technology and services to support patient care and make every patient story count. Flatiron partners with hundreds of cancer centers, 20-plus top
- [APA case study](https://healthmonix.com/apa-case-study/) - APA is the leading scientific and professional organization representing psychology in the United States, with more than 121,000 researchers, educators, clinicians, consultants and students as its members. APA’s mission is to promote the advancement, communication, and application of psychological science and knowledge to benefit society and improve lives. Challenge Unlike other provider specialties, mental and
- [MIPSpro pricing](https://healthmonix.com/mips-qualified-registry-pricing-plans/) - 20232024MVPs Basic $389 Per provider/billed yearly +$300 Implementation fee applied to first license Custom pricing available for large groups Basic includes: All clinical Quality measuresSpreadsheet upload from one data source Gaps in care analysisGroup and individual reportingPatient/provider drill downsLive, US-based support Standard $439 Per provider/billed yearly +$300 Implementation fee applied to first license Custom pricing available for
- [test](https://healthmonix.com/test-2/) - Lorem Ipsum Dolor Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum Dolor Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum Dolor Lorem Ipsum is simply dummy text of the printing and typesetting industry.
- [Supportive Care for Neurodegenerative Conditions MVP ID: M0004](https://healthmonix.com/supportive-care-for-neurodegenerative-conditions-mvp-id-m0004/) - Most applicable medical specialty: NeurologyThe Supportive Care for Neurodegenerative Conditions MVP focuses on the clinical theme of promoting quality care for patients with cognitive-based neurological disorders such as dementia, Parkinson’s Disease (PD), and Amyotrophic Lateral Sclerosis (ALS). Looking for a different MVP? Head back to our complete listing of MVPs. Begin your MVP journey today. __CONFIG_colors_palette__{“active_palette”:0,”config”:{“colors”:{“9296b”:{“name”:”Main
- [Promoting Wellness MVP ID: M0005](https://healthmonix.com/promoting-wellness-mvp-id-m0005/) - Most applicable medical specialties: Preventive Medicine, Internal Medicine, Family Medicine, GeriatricsThe Promoting Wellness MVP focuses on the clinical theme of promoting quality care for patients in order to reduce the risk of diseases, disabilities, and death. Looking for a different MVP? Head back to our complete listing of MVPs. Begin your MVP journey today. __CONFIG_colors_palette__{“active_palette”:0,”config”:{“colors”:{“9296b”:{“name”:”Main Accent”,”parent”:-1}},”gradients”:[]},”palettes”:[{“name”:”Default
- [Patient Safety and Support of Positive Experiences with Anesthesia MVP ID: G0059](https://healthmonix.com/patient-safety-and-support-of-positive-experiences-with-anesthesia-mvp-id-g0059/) - Most applicable medical specialty: Anesthesiology The Patient Safety and Support of Positive Experiences with Anesthesia MVP focuses on increasing quality of anesthesia care, improving postoperative outcomes, promoting patient safety, and enhancing satisfaction for patients receiving anesthesia. The measures are used for a variety of surgical procedures that anesthesiologists deliver care for, and are broadly applicable
- [Optimizing Chronic Disease Management MVP ID: G0056](https://healthmonix.com/optimizing-chronic-disease-management-mvp-id-g0056/) - Most applicable medical specialties: Cardiology, Internal Medicine, Family MedicineThe Optimizing Chronic Disease Management MVP focuses on the clinical theme of providing fundamental treatment and management of chronic disease such as diabetes, coronary artery disease, chronic obstructive disease, and major adult depression. Looking for a different MVP? Head back to our complete listing of MVPs. Begin your
- [Optimal Care for Patients with Episodic Neurological Conditions MVP ID: M0003](https://healthmonix.com/optimal-care-for-patients-with-episodic-neurological-conditions-mvp-id-m0003/) - Most applicable medical specialty: NeurologyThe Optimal Care for Patients with Episodic Neurological Conditions MVP focuses on the clinical theme of promoting quality care for patients suffering from episodic neurological conditions. Looking for a different MVP? Head back to our complete listing of MVPs. Begin your MVP journey today. __CONFIG_colors_palette__{“active_palette”:0,”config”:{“colors”:{“9296b”:{“name”:”Main Accent”,”parent”:-1}},”gradients”:[]},”palettes”:[{“name”:”Default Palette”,”value”:{“colors”:{“9296b”:{“val”:”rgb(255, 255, 255)”}},”gradients”:[]},”original”:{“colors”:{“9296b”:{“val”:”rgb(19, 114, 211)”,”hsl”:{“h”:210,”s”:0.83,”l”:0.45,”a”:1}}},”gradients”:[]}}]}__CONFIG_colors_palette__ Contact
- [MVP: Optimal Care for Kidney Health ](https://healthmonix.com/optimal-care-for-kidney-health-mvp-id-m0002/) - Most applicable medical specialty: NephrologyThe Optimal Care for Kidney Health MVP focuses on the clinical theme of providing fundamental treatment and management of costly clinical conditions that contribute to, or may result from, kidney disease. Looking for a different MVP? Head back to our complete listing of MVPs. Begin your MVP journey today. __CONFIG_colors_palette__{“active_palette”:0,”config”:{“colors”:{“9296b”:{“name”:”Main Accent”,”parent”:-1}},”gradients”:[]},”palettes”:[{“name”:”Default Palette”,”value”:{“colors”:{“9296b”:{“val”:”rgb(255,
- [Mipspro Enterprise QCDR Measures 2023](https://healthmonix.com/mipspro-enterprise-qcdr-measures-2023/)
- [Healthmonix 2023 MIPSpro Enterprise QCDR Measures (PT/OT)](https://healthmonix.com/mipspro-enterprise-qcdr-measures-2023-2/)
- [MIPS Webinars and Downloads](https://healthmonix.com/mips-webinars-and-downloads/)
- [APP Quality Measures](https://healthmonix.com/app-quality-measures/) - 2023 QUALITY MEASURES
- [APP Measures Home](https://healthmonix.com/app-measures/) - APP Quality & Promoting Interoperability Measures
- [Products](https://healthmonix.com/products/)
- [Mips Pro Home](https://healthmonix.com/mips-pro/) - MIPSpro Qualified Registry and QCDR Our integrated approach optimizes your MIPS score and drives higher Medicare reimbursements. Take the first steps in conquering MIPS The landscape of the Merit-based Incentive Payment System (MIPS) has changed. The penalties have increased and the Centers for Medicare & Medicaid Services (CMS) has made it harder to achieve a
- [Help and Support](https://healthmonix.com/help-and-support/)
- [Team](https://healthmonix.com/team/)
- [Webinars](https://healthmonix.com/webinars/)
- [Our story](https://healthmonix.com/our-story/)
- [MIPS Analytics](https://healthmonix.com/mips-analytics/)
- [MIPS Cost Analytics](https://healthmonix.com/mips-cost-analytics-2/)
- [APP Impact](https://healthmonix.com/app-impact-2/)
- [Healthcare payers](https://healthmonix.com/healthcare-payers/)
- [test](https://healthmonix.com/test/)
- [Healthmonix Analytics PRO](https://healthmonix.com/hospital-analytics/) - Turning data into meaningful Care Recommendations Provide your team with meaningful MIPS Analytics to rapidly evaluate, remediate, and continuously improve performance and quality of medical care outcomes for value based care. With our tools your organization can minimize FTE expenses, reduce readmissions, make process change recommendations, and achieve better scores and patient outcomes. We deliver
- [Leadership Team](https://healthmonix.com/leadership-team/) - Our Leadership Team Meet the leaders behind Healthmonix CEO | LAUREN PATRICK As CEO of Healthmonix, Lauren specializing in innovative registry, quality improvement, and analytics programs to improve patient outcomes and lower cost. She has been implementing game-changing healthcare tools for over a decade, building on her background at Ernst & Young and Cap Gemini
- [Main Site: QCDRs & Specialty Measures Landing Page](https://healthmonix.com/qcdrs-and-specialty-measures/) - Healthmonix Qualified Clinical Data Registries (QCDRs) and specialty measures QCDRs and measures designed for your specialty We understand that finding quality measures relevant to your practice specialty can be challenging. That’s why we’ve worked with leaders across specialties to develop the most relevant measures for quality measurement and inclusion in the MIPS program. We also
- [Healthmonix Home](https://healthmonix.com/home2/) - Maximize your value-based payments with powerful healthcare analytics Healthmonix offers cutting-edge healthcare technology, analytics, and quality reporting expertise to maximize your value-based payments from Medicare and commercial payers, reduce healthcare spending, and improve patient outcomes. Are you an RCM company looking to navigating the complexities of MIPS reporting? With MIPSpro, you can revolutionize your MIPS reporting process and take your business
- [MIPS Partners](https://healthmonix.com/mips-partners/) - Our partners Healthmonix is the industry leader in value-based care applications.Our flexible APIs, white-labeling options, and measure engine allow partners to deliver an industry-leading MIPS platform to their users. We handle all compliance and regulatory updates, maintain measures, and submit data to CMS on your users’ behalf. Our platform gives users real-time dashboards, MIPS scoring,
- [Healthmonix MIPS Cost Analytics Home Page- 2023](https://healthmonix.com/mips-cost-analytics/) - Gain easy, valuable insights into your MIPS Cost score and the Cost category Harness data to enhance efficiency, improve patient outcomes, and boost reimbursements. Find clarity in complex cost measures As CMS returns to providing Cost category scores and many MIPS-eligible providers receive subpar scores, the need to understand cost measures has spiked. Our industry-first
- [MIPSPRO Advantage](https://healthmonix.com/mipspro-advantages/) - MIPS score optimization with a trusted partner Feel secure with your MIPS submission knowing MIPSpro® validates your data using the most up-to-date reporting requirements and years of experience. Our success rate of 10.73% higher MIPS Quality scores than the national average, industry leading solutions, and world class support have placed MIPSpro as one of the largest
- [Healthmonix MIPS Cost Analytics](https://healthmonix.com/mips-cost-analytics-old-2/) - MIPS Cost Analytics Drive higher Medicare reimbursements and more clinical success through smart MIPS software with advanced analytics and reporting! Learn how MIPS Cost Analytics can help you achieve your revenue goals, while also impacting patient care. Learn how MIPS Cost Analytics can help you improve your practice, as well as your MIPS cost score.
- [Job Opportunities](https://healthmonix.com/careers/) - Careers at Healthmonix ABOUT USHealthmonix tracks and enhances the quality of healthcare delivery to improve patient outcomes. Our cutting-edge platform provides industry-leading, SaaS-based quality measurement and improvement solutions in an ever-changing healthcare landscape. Healthmonix helps thousands of healthcare professionals achieve top 1% level quality reporting, while combining quality measurement technology and clinical education tools to
- [MIPS Pro – Risk Score Management](https://healthmonix.com/mips-pro-risk-score-management/) - Risk Score Management Ready to increase your score? Optimize revenue with risk adjustment factor (RAF) scores that reflect patient population(s). Risk adjustment is becoming a standard feature of quality and utilization-based programs under CMS and increasingly by commercial payers. Organizations benefit significantly from ongoing audits and educational programs oriented towards accurate HCC coding. Common provider
- [MIPS Pro – Gaps in Care](https://healthmonix.com/mips-pro-gaps-in-care/) - Gaps in Care Analysis Ready to earn the highest MIPS incentive possible? Address & identify gaps in care with our customizable reports. MIPS is becoming increasingly challenging, and a proactive approach to identifying and addressing care gaps throughout the year can significantly increase your chances of receiving the highest MIPS incentive. At Healthmonix, we prioritize
- [APP Promoting Interoperability Measures](https://healthmonix.com/app-promoting-interoperability-measures/) - Promoting Interoperability Measures2021 APP YOU MUST HAVE 2015 EDITION CEHRT IN ORDER TO REPORT THESE MEASURES FOUR OBJECTIVES CMS has instituted a scoring methodology consisting of one set of four objectives, encompassing six measures.* Clinicians must report on all six measures in order to earn a score
- [MIPS Reporting for Hospitals and Health Systems](https://healthmonix.com/hospitals-health-systems/) - QPP Reporting for Hospitals & Health Systems Under the Quality Payment Program, clinicians are reimbursed for Medicare Part B services based on their participation in the Merit Based Incentive Payment System (MIPS) or Advanced Alternative Payment Models (APMs). Performance under both tracks can result in a positive or negative payment adjustment to reimbursement rates for Medicare Part
- [MIPS Pro – QCDRs & Specialty Measures (Six Pages)](https://healthmonix.com/mips-pro-qcdrs-specialty-measures/) - QCDRs & Specialty Measures Ready to earn the 9% incentive? Specialty measures & QCDRs can help! We understand that finding quality measures that are relevant to your practice specialty can be a challenge. That’s why we’ve partnered with leaders across specialties to develop the most relevant measures for quality measurement and inclusion in the MIPS
- [MIPS Measure Home](https://healthmonix.com/mips-measures-home/) - MIPS Quality Measures & Activities See Promoting Interoperability (PI), Improvement Activities (IA) and Cost measures below. MIPS Quality measures MIPS Quality measures are organized into three different categories: All available measures, Healthmonix recommended specialty measures and CMS specialty measures sets. Search all Quality measures (CQMs, eCQMs, & MBHRs) Search Healthmonix recommended specialty measures. These include
- [MIPS Cost Performance Category Old](https://healthmonix.com/mips-cost-performance-category-old/) - MIPS Cost Performance Category Our system captures 25 essential measures from claims data, including 15 episode-based measures, 6 acute-episode measures, and 2 chronic care episode measures Enjoy quality care made easy with our automated system Track yourMIPS Cost performance over a full calendar year with our system’s Total Category Score calculation, which averages the score
- [MIPS Quality Measures 2023](https://healthmonix.com/mips-quality-measures-2023/) - 2023 MIPS Quality Measures For information on any of the below measure categories, select the given titles to see a more detailed list. 2023 MIPS Quality Measures
- [MBHR Measures 2023](https://healthmonix.com/mbhr-measures-2023/) - Healthmonix 2023 MBHR Measures Quality IdMeasure NameHigh PriorityMeasure TypeMBHR01Use of Anxiety SeverityProcessDetailsMBHR02Anxiety Response at 6-monthsOutcomeDetailsMBHR03Pain Interference Response utilizing PROMISOutcomeDetailsMBHR05Monitoring for psychosocial problems among children and youthOutcomeDetailsMBHR07Posttraumatic Stress Disorder (PTSD) Outcome Assessment for Adults and ChildrenOutcomeDetailsMBHR08Alcohol Use Disorder Outcome ResponseOutcomeDetailsMBHR09Outcome monitoring of ADHD functional impairment in children and youthOutcomeDetailsMBHR10Symptom Improvement in adults with ADHDOutcomeDetailsMBHR11Cognitive Assessment with
- [QCDR EACCR Measures 2023](https://healthmonix.com/qcdr-eaccr-measures-2023/) - Healthmonix 2023 QCDR EACCR Measures Quality IdMeasure NameHigh PriorityMeasure TypeMeasure DescriptionACEP59Chest Pain: Avoidance of admission for adult patients with low-risk chest painOutcomeDetailsAQI48Patient-Reported Experience with AnesthesiaOutcomeDetailsAQI69Intraoperative Antibiotic RedosingProcessDetailsAQI72Perioperative Anemia ManagementProcessDetailsAQI73Prevention of Arterial Line-Related Bloodstream InfectionsProcessDetailsECPR39Avoid Head CT for Patients with Uncomplicated SyncopeProcessDetailsECPR46Avoidance of Opiate Prescriptions for Low Back Pain or MigrainesProcessDetailsECPR51Discharge Prescription of Naloxone after Opioid
- [QCDR Measures 2022](https://healthmonix.com/qcdr-measures-2022/) - Healthmonix 2022 MIPSpro Enterprise QCDR Measures (PT/OT and Audiology ) See Healthmonix 2022 Audiology QCDR measures below. Quality IdMeasure NameHigh PriorityMeasure TypeMeasure DescriptionIROMS122022 QCDR Measure: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation of
- [QCDR EACCR Measures 2022](https://healthmonix.com/qcdr-eaccr-measures-2022/) - Healthmonix 2022 QCDR EACCR Measures Quality IdMeasure NameHigh PriorityMeasure TypeMeasure DescriptionACEP50ED Median Time from ED arrival to ED departure for all Adult PatientsYesOutcomeTime (in minutes) from ED arrival to ED departure for all Adult PatientsDetailsHCPR14Venous Thromboembolism (VTE) ProphylaxisYesProcessPercentage of Adult Patients Who Had VTE Prophylaxis Ordered at the Time of Admission OR Have Documentation of
- [MBHR Measures 2022](https://healthmonix.com/mbhr-measures-2022/) - Healthmonix 2022 MBHR Measures See Healthmonix Recommended MIPS Measures for MBHR Practioners below. Quality IdMeasure NameHigh PriorityMeasure TypeMeasure DescriptionMBHR01Use of Anxiety Severity MeasureNoProcessThe percentage of adult patients (18 years and older) with an anxiety disorder diagnosis (e.g., generalized anxiety disorder, social anxiety disorder, or panic disorder) who have completed a standardized tool (e.g., GAD-7, BAI) during measurement
- [MIPS Quality Measures 2022](https://healthmonix.com/mips-quality-measures-2022/) - 2022 MIPS Quality Measures For information on any of the below measure categories, select the given titles to see a more detailed list. See Quality measures for other reporting years here. Quality IdMeasure NameHigh PriorityMeasure TypeMeasure Description3762022 MIPS Measure #376: Functional Status Assessment for Total Hip ReplacementeCQMPercentage of patients 18 years of age and older who
- [MVPs Homepage](https://healthmonix.com/mips-pro-mips-value-pathways/) - MIPSpro Qualified Registry & QCDR for MIPS Value Pathways (MVPs) The next phase of MIPS reporting is here. MIPS Value Pathways are available in 2023 as a new reporting option to fulfill MIPS reporting requirements. The Centers for Medicare & Medicaid Services (CMS) created MVPs “to simplify MIPS clinician experience, improve value, reduce burden, and
- [Learning Management System](https://healthmonix.com/learning-solutions/) - Learning Management System for continuous professional development and quality improvement. Integrated with industry recognized guidelines and accreditations. Personalized dashboards for curriculum, transcripts, certification, and certificate tracking. Detailed reporting, charting, and analysis of learner outcomes. Granular configuration of courses, tests,evaluations, and certificates Trusted eLearning platform of the largest medical societies. Powerful infrastructure for user registration, class
- [ACO Benefits](https://healthmonix.com/aco-benefits/) - Benefits of Our ACO Healthmonix is a value-based care technology company focused on designing solutions to help transition provider organizations towards the emerging payment models. Our Success 13+ Years Expertise in Quality Reporting 50k+ NPIs Use Our Tech Annually 3k+ Provider Practices As Our Customers 12.87% Higher MIPS Quality Score Than the National Average The
- [ACO Services](https://healthmonix.com/aco-services/) - Services Transitioning to value-based contracts doesn’t need to be overwhelming. The Healthmonix ACO provides a true pathway by leveraging Healthmonix’s best-in-breed technology, expert team and proven success in quality reporting. MIPS REPORTING We enhance your practice’s MIPS performance and leverage the data to establish a baseline and work towards shared savings and additional revenue. Quality performance
- [MIPS Pro – MIPS & APM Consulting](https://healthmonix.com/mips-pro-mips-apm-consulting/) - MIPS & APM Consulting Ready to earn the highest MIPS incentive possible? Leverage our consulting services. Let the experts guide you on what is most important for your organization to maximize score ROI for QPP participation and to improve patient outcomes. APM Track Prepare to participate in Alternative Payment Models like BPCI, CPC+, ACOs, and
- [MIPS Pro – Data Integration](https://healthmonix.com/mips-pro-data-integration/) - Data Integration Wondering how to safely integrate your organization’s data? MIPSpro makes it simple. Exchange healthcare data with ease by tapping into our integration network. With MIPSpro®, you can view information from multiple EHRs and practice management systems all on one dashboard for simplified reporting and performance improvement. Multiple EHRs? No problem! Healthmonix has provided
- [MIPS Pro – Chronic Care Management 1](https://healthmonix.com/mips-pro-chronic-care-management/) - Chronic Care Management Close gaps in care & MIPS performance With a fully managed care coordination programs for your patients. A Chronic Care Management Program (CCM) leads to increased recurring revenue and decreased emergency room utilization, mortality rates, and hospital costs. Because of this influence, a CCM program also has the effect of improving MIPS
- [Clone of APP Home](https://healthmonix.com/app-impact/) - APP Impact Reporting Registry Helping MIPS APMs & ACOs Succeed at eCQM/CQM Reporting Our integrated approach optimizes the APP score by 23%, drives higher Medicare reimbursements and helps ACOs continue to see shared savings. Grappling with the transition to eCQM/CQM reporting as part of the APM Performance Pathway (APP)? Healthmonix is the most trusted name in quality
- [Audiology Pricing Page](https://healthmonix.com/audiology-pricing/) - Audiology MIPS Reporting Pricing Reporting Packages TRACKING QUALITY OUTCOMES For clinicians not reporting to MIPS, track performance and quality outcomes on your patients, utilizing measures identified by the discipline as being the most meaningful to both practitioners and those we serve. Ability to track MIPS style improvement activities is also available. $120 per year per
- [PT/OT/Orthopedics Pricing](https://healthmonix.com/pt-ot-ortho-pricing/) - MIPS Qualified Registry Pricing Physical Therapy, Occupational Therapy & Orthopedics 2022 2023 Plan Details Price per provider per year* Real-time dashboards Live, US-based support:email, chat & phone** Gaps in care analysis Patient/provider drill downs Group and individual reporting All clinical quality measures Improvement activities Promoting interoperability Data integration Cost tracking & insights Basic *Base price
- [Clone of EHR Integration with Healthmonix](https://healthmonix.com/ehr-integration-with-healthmonix/) - MIPS Registry Integration for EHRs/EMRs Partnering with EHR vendors who want to help customersachieve greater success in MIPS and other value-based models. View our current EHR partners -> Help Customers Earn a 10.73% Higher MIPS Quality Score MIPSpro® integrates directly with EHRs to optimize the MIPS score & drive higher Medicare reimbursements. Providing MIPS Reporting capabilities
- [Flatiron Health Case Study](https://healthmonix.com/flatiron-health-case-study/) - Flatiron Health Case Study Flatiron Health Drives MIPS Performance through Seamless Integration with MIPSpro Services Provided by Flatiron Flatiron Health® is a healthtech company dedicated to improving cancer treatment and advancing research. As the pioneer in real-world evidence for oncology, they provide technology and services to support patient care and make every patient story count.
- [MIPS Promoting Interoperability Performance Category in 2022](https://healthmonix.com/mips-promoting-interoperability-performance-category/) - Promoting interoperability performance category2022 MIPS Must report on all required measures across the 4 objectives in order to receive category credit Performance is measured over at least 90 consecutive days. The Verify Opioid Treatment Agreement Measure is removed Query of PDMP measure is included as optional with a yes/no response If a clinician fails to report
- [2022 MIPS Promoting Interoperability Measures](https://healthmonix.com/2022-mips-promoting-interoperability-measures/) - Promoting Interoperability Measures2022 MIPS YOU MUST HAVE 2015 EDITION CEHRT IN ORDER TO REPORT THESE MEASURES FOUR OBJECTIVES CMS has instituted a scoring methodology consisting of one set of four objectives, encompassing six measures.* Clinicians must report on all six measures in order to earn a score
- [MIPSpro Add-Ons](https://healthmonix.com/mipspro-add-ons/) - Maximize your MIPS reporting experience with add-ons to MIPSpro Add-Ons MIPSpro Analytics Proactively monitor the complete Quality performance picture across multiple TINs within one organization. With real-time access to data that can be analyzed based on locations, provider groups and other criteria that is most meaningful to the health system, your organization can optimize MIPS
- [MIPSpro Analytics](https://healthmonix.com/mipspro-analytics-3/) - MIPSpro Analytics Want to maximize MIPS performance across your health system or multispecialty group?Leverage all the benefits of MIPSpro, now with deeper analytics and population health insights. MIPSpro® Analytics provide enhanced reporting and actionable insights to proactively drive MIPS performance across your entire organization. The Centers for Medicare & Medicaid Services (CMS) has made it harder to
- [Covid-19 Study Press Release](https://healthmonix.com/covid-19-press-release/) - COVID-19 Study Press Release Healthmonix Study Reveals 80% of Providers Are Using Telehealth Data suggests telehealth will remain despite many statesreopening MALVERN, PA — July 1, 2020 — Telehealth has exploded as a way to continue patient care during COVID-19, and new research from leading healthcare analytics firm Healthmonix, reveals almost 80% of healthcare practices
- [Healthmonix MIPS Cost Analytics Partners](https://healthmonix.com/mips-cost-analytics-partners/) - MIPS Cost Analytics EHR Partners Leverage Healthmonix’s MIPS Cost Analytics Software to Enhance Your Value-Based Healthcare Products and Services Help Clients Gain Cost and Revenue Transparency in MIPS and Other Quality Programs Your organization wants to provide the most cutting-edge, high-impact services to help healthcare clients drive value-based care. Yet, you’re under constant pressure to
- [Healthmonix MIPS Cost Analytics Hospitals and Health Systems](https://healthmonix.com/mips-cost-analytics-hospitals-and-health-systems/) - MIPS Cost Analytics for Hospitals & Healthcare Systems Streamline Medicare Claims and Payment Data Throughout Your Health System’s Reporting Operating margins are extremely small and competition among healthcare providers has never been more intense. Pressure is also mounting from boards and stakeholders, yet you don’t have access to the data that can help you increase
- [Healthmonix MIPS Cost Analytics Provider Networks](https://healthmonix.com/mips-cost-analytics-provider-networks/) - Provider Networks Smart Data and Reporting Control Medicare Costs and Drive Data The cost of services for Medicare patients is important in determining an organization’s MIPS score, yet you likely have no access to your data. MIPS Cost Analytics is the first and only technology platform that provides current cost data for all Medicare patientsquarterly. Why
- [WebPT Case Study](https://healthmonix.com/webpt-case-study/) - WebPT Case Study WebPT Outperforms National Averages on Clinical Quality Measures in MIPS 2021 Services Provided by WebPT WebPT is a robust end-to-end solution covering the entire rehab therapy business cycle, from billing and managing a practice to delivering quality, evidence-based care. Known in the healthcare industry as “the leading rehab therapy platform for enhancing
- [CMS MIPS Specialty Measure Sets for the 2022 Performance Year](https://healthmonix.com/cms-mips-specialty-measure-sets-for-the-2022-performance-year/) - 2022 MIPS CMS Specialty Measure Sets Specialty measure sets can be reported as an alternative to selecting six quality measures out of all possible quality measures. To learn more, start by searching for your specialty below. Then choose six quality measures, including one outcome measure. Alternatively, report six measures including one outcome measure from a
- [APP Data Integration](https://healthmonix.com/app-impact-data-integration/) - Data Integration Wondering how to safely integrate your organization’s data for participation in the APM Performance Pathway (APP)? APP Impact powered by Healthmonix® makes it simple. Exchange healthcare data with ease by tapping into our integration network. With APP Impact, you can view information from multiple EHRs and practice management systems all on one dashboard
- [MIPS Cost Performance Category in 2022](https://healthmonix.com/mips-cost-performance-category-in-2022/) - MIPS Cost Performance Category MIPS 2022 25 measures, including 15 episode-based measures, 6 acute-episode measures and 2 chronic care episode measures are automatically captured through claims data. Total Category Score is averaged from the score of all applicable measures. Measure performance is tracked over a full calendar year. Clinicians can preview 2018-2022 performance on a
- [2022 MIPS Improvement Activities](https://healthmonix.com/2022-mips-improvement-activities/) - 2022 MIPS Score Improvement Activities Activity IdActivity NameActivity WeightingActivity DescriptionIA_EPA_1Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical RecordHighIncrease patient access to eligible clinicians who work in an outpatient setting with the goal of reducing unnecessary emergency room visits.DetailsIA_EPA_2Use of telehealth services that expand practice accessMediumImprove health outcomes
- [Audiology How to Report MIPS 2021](https://healthmonix.com/audiology-how-to-report-mips-2021/) - Audiology MIPS Reporting in 2022Learn more about important MIPS 2022 updates Step 1: Discover if you’re MIPS-eligible Since 2019, the pool of eligible clinicians has expanded to include some of the previously excluded professions, including Physical / Occupational Therapists, Speech-Language Pathologists, Audiologists, Clinical Psychologists and Dietitians/Nutritional Professionals in MIPS reporting . Read More About Eligibility In addition,
- [American Psychological Association Case Study](https://healthmonix.com/american-psychological-association-case-study/) - American Psychological Association (APA) Case Study Services Provided by APA APA is the leading scientific and professional organization representing psychology in the United States, with more than 121,000 researchers, educators, clinicians, consultants and students as its members. APA’s mission is to promote the advancement, communication, and application of psychological science and knowledge to benefit society
- [PT/OT/Orthopedics Measures Home](https://healthmonix.com/pt-ot-ortho-measures/) - PT/OT/Orthopedics QCDR Quality Measures MIPS Quality Measures Choose six quality measures, including one outcome measure. Alternatively, report six measures, including one outcome measure from a measure set.
- [iFrame Test](https://healthmonix.com/iframe-test/)
- [Latest Updates and Resources on COVID-19](https://healthmonix.com/latest-updates-and-resources-on-covid-19/) - Latest updates & resources on COVID-19 COVID-19 has created unprecedented challenges and uncertainty, particularly for the healthcare community. We understand that staying on top of the latest updates from CMS and other entities, can be difficult with this rapidly changing disease. During these challenging times, Healthmonix has committed to serving as a news hub where
- [ACO Contact Us](https://healthmonix.com/aco-contact-us/) - Contact Us We’d love to show your practice how the Healthmonix ACO drives higher incentive payments from CMS and commercial payers, without any risk to you! Here are a few ways to reach out to our team. Email Healthmonix Email us directly at contact@hmximport.local. Call us directly at +1 888 720 4100 Chat with an
- [ACO ROI Calculator](https://healthmonix.com/aco-roi-calculator/) - Healthmonix ACO ROI Calculator See the impact of participation in the Healthmonix ACO on your revenue! The Healthmonix ACO enables independent clinicians to transition into value-based payments without risk. In just a few simple steps, our free calculator will help you gain an understanding of how the Healthmonix ACO can affect your potential incentives, shared savings and ultimately your
- [Healthmonix ACO](https://healthmonix.com/aco/) - Welcome to The Healthmonix ACO We are recruiting primary care clinicians for 2023! Take the next steps into value-based payments. Join our ACO and transition to successful ACO participation with no risk, while maintaining your independent practice. Best of all, participation is at no cost to you! Empowering Your Practice to Drive Value-Based Payments & Improved
- [Healthmonix MIPS Cost Analytics FAQ](https://healthmonix.com/mips-cost-analytics-faq/) - FAQs About Medicare Claims Data All your MIPS Cost Analytics questionsanswered here Healthmonix MIPS Cost Analytics are revolutionizing value-based care with the fastest access to current claims data for all your Medicare patients. You can now access insights into Cost performance that can help your practice or network transform patient care. Get all your questions
- [Covid-19-Study Parent](https://healthmonix.com/covid-19-study/) - MIPS COVID-19 StudyHealthcare Industry Trends Study Surviving COVID-19: A Healthcare Industry Trends Study is based on a survey among nearly 250 participants across the U.S. from healthcare practices and hospital systems. The purpose of the study was to gain a better understanding of how the coronavirus was impacting day-to-day operations, relief and resources being
- [2021 MIPS Promoting Interoperability Measures](https://healthmonix.com/2021-mips-promoting-interoperability/) - Promoting Interoperability Measures2021 MIPS YOU MUST HAVE 2015 EDITION CEHRT IN ORDER TO REPORT THESE MEASURES FOUR OBJECTIVES CMS has instituted a scoring methodology consisting of one set of four objectives, encompassing six measures.* Clinicians must report on all six measures in order to earn a score
- [2022 MIPS Quality Measures (eCQMs)](https://healthmonix.com/2022-mips-quality-measures-ecqms/) - 2022 MIPS Quality Measures (eCQMs) Quality IdMeasure NameMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_types3752022 MIPS Measure #375: Functional Status Assessment for Total Knee ReplacementeCQMPercentage of patients 18 years of age and older who received an elective primary total hip arthroplasty (THA) and completed a functional status assessment within 90 days prior to the surgery and in the 270-365 days
- [New York Cancer and Blood Specialists Case Study](https://healthmonix.com/new-york-cancer-blood-specialists-case-study/) - New York Cancer & Blood Specialists Case Study New York Cancer & Blood Specialists Achieve Exceptional Performance with MIPSpro Services Provided by New York Cancer & Blood Specialists New York Cancer & Blood Specialists (NYCBS) are a group of community oncology treatment centers. They have 25 locations and are still growing. Their patient mission is
- [About Healthmonix](https://healthmonix.com/about-healthmonix/)
- [Alteon Health Case Study](https://healthmonix.com/alteon-health-case-study/) - Alteon Health Case Study Alteon Achieves Year-Over-Year Exceptional Performance with MIPSpro Services Provided by Alteon Alteon Health is one of the largest physician-owned and physician-led acute care medical groups in the United States. Founded in 1971, Alteon has nearly 50 years of experience building custom solutions for many of the country’s most prestigious and well-respected
- [ACO Main Booking Calendar](https://healthmonix.com/aco-main-booking-calendar/) - Schedule a consultation We’d love to show your practice how the Healthmonix ACO drives higher incentive payments from CMS and commercial payers, without any risk to you! Here are a few ways to reach out to our team. [tcb-script type=”text/javascript” src=”https://static.hsappstatic.net/MeetingsEmbed/ex/MeetingsEmbedCode.js”][/tcb-script]
- [MIPS Quality Measures 2021](https://healthmonix.com/mips-quality-measures-2021/) - 2021 MIPS Quality Measures Filter through Quality measures by clicking any of the three buttons below. To search for a specific Quality measure, type in the search bar or review the full list below. Quality IdMeasure NameHigh PriorityMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_types009Anti-Depressant Medication ManagementnoProcessPercentage of patients 18 years of age and older who were treated with antidepressant
- [Audiology Measures Home](https://healthmonix.com/audiology-measures/) - Audiology QCDR Quality Measures MIPS Quality Measures Choose six quality measures, including one outcome measure. Alternatively, report six measures, including one outcome measure from a measure set.
- [PT/OT/Orthopedics Home](https://healthmonix.com/pt-ot-ortho/) - Physical Therapy, Occupational Therapy & Orthopedics Clinical Registry THE HEALTHMONIX PT, OT & ORTHOPEDICS CLINICAL REGISTRY HELPS YOU THRIVE IN THE FUTURE OF VALUE-BASED CARE! Track quality & report MIPS We understand the pressures being placed on physical therapy, occupational therapy and orthopedic surgery practices, and the need to make your MIPS participation more meaningful
- [Audiology Home](https://healthmonix.com/audiology/) - Audiology Clinical Registry HEALTHMONIX’S AUDIOLOGY CLINICAL REGISTRY HELPS YOU THRIVE IN THE FUTURE OF VALUE-BASED CARE! Track quality & report MIPS If you’re an audiologist, you know that for years the measures available in the PQRS / MIPS program have not aligned well with your practice. We’ve addressed that need. In fact, you can now
- [QCDR EACCR Measures 2021](https://healthmonix.com/qcdr-eaccr-measures-2021/) - Healthmonix 2021 QCDR EACCR Measures Quality IdMeasure NameHigh PriorityMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_typesECPR462021 ECPR46: Avoidance of Opiates for Low Back Pain or MigrainesYESProcessPercentage of Patients with Low Back Pain and/or Migraines Who Were Not Prescribed an OpiateDetailsHCPR202021 HCPR20: Clostridium Difficile – Risk Assessment and Plan of CareYESProcessPercentage of Adult Patients Who Had a Risk Assessment for C.
- [Main Site: Audiology QCDR Measures 2022](https://healthmonix.com/audiology-qcdr-measures-2022/) - Healthmonix 2022 Audiology QCDR Measures See Healthmonix Recommended MIPS Measures for Audiologists below. Quality IdMeasure NameHigh PriorityMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_typesHM092022 HM9: Functional Benefit of a Cochlear ImplantYESPatient Reported Outcome (PRO)Percentage of patients aged 18 years and older, who are evaluated for hearing loss and complete a hearing loss self-assessment tool that indicated an impact of hearing-related quality
- [MIPS Topped Out Quality Measures eCQM 2021](https://healthmonix.com/mips-topped-out-quality-measures-ecqm-2021/) - 2021 Topped Out MIPS Quality Measures: eCQMs These measures are capped at 7 points for the 2021 performance period. CMS defines a topped-out measure as one whose median performance score is 95% or higher and whose performance is “so high and unvarying that meaningful distinctions and improvement in performance can no longer be made.” CMS
- [Home -mobile](https://healthmonix.com/clone-of-home-3/) - Driving change through value-based care analytics The Healthmonix approach delivers all-inclusive value-based payment products for health systems, medical groups and payors. We deliver clear direction and specific actions to improve patient health outcomes and maximize revenue. Introducing APP Impact APP Impact powered by Healthmonix® is our latest value-based care product, a CMS qualified registry for
- [Privacy Policy](https://healthmonix.com/privacy-policy/) - HEALTHMONIX PRIVACY POLICY Healthmonix (“we,” “our,” or “us”) respects and is committed to protecting your privacy. That is why we have adopted this Privacy Policy. This Privacy Policy lets you know how and for what purposes we are collecting, processing and using your Personal Information (as defined herein). We pledge that we will take reasonable
- [MIPS Eligibility and Exemptions](https://healthmonix.com/mips-eligible-clinicians/) - MIPS Eligibility and Exemptions Who is considered a MIPS eligible clinician? To check your specific eligibility, use our online MIPS reporting eligibility tool. Performance Year Adjustment Year MIPS Eligible Clinicians 2020 2022 Physicians, Physician Assistants, Nurse Practitioners, Clinical Nurse Specialists, Certified Registered Nurse Anesthetists Physical / Occupational Therapists, Speech-Language Pathologists, Audiologists, Clinical Psychologists, Dietitians/Nutritional Professionals 2021
- [CMS MIPS Specialty Measure Sets for the 2019 Performance Year](https://healthmonix.com/cms-mips-specialty-measure-sets-2019/) - 2019 MIPS Quality Specialty Measure Sets Specialty measure sets can be reported as an alternative to selecting six Quality measures out of all possible quality measures. To learn more, start by searching for your specialty below. Then choose six Quality measures, including one outcome measure. Alternatively, report six measures including one outcome measure from a
- [REVlytix Cost Performance Category in 2020](https://healthmonix.com/mips-cost-analytics-old/revlytix-cost-performance-category-in-2020/) - 2020 MIPS Cost Performance Category Measure performance is tracked over a full year. 10 new episode-based measures added which revise the Medicare Spending per Beneficiary Clinician and Total Per Capita Cost measures. Clinicians can preview 2018-2020 performance on a quarterly basis via MIPSpro Enterprise or through MIPS Cost Analytics packages. Total Category Score is averaged
- [Healthmonix Store Home](https://healthmonix.com/healthmonix-store-home/) - Healthmonix StoreGet started today! Welcome to the beginning Explore all that Healthmonix has to offer in quality reporting, including MIPS/APM reporting, MIPS Cost analytics, specialty measures and QCDRs. Drill into our solutions and pricing below. Please select your desired product to see package offerings Not sure which product is right for you?
- [MIPS Specialty Measures 2021](https://healthmonix.com/mips-specialty-measures-2021/) - Quality Measure Recommendations by Specialty2021 MIPS Choose six Quality measures, including one outcome measure. Alternatively, report six measures including one outcome measure from a measure set. If a measure set has less than six measures, report full measure set. SpecialtyAllergy, Asthma, and Clinical Immunology MIPS Quality Measures and Improvement Activities – 2021DetailsAnesthesiology MIPS Quality Measures
- [MIPS & APM Consulting](https://healthmonix.com/app-mips-apm-consulting/) - MIPS & APM Consulting Ready to maximize your MIPS or APM score? Leverage our consulting services. Let the experts guide your organization on how to maximize your score and ROI for QPP participation, while also improving patient outcomes. APM Track Prepare to participate in Alternative Payment Models like the APM Performance Pathway, PCF, BPCI, CPC+
- [APP Resources Landing Page](https://healthmonix.com/app-resources/) - APP Resources Welcome to our resources directory!
- [APP FAQ](https://healthmonix.com/app-impact-faqs/) - FAQs: the APP Impact All your APP Impact questions answered here The new APM Performance Pathway (APP) can feel overwhelming and confusing. Below are some frequently asked questions and how Healthmonix is prepared to support the APP though our APP Impact. When can we start tracking our APP measures? A. You can track your measures
- [MIPS Cost Performance Category in 2021](https://healthmonix.com/mips-cost-performance-category-in-2021/) - MIPS Cost Performance Category 2021 MIPS 20 measures, including 2 overall primary care measures, and 18 episode-based measures, are automatically captured through claims data. Total Category Score is averaged from the score of all applicable measures. Measure performance is tracked over a full calendar year. Clinicians can preview 2018-2021 performance on a quarterly basis via
- [APP Risk Score Management](https://healthmonix.com/app-risk-score-management/) - Risk Score Management Ready to impact your APM Performance Pathway (APP) score? Optimize revenue with risk adjustment factor (RAF) scores that reflect patient population(s). Risk adjustment is becoming a standard feature of quality and utilization-based programs under CMS and increasingly by commercial payers. Organizations benefit significantly from ongoing audits and educational programs oriented towards accurate
- [APP Gaps in Care](https://healthmonix.com/app-impact-gaps-in-care/) - Gaps in Care Analysis Ready to maximize your APP score? Identify & address gaps in care with our customizable reports. Understanding the nuances of the APM Performance Pathway (APP) can be overwhelming, potentially making you unsure your organization knows how to earn a good score. One way to maximize your score is to proactively identify
- [APP Educational Resources](https://healthmonix.com/app-education/) - Educational Resources for APP Reporting The Overview of the APP Impact summarizes the main reporting goals of the APP and highlights the unique features of Healthmonix’s APP Impact. Learn how our product enables participants to track, report, and maximize their score. ADDITIONAL RESOURCES AVAILABLE TO YOU!
- [Main Site: QCDR (PT/OT) Quality Measures 2021](https://healthmonix.com/pt-ot-qcdr-quality-measures-2021/) - Want to learn about our QCDR Quality measures for PT & OT groups? Healthmonix 2021 PT/OT/Orthopedics Quality Measures Quality IdMeasure NameHigh PriorityMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_typesMBHR03Pain Interference Response utilizing PROMISyesPatient Reported OutcomeThe percentage of adult patients (18 years of age or older) who report pain issues and demonstrated a response to treatment at one month from the
- [Audiology QCDR Quality Measures 2021](https://healthmonix.com/audiology-qcdr-quality-measures-2021/) - Healthmonix 2021 Audiology QCDR Measures See Healthmonix Recommended MIPS Measures for Audiologists below. Quality IdMeasure NameHigh PriorityMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_typesHM102021 HM10: Outcomes of Hearing Loss TreatmentYESPatient Reported Outcome (PRO)Percentage of patients aged 50 years and older, who are screened with a hearing loss self-assessment tool that indicated an impact on hearing-related QoL AND if diagnosed with a mild
- [Main Site: Audiology QCDR Measures 2021](https://healthmonix.com/audiology-qcdr-measures-2021/) - Healthmonix 2021 Audiology QCDR Measures See Healthmonix Recommended MIPS Measures for Audiologists below. Quality IdMeasure NameHigh PriorityMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_typesHM102021 HM10: Outcomes of Hearing Loss TreatmentYESPatient Reported Outcome (PRO)Percentage of patients aged 50 years and older, who are screened with a hearing loss self-assessment tool that indicated an impact on hearing-related QoL AND if diagnosed with a
- [2021 NON Telehealth-related Quality Measures – CQMs](https://healthmonix.com/2021-non-telehealth-related-quality-measures-cqms/) - 2021 NON Telehealth-Related Quality Measures: CQMs With the advent of COVID-19 pandemic outbreak, we recognize that a significant amount of healthcare is now being delivered via telehealth. Identifying those measures which are NOT relevant to telehealth will help many providers limit the amount of reporting done for MIPS in 2021. Quality IdMeasure NameMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_types006Coronary
- [2021 Telehealth-related Quality Measures – CQMs](https://healthmonix.com/2021-telehealth-related-quality-measures-cqms/) - 2021 Telehealth-related Quality Measures: CQMs With the advent of COVID-19 pandemic outbreak, we recognize that a significant amount of healthcare is now being delivered via telehealth. Identifying those measures which are relevant to telehealth will help many providers successfully report relevant measures as they shift to participating in telehealth. Quality IdMeasure NameMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_types024Communication with
- [MIPS Topped Out Quality Measures Medicare Part B Claims 2021](https://healthmonix.com/mips-topped-out-quality-measures-medicare-part-b-claims-2021/) - 2021 Topped Out MIPS Quality Measures: Claims Reporting These measures are capped at 7 points for the 2021 performance period. CMS defines a topped-out measure as one whose median performance score is 95% or higher and whose performance is “so high and unvarying that meaningful distinctions and improvement in performance can no longer be made.”
- [MIPS Topped Out Quality Measures MIPS CQM 2021](https://healthmonix.com/mips-topped-out-quality-measures-mips-cqm-2021/) - 2021 Topped Out MIPS Quality Measures: CQMs These measures are capped at 7 points for the 2021 performance period. CMS defines a topped-out measure as one whose median performance score is 95% or higher and whose performance is “so high and unvarying that meaningful distinctions and improvement in performance can no longer be made.” CMS
- [MIPS Topped Out Quality Measures eCQM 2020](https://healthmonix.com/mips-topped-out-quality-measures-ecqm-2020/) - 2020 Topped Out MIPS Quality Measures: eCQMs These measures are capped at 7 points for the 2020 performance period. CMS defines a topped-out measure as one whose median performance score is 95% or higher and whose performance is “so high and unvarying that meaningful distinctions and improvement in performance can no longer be made.” CMS
- [Main Site: QCDR (PT/OT) Quality Measures 2020](https://healthmonix.com/qcdr-quality-measures-2020/) - Want to learn about our QCDR Quality measures for PT & OT groups? Healthmonix 2020 PT/OT QCDR Quality Measures Quality IdMeasure NameHigh PriorityMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_types
- [MIPS Topped Out Quality Measures MIPS CQM 2020](https://healthmonix.com/mips-topped-out-quality-measures-mips-cqm-2020/) - 2020 Topped Out MIPS Quality Measures: CQMs These measures are capped at 7 points for the 2020 performance period. CMS defines a topped-out measure as one whose median performance score is 95% or higher and whose performance is “so high and unvarying that meaningful distinctions and improvement in performance can no longer be made.” CMS
- [2020 Telehealth-related Quality Measures – CQMs](https://healthmonix.com/2020-telehealth-related-quality-measures-cqms/) - 2020 Telehealth-related Quality Measures: CQMs With the advent of COVID-19 pandemic outbreak, we recognize that a significant amount of healthcare is now being delivered via telehealth. Identifying those measures which are relevant to telehealth will help many providers successfully report relevant measures as they shift to participating in telehealth. Quality IdMeasure NameMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_types
- [QCDR Quality Measures 2021](https://healthmonix.com/qcdr-quality-measures-2021-2/) - Healthmonix 2021 QCDR Quality Measures Quality IdMeasure NameHigh PriorityMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_typesMBHR032021 MBHR Measure: Pain Interference Response utilizing PROMISYESPatient Reported Outcome (PRO)The percentage of adult patients (18 years of age or older) who report pain issues and demonstrated a response to treatment at one month from the index scoreDetailsHM102021 HM10: Outcomes of Hearing Loss TreatmentYESPatient Reported
- [MIPS Quality Measures 2019](https://healthmonix.com/mips-quality-measures-2019/) - 2019 MIPS Quality Measures Choose six Quality measures, including one outcome measure. Alternatively, report six measures including one outcome measure from a measure set. If a measure set has less than six measures, report full measure set. Quality IdMeasure NameHigh PriorityMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_types
- [MBHR Measures 2021](https://healthmonix.com/mbhr-measures-2021/) - Healthmonix 2021 MBHR Measures Quality IdMeasure NameHigh PriorityMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_typesMBHR032021 MBHR Measure: Pain Interference Response utilizing PROMISYESPatient Reported Outcome (PRO)The percentage of adult patients (18 years of age or older) who report pain issues and demonstrated a response to treatment at one month from the index scoreDetailsMBHR042021 MBHR Measure: Social Role Functioning Outcome utilizing PROMISYESPatient
- [CMS MIPS Specialty Measure Sets for the 2020 Performance Year](https://healthmonix.com/cms-mips-specialty-measure-sets-for-the-2020-performance-year/) - 2020 MIPS CMS Quality Measure Sets Specialty measure sets can be reported as an alternative to selecting six quality measures out of all possible quality measures. To learn more, start by searching for your specialty below. Then choose six quality measures, including one outcome measure. Alternatively, report six measures including one outcome measure from a
- [CMS MIPS Specialty Measure Sets for the 2021 Performance Year](https://healthmonix.com/cms-mips-specialty-measure-sets-for-the-2021-performance-year/) - 2021 MIPS CMS Quality Measure Sets Specialty measure sets can be reported as an alternative to selecting six quality measures out of all possible quality measures. To learn more, start by searching for your specialty below. Then choose six quality measures, including one outcome measure. Alternatively, report six measures including one outcome measure from a
- [MIPS Specialty Measures 2020](https://healthmonix.com/mips-specialty-measures-2020/) - Quality Measure Recommendations by Specialty2020 MIPS Choose six Quality measures, including one outcome measure. Alternatively, report six measures including one outcome measure from a measure set. If a measure set has less than six measures, report full measure set. Specialty
- [MIPS Cost Measures 2020](https://healthmonix.com/mips-cost-measures-2020/) - 2020 MIPS Cost Measures Cost IdMeasure NameTypeMeasure Description
- [2020 MIPS Improvement Activities](https://healthmonix.com/2020-mips-improvement-activities/) - 2020 MIPS Score Improvement Activities Activity IdActivity NameActivity WeightingActivity Description
- [MIPS Topped Out Quality Measures Medicare Part B Claims 2020](https://healthmonix.com/mips-topped-out-quality-measures-medicare-part-b-claims-2020/) - 2020 Topped Out MIPS Quality Measures: Claims Reporting These measures are capped at 7 points for the 2020 performance period. CMS defines a topped-out measure as one whose median performance score is 95% or higher and whose performance is “so high and unvarying that meaningful distinctions and improvement in performance can no longer be made.”
- [2020 NON Telehealth-related Quality Measures – CQMs](https://healthmonix.com/2020-non-telehealth-related-quality-measures-cqms/) - 2020 NON Telehealth-Related Quality Measures: CQMs With the advent of COVID-19 pandemic outbreak, we recognize that a significant amount of healthcare is now being delivered via telehealth. Identifying those measures which are NOT relevant to telehealth will help many providers limit the amount of reporting done for MIPS in 2020. Quality IdMeasure NameMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_types
- [2021 MIPS Improvement Activities](https://healthmonix.com/2021-mips-improvement-activities/) - 2021 MIPS Score Improvement Activities Activity IdActivity NameActivity WeightingActivity DescriptionIA_EPA_2Use of telehealth services that expand practice accessMediumUse of telehealth services and analysis of data for quality improvement, such as participation in remote specialty care consults or teleaudiology pilots that assess ability to still deliver quality care to patients.DetailsIA_EPA_1Provide 24/7 Access to MIPS Eligible Clinicians or
- [How to Report MIPS in 2020](https://healthmonix.com/how-to-report-mips-in-2020/) - MIPS Reporting in 2020Learn more about MIPS in 2021 Step 1: Discover if you’re MIPS-eligible Since 2019, the pool of eligible clinicians has expanded to include some of the previously excluded professions, including Physical / Occupational Therapists, Speech-Language
- [PT/OT/Orthopedics QCDR Quality Measures 2021](https://healthmonix.com/pt-ot-ortho-qcdr-quality-measures-2021/) - PT/OT/Orthopedics Quality QCDR Measures: 2021 Quality IdMeasure NameHigh PriorityMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_typesMBHR03Pain Interference Response utilizing PROMISyesPatient Reported OutcomeThe percentage of adult patients (18 years of age or older) who report pain issues and demonstrated a response to treatment at one month from the index scoreDetailsHM04Functional Status Change for Patients With Upper-limb Functional Status DeficityesPatient Reported OutcomePercentage
- [MIPS Specialty Measures 2019](https://healthmonix.com/mips-specialty-measures-2019/) - 2019 Quality Measure Recommended by Specialty Choose six Quality measures, including one outcome measure. Alternatively, report six measures including one outcome measure from a measure set. If a measure set has less than six measures, report full measure set. SpecialtyDetails
- [Audiology Resources](https://healthmonix.com/audiology-resources/) - Audiology MIPS Reporting Resources Welcome to our resources directory!
- [PT/OT/Orthopedics Resources](https://healthmonix.com/pt-ot-ortho-resources/) - MIPS PT, OT & Orthopedics Resources Welcome to our resources directory!
- [Partnerships with Healthmonix](https://healthmonix.com/partnerships-with-healthmonix-consultants/) - MIPS Registry for Consultants This page is for RCM companies, billers, coders, and consultants considering a partnership with MIPSpro®. View our current consultant partners > Adding Value through MIPS Reporting: Buy or DIY? Providing MIPS reporting capabilities is an excellent value add for your clients — but in order to set a MIPS initiative up for
- [Healthmonix MIPS Cost Analytics EHRs](https://healthmonix.com/mips-cost-analytics-ehrs/) - Partners Your organization wants to provide the most cutting-edge EHR possible, leveraging integration partners as needed, to help healthcare facilities drive value-based care. Yet, you’re under constant pressure to compete with other EHRs and keep up with never-ending regulatory changes. Introducing REVlytix, the first and only technology platform that provides current year payment data for all
- [Healthmonix MIPS Cost Analytics Booking Calendar](https://healthmonix.com/mips-cost-analytics-booking-calendar/) - Schedule a MIPS Cost Analytics consultation Learn how MIPS Cost Analytics can help you achieve your revenue goals, while also impacting patient care. MIPS Cost Analytics can help you improve your practice and your MIPS Cost score, and our integration program can add powerful Medicare cost data to your platforms. Schedule a sales consultation [tcb-script
- [PT/OT/Orthopedics How to Report MIPS 2021](https://healthmonix.com/pt-ot-ortho-how-to-report-2021/) - MIPS Reporting in 2021 Learn more about important MIPS 2021 updates Step 1: Discover if you’re MIPS-eligible Since 2019, the pool of eligible clinicians has expanded to include some of the previously excluded professions, including Physical / Occupational Therapists, Speech-Language Pathologists, Audiologists, Clinical Psychologists and
- [PT/OT 2021 MIPS Improvement Activities](https://healthmonix.com/pt-ot-ortho-2021-mips-improvement-activities/) - 2021 MIPS Score Improvement Activities Physical Therapy, Occupational Therapy & Orthopedics Activity IdActivity NameActivity WeightingActivity DescriptionIA_EPA_2Use of telehealth services that expand practice accessMediumUse of telehealth services and analysis of data for quality improvement, such as participation in remote specialty care consults or teleaudiology pilots that assess ability to still deliver quality care to patients.DetailsIA_EPA_1Provide 24/7
- [PT/OT/Orthopedics All Quality Measures 2021](https://healthmonix.com/pt-ot-ortho-all-quality-measures-2021/) - All Quality Measures: 2021 For information on any of the below measure categories, select the given titles to see a more detailed list. See Quality measures for other reporting yearshere. Quality IdMeasure NameHigh PriorityMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_types009Anti-Depressant Medication ManagementnoProcessPercentage of patients 18 years of age and older who were treated with antidepressant medication, had a diagnosis
- [Audiology 2021 MIPS Improvement Activities](https://healthmonix.com/audiology-2021-mips-improvement-activities/) - 2021 MIPS Score Improvement Activities for Audiology Activity IdActivity NameActivity WeightingActivity DescriptionIA_EPA_2Use of telehealth services that expand practice accessMediumUse of telehealth services and analysis of data for quality improvement, such as participation in remote specialty care consults or teleaudiology pilots that assess ability to still deliver quality care to patients.DetailsIA_EPA_1Provide 24/7 Access to MIPS Eligible
- [Audiology All Quality Measures 2021](https://healthmonix.com/audiology-all-quality-measures-2021/) - Audiology Quality Measures: 2021 For information on any of the below measure categories, select the given titles to see a more detailed list. See Quality measures for other reporting yearshere. Quality IdMeasure NameHigh PriorityMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_types009Anti-Depressant Medication ManagementnoProcessPercentage of patients 18 years of age and older who were treated with antidepressant medication, had a diagnosis
- [MIPS Cost Measures 2021](https://healthmonix.com/mips-cost-measures-2021/) - 2021 MIPS Cost Measures Cost IdMeasure NameTypeMeasure Description019Elective Primary Hip ArthroplastyProceduralEpisode-based cost measures represent the cost to Medicare for the items and services provided to a patient during an episode of care (“episode”). In all supplemental documentation, “cost” generally means the standardized Medicare allowed amount, and claims data from Medicare Parts A and B are
- [MIPS Quality Measures 2020](https://healthmonix.com/mips-quality-measures-2020-2/) - 2020 MIPS Quality Measures For information on any of the below measure categories, select the given titles to see a more detailed list. See Quality measures for other reporting yearshere. Quality IdMeasure NameHigh PriorityMeasure TypeMeasure Descriptionhf:tax:specialty_measure_setshf:tax:collection_types
- [MIPS Improvement Activities](https://healthmonix.com/mips-ia/) - 2019 MIPS Improvement Activities Activity IdActivity NameActivity WeightingDetailsActivity DescriptionFull Specifications
- [McKesson Customer Sales](https://healthmonix.com/mck/) - McKesson Medical-Surgical customers qualify for an exclusive discount to MIPSPRO packages. Fill out the form below and a representative will contact you shortly to discuss pricing. First Name*Last Name*E-mail Address*Company Name*Phone Number*Number of ProvidersMessageMcKesson Account Representative*Please Select Your RepresentativeALFORD, AMY REBECCABOTTER, DAVID BBRISTER, DUSTIN BCOATS, ROBERTDAVIS JR, DONALD SFAIRLEY, ANTHONY GFRAZIER, STEVE GGENTRY, DAVID GHICKS, TIMOTHYMCNAMARA
- [Roadmap to Reporting MIPS](https://healthmonix.com/roadmap-reporting-mips/) - Roadmap to Reporting MIPS Step-by-Step Navigation to successful MIPS reporting. The MIPSPRO Roadmap to reporting MIPS guides you from start to finish of the MIPS reporting process. Whether you are just looking to avoid the MIPS penalty, or want maximize your incentive, this roadmap will show you the way! This map with guide you through reporting
- [Selecting a Solution for MIPS Reporting](https://healthmonix.com/mips-reporting-solution/) - Selecting a Solution for MIPS Reporting Comparing the many methods of MIPS reporting is a time-intensive process. MIPSPRO is the most adaptable and comprehensive end-to-end clinical quality measurement software available, allowing you to conquer MIPS and any other value-based payment model you should choose to pursue. With real-time dashboards that reflect your current MIPS score and its impact
- [Catalyst](https://healthmonix.com/catalyst/) - Catalyst Healthmonix has partnered with industry leaders to launch an evidence-based tool that offers your providers the opportunity to improve performance in 10 MIPS primary care measures. Benefits of Participation Free to participate for MIPSPRO users Small time commitment (15 minutes per case study) Eligible to earn ABIM MOC points, AMA PRA Category 1™ credits,
- [MIPS Quality Measures for Diabetes QCDR](https://healthmonix.com/diabetes-qcdr-measures/) - Measure ID Measure Title Measure Details PPRNET32 Screening for albuminuria in patients at risk for CKD (DM and/or HTN) QCDR Name: Diabetes QCDR Description: Test for albuminuria or urine protein in adults with Diabetes Mellitus or Hypertension and without CKD Numerator: Test for albuminuria or urine protein (spot albumin to creatinine, albumin specific dipstick, urine protein/creat ration, 24
- [Now Available! The Value-Based Care Institute](https://healthmonix.com/value-based-care-institute/) - NOW AVAILABLE!Value-Based Care Institute Enter your email below to receive notifications about course availability.
- [CMS MIPS Specialty Measure Sets for the 2018 Performance Year](https://healthmonix.com/mips-measure-sets-2018/) - MIPS Quality performance category Specialty measure sets can be reported as an alternative to selecting 6 Quality measures out of all possible Quality measures. To learn more, search for your specialty below. 2019 MIPS Quality Performance Category Specialty Measure Sets Jump to 2018 Specialty Measure Sets > Specialty Measure SetDetails 2018 MIPS Quality Performance Category
- [The MIPSPRO Advantage](https://healthmonix.com/mips-registry-mipspro/) - MIPS registry optimization with a trusted partner. Feel secure with your MIPS submission knowing MIPSpro® validates your data using the most up-to-date reporting requirements and years of experience. Our unparalleled 100% success rate, industry leading solutions, and world class support have placed MIPSpro as one of the largest CMS registries in the United States.
- [Improvement Activities Performance Category](https://healthmonix.com/improvement-activities/) - MIPS improvement activities performance category Summary of the Improvement Activities (IA) Performance Category Minimum of one Improvement Activity out of the 90+ proposed activities to be selected Activities are weighted as “high” (20 points) or “medium” (10 points) A full score in the Improvement performance category is 40 points (or 20 for small or rural practices) View Improvement
- [ACO Quality Measures](https://healthmonix.com/aco-quality-measures/) - 2019 ACO quality measures We track your Clinical Quality Measure performance throughout the reporting period, compare your performance to peer benchmarks, and provide you with improvement resources. Web-Interface Measures Claims Measures CAHPS Measures CMS Web Interface Measures ACO Measure # Measure Title NQF # WI # Domain: Care Coordination / Patient Safety ACO-12 Medication Reconciliation
- [MIPS Quality Performance Category in 2019](https://healthmonix.com/mips-quality-performance-category-2019/) - Quality performance category2019 MIPS Select 6 measures 1 outcome or high-priority measure Alternatively, a specialty or sub-specialty measure set may be used Report 60% of applicable visits from a full calendar year Population measure automatically calculated, if applicable 45%MIPS Final Score Key Changes from 2018 Click each option to learn more! Quality comprises 45% of the
- [Chirpy Bird Lead Form](https://healthmonix.com/chirpy-bird-lead-form/)
- [MIPS Promoting Interoperability Performance Category in 2019](https://healthmonix.com/mips-promoting-interoperability-performance-category-in-2019/) - Promoting interoperability performance category2019 MIPSMust report on all required measures across the 4 objectives in order to receive category credit.Performance is measured over at least 90 consecutive days.If a clinician fails to report on a required measure or claim an exclusion (if applicable), the clinician will not receive a score for the PI performance category. Must use 2015
- [2019 MIPS Improvement Activities](https://healthmonix.com/2019-mips-improvement-activities/) - 2019 MIPS Improvement Activities Activity IdActivity NameActivity WeightingActivity Description
- [MIPS Cost Performance Category in 2019](https://healthmonix.com/mips-cost-performance-category-in-2019/) - Cost performance category2019 MIPS 10 measures, including 2 overall primary care measures and 8 new episode-based measures, are automatically captured through claims data. Total Category Score is averaged from the score of all applicable measures. Measure performance is tracked over a full calendar year. Clinicians can preview 2018 performance in July of 2019, and 2019
- [Quality Measures Finalized for Removal in 2020 Reporting Year](https://healthmonix.com/quality-measures-finalized-for-removal-in-2020-reporting-year/) - 2020 MIPS Quality performance category Quality measures finalized for removal in 2020 reporting year #46 – Medication Reconciliation Post-Discharge #51 – Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation #68 – Hematology: Myelodysplastic Syndrome (MDS): Documentation of Iron Stores in Patients Receiving Erythropoietin Therapy #91 – Acute Otitis Externa (AOE): Topical Therapy #109 – Osteoarthritis (OA): Function and Pain Assessment
- [MIPS Quality Performance Category in 2020](https://healthmonix.com/mips-quality-performance-category-in-2020/) - Quality performance category2020 MIPS Select 6 measures 1 outcome or high-priority measure Alternatively, a specialty or sub-specialty measure set may be used Report 70% of applicable visits from a full calendar year Population measure automatically calculated, if applicable 45%MIPS Final Score Key changes from 2019 Click each option to learn more! Data completeness threshold increased from
- [MIPS Improvement Activities Performance Category in 2020](https://healthmonix.com/mips-improvement-activities-performance-category-in-2020/) - Improvement activities performance category2020 MIPS Select activities that will combine to award 40 points. High-weight activities worth 20 points. Medium-weight activities worth 10 points. Activities must be performed for at least 90 consecutive days. Partial credit (20 points) awarded to non-patient facing clinicians, small or rural practices and HPSAs. Full credit awarded to Recognized Patient Centered Medical
- [MIPS Cost Measures 2019](https://healthmonix.com/mips-cost-measures-2019/) - 2019 MIPS Cost Measures Cost IdMeasure NameTypeMeasure Description
- [MIPS QCDR Measures 2020](https://healthmonix.com/mips-qcdr-measures-2020/) - 2020 MIPS QCDR Measures Quality IdMeasure NameHigh PriorityMeasure TypeDetailsMeasure DescriptionFull Specificationshf:tax:specialty_measure_setshf:tax:collection_types
- [CareCloud MIPS Registry Integration](https://healthmonix.com/carecloud-mips-registry-integration/) - CareCloud integrates with MIPSpro to make MIPS reporting easy! CareCloud clients have exclusive access to the industry’s leading MIPS registry reporting solution. To get started, contact your CareCloud Client Success Manager or contact customer support at 1-866-931-3832. How can we help you? What is MIPS? On January 1, 2017, CMS launched the Merit-based Incentive Payment System
- [MIPS Quality Measures](https://healthmonix.com/mips-quality-measures-2018/) - 2018 MIPS Quality Measures Quality IdMeasure NameHigh PriorityMeasure TypeDetailsMeasure DescriptionFull Specificationshf:tax:specialty_measure_setshf:tax:collection_types 2019 MIPS Quality Measures Quality IdMeasure NameHigh PriorityMeasure TypeDetailsMeasure DescriptionFull Specificationshf:tax:specialty_measure_setshf:tax:collection_types
- [MIPSPRO QCDR Measures](https://healthmonix.com/qcdr-quality-measures/) - Quality IdMeasure NameHigh PriorityMeasure TypeDetailsMeasure DescriptionFull Specificationshf:tax:specialty_measure_setshf:tax:collection_types
- [McKesson Rep Portal](https://healthmonix.com/mreps/) - McKesson Sales Account Manager Portal Thank you for doing business with Healthmonix! What do you want to do? Learn about MIPSDownload MaterialsWatch a short demoSubmit a lead Submit a lead Complete the form to submit your lead to the Healthmonix McKesson team. Client First Name*Client Last Name*Client e-mail*Company Name*Phone Number*Number of ProvidersMessageMcKesson Sales Representative*Please Select
- [DenisTest](https://healthmonix.com/denistest/) - TEST WITH TAG Cardiology-2020Activity IdActivity NameActivity WeightingActivity DescriptionDetailsTEST WITH TAG Emergency Medicine-2020 Activity IdActivity NameActivity WeightingActivity DescriptionDetails TEST WITH TAG Allergy/Immunology-2020Activity IdActivity NameActivity WeightingActivity DescriptionDetails TEST WITH TAG RANDOMActivity IdActivity NameActivity WeightingActivity DescriptionDetailsfxcvbgcvfbQuality IdMeasure NameHigh PriorityMeasure TypeMeasure DescriptionDetailshf:tax:specialty_measure_setshf:tax:collection_types
- [Covid-19 Study Book](https://healthmonix.com/covid-19-study-book/) - COVID-19 Study

## Products

- [MIPS Value Pathways (MVPs)](https://healthmonix.com/product/mips-value-pathways-mvps/) - The next phase of MIPS reporting is here MIPS Value Pathways are the newest reporting option to fulfill MIPS reporting requirements. The Centers for Medicare & Medicaid Services (CMS) created MVPs “to simplify MIPS clinician experience, improve value, reduce burden, and better inform patient choice in selecting clinicians.” Each MVP is developed for a specialty
- [MIPS Cost Analytics](https://healthmonix.com/product/cost-analytics/) - Find clarity in complex cost measures As CMS returns to providing Cost category scores and many MIPS-eligible providers receive subpar scores, the need to understand cost measures has grown. Our industry-first MIPS Cost Analytics software gives you the insights you need to succeed in the Cost category. MIPS Cost Analytics provides a clear picture of the cost measures included
- [ACO Impact](https://healthmonix.com/product/aco-impact/) - Help your ACO succeed with eCQM, CQM, and Medicare CQM reporting With the advent of the APM Performance Pathway (APP), ACOs face tougher requirements to succeed in quality performance reporting. Healthmonix’s ACO Impact solution empowers your ACO’s success in eCQM, CQM, and Medicare CQM reporting. We provide all the technical, regulatory, and clinical measure know-how
- [MIPSpro](https://healthmonix.com/product/mips-pro/) - Succeed with MIPS reporting today and tomorrow Selecting the right MIPS registry partner matters. MIPSpro registries saved customers over $500 million in penalties in 2022 reporting. In addition, we secured them over $200 million in incentives. Our registries and associated services are designed to help providers enhance their financial outcomes within the MIPS framework. Our
- [MIPS Analytics](https://healthmonix.com/product/mips-analytics/) - Get more from your MIPS data Elevate your care quality and performance with our cutting-edge tools. MIPS Analytics transforms your approach to healthcare excellence by enabling you to: Gain a panoramic view of performance across your entire organization, down to the finest detail. Compare each department, location, and provider against benchmarks. Equip clinicians with instant

## Team

- [Bill Marella](https://healthmonix.com/team/bill-marella/) - Bill Marella is the Chief Operating Officer at Healthmonix, where he helps guide day-to-day operations, support the company’s growth, and strengthen Healthmonix’s role as a trusted partner in quality/cost analytics and value-based care. Bill brings more than two decades of experience working at the intersection of healthcare quality, medical informatics, and large-scale data integration. Before
- [Paul Grant](https://healthmonix.com/team/paul-grant/) - Paul Grant oversees strategic planning and sales team leadership at Healthmonix, focusing on aligning sales operations with the company’s revenue goals. His leadership ensures that the sales strategies support the overall mission of driving growth and success. With a deep passion for helping healthcare organizations navigate complex challenges and deliver cost-effective patient care, Paul was
- [Michael Lewis](https://healthmonix.com/team/michael-lewis/) - At Healthmonix, Mike oversees the sales department that includes the provider, hospital, ACO, and partner verticals. His responsibilities include cultivating enterprise accounts, driving growth, providing value-based education, and developing and mentoring the Sales team. Mike uses his consulting background and his industry expertise to find the best solutions for his customers. Building happy, long-lasting relationships
- [Eduardo Chavero](https://healthmonix.com/team/eduardo-chavero/) - With over 25 years of experience leading IT services and security frameworks, Eduardo serves as Healthmonix’s Chief Information Security Officer (CISO) and Chief Information Officer (CIO). His primary focus is information security to comply with HIPAA and PCI. He also works to ensure Healthmonix protects ePHI and PII confidentiality and integrity. Eduardo’s other responsibilities include
- [Lauren Patrick](https://healthmonix.com/team/lauren-patrick/) - As CEO of Healthmonix, Lauren specializes in creating innovative registry, quality improvement, and analytics programs to improve patient outcomes and lower cost of care. She has been implementing game-changing healthcare tools for over a decade, building on her background at Ernst & Young and Cap Gemini, where she led large-scale IT implementation projects. Lauren is

## Webinars

- [Preparing for CMS' Ambulatory Specialty Model (ASM)](https://healthmonix.com/webinar/preparing-for-cms-ambulatory-specialty-model-asm/) - CMS’ 2026 Final Rule marks a pivotal turning point for clinicians and healthcare organizations engaged in quality reporting. As traditional MIPS gives way to MVPs—and ultimately to the Ambulatory Specialty Model (ASM), CMS is driving toward a more unified, outcomes-based, and digitally enabled ecosystem. Join Healthmonix CEO Lauren Patrick and Subject Matter Expert Phillip Spence
- [ACO Fireside Chat: Advancing quality reporting with Physician Health Partners](https://healthmonix.com/webinar/aco-fireside-chat-advancing-quality-reporting-with-physician-health-partners/) - Join Healthmonix and Physician Health Partners for an exclusive fireside chat exploring how a physician-led ACO improves quality performance across a diverse network of independent practices. In this session, PHP leaders will share practical, real-world strategies for simplifying quality reporting, strengthening data accuracy, and preparing practices for the 2025–2027 APP landscape. Whether you're an ACO
- [2026 PFS Final Rule: What’s ahead for MIPS, APP & ASM](https://healthmonix.com/webinar/2026-pfs-final-rule-whats-ahead-for-mips-app-asm/) - The 2026 Final Rule is here, and there's a lot to take in! Join us on an upcoming webinar where Healthmonix President Lauren Patrick and VP of Customer Success Michael Lewis will lay out the 2026 Final Rule in under an hour. Learn what’s changing for quality reporting, ACO participation, and the new Ambulatory Specialty Model launching
- [How Northwell Health drives quality excellence across practices and programs ](https://healthmonix.com/webinar/how-northwell-health-drives-quality-excellence-across-practices-and-programs/) - Join Healthmonix for an exclusive fireside chat with Northwell Health leaders as they share how one of the nation’s largest health systems operationalizes quality excellence across practices and programs. In this 60-minute discussion, panelists will explore how Northwell is transforming performance tracking, clinician engagement, and change management to meet evolving reporting and value-based care requirements.
- [The road ahead: Tackling tough 2025 MIPS measures](https://healthmonix.com/webinar/the-road-ahead-tackling-tough-2025-mips-measures/) - MIPS reporting is evolving, and the stakes are higher than ever. Join our experts from Healthmonix as they break down the new and challenging 2025 measures, share practical guidance for measure selection and implementation, and help your organization prepare for the future of MIPS. Presenters Michael Lewis, VP of Customer Success Tara Kalra, Healthcare Quality Measurement Manager Josh
- [Navigating CMS' proposed Ambulatory Specialty Model (ASM): What specialists need to know](https://healthmonix.com/webinar/naviagting-cms-proposed-ambulatory-specialty-model-asm-what-specialists-need-to-know/) - A deep-dive into the new proposed outpatient chronic-care model Join us for a deep-dive into CMS’ proposed mandatory outpatient chronic-care model. Our CEO Lauren Patrick and Subject Matter Expert Phillip Spence will walk you through everything specialists need to prepare for the Ambulatory Specialty Model (ASM). Key topics ASM overview: What it is and why it matters
- [2026 PFS Proposed Rule: Understanding the impact on MIPS](https://healthmonix.com/webinar/2026-pfs-proposed-rule-understanding-the-impact-on-mips/) - CMS has released the 2026 Medicare Physician Fee Schedule (PFS) Proposed Rule. Are you prepared? Significant changes are coming that will impact MIPS, MVPs, ACOs, and more. Join Healthmonix’s emergency webinar for a breakdown of critical updates and what they mean for your organization. Key topics: Expansion and evolution of MIPS Value Pathways (MVPs) MIPS
- [Understanding MIPS: Updates, MVPs, and score optimization](https://healthmonix.com/webinar/understanding-mips-updates-mvps-and-score-optimization/) - Staying ahead with the latest updates to the Merit-based Incentive Payment System (MIPS) for 2025 is more important than ever. Whether you're sticking with Traditional MIPS, shifting to MIPS Value Pathways (MVPs), or exploring a blend of both, our upcoming webinar is tailored to sharpen your understanding and refine your strategy. Audience: Intermediate Key topics
- [Navigating ACO quality in 2025: Lessons learned and future directions.](https://healthmonix.com/webinar/navigating-aco-quality-in-2025-lessons-learned-and-future-directions/) - As we move into 2025, Accountable Care Organizations (ACOs) must stay ahead of evolving quality requirements and reporting changes. Join us for an in-depth discussion on lessons learned from past ACO implementation, key areas for improvement, and the impact of Medicare Clinical Quality Measures (CQMs). Key topics Lessons learned from ACO implementation Focus areas for
- [Mastering cost measures for better performance](https://healthmonix.com/webinar/mastering-cost-measures-for-better-performance/) - Unlock the key to improving cost performance Struggling to optimize your cost score? Understanding where your organization stands and how to make impactful changes is critical in today’s healthcare landscape. This webinar will break down key cost drivers, real-world examples, and data-driven strategies to help you enhance your scores and gain actionable insights into impacting
- [Traditional MIPS Reporting: Back to the basics](https://healthmonix.com/webinar/traditional-mips-reporting-back-to-the-basics/) - Are you new to the Merit-based Incentive Payment System (MIPS)? Or do you need to brush up on some of the program requirements? Join us on our next webinar where Healthmonix MIPS Specialist Mike Lewis will break down the fundamentals of the MIPS program. Key topics What MIPS is and why your organization needs to
- [2025 PFS Proposed Rule: Understanding the impact on MIPS](https://healthmonix.com/webinar/2025-pfs-proposed-rule-understanding-the-impact-on-mips/) - The 2025 Proposed Rule has arrived, bringing with it changes that will significantly impact the MIPS program. To help you understand the implications and prepare for the upcoming shifts, we have organized an emergency webinar featuring two esteemed experts in the field: Healthmonix President Lauren Patrick and MIPS Specialist Mike Lewis. Key topics: The addition of 6 MVPs for the
- [Tough measures in 2024: Navigating the challenges ahead](https://healthmonix.com/webinar/tough-measures-in-2024-navigating-the-challenges-ahead/) - Join us for an insightful webinar where our expert panel will guide you through the toughest measures in 2024, helping you understand the challenges and providing actionable strategies to ensure your organization’s success. Whether you're a healthcare provider, an ACO leader, or involved in quality reporting, this webinar is designed to give you the tools
- [Boost your practice: Simplifying quality measures for Derm, Uro, and GI](https://healthmonix.com/webinar/boost-your-practice-simplifying-quality-measures-for-derm-uro-and-gi/) - Join us for an insightful webinar that covers the critical aspects of quality measures, workflow integration, and data collection tailored for Dermatology, Urology, and GI practices. Learn how to streamline your workflows to meet MIPS requirements and maximize your performance scores from experts in the industry. Key topics Understanding quality measures for Dermatology, Urology, and
- [2025 PFS Final Rule: Understanding the impact on MIPS](https://healthmonix.com/webinar/2025-pfs-final-rule-understanding-the-impact-on-mips/) - The 2025 Final Rule is here, and there's a lot to take in! Join us on an upcoming webinar where Healthmonix President Lauren Patrick and VP of Customer Success Michael Lewis will discuss the final changes and the impact to the MIPS program. Key topics The addition of 6 MVPs The establishment of the APP
- [2024 PFS Final Rule: Understanding the Impact on MIPS.](https://healthmonix.com/webinar/2024-pfs-final-rule-understanding-the-impact-on-mips/) - The 2024 PFS Final Rule is here, and there are important updates you need to know for MIPS reporting.Join Healthmonix MIPS Specialists Steven Tyson and Maura Flaherty on our upcoming webinar. They'll break down changes for the 2024 MIPS program, including: Updates to Traditional MIPS The removal, additional, and modification of quality measures The arrival of
- [Navigating ACO Quality in 2024: Lessons Learned and Future Directions](https://healthmonix.com/webinar/navigating-aco-quality-in-2024-lessons-learned-and-future-directions/) - Discover key insights and strategies for ACO success in 2024! Join us for an engaging webinar featuring industry experts discussing lessons learned, Medicare CQMs, and upcoming ACO quality initiatives. Webinar highlights Lessons learned from ACO implementation Focus areas for ACO improvement Understanding Medicare Clinical Quality Measures (CQMs) Review of upcoming ACO quality initiatives for 2024
- [The crucial role of the MIPS Cost category and strategies for success](https://healthmonix.com/webinar/upcoming-the-crucial-role-of-the-mips-cost-category-and-strategies-for-success/) - In today's healthcare landscape, achieving MIPS excellence isn't an option; it's a necessity. With the MIPS Cost category accounting for 30% of your MIPS score, its importance can't be overstated. As more measures are added each year, understanding and mastering this category is crucial for optimizing your overall MIPS performance and securing financial incentives. Webinar topics include:
- [Unlocking success with MIPS Value pathways](https://healthmonix.com/webinar/unlocking-success-with-mips-value-pathways/) - Attention healthcare professionals, Mark your calendar for our upcoming webinar on MIPS Value Pathways (MVPs)! Join us on Tuesday, March 26, at 1 pm ET, for a deep dive into the dynamic world of MVPs. This insightful session will unravel the details, exploring MVP benefits, different pathways, and implementation strategies that will elevate your MIPS
- [Mastering MIPS reporting for 2023](https://healthmonix.com/webinar/mastering-mips-reporting-for-2023/) - Attention healthcare professionals, As the MIPS reporting season rolls along, it's time to ensure you're equipped to conquer the challenges ahead. Join us on Thursday, Jan. 25 for an exclusive webinar, "Mastering MIPS reporting for 2023," featuring MIPS experts Mike Lewis and Kelly Healy. Important topics we'll cover include: Navigating the MIPS landscape Learning strategies
- [Maximizing MIPS reporting success in 2023: Don't wait!](https://healthmonix.com/webinar/maximizing-mips-reporting-success-in-2023-dont-wait/) - MIPS Specialist Mike Lewis and Account Manager Kelly Healy share essential information on how avoiding last-minute reporting can alleviate stress, ensure compliance, and position your organization for success in MIPS this year. Discover expert tips and tricks to navigate the evolving program landscape. Topics include: Why starting now matters Getting the most out of your
- [2024 PFS Proposed Rule: Understanding the impact on MIPS](https://healthmonix.com/webinar/2024-pfs-proposed-rule-understanding-the-impact-on-mips/) - The 2024 Proposed Rule is here and there's a lot to take in! Healthmonix President Lauren Patrick and MIPS Specialist Mike Lewis will discuss the proposed changes and the impact to the MIPS program. Topics include: What's the impact Performance threshold raised again Five new Cost measures Potential removal of commonly used Quality measures Health
- [Measuring up with MIPS reporting: New changes, New measures, New opportunities](https://healthmonix.com/webinar/measuring-up-with-mips-reporting-new-changes-new-measures-new-opportunities/) - Measures webinar hosted by Healthmonix MIPS Specialist Mike Lewis where Lead Measure Developer Tara Kalra and Software Engineer Josh Hall will dive into 2023 quality measures. They will explore the world of MIPS reporting and review the latest updates and changes to quality measures. Topics include: Quality measures for MIPS reporting overview New measures and
- [ Getting Started With MIPS 2023: What You Can Do to Improve?](https://healthmonix.com/webinar/getting-started-with-mips-2023-what-you-can-do-to-improve/) - Are you ready to take the steps to improve your MIPS score? Join our MIPS Specialist Mike Lewis for a comprehensive webinar on 2023 MIPS strategies for Small & Large practices. He will provide valuable insights and guidance for your practice whether you're a seasoned MIPS reporter or just getting started! In this webinar, he
- [Traditional MIPS Reporting:Back to the Basics](https://healthmonix.com/webinar/traditional-mips-reportingback-to-the-basics/) - Are you new to the Merit-based Incentive Payment System (MIPS)? Or do you need to brush up on some of the program requirements? Join us on our next webinar where Healthmonix MIPS Specialist Mike Lewis will break down the fundamentals of the MIPS program. He'll cover the following: What MIPS is and why your organization
- [2024 MIPS measures: A deep dive into new changes, new measures, and scoring](https://healthmonix.com/webinar/2024-mips-measures-a-deep-dive-into-new-changes-new-measures-and-scoring/) - Things you need to know for the 2024 MIPS measures. Discover the insights you need in our upcoming comprehensive webinar focused on 2024 MIPS measures, benchmarking best practices, measure scoring, and health equity achievement. Join us for an enlightening session designed to provide education and guidance as you navigate the intricacies of 2024 MIPS measures.
- [Successful ACO Reporting: Excelling in the Depression Screening Measure](https://healthmonix.com/webinar/successful-aco-reporting-excelling-in-the-depression-screening-measure/) - As ACOs embark on eCQM/ MIPS CQM reporting, the depression screening measure is the hardest measure that must be reported. Join representatives from American Psychological Association, Healthmonix and Videra Health as they discuss best practices and technologies for driving performance in this measure. They'll cover the following: Measurement-based care vs. quality reporting Benefits of engaging
- [MVPs and MIPS Cost: Everything you need to know](https://healthmonix.com/webinar/mvps-and-mips-cost-everything-you-need-to-know/) - Are you maximizing your healthcare practice's potential by leveraging MIPS Value Pathways (MVPs) and optimizing cost measures? Join us for an informative webinar focusing on MVPs and the MIPS Cost category, featuring industry experts Lauren Patrick, Healthmonix CEO, and Michael Lewis, MIPS Specialist. Important topics we'll cover include: The benefits of reporting an MVP How
- [Cracking the code on the MIPS Cost category: Unleashing financial success](https://healthmonix.com/webinar/cracking-the-code-on-the-mips-cost-category-unleashing-financial-success/) - Are you ready to find out what you're being measured on in the MIPS Cost category? Join us for an enlightening session with CEO Lauren Patrick, MIPS Specialist Michael Lewis, and Product Owner Daniel Patrick as they guide you through the crucial aspects of the MIPS Cost category. Gain expert insights to harness your opportunities
- [The Next Phase of MIPS: How to Succeed in Traditional MIPS & MVPs](https://healthmonix.com/webinar/the-next-phase-of-mips-how-to-succeed-in-traditional-mips-mvps/) - Now that MIPS Value Pathways (MVPs) are available in 2023, you may be wondering how they work with Traditional MIPS reporting, if they are right for your organization, and how you would implement them if your organization has multiple specialties. Join Healthmonix MIPS Specialists Debbie Belczyk and Michael Lewis on our upcoming webinar, as they
- [Encore Webinar: Getting Started with MIPS Value Pathways in 2023](https://healthmonix.com/webinar/encore-webinar-getting-started-with-mips-value-pathways-in-2023/) - MIPS Value Pathways (MVPs) are finally here in 2023! Join Healthmonix MIPS Specialists Seretha Curry and Michael Lewis on our upcoming webinar, as they discuss this next phase of MIPS reporting and how to maximize performance in MVPs by using our success plan. They'll cover the following: CMS's goals for MVPs MVPs available in 2023 MVP

## Thrive Symbols

- [2023 PI Measures](https://healthmonix.com/?post_type=tcb_symbol&p=38712)
- [Reporting Requirements](https://healthmonix.com/?post_type=tcb_symbol&p=38711)
- [ONC Certified](https://healthmonix.com/?post_type=tcb_symbol&p=38710)
- [Search for a measure](https://healthmonix.com/?post_type=tcb_symbol&p=38328)
- [Search For a measure #1](https://healthmonix.com/?post_type=tcb_symbol&p=38327)
- [Cost table new](https://healthmonix.com/?post_type=tcb_symbol&p=38297)
- [Cost Measures](https://healthmonix.com/?post_type=tcb_symbol&p=38270)
- [Purchase a License](https://healthmonix.com/?post_type=tcb_symbol&p=38247)
- [Titles](https://healthmonix.com/?post_type=tcb_symbol&p=38245)
- [Reporting PI](https://healthmonix.com/?post_type=tcb_symbol&p=37575)
- [Quality Measures](https://healthmonix.com/?post_type=tcb_symbol&p=37574)
- [Reporting IA](https://healthmonix.com/?post_type=tcb_symbol&p=37570)
- [Reporting Quality](https://healthmonix.com/?post_type=tcb_symbol&p=37569)
- [Search a measure](https://healthmonix.com/?post_type=tcb_symbol&p=37563)
- [Tabs](https://healthmonix.com/?post_type=tcb_symbol&p=37522)
- [Footer](https://healthmonix.com/?post_type=tcb_symbol&p=37521)
- [Header](https://healthmonix.com/?post_type=tcb_symbol&p=37520)
- [Countdown 2.0](https://healthmonix.com/?post_type=tcb_symbol&p=37142)
- [Medical Specialty](https://healthmonix.com/?post_type=tcb_symbol&p=36982)
- [MVPs Homepage link](https://healthmonix.com/?post_type=tcb_symbol&p=36826)
- [MVP CTA](https://healthmonix.com/?post_type=tcb_symbol&p=36823)
- [MVPs](https://healthmonix.com/?post_type=tcb_symbol&p=36799)
- [FAQs](https://healthmonix.com/?post_type=tcb_symbol&p=36794)
- [Foundational Layer - Population Health](https://healthmonix.com/?post_type=tcb_symbol&p=36704)
- [Measures](https://healthmonix.com/?post_type=tcb_symbol&p=36437)
- [Measures table Tabs](https://healthmonix.com/?post_type=tcb_symbol&p=35348)
- [Blog](https://healthmonix.com/?post_type=tcb_symbol&p=34880)
- [Column Partners](https://healthmonix.com/?post_type=tcb_symbol&p=34776)
- [Partners-2](https://healthmonix.com/?post_type=tcb_symbol&p=34775)
- [Integration](https://healthmonix.com/?post_type=tcb_symbol&p=34773)
- [Contact Us alternate](https://healthmonix.com/?post_type=tcb_symbol&p=34746)
- [Partners](https://healthmonix.com/?post_type=tcb_symbol&p=34743)
- [FAQ](https://healthmonix.com/?post_type=tcb_symbol&p=34731)
- [Add-ons](https://healthmonix.com/?post_type=tcb_symbol&p=34686)
- [MIPS Pricing](https://healthmonix.com/?post_type=tcb_symbol&p=34600)
- [Contact Us](https://healthmonix.com/?post_type=tcb_symbol&p=34500)
- [Clients and partners](https://healthmonix.com/?post_type=tcb_symbol&p=33493)
- [Buttons](https://healthmonix.com/?post_type=tcb_symbol&p=33486)
- [Proudly Certified](https://healthmonix.com/?post_type=tcb_symbol&p=33431)
- ["They Say"](https://healthmonix.com/?post_type=tcb_symbol&p=33260)
- [MIPS Pro](https://healthmonix.com/?post_type=tcb_symbol&p=33138)
- [Phone](https://healthmonix.com/?post_type=tcb_symbol&p=31574)
- [MIPS Pro Categories](https://healthmonix.com/?post_type=tcb_symbol&p=31547)
- [MIPS Calculator](https://healthmonix.com/?post_type=tcb_symbol&p=31050)
- [Calculator](https://healthmonix.com/?post_type=tcb_symbol&p=31047)
- [MIPS buttons](https://healthmonix.com/?post_type=tcb_symbol&p=31006)
- [NEW TEST](https://healthmonix.com/?post_type=tcb_symbol&p=28115) - __CONFIG_widget_menu__{"menu_id":"2","dropdown_icon":"style_1","mobile_icon":"style_1","dir":"tve_horizontal","icon":{"top":"","sub":""},"layout":{"default":"grid"},"type":"regular","mega_desc":{},"actions":{},"uuid":"m-16ea7c4561e","template":-1,"template_name":"Basic","unlinked":[],"top_cls":{"main":"c-underline"}}__CONFIG_widget_menu__
- [Thrive Test 123](https://healthmonix.com/?post_type=tcb_symbol&p=28106)
- [Thrive Test](https://healthmonix.com/?post_type=tcb_symbol&p=28104)
- [APM GEAR DIRECTORY](https://healthmonix.com/?post_type=tcb_symbol&p=27632)
- [Default Header for Shapeshift Theme](https://healthmonix.com/?post_type=tcb_symbol&p=20552)
- [Copy of Default Header for Shapeshift Theme](https://healthmonix.com/?post_type=tcb_symbol&p=27148)
- [CountDown](https://healthmonix.com/?post_type=tcb_symbol&p=26657)
- [Cost Table](https://healthmonix.com/?post_type=tcb_symbol&p=26291)
- [Cost Analytics Benefits](https://healthmonix.com/?post_type=tcb_symbol&p=26277)
- [QUALITY MEASURE BREAKDOWNS](https://healthmonix.com/?post_type=tcb_symbol&p=26072)
- [Program overview](https://healthmonix.com/?post_type=tcb_symbol&p=21304)
- [Default Footer for Shapeshift Theme](https://healthmonix.com/?post_type=tcb_symbol&p=20577)
- [01 - Logo - Menu - Call to Action](https://healthmonix.com/?post_type=tcb_symbol&p=20475)
- [01 - Columns](https://healthmonix.com/?post_type=tcb_symbol&p=20476)

## MIPS Quality Measures

- [2025 #134 MIPS Measure Preventive Care and Screening: Screening for Depression and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/preventive-care-and-screening-screening-for-depression-and-follow-up-plan/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process ‌Description: ‌Percentage of patients aged 12 years and older screened for depression on the date of the encounter or up to 14 days prior to the date of the encounter using an age-appropriate standardized depression screening tool AND if positive, a follow-up plan is
- [2025 #511 MIPS Measure Percentage of Prevalent Patients Waitlisted (PPPW) and Percentage of Prevalent Patients Waitlisted in Active Status (aPPPW)](https://healthmonix.com/mips_quality_measure/percentage-of-prevalent-patients-waitlisted-pppw-and-percentage-of-prevalent-patients-waitlisted-in-active-status-apppw/) - ‌2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: The measure tracks dialysis patients who are under the age of 75 in a practitioner group and on the kidney or kidney- pancreas transplant waitlist (all patients or patients in active status). This measure is a risk-adjusted percentage of waitlist events among dialysis
- [2025 #510 MIPS Measure First Year Standardized Waitlist Ratio (FYSWR)](https://healthmonix.com/mips_quality_measure/first-year-standardized-waitlist-ratio-fyswr/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: The number of newly initiated patients on dialysis in a practitioner group who are under the age of 75 and were either listed on the kidney or kidney-pancreas transplant waitlist or received a living donor transplant within the first year of initiating dialysis.
- [2025 #509 MIPS Measure Melanoma: Tracking and Evaluation of Recurrence](https://healthmonix.com/mips_quality_measure/melanoma-tracking-and-evaluation-of-recurrence/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of patients who had an excisional surgery for melanoma or melanoma in situ with initial American Joint Committee on Cancer (AJCC) staging of 0, I, or II, in the past 5 years in which the operating clinician examines and/or
- [2025 #508 MIPS Measure Adult COVID-19 Vaccination Status](https://healthmonix.com/mips_quality_measure/adult-covid-19-vaccination-status/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients aged 18 years and older seen for a visit during the performance period that are up-to-date on their COVID-19 vaccinations as defined by Centers for Disease Control and Prevention (CDC) recommendations on current vaccination. ‌Instructions: This measure is to be
- [2025 #507 MIPS Measure Appropriate Germline Testing for Ovarian Cancer Patients](https://healthmonix.com/mips_quality_measure/appropriate-germline-testing-for-ovarian-cancer-patients/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: ‌Process ‌Description: ‌Percentage of patients aged 18 years and older diagnosed with epithelial ovarian, fallopian tube, or primary peritoneal cancer who undergo germline testing within 6 months of diagnosis. Instructions: This measure is to be submitted a minimum of once per performance period for patients
- [2025 #506 MIPS Measure Positive PD-L1 Biomarker Expression Test Result Prior to First-Line Immune Checkpoint Inhibitor Therapy‌‌‌](https://healthmonix.com/mips_quality_measure/positive-pd-l1-biomarker-expression-test-result-prior-to-first-line-immune-checkpoint-inhibitor-therapy/) - 2025 COLLECTION TYPE:‌ MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description:‌ ‌Percentage of patients aged 18 years and older with a diagnosis of metastatic non-small cell lung cancer (NSCLC) or squamous cell carcinoma of head and neck (HNSCC) on first-line immune checkpoint inhibitor (ICI) therapy, who had a positive PD-L1 biomarker
- [2025 #505 MIPS Measure Reduction in Suicidal Ideation or Behavior Symptoms](https://healthmonix.com/mips_quality_measure/reduction-in-suicidal-ideation-or-behavior-symptoms-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure (PRO-PM) – High Priority ‌Description: The percentage of patients aged 18 years and older with a mental and/or substance use disorder AND suicidal thoughts, behaviors or risk symptoms who demonstrated a reduction in suicidal ideation and/or behavior symptoms based on results
- [2025 #504 MIPS Measure Initiation, Review, and/or Update to Suicide Safety Plan for Individuals with Suicidal Thoughts, Behavior, or Suicide Risk](https://healthmonix.com/mips_quality_measure/initiation-review-and-or-update-to-suicide-safety-plan-for-individuals-with-suicidal-thoughts-behavior-or-suicide-risk-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of patients aged 12 years and older with suicidal ideation or behavior symptoms (based on results of a standardized assessment tool or screening tool) or increased suicide risk (based on the clinician's evaluation or clinician-rating tool) for whom a
- [2025 #503 MIPS Measure Gains in Patient Activation Measure (PAM) Scores at 12 Months](https://healthmonix.com/mips_quality_measure/gains-in-patient-activation-measure-pam-scores-at-12-months-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Measure (PRO-PM) – High Priority ‌Description: The Patient Activation Measure® (PAM®) is a 10- or 13-item questionnaire that assesses an individual´s knowledge, skills, and confidence for managing their health and health care. The measure assesses individuals on a 0-100 scale that converts to
- [2025 #502 MIPS Measure Improvement or Maintenance of Functioning for Individuals with a Mental and/or Substance Use Disorder](https://healthmonix.com/mips_quality_measure/improvement-or-maintenance-of-functioning-for-individuals-with-a-mental-and-or-substance-use-disorder-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-based Performance Measure (PRO-PM) – High Priority ‌Description: The percentage of patients aged 18 and older with a mental and/or substance use disorder who demonstrated improvement or maintenance of functioning based on results from the 12-item World Health Organization Disability Assessment Schedule (WHODAS 2.0)
- [2025 #501 MIPS Measure Acute Posterior Vitreous Detachment and Acute Vitreous Hemorrhage Appropriate Examination and Follow-up](https://healthmonix.com/mips_quality_measure/acute-posterior-vitreous-detachment-and-acute-vitreous-hemorrhage-appropriate-examination-and-follow-up-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients with a diagnosis of acute posterior vitreous detachment (PVD) and acute vitreous hemorrhage in either eye who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks. ‌Instructions: This measure is to be submitted once
- [2025 #500 MIPS Measure Acute Posterior Vitreous Detachment Appropriate Examination and Follow-up](https://healthmonix.com/mips_quality_measure/acute-posterior-vitreous-detachment-appropriate-examination-and-follow-up-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients with a diagnosis of acute posterior vitreous detachment (PVD) in either eye who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks. ‌Instructions: This measure is to be submitted once for each occurrence of
- [2025 #499 MIPS Measure Appropriate Screening and Plan of Care for Elevated Intraocular Pressure Following Intravitreal or Periocular Steroid Therapy](https://healthmonix.com/mips_quality_measure/appropriate-screening-and-plan-of-care-for-elevated-intraocular-pressure-following-intravitreal-or-periocular-steroid-therapy-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients who had an intravitreal or periocular corticosteroid injection (e.g., triamcinolone, preservative- free triamcinolone, dexamethasone, dexamethasone intravitreal implant, or fluocinolone intravitreal implant) who, within seven (7) weeks following the date of injection, are screened for elevated intraocular pressure (IOP) with tonometry
- [2025 #498 MIPS Measure Connection to Community Service Provider](https://healthmonix.com/mips_quality_measure/connection-to-community-service-provider-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percent of patients 18 years or older who screen positive for one or more of the following health-related social needs (HRSNs): food insecurity, housing instability, transportation needs, utility help needs, or interpersonal safety; and had contact with a Community Service
- [2025 #497 MIPS Measure Preventive Care and Wellness (Composite)](https://healthmonix.com/mips_quality_measure/preventive-care-and-wellness-composite-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients who received age-and sex-appropriate preventive screenings and wellness services. This measure is a composite of seven component measures that are based on recommendations for preventive care by the U.S. Preventive Services Task Force (USPSTF), Advisory Committee on Immunization Practices (ACIP),
- [2025 #496 MIPS Measure Cardiovascular Disease (CVD) Risk Assessment Measure - Proportion of Pregnant/Postpartum Patients that Receive CVD Risk Assessment with a Standardized Instrument‌](https://healthmonix.com/mips_quality_measure/cardiovascular-disease-cvd-risk-assessment-measure-proportion-of-pregnant-postpartum-patients-that-receive-cvd-risk-assessment-with-a-standardized-instrument-2/) - 2025 COLLECTION TYPE:‌ MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: ‌Percentage of pregnant or postpartum patients who received a cardiovascular disease (CVD) risk assessment with a standardized instrument. ‌Instructions: ‌This measure is to be submitted a minimum of once per performance period for all patients seen for pregnancy or postpartum care during the
- [2025 #495 MIPS Measure Ambulatory Palliative Care Patients' Experience of Feeling Heard and Understood](https://healthmonix.com/mips_quality_measure/ambulatory-palliative-care-patients-experience-of-feeling-heard-and-understood-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure (PRO-PM) – High Priority ‌Description: The percentage of top-box responses among patients aged 18 years and older who had an ambulatory palliative care visit and report feeling heard and understood by their palliative care clinician and team within 2 months (60
- [2025 #493 MIPS Measure Adult Immunization Status](https://healthmonix.com/mips_quality_measure/adult-immunization-status/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: ‌Percentage of patients 19 years of age and older who are up-to-date on recommended routine vaccines for influenza; tetanus and diphtheria (Td) or tetanus, diphtheria and acellular pertussis (Tdap); zoster; and pneumococcal. Instructions: This measure is to be submitted a minimum of once
- [2025 #491 MIPS Measure Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing Status](https://healthmonix.com/mips_quality_measure/mismatch-repair-mmr-or-microsatellite-instability-msi-biomarker-testing-status/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of surgical pathology reports for primary colorectal, endometrial, gastroesophageal or small bowel carcinoma, biopsy or resection, that contain impression or conclusion of or recommendation for testing of mismatch repair (MMR) by immunohistochemistry (biomarkers MLH1, MSH2, MSH6, and PMS2), or
- [2025 #490 MIPS Measure Appropriate Intervention of Immune-Related Diarrhea and/or Colitis in Patients Treated with Immune Checkpoint Inhibitors](https://healthmonix.com/mips_quality_measure/appropriate-intervention-of-immune-related-diarrhea-and-or-colitis-in-patients-treated-with-immune-checkpoint-inhibitors/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients, aged 18 years and older, with a diagnosis of cancer, on immune checkpoint inhibitor therapy, and grade 2 or above diarrhea and/or grade 2 or above colitis, who have immune checkpoint inhibitor therapy held and corticosteroids or immunosuppressants prescribed or
- [2025 #489 MIPS Measure Adult Kidney Disease: Angiotensin Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy](https://healthmonix.com/mips_quality_measure/adult-kidney-disease-angiotensin-converting-enzyme-ace-inhibitor-or-angiotensin-receptor-blocker-arb-therapy/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: ‌Percentage of patients aged 18 years and older with a diagnosis of chronic kidney disease (CKD) (Stages 1-5, not receiving Renal Replacement Therapy (RRT)) and proteinuria who were prescribed ACE inhibitor or ARB therapy within a 12-month period. Instructions: This measure is to
- [2025 #488 MIPS Measure Kidney Health Evaluation](https://healthmonix.com/mips_quality_measure/kidney-health-evaluation/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients aged 18-85 years with a diagnosis of diabetes who received a kidney health evaluation defined by an Estimated Glomerular Filtration Rate (eGFR) AND Urine Albumin-Creatinine Ratio (uACR) within the performance period. ‌Instructions: This measure is to be submitted a minimum
- [2025 #487 MIPS Measure Screening for Social Drivers of Health](https://healthmonix.com/mips_quality_measure/screening-for-social-drivers-of-health/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: ‌Process – High Priority Description: ‌Percent of patients 18 years and older screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety. Instructions: This measure is to be submitted a minimum of once per performance period for patients seen during the performance
- [2025 #486 MIPS Measure Dermatitis – Improvement in Patient-Reported Itch Severity](https://healthmonix.com/mips_quality_measure/dermatitis-improvement-in-patient-reported-itch-severity/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: ‌Patient-Reported Outcome-based Performance Measure – High Priority Description: ‌The percentage of patients aged 8 years and older, with a diagnosis of dermatitis where at an initial (index) visit have a patient-reported itch severity assessment performed, score greater than or equal to 4, and who achieve
- [2025 #485 MIPS Measure Improvement in Patient-Reported Itch Severity](https://healthmonix.com/mips_quality_measure/improvement-in-patient-reported-itch-severity/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Patient-reported Outcome-based Performance Measure – High Priority ‌Description: The percentage of patients aged 8 years and older, with a diagnosis of psoriasis where at an initial (index) visit have a patient-reported itch severity assessment performed, score greater than or equal to 4, and who achieve
- [2025 #483 MIPS Measure Person-Centered Primary Care Measure Patient Reported Outcome Performance Measure (PCPCM PRO-PM)](https://healthmonix.com/mips_quality_measure/person-centered-primary-care-measure-patient-reported-outcome-performance-measure-pcpcm-pro-pm/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority ‌Description: The Person-Centered Primary Care Measure Patient Reported Outcome Performance Measure (PCPCM PRO-PM) uses the PCPCM Patient Reported Outcome Measure (PROM) a comprehensive and parsimonious set of 11 patient-reported items - to assess the broad scope of primary
- [2025 #482 MIPS Measure Hemodialysis Vascular Access: Practitioner Level Long-term Catheter Rate](https://healthmonix.com/mips_quality_measure/hemodialysis-vascular-access-practitioner-level-long-term-catheter-rate/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: ‌Intermediate outcome – High Priority Description: Percentage of adult hemodialysis (HD) patient-months using a catheter continuously for three months or longer for vascular access attributable to an individual practitioner or group practice. ‌Instructions: This measure is to be submitted a minimum of once per month
- [2025 #478 MIPS Measure Functional Status Change for Patients with Neck Impairments](https://healthmonix.com/mips_quality_measure/functional-status-change-for-patients-with-neck-impairments/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: ‌Patient-Reported Outcome-Based Performance Measure – High Priority Description: ‌A patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients 14 years+ with neck impairments. The change in FS is assessed using the FOTO Neck FS PROM. The measure is adjusted to patient
- [2025 #477 MIPS Measure Multimodal Pain Management](https://healthmonix.com/mips_quality_measure/multimodal-pain-management/) - ‌2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of patients, aged 18 years and older, undergoing selected surgical procedures that were managed with multimodal pain management. ‌Instructions: ‌This measure is to be reported each time a patient undergoes a selected surgical procedure during the performance period. It
- [2025 #471 MIPS Measure Functional Status After Lumbar Surgery](https://healthmonix.com/mips_quality_measure/functional-status-after-lumbar-surgery/) - ‌2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority ‌Description: For patients age 18 and older who had lumbar discectomy/laminectomy or fusion procedure, functional status is rated by the patient as less than or equal to 22 OR an improvement of 30 points or greater on the
- [2025 #470 MIPS Measure Functional Status After Primary Total Knee Replacement](https://healthmonix.com/mips_quality_measure/functional-status-after-primary-total-knee-replacement/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority ‌Description: ‌For patients age 18 and older who had a primary total knee replacement procedure, functional status is rated by the patient as greater than or equal to 37 on the Oxford Knee Score (OKS) or a 71
- [2025 #468 MIPS Measure Continuity of Pharmacotherapy for Opioid Use Disorder (OUD)](https://healthmonix.com/mips_quality_measure/continuity-of-pharmacotherapy-for-opioid-use-disorder-oud/) - ‌2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of adults aged 18 years and older with pharmacotherapy for opioid use disorder (OUD) who have at least 180 days of continuous treatment. ‌Instructions: This measure is to be submitted a minimum of once per performance period for all
- [2025 #465 MIPS Measure Uterine Artery Embolization Technique: Documentation of Angiographic Endpoints and Interrogation of Ovarian Arteries](https://healthmonix.com/mips_quality_measure/uterine-artery-embolization-technique-documentation-of-angiographic-endpoints-and-interrogation-of-ovarian-arteries/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: ‌Process – High Priority Description: The percentage of patients with documentation of angiographic endpoints of embolization AND the documentation of embolization strategies in the presence of unilateral or bilateral absent uterine arteries. ‌Instructions: This measure is to be submitted each time a procedure for uterine
- [2025 #464 MIPS Measure Otitis Media with Effusion: Systemic Antimicrobials - Avoidance of Inappropriate Use](https://healthmonix.com/mips_quality_measure/otitis-media-with-effusion-systemic-antimicrobials-avoidance-of-inappropriate-use/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: ‌Process – High Priority Description: Percentage of patients aged 2 months through 12 years with a diagnosis of OME who were not prescribed systemic antimicrobials. ‌Instructions: This measure is to be submitted once for each occurrence of otitis media with effusion (OME) in children seen
- [2025 #463 MIPS Measure Prevention of Post-Operative Vomiting (POV) – Combination Therapy (Pediatrics)](https://healthmonix.com/mips_quality_measure/prevention-of-post-operative-vomiting-pov-combination-therapy-pediatrics/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of patients aged 3 through 17 years, who undergo a procedure under general anesthesia in which an inhalational anesthetic is used for maintenance AND who have two or more risk factors for post-operative vomiting (POV), who receive combination therapy
- [2025 #461 MIPS Measure Leg Pain After Lumbar Surgery](https://healthmonix.com/mips_quality_measure/leg-pain-after-lumbar-surgery/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority ‌Description: For patients 18 years of age or older who had a lumbar discectomy/laminectomy or fusion procedure, leg pain is rated by the patient as less than or equal to 3.0 OR an improvement of 5.0 points or
- [2025 #459 MIPS Measure Back Pain After Lumbar Surgery](https://healthmonix.com/mips_quality_measure/back-pain-after-lumbar-surgery/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority ‌Description: For patients 18 years of age or older who had a lumbar discectomy/laminectomy or fusion procedure, back pain is rated by the patients as less than or equal to 3.0 OR an improvement of 5.0 points or
- [2025 #457 MIPS Measure Percentage of Patients who Died from Cancer Admitted to Hospice for Less than 3 Days (lower score – better)](https://healthmonix.com/mips_quality_measure/percentage-of-patients-who-died-from-cancer-admitted-to-hospice-for-less-than-3-days-lower-score-better/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of patients who died from cancer, and admitted to hospice and spent less than 3 days there. ‌Instructions: This measure is to be submitted a minimum of once per performance period for patients who died of cancer during the
- [2025 #453 MIPS Measure Percentage of Patients who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life (lower score – better)](https://healthmonix.com/mips_quality_measure/percentage-of-patients-who-died-from-cancer-receiving-systemic-cancer-directed-therapy-in-the-last-14-days-of-life-lower-score-better-2/) - ‌2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE:‌Process – High Priority Description: ‌Percentage of patients who died from cancer receiving systemic cancer-directed therapy in the last 14 days of life. Instructions: This measure is to be submitted a minimum of once per performance period for patients who died of cancer during the measurement
- [2025 #451 MIPS Measure RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who Receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy](https://healthmonix.com/mips_quality_measure/ras-kras-and-nras-gene-mutation-testing-performed-for-patients-with-metastatic-colorectal-cancer-who-receive-anti-epidermal-growth-factor-receptor-egfr-monoclonal-antibody-therapy-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of adult patients (aged 18 or over) with metastatic colorectal cancer who receive anti-epidermal growth factor receptor monoclonal antibody therapy for whom RAS (KRAS and NRAS) gene mutation testing was performed. ‌Instructions: This measure is to be submitted once per performance period
- [2025 #450 MIPS Measure Appropriate Treatment for Patients with Stage I (T1c) – III HER2 Positive Breast Cancer](https://healthmonix.com/mips_quality_measure/appropriate-treatment-for-patients-with-stage-i-t1c-iii-her2-positive-breast-cancer-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE:Process – High Priority ‌Description: Percentage of patients aged 18 to 70 with stage I (T1c) – III HER2 positive breast cancer for whom appropriate treatment is initiated. ‌Instructions: This measure is to be submitted a minimum of once per performance period for patients with breast
- [2025 #448 MIPS Measure Appropriate Workup Prior to Endometrial Ablation](https://healthmonix.com/mips_quality_measure/appropriate-workup-prior-to-endometrial-ablation/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: ‌Process - High Priority Description: ‌Percentage of patients, aged 18 years and older, who undergo endometrial sampling or hysteroscopy with biopsy and results are documented before undergoing an endometrial ablation. Instructions: This measure is to be submitted once per performance period. This measure is to
- [2025 #445 MIPS Measure Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)](https://healthmonix.com/mips_quality_measure/risk-adjusted-operative-mortality-for-coronary-artery-bypass-graft-cabg/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE:Outcome – High Priority ‌Description: ‌Percent of patients aged 18 years and older undergoing isolated CABG who die, including both all deaths occurring during the hospitalization in which the CABG was performed, even if after 30 days, and those deaths occurring after discharge from the hospital,
- [2025 #443 MIPS Measure Non-Recommended Cervical Cancer Screening in Adolescent Females](https://healthmonix.com/mips_quality_measure/non-recommended-cervical-cancer-screening-in-adolescent-females/) - ‌2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: ‌Process – High Priority Description: The percentage of adolescent females 16–20 years of age who were screened unnecessarily for cervical cancer. ‌Instructions: This measure is to be submitted once per performance period for female patients seen during the performance period. There is no diagnosis associated
- [2025 #441 MIPS Measure Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)](https://healthmonix.com/mips_quality_measure/ischemic-vascular-disease-ivd-all-or-none-outcome-measure-optimal-control-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Intermediate Outcome – High Priority ‌Description: The IVD All-or-None Measure is one outcome measure (optimal control). The measure contains four goals. All four goals within a measure must be reached in order to meet that measure. The numerator for the all-or-none measure should be collected
- [2025 #440 MIPS Measure Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician](https://healthmonix.com/mips_quality_measure/skin-cancer-biopsy-reporting-time-pathologist-to-clinician/) - 2025 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of biopsies with a diagnosis of cutaneous basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), or melanoma (including in situ disease) in which the pathologist communicates results to the clinician within 7 days from the time when the
- [2025 #438 MIPS Measure Statin Therapy for the Prevention and Treatment of Cardiovascular Disease](https://healthmonix.com/mips_quality_measure/statin-therapy-for-the-prevention-and-treatment-of-cardiovascular-disease/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of the following patients - all considered at high risk of cardiovascular events - who were prescribed or were on statin therapy during the performance period: All patients who were previously diagnosed with or currently have a diagnosis ofclinical atherosclerotic cardiovascular disease
- [2025 #432 MIPS Measure Proportion of Patients Sustaining a Bladder or Bowel Injury at the time of any Pelvic Organ Prolapse Repair](https://healthmonix.com/mips_quality_measure/proportion-of-patients-sustaining-a-bladder-or-bowel-injury-at-the-time-of-any-pelvic-organ-prolapse-repair/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: ‌Outcome – High Priority Description: Percentage of patients undergoing surgical repair of pelvic organ prolapse that is complicated by a bladder or bowel injury at the time of index surgery that is recognized intraoperatively or within 30 days after surgery. ‌Instructions: This measure is to
- [2025 #431 MIPS Measure Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling](https://healthmonix.com/mips_quality_measure/preventive-care-and-screening-unhealthy-alcohol-use-screening-brief-counseling/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process ‌Description: ‌Percentage of patients aged 18 years and older who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 12 months AND who received brief counseling if identified as an unhealthy alcohol user. Instructions: This measure
- [2025 #430 MIPS Measure Prevention of Post-Operative Nausea and Vomiting (PONV) – Combination Therapy](https://healthmonix.com/mips_quality_measure/prevention-of-post-operative-nausea-and-vomiting-ponv-combination-therapy/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of patients, aged 18 years and older, who undergo a procedure under an inhalational general anesthetic, AND who have three or more risk factors for post-operative nausea and vomiting (PONV), who receive combination therapy consisting of at least two
- [2025 #424 MIPS Measure Perioperative Temperature Management](https://healthmonix.com/mips_quality_measure/perioperative-temperature-management/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome – High Priority ‌Description: Percentage of patients, regardless of age, who undergo surgical or therapeutic procedures under general or neuraxial anesthesia of 60 minutes duration or longer for whom at least one body temperature greater than or equal to 35.5 degrees Celsius (or 95.9
- [2025 #422 MIPS Measure Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury](https://healthmonix.com/mips_quality_measure/performing-cystoscopy-at-the-time-of-hysterectomy-for-pelvic-organ-prolapse-to-detect-lower-urinary-tract-injury/) - ‌2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of patients who undergo cystoscopy to evaluate for lower urinary tract injury at the time of hysterectomy for pelvic organ prolapse. ‌Instructions: This measure is to be submitted each time a procedure is performed during the performance period for
- [2025 #421 MIPS Measure Appropriate Assessment of Retrievable Inferior Vena Cava (IVC) Filters for Removal](https://healthmonix.com/mips_quality_measure/appropriate-assessment-of-retrievable-inferior-vena-cava-ivc-filters-for-removal/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: ‌Percentage of patients in whom a retrievable IVC filter is placed who, within 3 months post-placement, have a documented assessment for the appropriateness of continued filtration, device removal, or the inability to contact the patient with at least two attempts. Instructions: This measure
- [2025 #420 MIPS Measure Varicose Vein Treatment with Saphenous Ablation: Outcome Survey](https://healthmonix.com/mips_quality_measure/varicose-vein-treatment-with-saphenous-ablation-outcome-survey/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE:Patient Reported Outcome -Based Performance Measure – High Priority ‌Description: Percentage of patients treated for varicose veins (CEAP C2-S) who are treated with saphenous ablation (with or without adjunctive tributary treatment) that report an improvement on a disease specific patient reported outcome survey instrument after treatment.
- [2025 #419 MIPS Measure Overuse of Imaging for the Evaluation of Primary Headache](https://healthmonix.com/mips_quality_measure/overuse-of-imaging-for-the-evaluation-of-primary-headache/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: ‌Percentage of patients for whom imaging of the head (CT or MRI) is obtained for the evaluation of primary headache when clinical indications are not present. Instructions: This measure is to be submitted at each denominator eligible visit for patients
- [2025 #418 MIPS Measure Osteoporosis Management in Women Who Had a Fracture](https://healthmonix.com/mips_quality_measure/osteoporosis-management-in-women-who-had-a-fracture/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: The percentage of women 50-85 years of age who suffered a fracture and who had either a bone mineral density (BMD) test or prescription for a drug to treat osteoporosis in the 180 days after the fracture. ‌Instructions: This measure is to be
- [2025 #416 MIPS Measure Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years](https://healthmonix.com/mips_quality_measure/emergency-medicine-emergency-department-utilization-of-ct-for-minor-blunt-head-trauma-for-patients-aged-2-through-17-years/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Efficiency – High Priority ‌Description: Percentage of emergency department visits for patients aged 2 through 17 years who presented with a minor blunt head trauma who had a head CT for trauma ordered by an emergency care provider who are classified as low risk according
- [2025 #415 MIPS Measure Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older](https://healthmonix.com/mips_quality_measure/emergency-medicine-emergency-department-utilization-of-ct-for-minor-blunt-head-trauma-for-patients-aged-18-years-and-older/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Efficiency – High Priority ‌Description: Percentage of emergency department visits for patients aged 18 years and older who presented with a minor blunt head trauma who had a head CT for trauma ordered by an emergency care provider who have an indication for a head
- [2025 #413 MIPS Measure Door to Puncture Time for Endovascular Stroke Treatment](https://healthmonix.com/mips_quality_measure/door-to-puncture-time-for-endovascular-stroke-treatment/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Intermediate Outcome – High Priority ‌Description: ‌Percentage of patients undergoing endovascular stroke treatment who have a door to puncture time of 90 minutes or less. Instructions: ‌This measure is to be submitted each time a patient undergoes a procedure for treatment of a cerebrovascular accident
- [2025 #410 MIPS Measure Psoriasis: Clinical Response to Systemic Medications](https://healthmonix.com/mips_quality_measure/psoriasis-clinical-response-to-systemic-medications/) - ‌2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Outcome – High Priority ‌Description: Percentage of psoriasis vulgaris patients receiving systemic medication who meet minimal physician-or patient- reported disease activity levels. It is implied that establishment and maintenance of an established minimum level of disease control as measured by physician-and/or patient-reported outcomes will increase
- [2025 #406 MIPS Measure Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients](https://healthmonix.com/mips_quality_measure/appropriate-follow-up-imaging-for-incidental-thyroid-nodules-in-patients/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of final reports for computed tomography (CT), CT angiography (CTA) or magnetic resonance imaging (MRI) or magnetic resonance angiogram (MRA) studies of the chest or neck for patients aged 18 years and older with no known thyroid disease with
- [2025 #405 MIPS Measure Appropriate Follow-up Imaging for Incidental Abdominal Lesions](https://healthmonix.com/mips_quality_measure/appropriate-follow-up-imaging-for-incidental-abdominal-lesions/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of final reports for imaging studies for patients aged 18 years and older with one or more of the following noted incidentally with a specific recommendation for no follow‐up imaging recommended based on radiological findings: Cystic renal lesion that
- [2025 #404 MIPS Measure Anesthesiology Smoking Abstinence](https://healthmonix.com/mips_quality_measure/anesthesiology-smoking-abstinence/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Intermediate Outcome – High Priority ‌Description: The percentage of current smokers who abstain from cigarettes prior to anesthesia on the day of elective surgery or procedure. ‌Instructions: This measure is to be submitted each time an elective surgery, diagnostic, or pain procedure is performed under
- [2025 #401 MIPS Measure Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis](https://healthmonix.com/mips_quality_measure/hepatitis-c-screening-for-hepatocellular-carcinoma-hcc-in-patients-with-cirrhosis/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients aged 18 years and older with a diagnosis of chronic Hepatitis C cirrhosis who underwent imaging with either ultrasound, contrast enhanced CT or MRI for hepatocellular carcinoma (HCC) at least once within the 12- month submission period. ‌Instructions: This measure
- [2025 #400 MIPS Measure One-Time Screening for Hepatitis C Virus (HCV) and Treatment Initiation](https://healthmonix.com/mips_quality_measure/one-time-screening-for-hepatitis-c-virus-hcv-and-treatment-initiation/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients aged ≥ 18 years who have never been tested for Hepatitis C Virus (HCV) infection who receive an HCV infection test AND who have treatment initiated within three months or who are referred to a clinician who treats HCV infection
- [2025 #398 MIPS Measure Optimal Asthma Control](https://healthmonix.com/mips_quality_measure/optimal-asthma-control/) - 2025 COLLECTION TYPE:‌ MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE:‌ Outcome – High Priority ‌Description: ‌Composite measure of the percentage of pediatric and adult patients whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools and not at risk for exacerbation. ‌Instructions: This measure is to be submitted a
- [2025 #397 MIPS Measure Melanoma Reporting](https://healthmonix.com/mips_quality_measure/melanoma-reporting/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Pathology reports for primary malignant cutaneous melanoma that include the pT category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors. ‌Instructions: This measure is to be submitted each time
- [2025 #396 MIPS Measure Lung Cancer Reporting (Resection Specimens)](https://healthmonix.com/mips_quality_measure/lung-cancer-reporting-resection-specimens/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority ‌Description: ‌Pathology reports based on lung resection specimens with a diagnosis of primary lung carcinoma that include the pT category, pN category and for non-small cell lung cancer (NSCLC), histologic type. Instructions: ‌This measure is to be submitted each time a
- [2025 #395 MIPS Measure Lung Cancer Reporting (Biopsy/Cytology Specimens)](https://healthmonix.com/mips_quality_measure/lung-cancer-reporting-biopsy-cytology-specimens/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Pathology reports based on lung biopsy and/or cytology specimens with a diagnosis of primary non-small cell lung cancer classified into specific histologic type following the International Association for the Study of Lung Cancer (IASLC) guidance or classified as non-small cell
- [2025 #394 MIPS Measure Immunizations for Adolescents](https://healthmonix.com/mips_quality_measure/immunizations-for-adolescents/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: ‌Process Description: The percentage of adolescents 13 years of age who had one dose of meningococcal vaccine (serogroups A, C, W, Y), one tetanus, diphtheria toxoids and acellular pertussis (Tdap) vaccine, and have completed the Human Papillomavirus (HPV) vaccine series by their 13th birthday. ‌Instructions:
- [2025 #393 MIPS Measure Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision](https://healthmonix.com/mips_quality_measure/infection-within-180-days-of-cardiac-implantable-electronic-device-cied-implantation-replacement-or-revision/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Outcome – High Priority ‌Description: Infection rate following CIED device implantation, replacement, or revision. ‌Instructions: This measure is to be submitted a minimum of once per performance period for patients with a CIED device implantation, replacement, or revision performed from January 1, 2025, through June
- [2025 #392 MIPS Measure Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation Ablation](https://healthmonix.com/mips_quality_measure/cardiac-tamponade-and-or-pericardiocentesis-following-atrial-fibrillation-ablation/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Outcome – High Priority ‌Description: Rate of cardiac tamponade and/or pericardiocentesis following atrial fibrillation ablation. This measure is submitted as four rates stratified by age and gender: Submission Age Criteria 1: Females 18-64 years of age Submission Age Criteria 2: Males 18-64 years of age
- [2025 #389 MIPS Measure Cataract Surgery: Difference Between Planned and Final Refraction](https://healthmonix.com/mips_quality_measure/cataract-surgery-difference-between-planned-and-final-refraction/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome – High Priority ‌Description: Percentage of patients aged 18 years and older who had cataract surgery performed and who achieved a final refraction within +/- 1.0 diopters of their planned (target) refraction. ‌Instructions: This measure is to be submitted each time a cataract procedure
- [2025 #387 MIPS Measure Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users](https://healthmonix.com/mips_quality_measure/annual-hepatitis-c-virus-hcv-screening-for-patients-who-are-active-injection-drug-users/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients, regardless of age, who are active injection drug users who received screening for HCV infection within the 12-month reporting period. ‌Instructions: This measure is to be submitted a minimum of once per performance period for all patients, regardless of age,
- [2025 #386 MIPS Measure Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences](https://healthmonix.com/mips_quality_measure/amyotrophic-lateral-sclerosis-als-patient-care-preferences/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: ‌Process – High Priority Description: Percentage of patients diagnosed with Amyotrophic Lateral Sclerosis (ALS) who were offered assistance in planning for end of life issues (e.g., advance directives, invasive ventilation, lawful physician-hastened death, or hospice) or whose existing end of life plan was reviewed or
- [2025 #385 MIPS Measure Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement Within 90 Days of Surgery](https://healthmonix.com/mips_quality_measure/adult-primary-rhegmatogenous-retinal-detachment-surgery-visual-acuity-improvement-within-90-days-of-surgery/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: ‌Outcome – High Priority Description: ‌Patients aged 18 years and older who had surgery for primary rhegmatogenous retinal detachment and achieved an improvement in their visual acuity, from their preoperative level, within 90 days of surgery in the operative eye. Instructions: This measure is to
- [2025 #384 MIPS Measure Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room Within 90 Days of Surgery](https://healthmonix.com/mips_quality_measure/adult-primary-rhegmatogenous-retinal-detachment-surgery-no-return-to-the-operating-room-within-90-days-of-surgery/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: ‌Outcome – High Priority Description: Patients aged 18 years and older who had surgery for primary rhegmatogenous retinal detachment who did not require a return to the operating room within 90 days of surgery. ‌Instructions: This measure is to be submitted each time a procedure
- [2025 #383 MIPS Measure Adherence to Antipsychotic Medications For Individuals with Schizophrenia](https://healthmonix.com/mips_quality_measure/2025-mips-measure-adherence-to-antipsychotic-medications-for-individuals-with-schizophrenia/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE:‌Intermediate Outcome – High Priority Description: Percentage of individuals at least 18 years of age as of the beginning of the performance period with schizophrenia or schizoaffective disorder who had at least two prescriptions filled for any antipsychotic medication and who had a Proportion of Days
- [2025 #374 MIPS Measure Closing the Referral Loop: Receipt of Specialist Report](https://healthmonix.com/mips_quality_measure/closing-the-referral-loop-receipt-of-specialist-report-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: ‌Percentage of patients with referrals, regardless of age, for which the referring clinician receives a report from the clinician to whom the patient was referred. Instructions: This measure is to be submitted a minimum of once per performance period for
- [2025 #370 MIPS Measure Depression Remission at Twelve Months](https://healthmonix.com/mips_quality_measure/depression-remission-at-twelve-months/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Outcome – High Priority ‌Description: The percentage of adolescent patients 12 to 17 years of age and adult patients 18 years of age or older with major depression or dysthymia who reached remission 12 months (+/- 60 days) after an index event date. ‌Instructions: This
- [2025 #364 MIPS Measure Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended Guidelines](https://healthmonix.com/mips_quality_measure/optimizing-patient-exposure-to-ionizing-radiation-appropriateness-follow-up-ct-imaging-for-incidentally-detected-pulmonary-nodules-according-to-recommended-guidelines/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of final reports for CT imaging studies with a finding of an incidental pulmonary nodule for patients aged 35 years and older that contain an impression or conclusion that includes a recommended interval and modality for follow-up (e.g., type
- [2025 #360 MIPS Measure Optimizing Patient Exposure to Ionizing Radiation: Count of Potential High Dose Radiation Imaging Studies: Computed Tomography (CT) and Cardiac Nuclear Medicine Studies](https://healthmonix.com/mips_quality_measure/optimizing-patient-exposure-to-ionizing-radiation-count-of-potential-high-dose-radiation-imaging-studies-computed-tomography-ct-and-cardiac-nuclear-medicine-studies/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of computed tomography (CT) and cardiac nuclear medicine (myocardial perfusion or infarct avid imaging) reports for all patients, regardless of age, that document a count of known previous CT (any type of CT) and cardiac nuclear medicine (myocardial perfusion
- [2025 #358 MIPS Measure Patient-Centered Surgical Risk Assessment and Communication](https://healthmonix.com/mips_quality_measure/patient-centered-surgical-risk-assessment-and-communication/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority ‌Description: ‌Percentage of patients who underwent a non-emergency surgery who had their personalized risks of postoperative complications assessed by their surgical team prior to surgery using a clinical data-based, patient-specific risk calculator and who received personal discussion of those risks with
- [2025 #357 MIPS Measure Surgical Site Infection (SSI)](https://healthmonix.com/mips_quality_measure/surgical-site-infection-ssi/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Outcome – High Priority ‌Description: Percentage of patients aged 18 years and older who had a surgical site infection (SSI). ‌Instructions: This measure is to be submitted each time a surgical procedure listed in the denominator is performed during the performance period. There is no
- [2025 #356 MIPS Measure Unplanned Hospital Readmission within 30 Days of Principal Procedure](https://healthmonix.com/mips_quality_measure/unplanned-hospital-readmission-within-30-days-of-principal-procedure/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE:Outcome – High Priority ‌DESCRIPTION: ‌Percentage of patients aged 18 years and older who had an unplanned hospital readmission within 30 days of principal procedure. INSTRUCTIONS: This measure is to be submitted each time a surgical procedure listed in the denominator is performed during the performance period. There
- [2025 #355 MIPS Measure Unplanned Reoperation within the 30-Day Postoperative Period](https://healthmonix.com/mips_quality_measure/unplanned-reoperation-within-the-30-day-postoperative-period/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Outcome – High Priority ‌Description: ‌Percentage of patients aged 18 years and older who had any unplanned reoperation within the 30-day postoperative period. Instructions: This measure is to be submitted each time an operative procedure listed in the denominator is performed during the performance period.
- [2025 #354 MIPS Measure Anastomotic Leak Intervention](https://healthmonix.com/mips_quality_measure/anastomotic-leak-intervention/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Outcome – High Priority ‌Description: Percentage of patients aged 18 years and older who required an anastomotic leak intervention following gastric bypass or colectomy surgery. ‌Instructions: This measure is to be submitted each time a procedure for gastric bypass or colectomy surgery is performed during
- [2025 #351 MIPS Measure Total Knee or Hip Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation](https://healthmonix.com/mips_quality_measure/total-knee-or-hip-replacement-venous-thromboembolic-and-cardiovascular-risk-evaluation/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: ‌Percentage of patients regardless of age undergoing a total knee or total hip replacement who are evaluated for the presence or absence of venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., History of Deep
- [2025 #350 MIPS Measure Total Knee or Hip Replacement: Shared Decision-Making: Trial of Conservative (Non-surgical) Therapy](https://healthmonix.com/mips_quality_measure/total-knee-or-hip-replacement-shared-decision-making-trial-of-conservative-non-surgical-therapy/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: ‌Process – High Priority Description: Percentage of patients regardless of age undergoing a total knee or total hip replacement with documented shared decision-making with discussion of conservative (non-surgical) therapy (e.g., non-steroidal anti-inflammatory drug (NSAIDs), analgesics, weight loss, exercise, injections) prior to the procedure. ‌Instructions: This
- [2025 #344 MIPS Measure Rate of Carotid Endarterectomy (CEA) or Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2)](https://healthmonix.com/mips_quality_measure/rate-of-carotid-endarterectomy-cea-or-carotid-artery-stenting-cas-for-asymptomatic-patients-without-major-complications-discharged-to-home-by-post-operative-day-2/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome – High Priority ‌Description: Percent of asymptomatic patients undergoing Carotid Endarterectomy (CEA) or Carotid Artery Stenting (CAS) without major complication who are discharged to home no later than post-operative day #2. ‌Instructions: This measure is to be submitted each time a CEA or CAS
- [2025 #340 MIPS Measure HIV Annual Retention in Care](https://healthmonix.com/mips_quality_measure/hiv-annual-retention-in-care/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority ‌Description: ‌Percentage of patients, regardless of age, with a diagnosis of Human Immunodeficiency Virus (HIV) before or during the first 240 days of the performance period who had at least two eligible encounters or at least one eligible encounter and one
- [2025 #338 MIPS Measure HIV Viral Suppression](https://healthmonix.com/mips_quality_measure/hiv-viral-suppression-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: ‌Outcome – High Priority Description: Percentage of patients, regardless of age, diagnosed with HIV prior to or during the first 90 days of the performance period, with an eligible encounter in the first 240 days of the performance period, whose last HIV viral load test
- [2025 #336 MIPS Measure Maternity Care: Postpartum Follow-up and Care Coordination](https://healthmonix.com/mips_quality_measure/maternity-care-postpartum-follow-up-and-care-coordination/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: ‌Process – High Priority Description: Percentage of patients, regardless of age, who gave birth during a 12-month period who were seen for postpartum care before or at 12 weeks of giving birth and received the following at a postpartum visit: breastfeeding evaluation and education, postpartum
- [2025 #335 MIPS Measure Maternity Care: Elective Delivery (Without Medical Indication) at < 39 Weeks (Overuse)](https://healthmonix.com/mips_quality_measure/maternity-care-elective-delivery-without-medical-indication-at-39-weeks-overuse/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Outcome – High Priority ‌Description: Percentage of patients, regardless of age, who gave birth during a 12-month period, delivered a live singleton at < 39 weeks of gestation, and had elective deliveries (without medical indication) by cesarean birth or induction of labor. ‌Instructions: This measure
- [2025 #332 MIPS Measure Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use)](https://healthmonix.com/mips_quality_measure/adult-sinusitis-appropriate-choice-of-antibiotic-amoxicillin-with-or-without-clavulanate-prescribed-for-patients-with-acute-bacterial-sinusitis-appropriate-use/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: ‌Process – High Priority Description: ‌Percentage of patients aged 18 years and older with a diagnosis of acute bacterial sinusitis that were prescribed amoxicillin, with or without clavulanate, as a first line antibiotic at the time of diagnosis. Instructions: This measure may be submitted based
- [2025 #331 MIPS Measure Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse)](https://healthmonix.com/mips_quality_measure/adult-sinusitis-antibiotic-prescribed-for-acute-viral-sinusitis-overuse/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority ‌Description: Percentage of patients, aged 18 years and older, with a diagnosis of acute viral sinusitis who were prescribed an antibiotic within 10 days after onset of symptoms. ‌Instructions: This measure may be submitted based on the actions of the submitting
- [2025 #326 MIPS Measure Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy](https://healthmonix.com/mips_quality_measure/atrial-fibrillation-and-atrial-flutter-chronic-anticoagulation-therapy/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients aged 18 years and older with atrial fibrillation (AF) or atrial flutter who were prescribed an FDA- approved oral anticoagulant drug for the prevention of thromboembolism during the measurement period. ‌Instructions: This measure is to be submitted a minimum of
- [2025 #322 MIPS Measure Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low-Risk Surgery Patients](https://healthmonix.com/mips_quality_measure/cardiac-stress-imaging-not-meeting-appropriate-use-criteria-preoperative-evaluation-in-low-risk-surgery-patients/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Efficiency – High Priority ‌Description: Percentage of stress single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), stress echocardiogram (ECHO), multigated acquisition scan (MUGA), cardiac computed tomography angiography (CCTA), or cardiac magnetic resonance (CMR) performed in low-risk surgery patients 18 years or older for preoperative
- [2025 #320 MIPS Measure Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients](https://healthmonix.com/mips_quality_measure/appropriate-follow-up-interval-for-normal-colonoscopy-in-average-risk-patients/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: ‌Percentage of patients aged 45 to 75 years of age receiving a screening colonoscopy without biopsy or polypectomy who had a recommended follow-up interval of 10 years for repeat colonoscopy documented in their colonoscopy report. Instructions: ‌This measure is to
- [2025 #317 MIPS Measure Preventive Care and Screening: Screening for High Blood Pressure and Follow- Up Documented](https://healthmonix.com/mips_quality_measure/preventive-care-and-screening-screening-for-high-blood-pressure-and-follow-up-documented/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: ‌Process Description: Percentage of patient visits for patients aged 18 years and older seen during the performance period who were screened for high blood pressure AND a recommended follow-up plan is documented, as indicated, if blood pressure is elevated or hypertensive. ‌Instructions: This measure is
- [2025 #304 MIPS Measure Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery](https://healthmonix.com/mips_quality_measure/cataracts-patient-satisfaction-within-90-days-following-cataract-surgery/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Patient Engagement / Experience – High Priority ‌Description: ‌Percentage of patients aged 18 years and older who had cataract surgery and were satisfied with their care within 90 days following the cataract surgery, based on completion of the Consumer Assessment of Healthcare Providers and Systems
- [2025 #303 MIPS Measure Cataracts: Improvement in Patient’s Visual Function within 90 Days Following Cataract Surgery](https://healthmonix.com/mips_quality_measure/cataracts-improvement-in-patients-visual-function-within-90-days-following-cataract-surgery/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority ‌Description: Percentage of patients aged 18 years and older who had cataract surgery and had improvement in visual function achieved within 90 days following the cataract surgery, based on completing a pre-operative and post-operative visual function survey. ‌Instructions:
- [2025 #293 MIPS Measure Rehabilitative Therapy Referral for Patients with Parkinson’s Disease](https://healthmonix.com/mips_quality_measure/rehabilitative-therapy-referral-for-patients-with-parkinsons-disease/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority ‌Description: ‌Percentage of all patients with a diagnosis of Parkinson’s Disease (PD) who were referred to physical, occupational, speech, or recreational therapy once during the measurement period. Instructions: This measure is to be submitted a minimum of once per performance period
- [2025 #291 MIPS Measure Assessment of Cognitive Impairment or Dysfunction for Patients with Parkinson’s Disease](https://healthmonix.com/mips_quality_measure/assessment-of-cognitive-impairment-or-dysfunction-for-patients-with-parkinsons-disease/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: ‌Process Description: Percentage of all patients with a diagnosis of Parkinson’s disease (PD) who were assessed for cognitive impairment or dysfunction once during the measurement period. ‌Instructions: This measure is to be submitted a minimum of once per performance period for patients with a diagnosis
- [2025 #290 MIPS Measure Assessment of Mood Disorders and Psychosis for Patients with Parkinson’s Disease](https://healthmonix.com/mips_quality_measure/assessment-of-mood-disorders-and-psychosis-for-patients-with-parkinsons-disease/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of all patients with a diagnosis of Parkinson’s disease (PD) who were assessed for depression, anxiety, apathy, AND psychosis once during the measurement period. ‌Instructions: This measure is to be submitted a minimum of once per performance period for patients with a
- [2025 #288 MIPS Measure Dementia: Education and Support of Caregivers for Patients with Dementia](https://healthmonix.com/mips_quality_measure/dementia-education-and-support-of-caregivers-for-patients-with-dementia/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: ‌Percentage of patients with dementia whose caregiver(s) were provided with education on dementia disease management and health behavior changes AND were referred to additional resources for support in the last 12 months. Instructions: This measure is to be submitted a
- [2025 #286 MIPS Measure Safety Concern Screening and Follow-Up for Patients with Dementia](https://healthmonix.com/mips_quality_measure/safety-concern-screening-and-follow-up-for-patients-with-dementia/) - ‌2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of patients with dementia or their caregiver(s) for whom there was a documented safety concerns screening in two domains of risk: 1) dangerousness to self or others and 2) environmental risks; and if safety concerns screening was positive in
- [2025 #282 MIPS Measure Functional Status Assessment](https://healthmonix.com/mips_quality_measure/functional-status-assessment/) - ‌2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients with dementia for whom an assessment of functional status was performed at least once in the last 12 months. ‌Instructions: This measure is to be submitted a minimum of once per performance period for patients with a diagnosis of dementia
- [2025 #279 MIPS Measure Sleep Apnea: Assessment of Adherence to Obstructive Sleep Apnea (OSA) Therapy](https://healthmonix.com/mips_quality_measure/sleep-apnea-assessment-of-adherence-to-obstructive-sleep-apnea-osa-therapy/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: ‌Process Description: Percentage of patients aged 18 years and older with a diagnosis of obstructive sleep apnea (OSA) that were prescribed an evidence-based therapy that had documentation that adherence to therapy was assessed at least annually through an objective informatics system or through self-reporting (if
- [2025 #277 MIPS Measure Sleep Apnea: Severity Assessment at Initial Diagnosis](https://healthmonix.com/mips_quality_measure/sleep-apnea-severity-assessment-at-initial-diagnosis/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process ‌Description: ‌Percentage of patients aged 18 yearsand older with a diagnosis of obstructive sleep apnea who had an apnea hypopnea index (AHI), a respiratory disturbance index (RDI), or a respiratory event index (REI) documented or measured within 2 months after initial evaluation for suspected
- [2025 #275 MIPS Measure Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy](https://healthmonix.com/mips_quality_measure/inflammatory-bowel-disease-ibd-assessment-of-hepatitis-b-virus-hbv-status-before-initiating-anti-tnf-tumor-necrosis-factor-therapy/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients with a diagnosis of inflammatory bowel disease (IBD) who had Hepatitis B Virus (HBV) status assessed and results interpreted prior to initiating anti-TNF (tumor necrosis factor) therapy. Instructions: This measure is to be submitted a minimum of once per performance
- [2025 #268 MIPS Measure Counseling for Women of Childbearing Potential with Epilepsy](https://healthmonix.com/mips_quality_measure/counseling-for-women-of-childbearing-potential-with-epilepsy/) - ‌2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process ‌Description: ‌Percentage of all patients of childbearing potential (12 years and older) diagnosed with epilepsy who were counseled at least once a year about how epilepsy and its treatment may affect contraception and pregnancy. Instructions: This measure is to be submitted a minimum of
- [2025 #264 MIPS Measure Sentinel Lymph Node Biopsy for Invasive Breast Cancer](https://healthmonix.com/mips_quality_measure/sentinel-lymph-node-biopsy-for-invasive-breast-cancer/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: The percentage of clinically node negative (clinical stage T1N0M0 or T2N0M0) breast cancer patients before or after neoadjuvant systemic therapy, who undergo a sentinel lymph node (SLN) procedure. ‌Instructions: This measure is to be submitted each time a procedure is performed during the
- [2025 #261 MIPS Measure Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness](https://healthmonix.com/mips_quality_measure/referral-for-otologic-evaluation-for-patients-with-acute-or-chronic-dizziness/) - ‌2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: ‌Percentage of patients aged birth and older referred to a physician (preferably a physician specially trained in disorders of the ear) for an otologic evaluation subsequent to an audiologic evaluation after presenting with acute or chronic dizziness. Instructions: This measure
- [2025 #259 MIPS Measure Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #2)](https://healthmonix.com/mips_quality_measure/rate-of-endovascular-aneurysm-repair-evar-of-small-or-moderate-non-ruptured-infrarenal-abdominal-aortic-aneurysms-aaa-without-major-complications-discharged-to-home-by-post-operative-day-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Outcome – High Priority ‌Description: Percent of patients undergoing endovascular repair of small or moderate non-ruptured infrarenal abdominal aortic aneurysms (AAA) that do not experience a major complication (discharged to home no later than post-operative day #2). ‌Instructions: This measure is to be submitted each
- [2025 #250 MIPS Measure Radical Prostatectomy Pathology Reporting](https://healthmonix.com/mips_quality_measure/radical-prostatectomy-pathology-reporting/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process ‌Description: ‌Percentage of radical prostatectomy pathology reports that include the pT category, the pN category, the Gleason score and a statement about margin status. Instructions: This measure is to be submitted each time a radical prostatectomy surgical pathology examination is performed during the performance
- [2025 #249 MIPS Measure Barrett’s Esophagus](https://healthmonix.com/mips_quality_measure/barretts-esophagus/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process ‌Description: ‌Percentage of esophageal biopsy reports that document the presence of Barrett’s mucosa that also include a statement about dysplasia. Instructions: This measure is to be submitted each time a patient’s esophageal surgical pathology report demonstrates Barrett’s Esophagus; however, only one quality data code
- [2025 #243 MIPS Measure Cardiac Rehabilitation Patient Referral from an Outpatient Setting](https://healthmonix.com/mips_quality_measure/cardiac-rehabilitation-patient-referral-from-an-outpatient-setting/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process-High Priority ‌Description: Percentage of patients evaluated in an outpatient setting who within the previous 12 months have experienced an acute myocardial infarction (MI), coronary artery bypass graft (CABG) surgery, a percutaneous coronary intervention (PCI), cardiac valve surgery, or cardiac transplantation, or who have chronic
- [2025 #238 MIPS Measure Use of High-Risk Medications in Older Adults](https://healthmonix.com/mips_quality_measure/use-of-high-risk-medications-in-older-adults/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority ‌Description: Percentage of patients 65 years of age and older who were ordered at least two high-risk medications from the same drug class. ‌Instructions: This measure is to be submitted a minimum of once per performance period for patients seen during
- [2025 #236 MIPS Measure Controlling High Blood Pressure](https://healthmonix.com/mips_quality_measure/controlling-high-blood-pressure-2/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: ‌Intermediate Outcome – High Priority Description: ‌Percentage of patients 18-85 years of age who had a diagnosis of essential hypertension starting before and continuing into, or starting during the first six months of the measurement period, and whose most recent blood pressure was adequately controlled
- [2025 #226 MIPS Measure Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention](https://healthmonix.com/mips_quality_measure/preventive-care-and-screening-tobacco-use-screening-and-cessation-intervention/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: ‌Percentage of patients aged 12 years and older who were screened for tobacco use one or more times within the measurement period AND who received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period if
- [2025 #222 MIPS Measure Functional Status Change for Patients with Elbow, Wrist or Hand Impairments](https://healthmonix.com/mips_quality_measure/functional-status-change-for-patients-with-elbow-wrist-or-hand-impairments/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority ‌Description: A patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients 14 years+ with elbow, wrist, or hand impairments. The change in FS is assessed using the FOTO Elbow/Wrist/Hand FS PROM. The measure is
- [2025 #221 MIPS Measure Functional Status Change for Patients with Shoulder Impairments](https://healthmonix.com/mips_quality_measure/functional-status-change-for-patients-with-shoulder-impairments/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority ‌Description: A patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients 14 years+ with shoulder impairments. The change in FS is assessed using the FOTO Shoulder FS PROM. The measure is adjusted to patient
- [2025 #220 MIPS Measure Functional Status Change for Patients with Low Back Impairments](https://healthmonix.com/mips_quality_measure/functional-status-change-for-patients-with-low-back-impairments/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority ‌Description: A patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients 14 years+ with low back impairments. The change in FS is assessed using the FOTO Low Back FS PROM. The measure is adjusted
- [2025 #219 MIPS Measure Functional Status Change for Patients with Lower Leg, Foot or Ankle Impairments](https://healthmonix.com/mips_quality_measure/functional-status-change-for-patients-with-lower-leg-foot-or-ankle-impairments/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority ‌Description: A patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients 14 years+ with foot, ankle or lower leg impairments. The change in FS is assessed using the FOTO Lower Extremity Physical Function (LEPF)
- [2025 #218 MIPS Measure Functional Status Change for Patients with Hip Impairments](https://healthmonix.com/mips_quality_measure/functional-status-change-for-patients-with-hip-impairments/) - ‌2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority ‌Description: A patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients 14 years+ with hip impairments. The change in FS is assessed using the FOTO Lower Extremity Physical Function (LEPF) PROM. The measure is
- [2025 #217 MIPS Measure Functional Status Change for Patients with Knee Impairments](https://healthmonix.com/mips_quality_measure/functional-status-change-for-patients-with-knee-impairments/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority ‌Description: A patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients 14 years+ with knee impairments. The change in FS is assessed using the FOTO Lower Extremity Physical Function (LEPF) PROM. The measure is
- [2025 #205 MIPS Measure Sexually Transmitted Infection (STI) Testing for People with HIV](https://healthmonix.com/mips_quality_measure/sexually-transmitted-infection-sti-testing-for-people-with-hiv/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: ‌Process Description: ‌Percentage of patients 13 years of age and older with a diagnosis of HIV who had tests for syphilis, gonorrhea, and chlamydia performed within the performance period. Instructions: This measure is to be submitted a minimum of once per performance period for patients
- [2025 #191 MIPS Measure Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery](https://healthmonix.com/mips_quality_measure/cataracts-20-40-or-better-visual-acuity-within-90-days-following-cataract-surgery/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: ‌Outcome – High Priority Description: Percentage of cataract surgeries for patients aged 18 years and older with a diagnosis of uncomplicated cataract and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near)
- [2025 #187 MIPS Measure Stroke and Stroke Rehabilitation: Thrombolytic Therapy‌‌‌‌‌‌](https://healthmonix.com/mips_quality_measure/stroke-and-stroke-rehabilitation-thrombolytic-therapy/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients aged 18 years and older with a diagnosis of acute ischemic stroke who arrive at the hospital within 3.5 hours of time last known well and for whom IV thrombolytic therapy was initiated within 4.5 hours of time last known
- [2025 #185 MIPS Measure Colonoscopy Interval for Patients with a History of Adenomatous Polyps – Avoidance of Inappropriate Use](https://healthmonix.com/mips_quality_measure/colonoscopy-interval-for-patients-with-a-history-of-adenomatous-polyps-avoidance-of-inappropriate-use/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: Percentage of patients aged 18 years and older receiving a surveillance colonoscopy, with a history of prior adenomatous polyp(s) in previous colonoscopy findings, which had an interval of 3 or more years since their last colonoscopy. Instructions: This measure is
- [2025 #182 MIPS Measure Functional Outcome Assessment](https://healthmonix.com/mips_quality_measure/functional-outcome-assessment/) - ‌2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority ‌Description: Percentage of visits for patients aged 18 years and older with documentation of a current functional outcome assessment using a standardized functional outcome assessment tool on the date of the encounter AND documentation of a care plan based on identified
- [2025 #181 MIPS Measure Elder Maltreatment Screen and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/elder-maltreatment-screen-and-follow-up-plan/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: ‌Process – High Priority Description: ‌Percentage of patients aged 60 years and older with a documented elder maltreatment screen using an Elder Maltreatment Screening tool on the date of encounter AND a documented follow-up plan on the date of the positive screen. Instructions: ‌This measure
- [2025 #180 MIPS Measure Rheumatoid Arthritis (RA): Glucocorticoid Management](https://healthmonix.com/mips_quality_measure/rheumatoid-arthritis-ra-glucocorticoid-management/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients aged 18 years and older with two or more diagnoses of rheumatoid arthritis (RA) at least 90 days apart who have been assessed for glucocorticoid use and, for those on prolonged doses of prednisone >5 mg daily (or equivalent) with
- [2025 #178 MIPS Measure Rheumatoid Arthritis (RA): Functional Status Assessment](https://healthmonix.com/mips_quality_measure/rheumatoid-arthritis-ra-functional-status-assessment/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients aged 18 years and older with two or more diagnoses of rheumatoid arthritis (RA) at least 90 days apart for whom a functional status assessment was performed at least once during the performance period. ‌Instructions: This measure is to be
- [2025 #177 MIPS Measure Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity](https://healthmonix.com/mips_quality_measure/rheumatoid-arthritis-ra-periodic-assessment-of-disease-activity/) - ‌2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients aged 18 years and older with two or more diagnoses of rheumatoid arthritis (RA) at least 90 days apart who have an assessment of disease activity using an ACR-preferred RA disease activity assessment tool at ≥50% of encounters for RA
- [2025 #176 MIPS Measure Tuberculosis Screening Prior to First Course of Biologic and/or Immune Response Modifier Therapy](https://healthmonix.com/mips_quality_measure/tuberculosis-screening-prior-to-first-course-of-biologic-and-or-immune-response-modifier-therapy/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: If a patient has been newly prescribed a biologic and/or immune response modifier that includes a warning for potential reactivation of a latent infection, then the medical record should indicate TB testing in the preceding 12-month period. ‌Instructions: This measure is to be
- [2025 #168 MIPS Measure Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration](https://healthmonix.com/mips_quality_measure/coronary-artery-bypass-graft-cabg-surgical-re-exploration/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Outcome – High Priority ‌Description: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who require a return to the operating room (OR) for mediastinal bleeding with or without tamponade, unplanned coronary artery intervention (native vessel, graft or both), valve dysfunction, aortic
- [2025 #167 MIPS Measure Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure](https://healthmonix.com/mips_quality_measure/coronary-artery-bypass-graft-cabg-postoperative-renal-failure/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Outcome – High Priority ‌Description: Percentage of patients aged 18 years and older undergoing isolated CABG surgery (without pre-existing renal failure) who develop postoperative renal failure or require dialysis. ‌Instructions: This measure is to be submitted each time an isolated CABG procedure is performed during
- [2025 #164 MIPS Measure Coronary Artery Bypass Graft (CABG): Prolonged Intubation](https://healthmonix.com/mips_quality_measure/coronary-artery-bypass-graft-cabg-prolonged-intubation/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Outcome – High Priority ‌Description: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who require postoperative intubation > 24 hours. ‌Instructions: This measure is to be submitted each time an isolated CABG procedure is performed during the performance period. It is
- [2025 #155 MIPS Measure Falls: Plan of Care](https://healthmonix.com/mips_quality_measure/falls-plan-of-care/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of patients aged 65 years and older with a history of falls who had a plan of care for falls documented within 12 months. ‌Instructions: This measure is to be submitted a minimum of once per performance period for
- [2025 #145 MIPS Measure Radiology: Exposure Dose Indices Reported for Procedures Using Fluoroscopy](https://healthmonix.com/mips_quality_measure/coronary-artery-disease-cad-beta-blocker-therapy-prior-myocardial-infarction-mi-or-left-ventricular-systolic-dysfunction-lvef-less-than-or-equal-to-40/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: ‌Final reports for procedures using fluoroscopy that document radiation exposure indices. Instructions: This measure is to be submitted each time a procedure using fluoroscopy is performed in a hospital or outpatient setting during the performance period. There is no diagnosis
- [2025 #144 MIPS Measure Oncology: Medical and Radiation – Plan of Care for Pain](https://healthmonix.com/mips_quality_measure/oncology-medical-and-radiation-plan-of-care-for-pain/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of visits for patients, regardless of age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy who report having pain with a documented plan of care to address pain. ‌Instructions: This measure is to be submitted at
- [2025 #143 MIPS Measure Oncology: Medical and Radiation – Pain Intensity Quantified](https://healthmonix.com/mips_quality_measure/oncology-medical-and-radiation-pain-intensity-quantified/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified. ‌Instructions: This measure is to be submitted at each denominator eligible visit occurring during the
- [2025 #141 MIPS Measure Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 20% OR Documentation of a Plan of Care](https://healthmonix.com/mips_quality_measure/primary-open-angle-glaucoma-poag-reduction-of-intraocular-pressure-iop-by-20-or-documentation-of-a-plan-of-care/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: ‌Outcome – High Priority Description: ‌percentage of Patients Aged 18 Years and Older with A Diagnosis of Primary Open-Angle Glaucoma (poag) Whose Glaucoma Treatment Has Not Failed (the Most Recent Iop Was Reduced by At Least 20% from The Pre-Intervention Level) or If the Most
- [2025 #130 MIPS Measure Documentation of Current Medications in the Medical Record](https://healthmonix.com/mips_quality_measure/documentation-of-current-medications-in-the-medical-record-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of visits for which the eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter. ‌Instructions: This measure is to be submitted at each denominator eligible visit during
- [2025 #128 MIPS Measure Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/preventive-care-and-screening-body-mass-index-bmi-screening-and-follow-up-plan/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) – MIPS VALUE PATHWAYS (MVP) REPORTING ONLY ‌MEASURE TYPE: Process ‌Description: ‌Percentage of patients aged 18 years and older with a BMI documented during the current encounter or within the previous twelve months AND who had a follow-up plan documented if the most recent BMI was outside
- [2025 #127 MIPS Measure Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear‌‌‌‌‌‌‌](https://healthmonix.com/mips_quality_measure/2025-mips-measure-diabetes-mellitus-diabetic-foot-and-ankle-care-ulcer-prevention-evaluation-of-footwear/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who were evaluated for proper footwear and sizing. Instructions: This measure is to be submitted a minimum of once per performance period for patients with diabetes mellitus seen during
- [2025 #126 MIPS Measure Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy — Neurological Evaluation](https://healthmonix.com/mips_quality_measure/2025-mips-measure-diabetes-mellitus-diabetic-foot-and-ankle-care-peripheral-neuropathy-neurological-evaluation/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who had a neurological examination of their lower extremities within 12 months. ‌Instructions: This measure is to be submitted a minimum of once per performance period for patients with
- [2025 #118 MIPS Measure Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)](https://healthmonix.com/mips_quality_measure/coronary-artery-disease-cad-angiotensin-converting-enzyme-ace-inhibitor-or-angiotensin-receptor-blocker-arb-therapy-diabetes-or-left-ventricular-systolic-dysfunction-lvef-≤-40/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES ‌MEASURE TYPE: Process ‌Description: Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12- month period who also have diabetes OR a current or prior Left Ventricular Ejection Fraction (LVEF) ≤ 40% who were prescribed ACE inhibitor or ARB
- [2025 #117 MIPS Measure Diabetes: Eye Exam](https://healthmonix.com/mips_quality_measure/diabetes-eye-exam/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process ‌Description: Percentage of patients 18-75 years of age with diabetes and an active diagnosis of retinopathy in any part of the measurement period who had a retinal or dilated eye exam during the measurement period or diabetics with no diagnosis of retinopathy in any
- [2025 #116	MIPS Measure Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis](https://healthmonix.com/mips_quality_measure/avoidance-of-antibiotic-treatment-for-acute-bronchitis-bronchiolitis/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: The percentage of episodes for patients ages 3 months and older with a diagnosis of acute bronchitis/bronchiolitis that did not result in an antibiotic dispensing event. ‌Instructions: This measure is to be submitted at each occurrence of acute bronchitis/bronchiolitis during
- [2025 #113 MIPS Measure Colorectal Cancer Screening](https://healthmonix.com/mips_quality_measure/colorectal-cancer-screening/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) – MIPS VALUE PATHWAYS (MVP) REPORTING ONLY MEASURE TYPE: ‌Process Description: Percentage of patients 45-75 years of age who had appropriate screening for colorectal cancer ‌Instructions: This measure is to be submitted a minimum of once per performance period for patients seen during the performance period. There
- [2025 #112 MIPS Measure Breast Cancer Screening](https://healthmonix.com/mips_quality_measure/breast-cancer-screening/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) – MIPS VALUE PATHWAYS (MVP) REPORTING ONLY MEASURE TYPE: ‌Process Description: ‌Percentage of women 40 - 74 years of age who had a mammogram to screen for breast cancer in the 27 months prior to the end of the measurement period. Instructions: This measure is to be
- [2025 #102 MIPS Measure Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients](https://healthmonix.com/mips_quality_measure/prostate-cancer-avoidance-of-overuse-of-bone-scan-for-staging-low-risk-prostate-cancer-patients/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone
- [2025 #66 MIPS Measure Appropriate Testing for Pharyngitis](https://healthmonix.com/mips_quality_measure/appropriate-testing-for-pharyngitis/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority ‌Description: ‌The percentage of episodes for patients 3 years and older with a diagnosis of pharyngitis that resulted in an antibiotic order on or within 3 days after the episode date and a group A Streptococcus (Strep) test in the seven-day
- [2025 #65 MIPS Measure Appropriate Treatment for Upper Respiratory Infection (URI)](https://healthmonix.com/mips_quality_measure/appropriate-treatment-for-upper-respiratory-infection-uri/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: ‌Process – High Priority Description: ‌Percentage of episodes for patients 3 months of age and older with a diagnosis of upper respiratory infection (URI) that did not result in an antibiotic order. Instructions: This measure is to be submitted once for each occurrence of upper
- [2025 #52 MIPS Measure Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation and Long-Acting Inhaled Bronchodilator Therapy](https://healthmonix.com/mips_quality_measure/chronic-obstructive-pulmonary-disease-copd-spirometry-evaluation-and-long-acting-inhaled-bronchodilator-therapy/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients aged 18 years and older with a diagnosis of COPD with a documented FEV1/FVC < 70% measured by spirometry, who are symptomatic, and were prescribed a long-acting inhaled bronchodilator. ‌Instructions: This measure is to be submitted a minimum of once
- [2025 #50 MIPS Measure Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older](https://healthmonix.com/mips_quality_measure/urinary-incontinence-plan-of-care-for-urinary-incontinence-in-women-aged-65-years-and-older/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: ‌Process – High Priority Description: ‌Percentage of female patients aged 65 years and older with a diagnosis of urinary incontinence with a documented plan of care for urinary incontinence at least once within 12 months. Instructions: This measure is to be submitted a minimum of
- [2025 #48 MIPS Measure Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older](https://healthmonix.com/mips_quality_measure/urinary-incontinence-assessment-of-presence-or-absence-of-urinary-incontinence-in-women-aged-65-years-and-older/) - 2025 COLLECTION TYPE: ‌MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process ‌Description: Percentage of Female Patients Aged 65 Years and Older Who Were Assessed for The Presence or Absence of Urinary Incontinence Within 12 Months. ‌Instructions: This Measure Is to Be Submitted a Minimum of Once per Performance Period For Patients Seen During the Performance
- [2025 #47 MIPS Measure Advance Care Plan](https://healthmonix.com/mips_quality_measure/advance-care-plan-2/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of Patients Aged 65 Years and Older Who Have an Advance Care Plan or Surrogate Decision Maker Documented in The Medical Record or Documentation in The Medical Record that An Advance Care Plan Was Discussed but The Patient Did
- [2025 #39 MIPS Measure Screening for Osteoporosis for Women Aged 65-85 Years of Age](https://healthmonix.com/mips_quality_measure/screening-for-osteoporosis-for-women-aged-65-85-years-of-age/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of women 65-85 years of age who ever had a central dual-energy X-ray absorptiometry (DXA) test to check for osteoporosis. ‌Instructions: This measure is to be submitted a minimum of once per performance period for patients seen during the performance period. Women
- [2025 #24 MIPS Measure Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older](https://healthmonix.com/mips_quality_measure/communication-with-the-physician-or-other-clinician-managing-on-going-care-post-fracture-for-men-and-women-aged-50-years-and-older/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description: Percentage of patients aged 50 years and older treated for a fracture with documentation of communication, between the physician treating the fracture and the physician or other clinician managing the patient’s on-going care, that a fracture occurred and that the
- [2025 #8 MIPS Measure Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)](https://healthmonix.com/mips_quality_measure/heart-failure-hf-beta-blocker-therapy-for-left-ventricular-systolic-dysfunction-lvsd/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) ≤ 40% who were prescribed beta-blocker therapy either within a 12-month period when seen in the outpatient setting
- [2025 #7 MIPS Measure Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)](https://healthmonix.com/mips_quality_measure/coronary-artery-disease-cad-beta-blocker-therapy-prior-myocardial-infarction-mi-or-left-ventricular-systolic-dysfunction-lvef-≤-40/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12-month period who also have a prior MI or a current or prior LVEF ≤ 40% who were prescribed beta-blocker therapy. ‌Instructions: This measure is
- [2025 #6 MIPS Measure Coronary Artery Disease (CAD): Antiplatelet Therapy](https://healthmonix.com/mips_quality_measure/coronary-artery-disease-cad-antiplatelet-therapy/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease (CAD) seen within a 12- month period who were prescribed aspirin or clopidogrel. ‌Instructions: This Measure Is to Be Submitted a Minimum of Once per Performance Period For
- [2025 #5 MIPS Measure Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)](https://healthmonix.com/mips_quality_measure/heart-failure-hf-angiotensin-converting-enzyme-ace-inhibitor-or-angiotensin-receptor-blocker-arb-or-angiotensin-receptor-neprilysin-inhibitor-arni-therapy-for-left-ventricular-systolic-dysfun/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: Process ‌Description: Percentage of Patients Aged 18 Years and Older with A Diagnosis of Heart Failure (hf) with A Current or Prior Left Ventricular Ejection Fraction (lvef) ≤ 40% Who Were Prescribed Ace Inhibitor or Arb or Arni Therapy Either Within a 12-Month Period when
- [2025 #1 MIPS Measure Diabetes: Glycemic Status Assessment Greater Than 9%](https://healthmonix.com/mips_quality_measure/diabetes-glycemic-status-assessment-greater-than-9/) - 2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE:‌Intermediate Outcome – High Priority Description: ‌Percentage of patients 18-75 years of age with diabetes who had a glycemic status assessment (hemoglobin A1c [HbA1c] or glucose management indicator [GMI]) > 9.0% during the measurement period. Instructions: This Measure Is to Be Submitted a Minimum of Once
- [2026 # 340 HIV Annual Retention in Care](https://healthmonix.com/mips_quality_measure/2026-340-hiv-annual-retention-in-care/) - Title HIV Annual Retention in Care CMS eCQM ID CMS115v2 CBE ID Not Applicable MIPS Quality ID 340 Measure Steward Health Resources & Services Administration Description Percentage of patients, regardless of age, with a diagnosis of Human Immunodeficiency Virus (HIV) during the first 240 days of the measurement period or before the measurement period who
- [2026 # 475 HIV Screening](https://healthmonix.com/mips_quality_measure/2026-475-hiv-screening/) - Title HIV Screening CMS eCQM ID CMS349v8 CBE ID Not Applicable MIPS Quality ID 475 Measure Steward Centers for Disease Control and Prevention (CDC) Description Percentage of patients aged 15-65 at the start of the measurement period who were between 15-65 years old when tested for human immunodeficiency virus (HIV) Measure Scoring Proportion Measure Type
- [2026 # 338 HIV Viral Suppression](https://healthmonix.com/mips_quality_measure/2026-338-hiv-viral-suppression/) - Title HIV Viral Suppression CMS eCQM ID CMS314v3 CBE ID Not Applicable MIPS Quality ID 338 Measure Steward Health Resources & Services Administration Description Percentage of patients, regardless of age, diagnosed with Human Immunodeficiency Virus (HIV) prior to or during the first 90 days of the measurement period, with an eligible encounter in the first
- [2026 # 305 Initiation and Engagement of Substance Use Disorder Treatment](https://healthmonix.com/mips_quality_measure/2026-305-initiation-and-engagement-of-substance-use-disorder-treatment/) - Title Initiation and Engagement of Substance Use Disorder Treatment CMS eCQM ID CMS137v14 CBE ID Not Applicable MIPS Quality ID 305 Measure Steward National Committee for Quality Assurance Description Percentage of patients 13 years of age and older with a new substance use disorder (SUD) episode who received the following (Two rates are reported): a.
- [2026 # 481 Intravesical Bacillus-Calmette-Guerin for Non-Muscle Invasive Bladder Cancer](https://healthmonix.com/mips_quality_measure/2026-481-intravesical-bacillus-calmette-guerin-for-non-muscle-invasive-bladder-cancer/) - Title Intravesical Bacillus–Calmette–Guerin for Non-Muscle Invasive Bladder Cancer CMS eCQM ID CMS646v6 CBE ID Not Applicable MIPS Quality ID 481 Measure Steward Oregon Urology Description Percentage of patients initially diagnosed with non-muscle invasive bladder cancer and who received intravesical Bacillus-Calmette-Guerin (BCG) within 6 months of bladder cancer staging Measure Scoring Proportion Measure Type Process Stratification
- [2026 # 488 Kidney Health Evaluation](https://healthmonix.com/mips_quality_measure/2026-488-kidney-health-evaluation/) - Title Kidney Health Evaluation CMS eCQM ID CMS951v4 CBE ID Not Applicable MIPS Quality ID 488 Measure Steward National Kidney Foundation Description Percentage of patients aged 18-85 years with a diagnosis of diabetes who received a kidney health evaluation defined by an Estimated Glomerular Filtration Rate (eGFR) AND Urine Albumin-Creatinine Ratio (uACR) within the measurement
- [2026 # 143 Oncology: Medical and Radiation - Pain Intensity Quantified](https://healthmonix.com/mips_quality_measure/2026-143-oncology-medical-and-radiation-pain-intensity-quantified/) - Title Oncology: Medical and Radiation - Pain Intensity Quantified CMS eCQM ID CMS157v14 CBE ID 0384e MIPS Quality ID 143 Measure Steward American Society of Clinical Oncology Description Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified Measure Scoring
- [2026 # 128 Preventive Care and Screening Body Mass Index (BMI) Screening and Follow Up Plan](https://healthmonix.com/mips_quality_measure/2026-128-preventive-care-and-screening-body-mass-index-bmi-screening-and-follow-up-plan/) - Title Preventive Care and Screening Body Mass Index (BMI) Screening and Follow Up Plan CMS eCQM ID CMS69v14 CBE ID Not Applicable MIPS Quality ID 128 Measure Steward Centers for Medicare & Medicaid Services (CMS) Description Percentage of patients aged 18 years and older with a BMI documented during the current encounter or during the
- [2026 # 317 Preventive Care and Screening Screening for High Blood Pressure and Follow Up Documented](https://healthmonix.com/mips_quality_measure/2026-317-preventive-care-and-screening-screening-for-high-blood-pressure-and-follow-up-documented/) - Title Preventive Care and Screening Screening for High Blood Pressure and Follow Up Documented CMS eCQM ID CMS22v14 CBE ID Not Applicable MIPS Quality ID 317 Measure Steward Centers for Medicare & Medicaid Services (CMS) Description Percentage of patient visits for patients aged 18 years and older seen during the measurement period who were screened
- [2026 # 134 Preventive Care and Screening: Screening for Depression and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/2026-134-preventive-care-and-screening-screening-for-depression-and-follow-up-plan/) - Title Preventive Care and Screening: Screening for Depression and Follow-Up Plan CMS eCQM ID CMS22v15 CBE ID Not Applicable MIPS Quality ID 134 Measure Steward Centers for Medicare & Medicaid Services (CMS) Description Percentage of patients aged 12 years and older screened for depression on the date of the encounter or up to 14 days
- [2026 # 226 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention](https://healthmonix.com/mips_quality_measure/2026-226-preventive-care-and-screening-tobacco-use-screening-and-cessation-intervention/) - Title Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention CMS eCQM ID CMS138v14 CBE ID Not Applicable MIPS Quality ID 226 Measure Steward National Committee for Quality Assurance Description Percentage of patients aged 12 years and older who were screened for tobacco use one or more times during the measurement period AND who
- [2026 # 379 Primary Caries Prevention Intervention as Offered by Dentists](https://healthmonix.com/mips_quality_measure/2026-379-primary-caries-prevention-intervention-as-offered-by-dentists/) - Title Primary Caries Prevention Intervention as Offered by Dentists CMS eCQM ID CMS74v15 CBE ID Not Applicable MIPS Quality ID 379 Measure Steward Centers for Medicare & Medicaid Services (CMS) Description Percentage of children, 1-20 years of age, who received two fluoride varnish applications during the measurement period as determined by a dentist Measure Scoring
- [2026 # 012 Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation](https://healthmonix.com/mips_quality_measure/2026-012-primary-open-angle-glaucoma-poag-optic-nerve-evaluation/) - Title Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation CMS eCQM ID CMS143v14 CBE ID 0086e MIPS Quality ID 012 Measure Steward American Academy of Ophthalmology Description Percentage of patients aged 18 years and older with a diagnosis of primary open-angle glaucoma (POAG) who have an optic nerve head evaluation during one or more visits during
- [2026 # 102 Prostate Cancer Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients](https://healthmonix.com/mips_quality_measure/2026-102-prostate-cancer-avoidance-of-overuse-of-bone-scan-for-staging-low-risk-prostate-cancer-patients/) - Title Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients CMS eCQM ID CMS129v15 CBE ID Not Applicable MIPS Quality ID 102 Measure Steward Centers for Medicare & Medicaid Services (CMS) Description Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low)
- [2026 # 205 Sexually Transmitted Infection (STI) Testing for People with HIV](https://healthmonix.com/mips_quality_measure/2026-205-sexually-transmitted-infection-sti-testing-for-people-with-hiv/) - Title Sexually Transmitted Infection (STI) Testing for People with HIV CMS eCQM ID CMS118v3 CBE ID 3755e MIPS Quality ID 205 Measure Steward Health Resources & Services Administration Description Percentage of patients 13 years of age and older with a diagnosis of Human Immunodeficiency Virus (HIV) who had tests for syphilis, gonorrhea, and chlamydia performed
- [2026 # 438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease](https://healthmonix.com/mips_quality_measure/2026-438-statin-therapy-for-the-prevention-and-treatment-of-cardiovascular-disease/) - Title Statin Therapy for the Prevention and Treatment of Cardiovascular Disease CMS eCQM ID CMS347v9 CBE ID Not Applicable MIPS Quality ID 438 Measure Steward Centers for Medicare & Medicaid Services (CMS) Description Percentage of the following patients - all considered at high risk of cardiovascular events - who were prescribed or were on statin
- [2026 # 476 Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia](https://healthmonix.com/mips_quality_measure/2026-476-urinary-symptom-score-change-6-12-months-after-diagnosis-of-benign-prostatic-hyperplasia/) - Title Urinary Symptom Score Change 6–12 Months After Diagnosis of Benign Prostatic Hyperplasia CMS eCQM ID CMS77v7 CBE ID Not Applicable MIPS Quality ID 476 Measure Steward Large Urology Group Practice Association (LUGPA) Initial Population Male patients with an initial diagnosis of benign prostatic hyperplasia 6 months prior to the measurement period who had a
- [2026 # 238 Use of High-Risk Medications in Older Adults](https://healthmonix.com/mips_quality_measure/2026-238-use-of-high-risk-medications-in-older-adults/) - Title Use of High-Risk Medications in Older Adults CMS eCQM ID CMS156v14 CBE ID Not Applicable MIPS Quality ID 238 Measure Steward National Committee for Quality Assurance Description Percentage of patients 65 years of age and older who were ordered at least two high-risk medications from the same drug class. Three rates are reported. 1.
- [2026 # 239 Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents](https://healthmonix.com/mips_quality_measure/2026-239-weight-assessment-and-counseling-for-nutrition-and-physical-activity-for-children-adolescents/) - Title Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents CMS eCQM ID CMS155v14 CBE ID Not Applicable MIPS Quality ID 239 Measure Steward National Committee for Quality Assurance Description Percentage of patients 3-17 years of age who had an outpatient visit with a primary care physician (PCP) or obstetrician/gynecologist (OB/GYN) and who
- [2026 # 008 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)](https://healthmonix.com/mips_quality_measure/2026-008-heart-failure-hf-beta-blocker-therapy-for-left-ventricular-systolic-dysfunction-lvsd/) - Title Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) CMS eCQM ID CMS144v14 CBE ID 0083e MIPS Quality ID 008 Measure Steward American Heart Association Description Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF)
- [2026 # 005 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)](https://healthmonix.com/mips_quality_measure/2026-005-heart-failure-hf-angiotensin-converting-enzyme-ace-inhibitor-or-angiotensin-receptor-blocker-arb-or-angiotensin-receptor-neprilysin-inhibitor-arni-therapy-for-left-ventricular-syst/) - Title Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) CMS eCQM ID CMS135v14 CBE ID 0081e MIPS Quality ID 005 Measure Steward American Heart Association Description Percentage of patients aged 18 years and older with a diagnosis of heart
- [2026 # 377 Functional Status Assessments for Heart Failure](https://healthmonix.com/mips_quality_measure/2026-377-functional-status-assessments-for-heart-failure/) - Title Functional Status Assessments for Heart Failure CMS eCQM ID CMS90v15 CBE ID Not Applicable MIPS Quality ID 377 Measure Steward Centers for Medicare & Medicaid Services (CMS) Description Percentage of patients 18 years of age and older with heart failure who completed initial and follow-up patient-reported functional status assessments Measure Scoring Proportion Measure Type
- [2026 # 376 Functional Status Assessment for Total Hip Replacement](https://healthmonix.com/mips_quality_measure/2026-376-functional-status-assessment-for-total-hip-replacement/) - Title Functional Status Assessment for Total Hip Replacement CMS eCQM ID CMS56v14 CBE ID Not Applicable MIPS Quality ID 376 Measure Steward Centers for Medicare & Medicaid Services (CMS) Description Percentage of patients 19 years of age and older who received an elective primary total hip arthroplasty (THA) and completed a functional status assessment within
- [2026 # 366 Follow-Up Care for Children Prescribed ADHD Medication](https://healthmonix.com/mips_quality_measure/2026-366-follow-up-care-for-children-prescribed-adhd-medication/) - Title Follow-Up Care for Children Prescribed ADHD Medication CMS eCQM ID CMS136v15 CBE ID Not Applicable MIPS Quality ID 366 Measure Steward National Committee for Quality Assurance Description Percentage of children 6-12 years of age and newly prescribed a medication for attention-deficit/hyperactivity disorder (ADHD) who had appropriate follow-up care. Two rates are reported. a. Percentage
- [2026 # 318 Falls: Screening for Future Fall Risk](https://healthmonix.com/mips_quality_measure/2026-318-falls-screening-for-future-fall-risk/) - Title Falls: Screening for Future Fall Risk CMS eCQM ID CMS139v14 CBE ID Not Applicable MIPS Quality ID 318 Measure Steward National Committee for Quality Assurance Description Percentage of patients 65 years of age and older who were screened for future fall risk during the measurement period Measure Scoring Proportion Measure Type Process Stratification None
- [2026 # 494 Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography (CT) in Adults (Clinician Level)](https://healthmonix.com/mips_quality_measure/2026-494-excessive-radiation-dose-or-inadequate-image-quality-for-diagnostic-computed-tomography-ct-in-adults-clinician-level/) - Title Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography (CT) in Adults (Clinician Level) CMS eCQM ID CMS1056v3 CBE ID 3635e MIPS Quality ID 494 Measure Steward Alara Imaging, Inc. Description This measure provides a standardized method for monitoring the performance of diagnostic CT to discourage unnecessarily high radiation doses, a risk
- [2026 # 130 Documentation of Current Medications in the Medical Record](https://healthmonix.com/mips_quality_measure/2026-130-documentation-of-current-medications-in-the-medical-record/) - Title Documentation of Current Medications in the Medical Record CMS eCQM ID CMS68v15 CBE ID Not Applicable MIPS Quality ID 130 Measure Steward Centers for Medicare & Medicaid Services (CMS) Description Percentage of visits for which the eligible clinician attests to documenting a list of current medications using all immediate resources available on the date
- [2026 # 019 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care](https://healthmonix.com/mips_quality_measure/2026-019-diabetic-retinopathy-communication-with-the-physician-managing-ongoing-diabetes-care/) - Title Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care CMS eCQM ID CMS142v14 CBE ID Not Applicable MIPS Quality ID 019 Measure Steward American Academy of Ophthalmology Description Percentage of patients aged 18 years and older with a diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed with documented
- [2026 # 009 Diabetes: Glycemic Status Assessment Greater Than 9%](https://healthmonix.com/mips_quality_measure/2026-009-diabetes-glycemic-status-assessment-greater-than-9/) - Title Diabetes: Glycemic Status Assessment Greater Than 9% CMS eCQM ID CMS122v14 CBE ID Not Applicable MIPS Quality ID 001 Measure Steward National Committee for Quality Assurance Description Percentage of patients 18-75 years of age with diabetes who had a glycemic status assessment (hemoglobin A1c [HbA1c] or glucose management indicator [GMI]) > 9.0% during the
- [2026 # 117 Diabetes: Eye Exam](https://healthmonix.com/mips_quality_measure/2026-117-diabetes-eye-exam/) - Title Diabetes: Eye Exam CMS eCQM ID CMS131v14 CBE ID Not Applicable MIPS Quality ID 117 Measure Steward National Committee for Quality Assurance Description Percentage of patients 18-75 years of age with diabetes and an active diagnosis of retinopathy in any part of the measurement period who had a retinal or dilated eye exam by
- [2026 # 370 Depression Remission at Twelve Months](https://healthmonix.com/mips_quality_measure/2026-370-depression-remission-at-twelve-months/) - Title Depression Remission at Twelve Months CMS eCQM ID CMS159v14 CBE ID 0710e MIPS Quality ID 370 Measure Steward MN Community Measurement Description The percentage of adolescent patients 12 to 17 years of age and adult patients 18 years of age or older with major depression or dysthymia who reached remission 12 months (+/- 60
- [2026 # 281 Dementia: Cognitive Assessment](https://healthmonix.com/mips_quality_measure/2026-281-dementia-cognitive-assessment/) - Title Dementia: Cognitive Assessment CMS eCQM ID CMS149v14 CBE ID 2872e MIPS Quality ID 281 Measure Steward American Academy of Neurology Description Percentage of patients, regardless of age, with a diagnosis of dementia for whom an assessment of cognition is performed and the results reviewed at least once within the 12 months preceding a dementia
- [2026 # 007 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%)](https://healthmonix.com/mips_quality_measure/2026-007-coronary-artery-disease-cad-beta-blocker-therapy-prior-myocardial-infarction-mi-or-left-ventricular-systolic-dysfunction-lvef-less-than-or-equal-to-40/) - Title Coronary Artery Disease (CAD): Beta-Blocker Therapy–Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%) CMS eCQM ID CMS145v14 CBE ID 0070e MIPS Quality ID 007 Measure Steward American Heart Association Description Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12-month period
- [2026 # 113 Colorectal Cancer Screening](https://healthmonix.com/mips_quality_measure/2026-113-colorectal-cancer-screening/) - Title Colorectal Cancer Screening CMS eCQM ID CMS130v14 CBE ID Not Applicable MIPS Quality ID 113 Measure Steward National Committee for Quality Assurance Description Percentage of adults 45–75 years of age who had appropriate screening for colorectal cancer Measure Scoring Proportion Measure Type Process Stratification Report a total rate, and each of the following age
- [2026 # 374 Closing the Referral Loop: Receipt of Specialist Report](https://healthmonix.com/mips_quality_measure/2026-374-closing-the-referral-loop-receipt-of-specialist-report/) - Title Closing the Referral Loop: Receipt of Specialist Report CMS eCQM ID CMS50v14 CBE ID Not Applicable MIPS Quality ID 374 Measure Steward Centers for Medicare & Medicaid Services (CMS) Description Percentage of patients with referrals, regardless of age, for which the referring clinician receives a report from the clinician to whom the patient was
- [2026 # 310 Chlamydia Screening in Women](https://healthmonix.com/mips_quality_measure/2026-310-chlamydia-screening-in-women/) - Title Chlamydia Screening in Women CMS eCQM ID CMS153v14 CBE ID Not Applicable MIPS Quality ID 310 Measure Steward National Committee for Quality Assurance Description Percentage of women 16-24 years of age who were identified as sexually active at any time during the measurement period and who had at least one test for chlamydia during
- [2026 # 378 Children Who Have Dental Decay or Cavities](https://healthmonix.com/mips_quality_measure/2026-378-children-who-have-dental-decay-or-cavities/) - Title Children Who Have Dental Decay or Cavities CMS eCQM ID CMS75v14 CBE ID Not Applicable MIPS Quality ID 378 Measure Steward Centers for Medicare & Medicaid Services (CMS) Description Percentage of children, 1-20 years of age at the start of the measurement period, who have had dental decay or cavities during the measurement period
- [2026 # 240 Childhood Immunization Status](https://healthmonix.com/mips_quality_measure/2026-240-childhood-immunization-status/) - Title Childhood Immunization Status CMS eCQM ID CMS117v14 CBE ID Not Applicable MIPS Quality ID 240 Measure Steward National Committee for Quality Assurance Description Percentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DTaP); three polio (IPV), one measles, mumps and rubella (MMR); three or four H influenza type
- [2026 # 382 Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment](https://healthmonix.com/mips_quality_measure/2026-382-child-and-adolescent-major-depressive-disorder-mdd-suicide-risk-assessment/) - Title Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment CMS eCQM ID CMS177v14 CBE ID Not Applicable MIPS Quality ID 382 Measure Steward Mathematica Description Percentage of patient visits for those patients aged 6 through 16 at the start of the measurement period with a diagnosis of major depressive disorder (MDD) with an
- [2026 # 309 Cervical Cancer Screening](https://healthmonix.com/mips_quality_measure/2026-309-cervical-cancer-screening/) - Title Cervical Cancer Screening CMS eCQM ID CMS124v14 CBE ID Not Applicable MIPS Quality ID 309 Measure Steward National Committee for Quality Assurance Description Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria: - Women age 21-64 who had cervical cytology performed within the last
- [2026 # 191 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery](https://healthmonix.com/mips_quality_measure/2026-191-cataracts-20-40-or-better-visual-acuity-within-90-days-following-cataract-surgery/) - Title Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery CMS eCQM ID CMS133v14 CBE ID 0565e MIPS Quality ID 191 Measure Steward American Academy of Ophthalmology Description Percentage of cataract surgeries for patients aged 18 and older with a diagnosis of uncomplicated cataract and no significant ocular conditions impacting the visual
- [2026 # 112 Breast Cancer Screening](https://healthmonix.com/mips_quality_measure/2026-112-breast-cancer-screening/) - Title Breast Cancer Screening CMS eCQM ID CMS125v14 CBE ID Not Applicable MIPS Quality ID 112 Measure Steward National Committee for Quality Assurance Description Percentage of women 40-74 years of age who had a mammogram to screen for breast cancer in the 27 months prior to the end of the Measurement Period Measure Scoring Proportion
- [2026 # 462 Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy](https://healthmonix.com/mips_quality_measure/2026-462-bone-density-evaluation-for-patients-with-prostate-cancer-and-receiving-androgen-deprivation-therapy/) - Title Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy CMS eCQM ID CMS645v9 CBE ID Not Applicable MIPS Quality ID 462 Measure Steward Oregon Urology Description Percentage of patients determined as having prostate cancer who are currently starting or undergoing androgen deprivation therapy (ADT), for an anticipated period of 12
- [2026 # 065 Appropriate Treatment for Upper Respiratory Infection (URI)](https://healthmonix.com/mips_quality_measure/2026-065-appropriate-treatment-for-upper-respiratory-infection-uri/) - Title Appropriate Treatment for Upper Respiratory Infection (URI) CMS eCQM ID CMS154v14 CBE ID Not Applicable MIPS Quality ID 065 Measure Steward National Committee for Quality Assurance Description Percentage of episodes for patients 3 months of age and older with a diagnosis of upper respiratory infection (URI) that did not result in an antibiotic order.
- [2026 # 066 Appropriate Testing for Pharyngitis](https://healthmonix.com/mips_quality_measure/2026-066-appropriate-testing-for-pharyngitis/) - Title Appropriate Testing for Pharyngitis CMS eCQM ID CMS146v14 CBE ID Not Applicable MIPS Quality ID 066 Measure Steward National Committee for Quality Assurance Description The percentage of episodes for patients 3 years and older with a diagnosis of pharyngitis that resulted in an antibiotic order on or three days after the episode date and
- [2026 # 009 Antidepressant Medication Management](https://healthmonix.com/mips_quality_measure/2026-009-antidepressant-medication-management/) - Title Antidepressant Medication Management CMS eCQM ID CMS128v14 CBE ID Not Applicable MIPS Quality ID 009 Measure Steward National Committee for Quality Assurance Description Percentage of patients 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression, and who remained on an antidepressant medication treatment. Two rates
- [2025 MIPS Measure HIV Screening](https://healthmonix.com/mips_quality_measure/hiv-screening/)
- [2025 MIPS Measure Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment](https://healthmonix.com/mips_quality_measure/child-and-adolescent-major-depressive-disorder-mdd-suicide-risk-assessment/)
- [2025 MIPS Measure Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents](https://healthmonix.com/mips_quality_measure/weight-assessment-and-counseling-for-nutrition-and-physical-activity-for-children-adolescents/)
- [2025 MIPS Measure Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation](https://healthmonix.com/mips_quality_measure/primary-open-angle-glaucoma-poag-optic-nerve-evaluation/)
- [2025 MIPS Measure Childhood Immunization Status](https://healthmonix.com/mips_quality_measure/childhood-immunization-status/)
- [2025 MIPS Anti-depressant Medication Management](https://healthmonix.com/mips_quality_measure/anti-depressant-medication-management/)
- [2025 MIPS Measure Chlamydia Screening in Women](https://healthmonix.com/mips_quality_measure/chlamydia-screening-in-women/)
- [2025 MIPS Measure Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia](https://healthmonix.com/mips_quality_measure/urinary-symptom-score-change-6-12-months-after-diagnosis-of-benign-prostatic-hyperplasia/)
- [2025 MIPS Measure Primary Caries Prevention Intervention as Offered by Dentists](https://healthmonix.com/mips_quality_measure/primary-caries-prevention-intervention-as-offered-by-dentists/)
- [2025 MIPS Measure Intravesical Bacillus-Calmette-Guerin for Non-Muscle Invasive Bladder Cancer](https://healthmonix.com/mips_quality_measure/intravesical-bacillus-calmette-guerin-for-non-muscle-invasive-bladder-cancer/)
- [2025 MIPS Measure Initiation and Engagement of Substance Use Disorder Treatment](https://healthmonix.com/mips_quality_measure/initiation-and-engagement-of-substance-use-disorder-treatment/)
- [2025 MIPS Measure Functional Status Assessments for Heart Failure](https://healthmonix.com/mips_quality_measure/functional-status-assessments-for-heart-failure/)
- [2025 MIPS Measure Functional Status Assessment for Total Hip Replacement](https://healthmonix.com/mips_quality_measure/functional-status-assessment-for-total-hip-replacement/)
- [2025 MIPS Measure Follow-Up Care for Children Prescribed ADHD Medication (ADD)](https://healthmonix.com/mips_quality_measure/follow-up-care-for-children-prescribed-adhd-medication-add/)
- [2025 MIPS Measure Falls: Screening for Future Fall Risk](https://healthmonix.com/mips_quality_measure/falls-screening-for-future-fall-risk/)
- [2025 MIPS Measure Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care](https://healthmonix.com/mips_quality_measure/diabetic-retinopathy-communication-with-the-physician-managing-ongoing-diabetes-care/)
- [2025 MIPS Measure Dementia: Cognitive Assessment](https://healthmonix.com/mips_quality_measure/dementia-cognitive-assessment/)
- [2025 MIPS Measure Children Who Have Dental Decay or Cavities](https://healthmonix.com/mips_quality_measure/children-who-have-dental-decay-or-cavities/)
- [2025 MIPS Measure Cervical Cancer Screening](https://healthmonix.com/mips_quality_measure/cervical-cancer-screening/)
- [2025 MIPS Measure Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy](https://healthmonix.com/mips_quality_measure/bone-density-evaluation-for-patients-with-prostate-cancer-and-receiving-androgen-deprivation-therapy/)
- [2025 MIPS Measure Excessive Radiation Dose or Inadequate Image Quality for Diagnostic Computed Tomography (CT) in Adults (Clinician Level)](https://healthmonix.com/mips_quality_measure/excessive-radiation-dose-or-inadequate-image-quality-for-diagnostic-computed-tomography-ct-in-adults-clinician-level/)
- [PIMSH13 - Oncology: Mutation Testing for Stage IV Lung Cancer Completed Prior to the Start of Targeted Therapy](https://healthmonix.com/mips_quality_measure/pimsh-13/) - Measure Title: Oncology: Mutation Testing for Stage IV Lung Cancer Completed Prior to the Start of Targeted Therapy Measure Description Proportion of stage IV nsNSCLC patients tested for actionable biomarkers and received targeted therapy or chemotherapy based on biomarker results Denominator: Patients with stage IV non-squamous, NSCLC receiving initial treatment during the measurement period AND patient encounter
- [PIMSH17 - Oncology: Utilization of Prophylactic GCSF for Cancer Patients Receiving Low-Risk Chemotherapy (inverse measure)](https://healthmonix.com/mips_quality_measure/pimsh17-oncology-utilization-of-prophylactic-gcsf-for-cancer-patients-receiving-low-risk-chemotherapy-inverse-measure/) - Measure Title:Oncology: Utilization of Prophylactic GCSF for Cancer Patients Receiving Low-Risk Chemotherapy (inverse measure) Measure Description: Percentage of patients with cancer (solid tumors only) receiving any white cell growth factors with during the first cycle of low-risk chemotherapy. Denominator: Total number of patients with cancer (solid tumors only) receiving their first cycle of low-risk chemotherapy
- [2024 MIPS Measure #143: Oncology: Medical and Radiation – Pain Intensity Quantified](https://healthmonix.com/mips_quality_measure/provisional-oncology-medical-and-radiation-pain-intensity-quantified/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified.‌ ‌Instructions This measure is to be submitted at each denominator eligible visit occurring during the
- [2024 MIPS Measure #144: Oncology: Medical and Radiation – Plan of Care for Pain](https://healthmonix.com/mips_quality_measure/provisional-oncology-medical-and-radiation-plan-of-care-for-pain/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of visits for patients, regardless of age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy who report having pain with a documented plan of care to address pain. ‌Instructions This measure is to be submitted at
- [2024 MIPS Measure #24: Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older](https://healthmonix.com/mips_quality_measure/provisional-communication-with-the-physician-or-other-clinician-managing-on-going-care-post-fracture-for-men-and-women-aged-50-years-and-older/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority ‌Description ‌Percentage of patients aged 50 years and older treated for a fracture with documentation of communication, between the physician treating the fracture and the physician or other clinician managing the patient’s on-going care, that a fracture occurred and that the
- [2024 MIPS Measure #441: Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)](https://healthmonix.com/mips_quality_measure/ischemic-vascular-disease-ivd-all-or-none-outcome-measure-optimal-control/) - ‌2024 COLLECTION TYPE: ‌MIPS Clinical Quality Measures (CQMS) Measure Type Intermediate Outcome – High Priority ‌Description The IVD All-or-None Measure is one outcome measure (optimal control). The measure contains four goals. All four goals within a measure must be reached in order to meet that measure. The numerator for the all-or-none measure should be collected
- [2024 MIPS Measure #503: Gains in Patient Activation Measure (PAM) Scores at 12 Months](https://healthmonix.com/mips_quality_measure/gains-in-patient-activation-measure-pam-scores-at-12-months/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Measure (PRO-PM) – High Priority Description The Patient Activation Measure® (PAM®) is a 10- or 13-item questionnaire that assesses an individual´s knowledge, skills, and confidence for managing their health and health care. The measure assesses individuals on a 0-100 scale that converts to
- [2024 MIPS Measure #504: Initiation, Review, and/or Update to Suicide Safety Plan for Individuals with Suicidal Thoughts, Behavior, or Suicide Risk](https://healthmonix.com/mips_quality_measure/initiation-review-and-or-update-to-suicide-safety-plan-for-individuals-with-suicidal-thoughts-behavior-or-suicide-risk/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of adult aged 18 years and older with suicidal ideation or behavior symptoms (based on results of a standardized assessment tool or screening tool) or increased suicide risk (based on the clinician's evaluation or clinician-rating tool) for whom a
- [2024 MIPS Measure #502: Improvement or Maintenance of Functioning for Individuals with a Mental and/or Substance Use Disorder](https://healthmonix.com/mips_quality_measure/improvement-or-maintenance-of-functioning-for-individuals-with-a-mental-and-or-substance-use-disorder/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome-Based Performance Measure (PRO-PM) – High Priority Description ‌The percentage of patients aged 18 and older with a mental and/or substance use disorder who demonstrated improvement or maintenance of functioning based on results from the 12-item World Health Organization Disability Assessment Schedule (WHODAS 2.0) or
- [2024 MIPS Measure #500: Acute Posterior Vitreous Detachment Appropriate Examination and Follow-up](https://healthmonix.com/mips_quality_measure/acute-posterior-vitreous-detachment-appropriate-examination-and-follow-up/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of patients with a diagnosis of acute posterior vitreous detachment (PVD) in either eye who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks. Instructions This measure is to be submitted once for each occurrence of
- [2024 MIPS Measure #501: Acute Posterior Vitreous Detachment and Acute Vitreous Hemorrhage Appropriate Examination and Follow-up](https://healthmonix.com/mips_quality_measure/acute-posterior-vitreous-detachment-and-acute-vitreous-hemorrhage-appropriate-examination-and-follow-up/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of patients with a diagnosis of acute posterior vitreous detachment (PVD) and acute vitreous hemorrhage in either eye who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks. Instructions This measure is to be submitted once
- [2024 MIPS Measure #497: Preventive Care and Wellness (Composite)](https://healthmonix.com/mips_quality_measure/preventive-care-and-wellness-composite/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of patients who received age- and sex-appropriate preventive screenings and wellness services. This measure is a composite of seven component measures that are based on recommendations for preventive care by the U.S. Preventive Services Task Force (USPSTF), Advisory Committee on Immunization Practices
- [2024 MIPS Measure #495: Ambulatory Palliative Care Patients' Experience of Feeling Heard and Understood](https://healthmonix.com/mips_quality_measure/ambulatory-palliative-care-patients-experience-of-feeling-heard-and-understood/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: P‌atient-Reported Outcome-Based Performance Measure (PRO-PM) – High Priority Description The percentage of top-box responses among patients aged 18 years and older who had an ambulatory palliative care visit and report feeling heard and understood by their palliative care clinician and team within 2 months (60
- [2024 MIPS Measure #499: Appropriate Screening and Plan of Care for Elevated Intraocular Pressure Following Intravitreal or Periocular Steroid Therapy](https://healthmonix.com/mips_quality_measure/appropriate-screening-and-plan-of-care-for-elevated-intraocular-pressure-following-intravitreal-or-periocular-steroid-therapy/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of patients who had an intravitreal or periocular corticosteroid injection (e.g., triamcinolone, preservative-free triamcinolone, dexamethasone, dexamethasone intravitreal implant, or fluocinolone intravitreal implant) who, within seven (7) weeks following the date of injection, are screened for elevated intraocular pressure (IOP) with tonometry with
- [2024 MIPS Measure #498: Connection to Community Service Provider](https://healthmonix.com/mips_quality_measure/connection-to-community-service-provider/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Percent of patients 18 years or older who screen positive for one or more of the following health-related social needs (HRSNs): food insecurity, housing instability, transportation needs, utility help needs, or interpersonal safety; and had contact with a Community Service
- [2024 MIPS Measure #496: Cardiovascular Disease (CVD) Risk Assessment Measure - Proportion of Pregnant/Postpartum Patients that Receive CVD Risk Assessment with a Standardized Instrument](https://healthmonix.com/mips_quality_measure/cardiovascular-disease-cvd-risk-assessment-measure-proportion-of-pregnant-postpartum-patients-that-receive-cvd-risk-assessment-with-a-standardized-instrument/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of pregnant or postpartum patients who received a cardiovascular disease (CVD) risk assessment with a standardized instrument. ‌Instructions This measure is to be submitted a minimum of once per performance period for all patients seen for pregnancy or postpartum care during the
- [2024 MIPS Measure #490: Appropriate Intervention of Immune-Related Diarrhea and/or Colitis in Patients Treated with Immune Checkpoint Inhibitors](https://healthmonix.com/mips_quality_measure/provisional-appropriate-intervention-of-immune-related-diarrhea-and-or-colitis-in-patients-treated-with-immune-checkpoint-inhibitors/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of patients, aged 18 years and older, with a diagnosis of cancer, on immune checkpoint inhibitor therapy, and grade 2 or above diarrhea and/or grade 2 or above colitis, who have immune checkpoint inhibitor therapy held and corticosteroids or immunosuppressants prescribed or
- [2024 MIPS Measure #483: Person-Centered Primary Care Measure Patient Reported Outcome Performance Measure (PCPCM PRO-PM)](https://healthmonix.com/mips_quality_measure/provisional-person-centered-primary-care-measure-patient-reported-outcome-performance-measure-pcpcm-pro-pm/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE:Patient-Reported Outcome-Based Performance Measure – High Priority Description The Person-Centered Primary Care Measure Patient Reported Outcome Performance Measure (PCPCM PRO-PM) uses the PCPCM Patient Reported Outcome Measure (PROM) a comprehensive and parsimonious set of 11 patient- reported items - to assess the broad scope of primary
- [2024 MIPS Measure #478: Functional Status Change for Patients with Neck Impairments](https://healthmonix.com/mips_quality_measure/provisional-functional-status-change-for-patients-with-neck-impairments/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority Description A patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients 14 years+ with neck impairments. The change in FS is assessed using the FOTO Neck FS PROM. The measure is adjusted to patient
- [2024 MIPS Measure #470: Functional Status After Primary Total Knee Replacement](https://healthmonix.com/mips_quality_measure/provisional-functional-status-after-primary-total-knee-replacement/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority Description ‌For patients age 18 and older who had a primary total knee replacement procedure, functional status is rated by the patient as greater than or equal to 37 on the Oxford Knee Score (OKS) or a 71
- [2024 MIPS Measure #468: Continuity of Pharmacotherapy for Opioid Use Disorder (OUD)](https://healthmonix.com/mips_quality_measure/provisional-continuity-of-pharmacotherapy-for-opioid-use-disorder-oud/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Percentage of adults aged 18 years and older with pharmacotherapy for opioid use disorder (OUD) who have at least 180 days of continuous treatment. ‌Instructions This measure is to be submitted a minimum of once per performance period for all
- [2024 MIPS Measure #461: Leg Pain After Lumbar Surgery](https://healthmonix.com/mips_quality_measure/provisional-leg-pain-after-lumbar-surgery/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority Description ‌For patients 18 years of age or older who had a lumbar discectomy/laminectomy or fusion procedure, leg pain is rated by the patient as less than or equal to 3.0 OR an improvement of 5.0 points or
- [2024 MIPS Measure #459: Back Pain After Lumbar Surgery](https://healthmonix.com/mips_quality_measure/provisional-back-pain-after-lumbar-surgery/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority Description ‌For patients 18 years of age or older who had a lumbar discectomy/laminectomy or fusion procedure, back pain is rated by the patients as less than or equal to 3.0 OR an improvement of 5.0 points or
- [2024 MIPS Measure #448: Appropriate Workup Prior to Endometrial Ablation](https://healthmonix.com/mips_quality_measure/provisional-appropriate-workup-prior-to-endometrial-ablation/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Percentage of patients, aged 18 years and older, who undergo endometrial sampling or hysteroscopy with biopsy and results are documented before undergoing an endometrial ablation. Instructions This measure is to be submitted each time a procedure for endometrial ablation is
- [2024 MIPS Measure #438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease](https://healthmonix.com/mips_quality_measure/provisional-statin-therapy-for-the-prevention-and-treatment-of-cardiovascular-disease/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of the following patients - all considered at high risk of cardiovascular events - who were prescribed or were on statin therapy during the performance period: All patients who were previously diagnosed with or currently have a diagnosis of clinical atherosclerotic cardiovascular
- [2024 MIPS Measure #395: Lung Cancer Reporting (Biopsy/Cytology Specimens)](https://healthmonix.com/mips_quality_measure/provisional-lung-cancer-reporting-biopsy-cytology-specimens/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Pathology reports based on lung biopsy and/or cytology specimens with a diagnosis of primary non-small cell lung cancer classified into specific histologic type following the International Association for the Study of Lung Cancer (IASLC) guidance or classified as non-small cell
- [2024 MIPS Measure #386: Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences](https://healthmonix.com/mips_quality_measure/provisional-amyotrophic-lateral-sclerosis-als-patient-care-preferences/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process– High Priority Description Percentage of patients diagnosed with Amyotrophic Lateral Sclerosis (ALS) who were offered assistance in planning for end of life issues (e.g., advance directives, invasive ventilation, lawful physician-hastened death, or hospice) or whose existing end of life plan was reviewed or updated
- [2024 MIPS Measure #385: Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement Within 90 Days of Surgery](https://healthmonix.com/mips_quality_measure/provisional-adult-primary-rhegmatogenous-retinal-detachment-surgery-visual-acuity-improvement-within-90-days-of-surgery/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description ‌Patients aged 18 years and older who had surgery for primary rhegmatogenous retinal detachment and achieved an improvement in their visual acuity, from their preoperative level, within 90 days of surgery in the operative eye. Instructions This measure is to
- [2024 MIPS Measure #355: Unplanned Reoperation within the 30 Day Postoperative Period](https://healthmonix.com/mips_quality_measure/provisional-unplanned-reoperation-within-the-30-day-postoperative-period/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description ‌Percentage of patients aged 18 years and older who had any unplanned reoperation within the 30-day postoperative period. ‌Instructions This measure is to be submitted each time an operative procedure listed in the denominator is performed during the performance period.
- [2024 MIPS Measure #350: Total Knee or Hip Replacement: Shared Decision-Making: Trial of Conservative (Non-surgical) Therapy](https://healthmonix.com/mips_quality_measure/provisional-total-knee-or-hip-replacement-shared-decision-making-trial-of-conservative-nonsurgical-therapy/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of patients regardless of age undergoing a total knee or total hip replacement with documented shared decision-making with discussion of conservative (non-surgical) therapy (e.g., non-steroidal anti-inflammatory drug (NSAIDs), analgesics, weight loss, exercise, injections) prior to the procedure. ‌Instructions This
- [2024 MIPS Measure #291: Assessment of Cognitive Impairment or Dysfunction for Patients with Parkinson's Disease](https://healthmonix.com/mips_quality_measure/provisional-assessment-of-cognitive-impairment-or-dysfunction-for-patients-with-parkinsons-disease/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of all patients with a diagnosis of Parkinson’s disease (PD) who were assessed for cognitive impairment or dysfunction once during the measurement period. ‌Instructions This measure is to be submitted a minimum of once per performance period for patients with a diagnosis
- [2024 MIPS Measure #277: Sleep Apnea: Severity Assessment at Initial Diagnosis](https://healthmonix.com/mips_quality_measure/provisional-sleep-apnea-severity-assessment-at-initial-diagnosis/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of patients aged 18 years and older with a diagnosis of obstructive sleep apnea who had an apnea hypopnea index (AHI), a respiratory disturbance index (RDI), or a respiratory event index (REI) documented or measured within 2 months of initial evaluation for
- [2024 MIPS Measure #260: Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2)](https://healthmonix.com/mips_quality_measure/provisional-rate-of-carotid-endarterectomy-cea-for-asymptomatic-patients-without-major-complications-discharged-to-home-by-post-operative-day-2/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Percent of asymptomatic patients undergoing Carotid Endarterectomy (CEA) who are discharged to home no later than post-operative day #2. ‌Instructions This measure is to be submitted each time a CEA is performed during the performance period. It is anticipated that
- [2024 MIPS Measure #261: Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness](https://healthmonix.com/mips_quality_measure/provisional-referral-for-otologic-evaluation-for-patients-with-acute-or-chronic-dizziness/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Percentage of patients aged birth and older referred to a physician (preferably a physician specially trained in disorders of the ear) for an otologic evaluation subsequent to an audiologic evaluation after presenting with acute or chronic dizziness. ‌Instructions This measure
- [2024 MIPS Measure #254: Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal Pain or Vaginal Bleeding](https://healthmonix.com/mips_quality_measure/provisional-ultrasound-determination-of-pregnancy-location-for-pregnant-patients-with-abdominal-pain-or-vaginal-bleeding/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of pregnant female patients aged 14 to 50 who present to the emergency department (ED) with a chief complaint of abdominal pain or vaginal bleeding who receive a trans-abdominal or trans-vaginal ultrasound to determine pregnancy location. ‌Instructions ‌This measure is to be
- [2024 MIPS Measure #222: Functional Status Change for Patients with Elbow, Wrist or Hand Impairments](https://healthmonix.com/mips_quality_measure/provisional-functional-status-change-for-patients-with-elbow-wrist-or-hand-impairments/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority Description ‌A patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients 14 years+ with elbow, wrist, or hand impairments. The change in FS is assessed using the FOTO Elbow/Wrist/Hand FS PROM. The measure is adjusted
- [2024 MIPS Measure #217: Functional Status Change for Patients with Knee Impairments](https://healthmonix.com/mips_quality_measure/provisional-functional-status-change-for-patients-with-knee-impairments/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority ‌Description ‌A patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients 14 years+ with knee impairments. The change in FS is assessed using the FOTO Lower Extremity Physical Function (LEPF) PROM. The measure is
- [2024 MIPS Measure #205: Sexually Transmitted Infection (STI) Testing for People with HIV](https://healthmonix.com/mips_quality_measure/sexuallytransmitted-infection-sti-testing-for-people-with-hiv/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description ‌Percentage of patients 13 years of age and older with a diagnosis of HIV who had tests for syphilis, gonorrhea, and chlamydia performed within the performance period. Instructions This measure is to be submitted a minimum of once per performance period for patients
- [2024 MIPS Measure #191: Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery](https://healthmonix.com/mips_quality_measure/provisional-cataracts-20-40-or-better-visual-acuity-within-90-days-following-cataract-surgery/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Outcome – High Priority Description ‌Percentage of cataract surgeries for patients aged 18 years and older with a diagnosis of uncomplicated cataract and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near)
- [2024 MIPS Measure #180: Rheumatoid Arthritis (RA): Glucocorticoid Management](https://healthmonix.com/mips_quality_measure/provisional-rheumatoid-arthritis-ra-glucocorticoid-management/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have been assessed for glucocorticoid use and, for those on prolonged doses of prednisone >5 mg daily (or equivalent) with improvement or no change in disease activity,
- [2024 MIPS Measure #141: Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 20% OR Documentation of a Plan of Care](https://healthmonix.com/mips_quality_measure/provisional-primary-open-angle-glaucoma-poag-reduction-of-intraocular-pressure-iop-by-15-or-documentation-of-a-plan-of-care/) - ‌2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description ‌Percentage of patients aged 18 years and older with a diagnosis of primary open-angle glaucoma (POAG) whose glaucoma treatment has not failed (the most recent IOP was reduced by at least 20% from the pre-intervention level) OR if the most
- [2024 MIPS Measure #155: Falls: Plan of Care](https://healthmonix.com/mips_quality_measure/provisional-falls-plan-of-care/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority‌ Description Percentage of patients aged 65 years and older with a history of falls that had a plan of care for falls documented within 12 months. Instructions This measure is to be submitted a minimum of once per performance period for
- [2024 MIPS Measure #145: Radiology: Exposure Dose Indices Reported for Procedures Using Fluoroscopy](https://healthmonix.com/mips_quality_measure/provisional-radiology-exposure-dose-indices-reported-for-procedures-using-fluoroscopy/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Final reports for procedures using fluoroscopy that document radiation exposure indices. Instructions This measure is to be submitted each time a procedure using fluoroscopy is performed in a hospital or outpatient setting during the performance period. There is no diagnosis
- [2024 MIPS Measure #137: Melanoma: Continuity of Care – Recall System](https://healthmonix.com/mips_quality_measure/provisional-melanoma-continuity-of-care-recall-system/) - ‌2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Structure – High Priority Description Percentage of patients, regardless of age, with a current diagnosis of melanoma or a history of melanoma whose information was entered, at least once within a 12 month period, into a recall system that includes: A target date for the
- [2024 MIPS Measure #134: Preventive Care and Screening: Screening for Depression and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/provisional-preventive-care-and-screening-screening-for-depression-and-follow-up-plan/) - ‌2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description ‌Percentage of patients aged 12 years and older screened for depression on the date of the encounter or up to 14 days prior to the date of the encounter using an age-appropriate standardized depression screening tool AND if positive, a follow-up plan is
- [2024 MIPS Measure #130: Documentation of Current Medications in the Medical Record](https://healthmonix.com/mips_quality_measure/documentation-of-current-medications-in-the-medical-record/) - ‌2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of visits for patients aged 18 years and older for which the eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter. Instructions This measure is to be
- [2024 MIPS Measure #128: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/provisional-preventive-care-and-screening-body-mass-index-bmi-screening-and-follow-up-plan/) - 2024 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) – MIPS VALUE PATHWAYS (MVP) REPORTING ONLY MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of patients aged 18 years and older with a BMI documented during the current encounter or within the previous twelve months AND who had a follow-up plan documented if the
- [2024 MIPS Measure #126: Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy – Neurological Evaluation](https://healthmonix.com/mips_quality_measure/provisional-diabetes-mellitus-diabetic-foot-and-ankle-care-peripheral-neuropathy-neurological-evaluation/) - ‌2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process ‌Description ‌Percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who had a neurological examination of their lower extremities within 12 months. Instructions This measure is to be submitted a minimum of once per performance period for patients with
- [2024 MIPS Measure #118: Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF <= 40%)](https://healthmonix.com/mips_quality_measure/provisional-coronary-artery-disease-cad-angiotensin-converting-enzyme-ace-inhibitor-or-angiotensin-receptor-blocker-arb-therapy-diabetes-or-left-ventricular-systolic-dysfunction-lvef/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process ‌Description ‌Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12- month period who also have diabetes OR a current or prior Left Ventricular Ejection Fraction (LVEF) ≤ 40% who were prescribed ACE inhibitor or
- [2024 MIPS Measure #117: Diabetes: Eye Exam](https://healthmonix.com/mips_quality_measure/provisional-diabetes-eye-exam/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients 18-75 years of age with diabetes and an active diagnosis of retinopathy in any part of the measurement period who had a retinal or dilated eye exam during the measurement period or diabetics with no diagnosis of retinopathy in any
- [2024 MIPS Measure #116: Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis](https://healthmonix.com/mips_quality_measure/provisional-avoidance-of-antibiotic-treatment-for-acute-bronchitis-bronchiolitis/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description The percentage of episodes for patients ages 3 months and older with a diagnosis of acute bronchitis/bronchiolitis that did not result in an antibiotic dispensing event. Instructions This measure is to be submitted at each occurrence of acute bronchitis/bronchiolitis during
- [2024 MIPS Measure #113: Colorectal Cancer Screening](https://healthmonix.com/mips_quality_measure/provisional-colorectal-cancer-screening/) - 2024 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) – MIPS VALUE PATHWAYS (MVP) REPORTING ONLY MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of patients 45-75 years of age who had appropriate screening for colorectal cancer ‌Instructions This measure is to be submitted a minimum of once per performance period for patients seen
- [2024 MIPS Measure #112: Breast Cancer Screening](https://healthmonix.com/mips_quality_measure/provisional-breast-cancer-screening/) - 2024 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) – MIPS VALUE PATHWAYS (MVP) REPORTING ONLY MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of women 40 - 74 years of age who had a mammogram to screen for breast cancer in the 27 months prior to the end of the measurement period. ‌Instructions
- [2024 MIPS Measure #102: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients](https://healthmonix.com/mips_quality_measure/provisional-prostate-cancer-avoidance-of-overuse-of-bone-scan-for-staging-low-risk-prostate-cancer-patients/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone
- [2024 MIPS Measure #66: Appropriate Testing for Pharyngitis](https://healthmonix.com/mips_quality_measure/provisional-appropriate-testing-for-pharyngitis/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority ‌Description ‌The percentage of episodes for patients 3 years and older with a diagnosis of pharyngitis that resulted in an antibiotic order on or within 3 days after the episode date and a group A Streptococcus (Strep) test in the seven-day
- [2024 MIPS Measure #52: Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation and Long-Acting Inhaled Bronchodilator Therapy](https://healthmonix.com/mips_quality_measure/provisional-chronic-obstructive-pulmonary-disease-copd-long-acting-inhaled-bronchodilator-therapy/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process ‌Description Percentage of patients aged 18 years and older with a diagnosis of COPD with a documented FEV1/FVC < 70% measured by spirometry, who are symptomatic, and were prescribed a long-acting inhaled bronchodilator. Instructions This measure is to be submitted a minimum of once
- [2024 MIPS Measure #8: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)](https://healthmonix.com/mips_quality_measure/provisional-heart-failure-hf-beta-blocker-therapy-for-left-ventricular-systolic-dysfunction-lvsd/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process ‌Description ‌Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) ≤ 40% who were prescribed beta-blocker therapy either within a 12-month period when seen in the outpatient setting
- [2024 MIPS Measure #7: Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)](https://healthmonix.com/mips_quality_measure/provisional-coronary-artery-disease-cad-beta-blocker-therapy-prior-myocardial-infarction-mi-or-left-ventricular-systolic-dysfunction-lvef/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12-month period who also have a prior MI or a current or prior LVEF ≤ 40% who were prescribed beta-blocker therapy. ‌Instructions This measure is
- [2024 MIPS Measure #6: Coronary Artery Disease (CAD): Antiplatelet Therapy](https://healthmonix.com/mips_quality_measure/provisional-coronary-artery-disease-cad-antiplatelet-therapy/) - 2024 COLLECTION TYPE: ‌MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description ‌Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease (CAD) seen within a 12-month period who were prescribed aspirin or clopidogrel. Instructions This measure is to be submitted a minimum of once per performance period for all
- [2024 MIPS Measure #5: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)](https://healthmonix.com/mips_quality_measure/provisional-heart-failure-hf-angiotensin-converting-enzyme-ace-inhibitor-or-angiotensin-receptor-blocker-arb-or-angiotensin-receptor-neprilysin-inhibitor-arni-therapy-for-left-ventricular/) - ‌2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) ≤ 40% who were prescribed ACE inhibitor or ARB or ARNI therapy either within a 12-month period when
- [2024 MIPS Measure #505: Reduction in Suicidal Ideation or Behavior Symptoms](https://healthmonix.com/mips_quality_measure/reduction-in-suicidal-ideation-or-behavior-symptoms/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure (PRO-PM) – High Priority Description The percentage of patients aged 18 years and older with a mental and/or substance use disorder AND suicidal thoughts, behaviors or risk symptoms who demonstrated a reduction in suicidal ideation and/or behavior symptoms based on results
- [2024 MIPS Measure #493: Adult Immunization Status](https://healthmonix.com/mips_quality_measure/provisional-adult-immunization-status/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of patients 19 years of age and older who are up-to-date on recommended routine vaccines for influenza; tetanus and diphtheria (Td) or tetanus, diphtheria and acellular pertussis (Tdap); zoster; and pneumococcal. ‌Instructions This measure is to be submitted a minimum of once
- [2024 MIPS Measure #491: Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing Status in Colorectal Carcinoma, Endometrial, Gastroesophageal, or Small Bowel Carcinoma](https://healthmonix.com/mips_quality_measure/provisional-mismatch-repair-mmr-or-microsatellite-instability-msi-biomarker-testing-status-in-colorectal-carcinoma-endometrial-gastroesophageal-or-small-bowel-carcinoma/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Percentage of surgical pathology reports for primary colorectal, endometrial, gastroesophageal or small bowel carcinoma, biopsy or resection, that contain impression or conclusion of or recommendation for testing of mismatch repair (MMR) by immunohistochemistry (biomarkers MLH1, MSH2, MSH6, and PMS2), or
- [2024 MIPS Measure #489: Adult Kidney Disease: Angiotensin Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy](https://healthmonix.com/mips_quality_measure/provisional-adult-kidney-disease-angiotensin-converting-enzyme-ace-inhibitor-or-angiotensin-receptor-blocker-arb-therapy/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of patients aged 18 years and older with a diagnosis of chronic kidney disease (CKD) (Stages 1-5, not receiving Renal Replacement Therapy (RRT)) and proteinuria who were prescribed ACE inhibitor or ARB therapy within a 12-month period. Instructions This measure is to
- [2024 MIPS Measure #488: Kidney Health Evaluation](https://healthmonix.com/mips_quality_measure/provisional-kidney-health-evaluation/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of patients aged 18-75 years with a diagnosis of diabetes who received a kidney health evaluation defined by an Estimated Glomerular Filtration Rate (eGFR) AND Urine Albumin-Creatinine Ratio (uACR) within the measurement period. Instructions This measure is to be submitted a minimum
- [2024 MIPS Measure #487: Screening for Social Drivers of Health](https://healthmonix.com/mips_quality_measure/provisional-screening-for-social-drivers-of-health/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Percent of patients 18 years and older screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety. Instructions This measure is to be submitted a minimum of once per performance period for patients seen during the performance
- [2024 MIPS Measure #486: Dermatitis – Improvement in Patient-Reported Itch Severity](https://healthmonix.com/mips_quality_measure/provisional-dermatitis-improvement-in-patient-reported-itch-severity/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Patient-reported Outcome-based Performance Measure – High Priority Description The percentage of patients aged 8 years and older, with a diagnosis of dermatitis where at an initial (index) visit have a patient-reported itch severity assessment performed, score greater than or equal to 4, and who achieve
- [2024 MIPS Measure #485: Psoriasis – Improvement in Patient-Reported Itch Severity](https://healthmonix.com/mips_quality_measure/provisional-psoriasis-improvement-in-patient-reported-itch-severity/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Patient-reported Outcome-based Performance Measure – High Priority Description ‌The percentage of patients aged 8 years and older, with a diagnosis of psoriasis where at an initial (index) visit have a patient-reported itch severity assessment performed, score greater than or equal to 4, and who achieve
- [2024 MIPS Measure #482: Hemodialysis Vascular Access: Practitioner Level Long-term Catheter Rate](https://healthmonix.com/mips_quality_measure/provisional-hemodialysis-vascular-access-practitioner-level-long-term-catheter-rate/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: ‌Intermediate outcome – High Priority Description Percentage of adult hemodialysis (HD) patient-months using a catheter continuously for three months or longer for vascular access attributable to an individual practitioner or group practice. Instructions This measure is to be submitted a minimum of once per month
- [2024 MIPS Measure #477: Multimodal Pain Management](https://healthmonix.com/mips_quality_measure/provisional-multimodal-pain-management/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of patients, aged 18 years and older, undergoing selected surgical procedures that were managed with multimodal pain management. Instructions ‌This measure is to be reported each time a patient undergoes a selected surgical procedure during the reporting period. It
- [2024 MIPS Measure #471: Functional Status After Lumbar Surgery](https://healthmonix.com/mips_quality_measure/provisional-functional-status-after-lumbar-surgery/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: ‌Patient-Reported Outcome-Based Performance Measure – High Priority Description For patients age 18 and older who had lumbar discectomy/laminectomy or fusion procedure, functional status is rated by the patient as less than or equal to 22 OR an improvement of 30 points or greater on the
- [2024 MIPS Measure #465: Uterine Artery Embolization Technique: Documentation of Angiographic Endpoints and Interrogation of Ovarian Arteries](https://healthmonix.com/mips_quality_measure/provisional-uterine-artery-embolization-technique-documentation-of-angiographic-endpoints-and-interrogation-of-ovarian-arteries/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description The percentage of patients with documentation of angiographic endpoints of embolization AND the documentation of embolization strategies in the presence of unilateral or bilateral absent uterine arteries. Instructions This measure is to be submitted each time a procedure for uterine
- [2024 MIPS Measure #464: Otitis Media with Effusion: Systemic Antimicrobials - Avoidance of Inappropriate Use](https://healthmonix.com/mips_quality_measure/provisional-otitis-media-with-effusion-systemic-antimicrobials-avoidance-of-inappropriate-use/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of patients aged 2 months through 12 years with a diagnosis of OME who were not prescribed systemic antimicrobials. Instructions This measure is to be submitted once for each occurrence of otitis media with effusion (OME) in children seen
- [2024 MIPS Measure #463: Prevention of Post-Operative Vomiting (POV) – Combination Therapy (Pediatrics)](https://healthmonix.com/mips_quality_measure/provisional-prevention-of-post-operative-vomiting-pov-combination-therapy-pediatrics/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of patients aged 3 through 17 years, who undergo a procedure under general anesthesia in which an inhalational anesthetic is used for maintenance AND who have two or more risk factors for post-operative vomiting (POV), who receive combination therapy
- [2024 MIPS Measure #457: Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score – better)](https://healthmonix.com/mips_quality_measure/provisional-percentage-of-patients-who-died-from-cancer-admitted-to-hospice-for-less-than-3-days-lower-score-better/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Percentage of patients who died from cancer, and admitted to hospice and spent less than 3 days there. Instructions This measure is to be submitted a minimum of once per performance period for patients who died of cancer during the
- [2024 MIPS Measure #453: Percentage of Patients Who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life (lower score – better)](https://healthmonix.com/mips_quality_measure/percentage-of-patients-who-died-from-cancer-receiving-systemic-cancer-directed-therapy-in-the-last-14-days-of-life-lower-score-better/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Percentage of patients who died from cancer receiving systemic cancer-directed therapy in the last 14 days of life.. Instructions This measure is to be submitted a minimum of once per performance period for patients who died of cancer during the
- [2024 MIPS Measure #452: Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies](https://healthmonix.com/mips_quality_measure/patients-with-metastatic-colorectal-cancer-and-ras-kras-or-nras-gene-mutation-spared-treatment-with-anti-epidermal-growth-factor-receptor-egfr-monoclonal-antibodies/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of adult patients (aged 18 or over) with metastatic colorectal cancer and RAS (KRAS or NRAS) gene mutation spared treatment with anti-EGFR monoclonal antibodies. Instructions This measure is to be submitted once per performance period for patients with colorectal
- [2024 MIPS Measure #451: RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy](https://healthmonix.com/mips_quality_measure/ras-kras-and-nras-gene-mutation-testing-performed-for-patients-with-metastatic-colorectal-cancer-who-receive-anti-epidermal-growth-factor-receptor-egfr-monoclonal-antibody-therapy/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of adult patients (aged 18 or over) with metastatic colorectal cancer who receive anti-epidermal growth factor receptor monoclonal antibody therapy for whom RAS (KRAS and NRAS) gene mutation testing was performed. Instructions This measure is to be submitted once per performance period
- [2024 MIPS Measure #450: Appropriate Treatment for Patients with Stage I (T1c) – III HER2 Positive Breast Cancer](https://healthmonix.com/mips_quality_measure/appropriate-treatment-for-patients-with-stage-i-t1c-iii-her2-positive-breast-cancer/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of female patients aged 18 to 70 with stage I (T1c) – III HER2 positive breast cancer for whom appropriate treatment is initiated. Instructions This measure is to be submitted a minimum of once per performance period for patients
- [2024 MIPS Measure #445: Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)](https://healthmonix.com/mips_quality_measure/provisional-risk-adjusted-operative-mortality-for-coronary-artery-bypass-graft-cabg/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Percent of patients aged 18 years and older undergoing isolated CABG who die, including both all deaths occurring during the hospitalization in which the CABG was performed, even if after 30 days, and those deaths occurring after discharge from the
- [2024 MIPS Measure #443: Non-Recommended Cervical Cancer Screening in Adolescent Females](https://healthmonix.com/mips_quality_measure/provisional-non-recommended-cervical-cancer-screening-in-adolescent-females/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description The percentage of adolescent females 16–20 years of age who were screened unnecessarily for cervical cancer. Instructions This measure is to be submitted once per performance period for female patients seen during the performance period. There is no diagnosis associated
- [2024 MIPS Measure #440: Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician](https://healthmonix.com/mips_quality_measure/provisional-skin-cancer-biopsy-reporting-time-pathologist-to-clinician/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of biopsies with a diagnosis of cutaneous basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), or melanoma (including in situ disease) in which the pathologist communicates results to the clinician within 7 days from the time when the
- [2024 MIPS Measure #436: Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques](https://healthmonix.com/mips_quality_measure/provisional-radiation-consideration-for-adult-ct-utilization-of-dose-lowering-techniques/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of final reports for patients aged 18 years and older undergoing computed tomography (CT) with documentation that one or more of the following dose reduction techniques were used. Automated exposure control Adjustment of the mA and/or kV according to patient size Use
- [2024 MIPS Measure #433: Proportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse Repair](https://healthmonix.com/mips_quality_measure/provisional-proportion-of-patients-sustaining-a-bowel-injury-at-the-time-of-any-pelvic-organ-prolapse-repair/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description ‌Percentage of patients undergoing surgical repair of pelvic organ prolapse that is complicated by a bowel injury at the time of index surgery that is recognized intraoperatively or within 30 days after surgery. Instructions ‌This measure is to be submitted
- [2024 MIPS Measure #432: Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair](https://healthmonix.com/mips_quality_measure/provisional-proportion-of-patients-sustaining-a-bladder-injury-at-the-time-of-any-pelvic-organ-prolapse-repair/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Percentage of patients undergoing pelvic organ prolapse repairs who sustain an injury to the bladder recognized either during or within 30 days after surgery. ‌Instructions This measure is to be submitted each time an anterior and apical prolapse repair surgery
- [2024 MIPS Measure #431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling](https://healthmonix.com/mips_quality_measure/provisional-preventive-care-and-screening-unhealthy-alcohol-use-screening-brief-counseling/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of patients aged 18 years and older who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 12 months AND who received brief counseling if identified as an unhealthy alcohol user. ‌Instructions This measure
- [2024 MIPS Measure #430: Prevention of Post-Operative Nausea and Vomiting (PONV) – Combination Therapy](https://healthmonix.com/mips_quality_measure/provisional-prevention-of-post-operative-nausea-and-vomiting-ponv-combination-therapy/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of patients, aged 18 years and older, who undergo a procedure under an inhalational general anesthetic, AND who have three or more risk factors for post-operative nausea and vomiting (PONV), who receive combination therapy consisting of at least two
- [2024 MIPS Measure #439: Age Appropriate Screening Colonoscopy](https://healthmonix.com/mips_quality_measure/provisional-age-appropriate-screening-colonoscopy/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Efficiency – High Priority Description The percentage of screening colonoscopies performed in patients greater than or equal to 86 years of age from January 1 to December 31. Instructions ‌This measure is to be submitted each time a colonoscopy is performed for all patients during
- [2024 MIPS Measure #424: Perioperative Temperature Management](https://healthmonix.com/mips_quality_measure/provisional-perioperative-temperature-management/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Percentage of patients, regardless of age, who undergo surgical or therapeutic procedures under general or neuraxial anesthesia of 60 minutes duration or longer for whom at least one body temperature greater than or equal to 35.5 degrees Celsius (or 95.9
- [2024 MIPS Measure #422: Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury](https://healthmonix.com/mips_quality_measure/provisional-performing-cystoscopy-at-the-time-of-hysterectomy-for-pelvic-organ-prolapse-to-detect-lower-urinary-tract-injury/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of patients who undergo cystoscopy to evaluate for lower urinary tract injury at the time of hysterectomy for pelvic organ prolapse. Instructions This measure is to be submitted each time a procedure is performed during the performance period for
- [2024 MIPS Measure #421: Appropriate Assessment of Retrievable Inferior Vena Cava (IVC) Filters for Removal](https://healthmonix.com/mips_quality_measure/provisional-appropriate-assessment-of-retrievable-inferior-vena-cava-ivc-filters-for-removal/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of patients in whom a retrievable IVC filter is placed who, within 3 months post-placement, have a documented assessment for the appropriateness of continued filtration, device removal, or the inability to contact the patient with at least two attempts. Instructions This measure
- [2024 MIPS Measure #420: Varicose Vein Treatment with Saphenous Ablation: Outcome Survey](https://healthmonix.com/mips_quality_measure/provisional-varicose-vein-treatment-with-saphenous-ablation-outcome-survey/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Patient Reported Outcome -Based Performance Measure – High Priority Description Percentage of patients treated for varicose veins (CEAP C2-S) who are treated with saphenous ablation (with or without adjunctive tributary treatment) that report an improvement on a disease specific patient reported outcome survey instrument after
- [2024 MIPS Measure #419: Overuse of Imaging for the Evaluation of Primary Headache](https://healthmonix.com/mips_quality_measure/provisional-overuse-of-imaging-for-the-evaluation-of-primary-headache/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Percentage of patients for whom imaging of the head (CT or MRI) is obtained for the evaluation of primary headache when clinical indications are not present. Instructions This measure is to be submitted at each denominator eligible visit for patients
- [2024 MIPS Measure #418: Osteoporosis Management in Women Who Had a Fracture](https://healthmonix.com/mips_quality_measure/provisional-osteoporosis-management-in-women-who-had-a-fracture/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌The percentage of women 50-85 years of age who suffered a fracture and who had either a bone mineral density (BMD) test or prescription for a drug to treat osteoporosis in the six months after the fracture. Instructions This measure is to be
- [2024 MIPS Measure #416: Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 through 17 Years](https://healthmonix.com/mips_quality_measure/provisional-emergency-medicine-emergency-department-utilization-of-ct-for-minor-blunt-head-trauma-for-patients-aged-2-through-17-years/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Efficiency – High Priority Description Percentage of emergency department visits for patients aged 2 through 17 years who presented with a minor blunt head trauma who had a head CT for trauma ordered by an emergency care provider who are classified as low risk according
- [2024 MIPS Measure #415: Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older](https://healthmonix.com/mips_quality_measure/provisional-emergency-medicine-emergency-department-utilization-of-ct-for-minor-blunt-head-trauma-for-patients-aged-18-years-and-older/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Efficiency – High Priority Description Percentage of emergency department visits for patients aged 18 years and older who presented with a minor blunt head trauma who had a head CT for trauma ordered by an emergency care provider who have an indication for a head
- [2024 MIPS Measure #413: Door to Puncture Time for Endovascular Stroke Treatment](https://healthmonix.com/mips_quality_measure/provisional-door-to-puncture-time-for-endovascular-stroke-treatment/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Intermediate Outcome – High Priority Description ‌Percentage of patients undergoing endovascular stroke treatment who have a door to puncture time of 90 minutes or less. Instructions ‌This measure is to be submitted each time a patient undergoes a procedure for treatment of a cerebrovascular accident
- [2024 MIPS Measure #410: Psoriasis: Clinical Response to Systemic Medications](https://healthmonix.com/mips_quality_measure/provisional-psoriasis-clinical-response-to-systemic-medications/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Percentage of psoriasis vulgaris patients receiving systemic medication who meet minimal physician-or patient- reported disease activity levels. It is implied that establishment and maintenance of an established minimum level of disease control as measured by physician-and/or patient-reported outcomes will increase
- [2024 MIPS Measure #409: Clinical Outcome Post-Endovascular Stroke Treatment](https://healthmonix.com/mips_quality_measure/provisional-clinical-outcome-post-endovascular-stroke-treatment/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description ‌Percentage of patients with a Modified Rankin Score (mRS) score of 0 to 2 at 90 days following endovascular stroke intervention. ‌Instructions This measure is to be submitted a minimum of once per performance period for patients undergoing an endovascular
- [2024 MIPS Measure #406: Appropriate Follow-Up Imaging for Incidental Thyroid Nodules in Patients](https://healthmonix.com/mips_quality_measure/provisional-appropriate-follow-up-imaging-for-incidental-thyroid-nodules-in-patients/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of final reports for computed tomography (CT), CT angiography (CTA) or magnetic resonance imaging (MRI) or magnetic resonance angiogram (MRA) studies of the chest or neck for patients aged 18 years and older with no known thyroid disease with
- [2024 MIPS Measure #405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions](https://healthmonix.com/mips_quality_measure/provisional-appropriate-follow-up-imaging-for-incidental-abdominal-lesions/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of final reports for imaging studies for patients aged 18 years and older with one or more of the following noted incidentally with a specific recommendation for no follow‐up imaging recommended based on radiological findings: Cystic renal lesion that
- [2024 MIPS Measure #404: Anesthesiology Smoking Abstinence](https://healthmonix.com/mips_quality_measure/provisional-anesthesiology-smoking-abstinence/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Intermediate Outcome – High Priority Description The percentage of current smokers who abstain from cigarettes prior to anesthesia on the day of elective surgery or procedure. Instructions This measure is to be submitted each time an elective surgery, diagnostic, or pain procedure is performed under
- [2024 MIPS Measure #401: Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis](https://healthmonix.com/mips_quality_measure/provisional-hepatitis-c-screening-for-hepatocellular-carcinoma-hcc-in-patients-with-cirrhosis/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis of chronic Hepatitis C cirrhosis who underwent imaging with either ultrasound, contrast enhanced CT or MRI for hepatocellular carcinoma (HCC) at least once within the 12-month submission period. Instructions This measure is
- [2024 MIPS Measure #400: One-Time Screening for Hepatitis C Virus (HCV) and Treatment Initiation](https://healthmonix.com/mips_quality_measure/provisional-one-time-screening-for-hepatitis-c-virus-hcv-for-all-patients/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of patients aged ≥ 18 years who have never been tested for Hepatitis C Virus (HCV) infection who receive an HCV infection test AND who have treatment initiated within three months or who are referred to a clinician who treats HCV infection
- [2024 MIPS Measure #398: Optimal Asthma Control](https://healthmonix.com/mips_quality_measure/provisional-optimal-asthma-control/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description ‌Composite measure of the percentage of pediatric and adult patients whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools and not at risk for exacerbation. ‌Instructions This measure is to be submitted a
- [2024 MIPS Measure #397: Melanoma Reporting](https://healthmonix.com/mips_quality_measure/provisional-melanoma-reporting/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Pathology reports for primary malignant cutaneous melanoma that include the pT category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors. ‌Instructions This measure is to be submitted each time a
- [2024 MIPS Measure #396: Lung Cancer Reporting (Resection Specimens)](https://healthmonix.com/mips_quality_measure/provisional-lung-cancer-reporting-resection-specimens/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Pathology reports based on lung resection specimens with a diagnosis of primary lung carcinoma that include the pT category, pN category and for non-small cell lung cancer (NSCLC), histologic type. ‌Instructions This measure is to be submitted each time a
- [2024 MIPS Measure #387: Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users](https://healthmonix.com/mips_quality_measure/provisional-annual-hepatitis-c-virus-hcv-screening-for-patients-who-are-active-injection-drug-users/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of patients, regardless of age, who are active injection drug users who received screening for HCV infection within the 12-month reporting period.‌ Instructions This measure is to be submitted a minimum of once per performance period for all patients, regardless of age,
- [2024 MIPS Measure #394: Immunizations for Adolescents](https://healthmonix.com/mips_quality_measure/provisional-immunizations-for-adolescents/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌The percentage of adolescents 13 years of age who had one dose of meningococcal vaccine (serogroups A, C, W, Y), one tetanus, diphtheria toxoids and acellular pertussis (Tdap) vaccine, and have completed the Human Papillomavirus (HPV) vaccine series by their 13th birthday. ‌Instructions
- [2024 MIPS Measure #393: Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision](https://healthmonix.com/mips_quality_measure/provisional-infection-within-180-days-of-cardiac-implantable-electronic-device-cied-implantation-replacement-or-revision/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Infection rate following CIED device implantation, replacement, or revision. Instructions This measure is to be submitted a minimum of once per performance period for patients with a CIED device implantation, replacement, or revision performed from January 1, 2024 through June
- [2024 MIPS Measure #392: Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation Ablation](https://healthmonix.com/mips_quality_measure/provisional-cardiac-tamponade-and-or-pericardiocentesis-following-atrial-fibrillation-ablation/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Rate of cardiac tamponade and/or pericardiocentesis following atrial fibrillation ablation. This measure is submitted as four rates stratified by age and gender: Submission Age Criteria 1: Females 18-64 years of age Submission Age Criteria 2: Males 18-64 years of age
- [2024 MIPS Measure #389: Cataract Surgery: Difference Between Planned and Final Refraction](https://healthmonix.com/mips_quality_measure/provisional-cataract-surgery-difference-between-planned-and-final-refraction/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Percentage of patients aged 18 years and older who had cataract surgery performed and who achieved a final refraction within +/- 1.0 diopters of their planned (target) refraction. Instructions This measure is to be submitted each time a cataract procedure
- [2024 MIPS Measure #384: Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room Within 90 Days of Surgery](https://healthmonix.com/mips_quality_measure/provisional-adult-primary-rhegmatogenous-retinal-detachment-surgery-no-return-to-the-operating-room-within-90-days-of-surgery/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Patients aged 18 years and older who had surgery for primary rhegmatogenous retinal detachment who did not require a return to the operating room within 90 days of surgery. ‌Instructions This measure is to be submitted each time a procedure
- [2024 MIPS Measure #383: Adherence to Antipsychotic Medications for Individuals with Schizophrenia](https://healthmonix.com/mips_quality_measure/provisional-adherence-to-antipsychotic-medications-for-individuals-with-schizophrenia/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Intermediate Outcome – High Priority Description ‌Percentage of individuals at least 18 years of age as of the beginning of the performance period with schizophrenia or schizoaffective disorder who had at least two prescriptions filled for any antipsychotic medication and who had a Proportion of
- [2024 MIPS Measure #374: Closing the Referral Loop: Receipt of Specialist Report](https://healthmonix.com/mips_quality_measure/closing-the-referral-loop-receipt-of-specialist-report/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Percentage of patients with referrals, regardless of age, for which the referring clinician receives a report from the clinician to whom the patient was referred. ‌Instructions This measure is to be submitted a minimum of once per performance period for
- [2024 MIPS Measure #370: Depression Remission at Twelve Months](https://healthmonix.com/mips_quality_measure/provisional-depression-remission-at-twelve-months/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description ‌The percentage of adolescent patients 12 to 17 years of age and adult patients 18 years of age or older with major depression or dysthymia who reached remission 12 months (+/- 60 days) after an index event date. ‌Instructions This
- [2024 MIPS Measure #364: Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended Guidelines](https://healthmonix.com/mips_quality_measure/provisional-optimizing-patient-exposure-to-ionizing-radiation-appropriateness-follow-up-ct-imaging-for-incidentally-detected-pulmonary-nodules-according-to-recommended-guidelines/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of final reports for CT imaging studies with a finding of an incidental pulmonary nodule for patients aged 35 years and older that contain an impression or conclusion that includes a recommended interval and modality for follow-up (e.g., type
- [2024 MIPS Measure #360: Optimizing Patient Exposure to Ionizing Radiation: Count of Potential High Dose Radiation Imaging Studies: Computed Tomography (CT) and Cardiac Nuclear Medicine Studies](https://healthmonix.com/mips_quality_measure/provisional-optimizing-patient-exposure-to-ionizing-radiation-count-of-potential-high-dose-radiation-imaging-studies-computed-tomography-ct-and-cardiac-nuclear-medicine-studies/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of computed tomography (CT) and cardiac nuclear medicine (myocardial perfusion studies) imaging reports for all patients, regardless of age, that document a count of known previous CT (any type of CT) and cardiac nuclear medicine (myocardial perfusion) studies that
- [2024 MIPS Measure #358: Patient-Centered Surgical Risk Assessment and Communication](https://healthmonix.com/mips_quality_measure/provisional-patient-centered-surgical-risk-assessment-and-communication/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Percentage of patients who underwent a non-emergency surgery who had their personalized risks of postoperative complications assessed by their surgical team prior to surgery using a clinical data-based, patient-specific risk calculator and who received personal discussion of those risks with
- [2024 MIPS Measure #357: Surgical Site Infection (SSI)](https://healthmonix.com/mips_quality_measure/provisional-surgical-site-infection-ssi/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Percentage of patients aged 18 years and older who had a surgical site infection (SSI). ‌Instructions This measure is to be submitted each time a surgical procedure listed in the denominator is performed during the performance period. There is no
- [2024 MIPS Measure #356: Unplanned Hospital Readmission within 30 Days of Principal Procedure](https://healthmonix.com/mips_quality_measure/provisional-unplanned-hospital-readmission-within-30-days-of-principal-procedure/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description ‌Percentage of patients aged 18 years and older who had an unplanned hospital readmission within 30 days of principal procedure. ‌Instructions This measure is to be submitted each time a surgical procedure listed in the denominator is performed during the
- [2024 MIPS Measure #354: Anastomotic Leak Intervention](https://healthmonix.com/mips_quality_measure/provisional-anastomotic-leak-intervention/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Percentage of patients aged 18 years and older who required an anastomotic leak intervention following gastric bypass or colectomy surgery. ‌Instructions This measure is to be submitted each time a procedure for gastric bypass or colectomy surgery is performed during
- [2024 MIPS Measure #351: Total Knee or Hip Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation](https://healthmonix.com/mips_quality_measure/provisional-total-knee-or-hip-replacement-venous-thromboembolic-and-cardiovascular-risk-evaluation/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of patients regardless of age undergoing a total knee or total hip replacement who are evaluated for the presence or absence of venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., History of Deep
- [2024 MIPS Measure #344: Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2)](https://healthmonix.com/mips_quality_measure/provisional-rate-of-carotid-artery-stenting-cas-for-asymptomatic-patients-without-major-complications-discharged-to-home-by-post-operative-day-2/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Percent of asymptomatic patients undergoing CAS who are discharged to home no later than post-operative day #2. ‌Instructions This measure is to be submitted each time a CAS is performed during the performance period. It is anticipated that Merit-based Incentive
- [2024 MIPS Measure #340: HIV Medical Visit Frequency](https://healthmonix.com/mips_quality_measure/provisional-hiv-medical-visit-frequency/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Percentage of patients, regardless of age, with a diagnosis of HIV who had at least one medical visit in each 6-month period of the 24-month measurement period, with a minimum of 60 days between medical visits. ‌Instructions This measure is
- [2024 MIPS Measure #338: HIV Viral Suppression](https://healthmonix.com/mips_quality_measure/hiv-viral-suppression/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Percentage of patients, regardless of age, diagnosed with HIV prior to or during the first 90 days of the performance period, with an eligible encounter in the first 240 days of the performance period, whose last HIV viral load test
- [2024 MIPS Measure #336: Maternity Care: Postpartum Follow-Up and Care Coordination](https://healthmonix.com/mips_quality_measure/provisional-maternity-care-postpartum-follow-up-and-care-coordination/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of patients, regardless of age, who gave birth during a 12-month period who were seen for postpartum care before or at 12 weeks of giving birth and received the following at a postpartum visit: breastfeeding evaluation and education, postpartum
- [2024 MIPS Measure #335: Maternity Care: Elective Delivery (Without Medical Indication) at < 39 Weeks (Overuse)](https://healthmonix.com/mips_quality_measure/provisional-maternity-care-elective-delivery-without-medical-indication-at-39-weeks-overuse/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Percentage of patients, regardless of age, who gave birth during a 12-month period, delivered a live singleton at < 39 weeks of gestation, and had elective deliveries (without medical indication) by cesarean birth or induction of labor. Instructions This measure
- [2024 MIPS Measure #332: Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use)](https://healthmonix.com/mips_quality_measure/provisional-adult-sinusitis-appropriate-choice-of-antibiotic-amoxicillin-with-or-without-clavulanate-prescribed-for-patients-with-acute-bacterial-sinusitis-appropriate-use/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Percentage of patients aged 18 years and older with a diagnosis of acute bacterial sinusitis that were prescribed amoxicillin, with or without clavulanate, as a first line antibiotic at the time of diagnosis. Instructions This measure may be submitted based
- [2024 MIPS Measure #331: Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse)](https://healthmonix.com/mips_quality_measure/provisional-adult-sinusitis-antibiotic-prescribed-for-acute-viral-sinusitis-overuse/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of patients, aged 18 years and older, with a diagnosis of acute viral sinusitis who were prescribed an antibiotic within 10 days after onset of symptoms. Instructions This measure may be submitted based on the actions of the submitting
- [2024 MIPS Measure #326: Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy](https://healthmonix.com/mips_quality_measure/provisional-atrial-fibrillation-and-atrial-flutter-chronic-anticoagulation-therapy/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of patients aged 18 years and older with atrial fibrillation (AF) or atrial flutter who were prescribed an FDA-approved oral anticoagulant drug for the prevention of thromboembolism during the measurement period. ‌Instructions This measure is to be submitted a minimum of once
- [2024 MIPS Measure #322: Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low-Risk Surgery Patients](https://healthmonix.com/mips_quality_measure/provisional-cardiac-stress-imaging-not-meeting-appropriate-use-criteria-preoperative-evaluation-in-low-risk-surgery-patients/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Efficiency – High Priority Description Percentage of stress single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), stress echocardiogram (ECHO), cardiac computed tomography angiography (CCTA), or cardiac magnetic resonance (CMR) performed in low-risk surgery patients 18 years or older for preoperative evaluation during the 12-month
- [2024 MIPS Measure #322: Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients](https://healthmonix.com/mips_quality_measure/provisional-appropriate-follow-up-interval-for-normal-colonoscopy-in-average-risk-patients/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Percentage of patients aged 45 to 75 years of age receiving a screening colonoscopy without biopsy or polypectomy who had a recommended follow-up interval of at least 10 years for repeat colonoscopy documented in their colonoscopy report. ‌Instructions ‌This measure
- [2024 MIPS Measure #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented](https://healthmonix.com/mips_quality_measure/provisional-preventive-care-and-screening-screening-for-high-blood-pressure-and-follow-up-documented/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of patient visits for patients aged 18 years and older seen during the measurement period who were screened for high blood pressure AND a recommended follow-up plan is documented, as indicated, if blood pressure is elevated or hypertensive. ‌Instructions This measure is
- [2024 MIPS Measure #304: Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery](https://healthmonix.com/mips_quality_measure/provisional-cataracts-patient-satisfaction-within-90-days-following-cataract-surgery/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Patient Engagement / Experience – High Priority Description ‌Percentage of patients aged 18 years and older who had cataract surgery and were satisfied with their care within 90 days following the cataract surgery, based on completion of the Consumer Assessment of Healthcare Providers and Systems
- [2024 MIPS Measure #303:  Cataracts: Improvement in Patient’s Visual Function within 90 Days Following Cataract Surgery](https://healthmonix.com/mips_quality_measure/provisional-cataracts-improvement-in-patients-visual-function-within-90-days-following-cataract-surgery/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE:Patient-Reported Outcome-Based Performance Measure – High Priority Description ‌Percentage of patients aged 18 years and older who had cataract surgery and had improvement in visual function achieved within 90 days following the cataract surgery, based on completing a pre-operative and post-operative visual function survey. ‌Instructions This
- [2024 MIPS Measure #293: Rehabilitative Therapy Referral for Patients with Parkinson's Disease](https://healthmonix.com/mips_quality_measure/provisional-rehabilitative-therapy-referral-for-patients-with-parkinsons-disease/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Percentage of all patients with a diagnosis of Parkinson’s Disease (PD) who were referred to physical, occupational, speech, or recreational therapy once during the measurement period. ‌Instructions This measure is to be submitted a minimum of once per performance period
- [2024 MIPS Measure #290: Assessment of Mood Disorders and Psychosis for Patients with Parkinson’s Disease](https://healthmonix.com/mips_quality_measure/provisional-assessment-of-mood-disorders-and-psychosis-for-patients-with-parkinsons-disease/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of all patients with a diagnosis of Parkinson’s disease (PD) who were assessed for depression, anxiety, apathy, AND psychosis once during the measurement period. ‌Instructions This measure is to be submitted a minimum of once per performance period for patients with a
- [2024 MIPS Measure #288: Dementia: Education and Support of Caregivers for Patients with Dementia](https://healthmonix.com/mips_quality_measure/provisional-dementia-education-and-support-of-caregivers-for-patients-with-dementia/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of patients with dementia whose caregiver(s) were provided with education on dementia disease management and health behavior changes AND were referred to additional resources for support in the last 12 months. ‌Instructions This measure is to be submitted a minimum of once
- [2024 MIPS Measure #286: Dementia: Safety Concern Screening and Follow-Up for Patients with Dementia](https://healthmonix.com/mips_quality_measure/provisional-dementia-safety-concern-screening-and-follow-up-for-patients-with-dementia/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of patients with dementia or their caregiver(s) for whom there was a documented safety concerns screening in two domains of risk: 1) dangerousness to self or others and 2) environmental risks; and if safety concerns screening was positive in the last 12
- [2024 MIPS Measure #282: Dementia: Functional Status Assessment](https://healthmonix.com/mips_quality_measure/provisional-dementia-functional-status-assessment/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of patients with dementia for whom an assessment of functional status was performed at least once in the last 12 months. ‌Instructions This measure is to be submitted a minimum of once per performance period for patients with a diagnosis of dementia
- [2024 MIPS Measure #279: Sleep Apnea: Assessment of Adherence to Obstructive Sleep Apnea (OSA) Therapy](https://healthmonix.com/mips_quality_measure/provisional-sleep-apnea-assessment-of-adherence-to-positive-airway-pressure-therapy/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis of obstructive sleep apnea (OSA) that were prescribed an evidence-based therapy that had documentation that adherence to therapy was assessed at least annually through an objective informatics system or through self-reporting (if
- [2024 MIPS Measure #275: Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy](https://healthmonix.com/mips_quality_measure/provisional-inflammatory-bowel-disease-ibd-assessment-of-hepatitis-b-virus-hbv-status-before-initiating-anti-tnf-tumor-necrosis-factor-therapy/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description Percentage of patients with a diagnosis of inflammatory bowel disease (IBD) who had Hepatitis B Virus (HBV) status assessed and results interpreted prior to initiating anti-TNF (tumor necrosis factor) therapy. Instructions This measure is to be submitted a minimum of once per performance
- [2024 MIPS Measure #268: Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy](https://healthmonix.com/mips_quality_measure/provisional-epilepsy-counseling-for-women-of-childbearing-potential-with-epilepsy/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of all patients of childbearing potential (12 years and older) diagnosed with epilepsy who were counseled at least once a year about how epilepsy and its treatment may affect contraception and pregnancy. Instructions This measure is to be submitted a minimum of
- [2024 MIPS Measure #264: Sentinel Lymph Node Biopsy for Invasive Breast Cancer](https://healthmonix.com/mips_quality_measure/provisional-sentinel-lymph-node-biopsy-for-invasive-breast-cancer/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description The percentage of clinically node negative (clinical stage T1N0M0 or T2N0M0) breast cancer patients before or after neoadjuvant systemic therapy, who undergo a sentinel lymph node (SLN) procedure. ‌Instructions This measure is to be submitted each time a procedure is performed during the
- [2024 MIPS Measure #259: Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Infrarenal Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #2)](https://healthmonix.com/mips_quality_measure/provisional-rate-of-endovascular-aneurysm-repair-evar-of-small-or-moderate-non-ruptured-infrarenal-abdominal-aortic-aneurysms-aaa-without-major-complications-discharged-to-home-by-post-operat/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Percent of patients undergoing endovascular repair of small or moderate non-ruptured infrarenal abdominal aortic aneurysms (AAA) that do not experience a major complication (discharged to home no later than post-operative day #2). ‌Instructions This measure is to be submitted each
- [2024 MIPS Measure #250: Radical Prostatectomy Pathology Reporting](https://healthmonix.com/mips_quality_measure/provisional-radical-prostatectomy-pathology-reporting/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of radical prostatectomy pathology reports that include the pT category, the pN category, the Gleason score and a statement about margin status. ‌Instructions This measure is to be submitted each time a radical prostatectomy surgical pathology examination is performed during the performance
- [2024 MIPS Measure #249: Barrett's Esophagus](https://healthmonix.com/mips_quality_measure/provisional-barretts-esophagus/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of esophageal biopsy reports that document the presence of Barrett’s mucosa that also include a statement about dysplasia. ‌Instructions This measure is to be submitted each time a patient’s esophageal surgical pathology report demonstrates Barrett’s Esophagus; however, only one quality data code
- [2024 MIPS Measure #243: Cardiac Rehabilitation Patient Referral from an Outpatient Setting](https://healthmonix.com/mips_quality_measure/provisional-cardiac-rehabilitation-patient-referral-from-an-outpatient-setting/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description ‌Percentage of patients evaluated in an outpatient setting who within the previous 12 months have experienced an acute myocardial infarction (MI), coronary artery bypass graft (CABG) surgery, a percutaneous coronary intervention (PCI), cardiac valve surgery, or cardiac transplantation, or who
- [2024 MIPS Measure #238: Use of High-Risk Medications in Older Adults](https://healthmonix.com/mips_quality_measure/provisional-use-of-high-risk-medications-in-older-adults/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority Description Percentage of patients 65 years of age and older who were ordered at least two high-risk medications from the same drug class. ‌Instructions This measure is to be submitted a minimum of once per performance period for patients seen during
- [2024 MIPS Measure #236: Controlling High Blood Pressure](https://healthmonix.com/mips_quality_measure/controlling-high-blood-pressure/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Intermediate Outcome – High Priority Description ‌Percentage of patients 18-85 years of age who had a diagnosis of essential hypertension starting before and continuing into, or starting during the first six months of the measurement period, and whose most recent blood pressure was adequately controlled
- [2024 MIPS Measure #226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention](https://healthmonix.com/mips_quality_measure/provisional-preventive-care-and-screening-tobacco-use-screening-and-cessation-intervention/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process Description ‌Percentage of patients aged 12 years and older who were screened for tobacco use one or more times within the measurement period AND who received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period if
- [2024 MIPS Measure #221: Functional Status Change for Patients with Shoulder Impairments](https://healthmonix.com/mips_quality_measure/provisional-functional-status-change-for-patients-with-shoulder-impairments/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority Description ‌A patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients 14 years+ with shoulder impairments. The change in FS is assessed using the FOTO Shoulder FS PROM. The measure is adjusted to patient
- [2024 MIPS Measure #220: Functional Status Change for Patients with Low Back Impairments](https://healthmonix.com/mips_quality_measure/provisional-functional-status-change-for-patients-with-low-back-impairments/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority Description ‌A patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients 14 years+ with low back impairments. The change in FS is assessed using the FOTO Low Back FS PROM. The measure is adjusted
- [2024 MIPS Measure #219: Functional Status Change for Patients with Lower Leg, Foot or Ankle Impairments](https://healthmonix.com/mips_quality_measure/provisional-functional-status-change-for-patients-with-lower-leg-foot-or-ankle-impairments/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority ‌Description ‌A patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients 14 years+ with foot, ankle or lower leg impairments. The change in FS is assessed using the FOTO Lower Extremity Physical Function (LEPF)
- [2024 MIPS Measure #218: Functional Status Change for Patients with Hip Impairments](https://healthmonix.com/mips_quality_measure/provisional-functional-status-change-for-patients-with-hip-impairments/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure – High Priority ‌Description A patient-reported outcome measure (PROM) of risk-adjusted change in functional status (FS) for patients 14 years+ with hip impairments. The change in FS is assessed using the FOTO Lower Extremity Physical Function (LEPF) PROM. The measure is
- [2024 MIPS Measure #187: Stroke and Stroke Rehabilitation: Thrombolytic Therapy](https://healthmonix.com/mips_quality_measure/provisional-stroke-and-stroke-rehabilitation-thrombolytic-therapy/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients aged 18 years and older with a diagnosis of acute ischemic stroke who arrive at the hospital within 3.5 hours of time last known well and for whom IV thrombolytic therapy was initiated within 4.5 hours of time last known
- [2024 MIPS Measure #185: Colonoscopy Interval for Patients with a History of Adenomatous Polyps – Avoidance of Inappropriate Use](https://healthmonix.com/mips_quality_measure/provisional-colonoscopy-interval-for-patients-with-a-history-of-adenomatous-polyps-avoidance-of-inappropriate-use/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description ‌Percentage of patients aged 18 years and older receiving a surveillance colonoscopy, with a history of prior adenomatous polyp(s) in previous colonoscopy findings, which had an interval of 3 or more years since their last colonoscopy. Instructions ‌This measure is
- [2024 MIPS Measure #182: Functional Outcome Assessment](https://healthmonix.com/mips_quality_measure/provisional-functional-outcome-assessment/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description Percentage of visits for patients aged 18 years and older with documentation of a current functional outcome assessment using a standardized functional outcome assessment tool on the date of the encounter AND documentation of a care plan based on identified
- [2024 MIPS Measure #181: Elder Maltreatment Screen and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/provisional-elder-maltreatment-screen-and-follow-up-plan/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description ‌Percentage of patients aged 60 years and older with a documented elder maltreatment screen using an Elder Maltreatment Screening tool on the date of encounter AND a documented follow-up plan on the date of the positive screen. Instructions This measure
- [2024 MIPS Measure #178: Rheumatoid Arthritis (RA): Functional Status Assessment](https://healthmonix.com/mips_quality_measure/provisional-rheumatoid-arthritis-ra-functional-status-assessment/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process‌ Description Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) for whom a functional status assessment was performed at least once within 12 months. Instructions This measure is to be submitted a minimum of once per performance period
- [2024 MIPS Measure #177: Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity](https://healthmonix.com/mips_quality_measure/provisional-rheumatoid-arthritis-ra-periodic-assessment-of-disease-activity/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process‌ Description Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have an assessment of disease activity using an ACR-preferred RA disease activity assessment tool at ≥50% of encounters for RA for each patient during the measurement year.
- [2024 MIPS Measure #176: Tuberculosis Screening Prior to First Course of Biologic and/or Immune Response Modifier Therapy](https://healthmonix.com/mips_quality_measure/provisional-tuberculosis-screening-prior-to-first-course-of-biologic-and-or-immune-response-modifier-therapy/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process ‌Description If a patient has been newly prescribed a biologic and/or immune response modifier that includes a warning for potential reactivation of a latent infection, then the medical record should indicate TB testing in the preceding 12-month period. Instructions This measure is to be
- [2024 MIPS Measure #168: Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration](https://healthmonix.com/mips_quality_measure/provisional-coronary-artery-bypass-graft-cabg-surgical-re-exploration/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Outcome – High Priority‌ ‌Description Percentage of patients aged 18 years and older undergoing isolated CABG surgery who require a return to the operating room (OR) during the current hospitalization for mediastinal bleeding with or without tamponade, graft occlusion, valve dysfunction, or other cardiac reason.
- [2024 MIPS Measure #167: Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure](https://healthmonix.com/mips_quality_measure/provisional-coronary-artery-bypass-graft-cabg-postoperative-renal-failure/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Outcome – High Priority ‌Description Percentage of patients aged 18 years and older undergoing isolated CABG surgery (without pre-existing renal failure) who develop postoperative renal failure or require dialysis. ‌Instructions This measure is to be submitted each time an isolated CABG procedure is performed during
- [2024 MIPS Measure #164: Coronary Artery Bypass Graft (CABG): Prolonged Intubation](https://healthmonix.com/mips_quality_measure/provisional-coronary-artery-bypass-graft-cabg-prolonged-intubation/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Outcome – High Priority Description Percentage of patients aged 18 years and older undergoing isolated CABG surgery who require postoperative intubation > 24 hours. Instructions This measure is to be submitted each time an isolated CABG procedure is performed during the performance period. It is anticipated
- [2024 MIPS Measure #127: Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear](https://healthmonix.com/mips_quality_measure/provisional-diabetes-mellitus-diabetic-foot-and-ankle-care-ulcer-prevention-evaluation-of-footwear/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process‌ Description ‌Percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who were evaluated for proper footwear and sizing. Instructions This measure is to be submitted a minimum of once per performance period for patients with diabetes mellitus seen during
- [2024 MIPS Measure #104: Prostate Cancer: Combination Androgen Deprivation Therapy for High Risk or Very High Risk Prostate Cancer](https://healthmonix.com/mips_quality_measure/provisional-prostate-cancer-combination-androgen-deprivation-therapy-for-high-risk-or-very-high-risk-prostate-cancer/) - 2024 COLLECTION TYPE: ‌MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process ‌Description ‌Percentage of patients, regardless of age, with a diagnosis of prostate cancer at high or very high risk of recurrence receiving external beam radiotherapy to the prostate who were prescribed androgen deprivation therapy in combination with external beam radiotherapy to the prostate. Instructions
- [2024 MIPS Measure #65: Appropriate Treatment for Upper Respiratory Infection (URI)](https://healthmonix.com/mips_quality_measure/provisional-appropriate-treatment-for-upper-respiratory-infection-uri/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority ‌Description ‌Percentage of episodes for patients 3 months of age and older with a diagnosis of upper respiratory infection (URI) that did not result in an antibiotic order. Instructions This measure is to be submitted once for each occurrence of upper
- [2024 MIPS Measure #50: Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older](https://healthmonix.com/mips_quality_measure/provisional-urinary-incontinence-plan-of-care-for-urinary-incontinence-in-women-aged-65-years-and-older/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority ‌Description ‌Percentage of female patients aged 65 years and older with a diagnosis of urinary incontinence with a documented plan of care for urinary incontinence at least once within 12 months. Instructions This measure is to be submitted a minimum of
- [2024 MIPS Measure #48: Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older](https://healthmonix.com/mips_quality_measure/provisional-urinary-incontinence-assessment-of-presence-or-absence-of-urinary-incontinence-in-women-aged-65-years-and-older/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process ‌Description ‌Percentage of female patients aged 65 years and older who were assessed for the presence or absence of urinary incontinence within 12 months. Instructions This measure is to be submitted a minimum of once per performance period for patients seen during the performance
- [2024 MIPS Measure #47: Advance Care Plan](https://healthmonix.com/mips_quality_measure/advance-care-plan/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process – High Priority ‌Description Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record or documentation in the medical record that an advance care plan was discussed but the patient did
- [2024 MIPS Measure #46: Screening for Osteoporosis for Women Aged 65-85 Years of Age](https://healthmonix.com/mips_quality_measure/provisional-screening-for-osteoporosis-for-women-aged-65-85-years-of-age/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Process ‌Description Percentage of female patients aged 65-85 years of age who ever had a central dual-energy X-ray absorptiometry (DXA) to check for osteoporosis. Instructions This measure is to be submitted a minimum of once per performance period for patients seen during the performance period.
- [2024 MIPS Measure #19: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care](https://healthmonix.com/mips_quality_measure/provisional-diabetic-retinopathy-communication-with-the-physician-managing-ongoing-diabetes-care/) - 2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority ‌Description Percentage of patients aged 18 years and older with a diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed with documented communication to the physician who manages the ongoing care of the patient with diabetes mellitus
- [2024 MIPS Measure #1: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)](https://healthmonix.com/mips_quality_measure/diabetes-hemoglobin-a1c-hba1c-poor-control-9/) - ‌2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) ‌MEASURE TYPE: Intermediate Outcome – High Priority Description Percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the measurement period. Instructions This measure is to be submitted a minimum of once per performance period for patients with diabetes seen during
- [imported file test](https://healthmonix.com/mips_quality_measure/imported-file-test/) - Quality ID #1 (CBE 0059): Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) ‌Quality ID #1 (CBE 0059): Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) Quality ID #1 (CBE 0059): Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) ‌2024 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) ‌MEASURE TYPE: ‌Intermediate Outcome – High Priority DESCRIPTION: ‌Percentage
- [EHR Only Measures](https://healthmonix.com/mips_quality_measure/ehr-only-measures/)
- [ACRAD41 - Use of Quantitative Criteria for Oncologic FDG PET Imaging](https://healthmonix.com/mips_quality_measure/acrad-41/) - Measure Title: Use of Quantitative Criteria for Oncologic FDG PET Imaging Measure Description Percentage of final reports for all patients, regardless of age, undergoing non-CNS oncologic FDG PET studies that include at a minimum: a. Serum glucose (e.g., finger stick at time of injection) b. Uptake time (interval from injection to initiation of imaging) c. One reference
- [HM7  Functional Status Change for Patients with Vestibular Dysfunction](https://healthmonix.com/mips_quality_measure/hm7-functional-status-change-for-patients-with-vestibular-dysfunction/) - Measure Title: Functional Status Change for Patients with Vestibular DysfunctionMeasure Description: Percentage of patients aged 14 years and older diagnosed with vestibular dysfunction who achieve a Minimal Clinically Important Difference (MCID) as measured via the validated Dizziness Handicap Inventory or equivalent instrument to indicate functional, emotional, and physical improvement· Submission Age Criteria 1: Patients aged 14-17 years
- [MSK9 - Patients Suffering From a Lower Extremity Injury who Improve Pain](https://healthmonix.com/mips_quality_measure/msk-9/) - Measure Title: Patients Suffering From a Lower Extremity Injury who Improve Pain Measure Description Percentage of patients 18 years or older suffering from a lower extremity injury who achieve the Minimal Clinically Important Difference (MCID) in the Numeric Pain Rating Scale, or like mapped measure during the performance year. Additionally, a risk-adjusted MCID proportional difference determined by
- [MSK5 - Patients Suffering From a Knee Injury who Improve Physical Function](https://healthmonix.com/mips_quality_measure/msk-5/) - Measure Title: Patients Suffering From a Knee Injury who Improve Physical Function Measure Description Percentage of patients 18 years or older suffering from a knee injury who achieve the Minimal Clinically Important Difference (MCID) in the KOS or PROMIS Physical Function, or like mapped measure during the performance year. Additionally, a risk-adjusted MCID proportional difference determined by
- [MSK10 - Patients Suffering From a Knee Injury who Improve Pain](https://healthmonix.com/mips_quality_measure/msk10/) - Measure Title: Patients Suffering From a Knee Injury who Improve Pain Measure Description Percentage of patients 18 years or older suffering from a knee injury who achieve the Minimal Clinically Important Difference (MCID) in the Numeric Pain Rating Scale, or like mapped measure during the performance year. Additionally, a risk-adjusted MCID proportional difference determined by calculating the
- [MSK4 -  Patients Suffering From a Lower Extremity Injury who Improve Physical Function](https://healthmonix.com/mips_quality_measure/msk-4/) - Measure Title: Patients Suffering From a Lower Extremity Injury who Improve Physical Function Measure Description Percentage of patients 18 years or older suffering from a lower extremity injury who achieve the Minimal Clinically Important Difference (MCID) in the LEFS or PROMIS Physical Function, or like mapped measure during the performance year. Additionally, a risk-adjusted MCID proportional difference
- [MSK6 - Patients Suffering From a Neck Injury who Improve Pain](https://healthmonix.com/mips_quality_measure/msk-6/) - Measure Title: Patients Suffering From a Neck Injury who Improve Pain Measure Description Percentage of patients 18 years or older suffering from a neck injury who achieve the Minimal Clinically Important Difference (MCID) in the Numeric Pain Rating Scale, or like mapped measure during the performance year. Additionally, a risk-adjusted MCID proportional difference determined by calculating the
- [MSK7 -  Patients Suffering From an Upper Extremity Injury who Improve Pain](https://healthmonix.com/mips_quality_measure/msk-7/) - Measure Title: Patients Suffering From an Upper Extremity Injury who Improve Pain Measure Description Percentage of patients 18 years or older suffering from an upper extremity injury who achieve the Minimal Clinically Important Difference (MCID) in the Numeric Pain Rating Scale, or like mapped measure during the performance year. Additionally, a risk-adjusted MCID proportional difference determined by
- [MSK8 - Patients Suffering From a Back Injury who Improve Pain](https://healthmonix.com/mips_quality_measure/msk-8/) - Measure Title: Patients Suffering From a Back Injury who Improve Pain Measure Description Percentage of patients 18 years or older suffering from a back injury who achieve the Minimal Clinically Important Difference (MCID) in the Numeric Pain Rating Scale, or like mapped measure during the performance year. Additionally, a risk-adjusted MCID proportional difference determined by calculating the
- [MSK1 - Patients Suffering From a Neck Injury who Improve Physical Function](https://healthmonix.com/mips_quality_measure/msk1/) - Measure Title: Patients Suffering From a Neck Injury who Improve Physical Function Measure Description Percentage of patients 18 years or older suffering from a neck injury who achieve the Minimal Clinically Important Difference (MCID) in the NDI or PROMIS Pain Interference, or like mapped measure during the performance year. Additionally, a risk-adjusted MCID proportional difference determined by
- [MSK2 - Patients Suffering From an Upper Extremity Injury who Improve Physical Function](https://healthmonix.com/mips_quality_measure/msk-2/) - Measure Title: Patients Suffering From an Upper Extremity Injury who Improve Physical Function Measure Description Percentage of patients 18 years or older suffering from an upper extremity injury who achieve the Minimal Clinically Important Difference (MCID) in the QDASH or PROMIS Upper Extremity, or like mapped measure during the performance year. Additionally, a risk-adjusted MCID proportional difference
- [MSK3 - Patients Suffering From a Back Injury who Improve Physical Function](https://healthmonix.com/mips_quality_measure/msk-3/) - Measure Title: Patients Suffering From a Back Injury who Improve Physical Function Measure Description Percentage of patients 18 years or older suffering from a back injury who achieve the Minimal Clinically Important Difference (MCID) in the MDQ or PROMIS Pain Interference, or like mapped measure during the performance year. Additionally, a risk-adjusted MCID proportional difference determined by
- [ACRAD19 - Report Turnaround Time: PET](https://healthmonix.com/mips_quality_measure/acrad-19/) - Measure Title: Report Turnaround Time: PET Measure Description Mean PET report turnaround time (RTAT) Denominator: Total number of PET exams completed Numerator: Mean time from exam completion to final signature on report, in hours Denominator Exclusions: None Denominator Exceptions: None Numerator Exclusions: None Published Specialty: Radiology High Priority Measure: Yes Measure Type: Outcome Include Telehealth: No Inverse Measure: Yes Proportional Measure: No Continuous Variable Measure: Yes Ratio Measure: No Score
- [ACRAD25 - Report Turnaround Time: Mammography](https://healthmonix.com/mips_quality_measure/acrad-25/) - Measure Title: Report Turnaround Time: Mammography Measure Description Mean mammography report turnaround time (RTAT). Denominator: Total number of mammography exams completed Numerator: Mean time from exam completion to final signature on report, in hours Denominator Exclusions: None Denominator Exceptions: None Numerator Exclusions: None Published Specialty: Radiology High Priority Measure: Yes Measure Type: Outcome Include Telehealth: No Inverse Measure: Yes Proportional Measure: No Continuous Variable Measure: Yes Ratio Measure: No Score
- [ACRAD37 - Interpretation of CT Pulmonary Angiography (CTPA) for Pulmonary Embolism](https://healthmonix.com/mips_quality_measure/acrad-37/) - Measure Title: Interpretation of CT Pulmonary Angiography (CTPA) for Pulmonary Embolism Measure Description Percentage of final reports for patients aged 18 years and older undergoing CT pulmonary angiography (CTPA) with a finding of PE that specify the branching order level of the most proximal level of embolus (i.e. main, lobar, interlobar, segmental, sub segmental) Denominator: All final reports
- [ACRAD36 - Incidental Coronary Artery Calcification Reported on Chest CT](https://healthmonix.com/mips_quality_measure/acrad-36/) - Measure Title: Incidental Coronary Artery Calcification Reported on Chest CT Measure Description Percentage of final reports for male patients aged 18 years through 50 and female patients aged 18 through 65 years undergoing noncardiac noncontrast chest CT exams or with and without contrast chest CT exams that note presence or absence of coronary artery calcification or not
- [ACRAD18- Report Turnaround Time: CT](https://healthmonix.com/mips_quality_measure/acrad-18/) - Measure Title: Report Turnaround Time: CT Measure Description Mean CT report turnaround time (RTAT) Denominator: Total number of CT exams completed Numerator: Mean time from exam completion to final signature on report, in hours Denominator Exclusions: None Denominator Exceptions: None Numerator Exclusions: None Published Specialty: Radiology High Priority Measure: Yes Measure Type: Outcome Include Telehealth: No Inverse Measure: Yes Proportional Measure: No Continuous Variable Measure: Yes Ratio Measure: No Score
- [2023 # 110  Preventive Care and Screening: Influenza Immunization](https://healthmonix.com/mips_quality_measure/2023-110-preventive-care-and-screening-influenza-immunization-2/) - CMS Measure ID: #110 Collection Type: MVP Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Community, Population and Public Health Measure Age: > 2 years Instructions This measure is to be submitted a minimum of once for visits for patients seen between January and March for the 2022-2023 influenza
- [ACRAD17- Report Turnaround Time: MRI](https://healthmonix.com/mips_quality_measure/acrad-17/) - Measure Title: Report Turnaround Time: MRI Measure Description Mean MRI report turnaround time (RTAT) Denominator: Total number of MRI exams completed Numerator: Mean time from exam completion to final signature on report, in hours Denominator Exclusions: None Denominator Exceptions: None Numerator Exclusions: None Published Specialty: Radiology High Priority Measure: Yes Measure Type: Outcome Include Telehealth: No Inverse Measure: Yes Proportional Measure: No Continuous Variable Measure: Yes Ratio Measure: No Score
- [ACRAD16 Report Turnaround Time: Ultrasound](https://healthmonix.com/mips_quality_measure/acrad-16/) - Measure Title: Report Turnaround Time: Ultrasound (Excluding Breast US) Measure Description Mean Ultrasound report turnaround time (RTAT) Denominator: Total number of ultrasound exams completed (excluding breast Ultrasound) Numerator: Mean time from exam completion to final signature on report, in hours Denominator Exclusions: None Denominator Exceptions: None Numerator Exclusions: None Published Specialty: Radiology High Priority Measure: Yes Measure Type: Outcome Include Telehealth: No Inverse Measure: Yes Proportional
- [ACRAD15 -  Report Turnaround Time: Radiography](https://healthmonix.com/mips_quality_measure/acrad15/) - Measure Title: Report Turnaround Time: Radiography Measure Description Mean radiography report turnaround time (RTAT). (Does not include mammography.) Denominator: Total number of radiography exams completed Numerator: Mean time from exam completion to final signature on report, in hours Denominator Exclusions: None Denominator Exceptions: None Numerator Exclusions: None Published Specialty: Radiology High Priority Measure: Yes Measure Type: Outcome Include Telehealth: No Inverse Measure: Yes Proportional Measure: No Continuous
- [2023 # 111 Pneumococcal Vaccination Status for Older Adults](https://healthmonix.com/mips_quality_measure/2023-111-pneumococcal-vaccination-status-for-older-adults/) - *This measure can only be reported through an MVP*CMS Measure ID: #111 Collection Type: MVP Reporting Frequency: Once per patient per year Outcome: No High Priority: No NQS Domain: Community, Population and Public Health Measure Age: > 2 years Instructions This measure is to be submitted a minimum of once per performance period for patients
- [2023 # MBHR02  Anxiety Response at 6-months](https://healthmonix.com/mips_quality_measure/2023-mbhr02-anxiety-response-at-6-months/) - Measure Title: Anxiety Response at 6-monthsDescription: The percentage of adult patients (18 years of age or older) with an anxiety disorder (e.g., generalized anxiety disorder, social anxiety disorder, or panic disorder) who demonstrated a response to treatment (GAD-7 score at least 25% less than score at index event) at 6-months (+/- 60 days) after an index visit.To
- [2023 # 391 Follow-up After Hospitalization for Mental Illness (FUH)](https://healthmonix.com/mips_quality_measure/2023-391-follow-up-after-hospitalization-for-mental-illness-fuh/) - CMS Measure ID: #391Collection Type: Process Reporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted at each follow-up visit occurring within 30 and 7 days after each inpatient setting discharge with a principal diagnosis of mental illness or intentional self-harm. This measure may
- [2023 # 418 Osteoporosis Management in Women Who Had a Fracture](https://healthmonix.com/mips_quality_measure/2023-418-osteoporosis-management-in-women-who-had-a-fracture/) - CMS Measure ID: #418Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 years Instructions This measure is to be submitted after each occurrence of a fracture during the six months prior to the performance period through June 30 of the performance period. It is anticipated that Merit-based Incentive
- [2023 # 438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease](https://healthmonix.com/mips_quality_measure/2023-438-statin-therapy-for-the-prevention-and-treatment-of-cardiovascular-disease/) - CMS Measure ID: #438Collection Type: CQM, eCQM, MVP Reporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted once per measurement period for patients seen during the measurement period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who provide
- [2023 # 222 Functional Status Change for Patients with Elbow, Wrist or Hand Impairments](https://healthmonix.com/mips_quality_measure/2023-222-functional-status-change-for-patients-with-elbow-wrist-or-hand-impairments/) - CMS Measure ID: #222Collection Type: CQM Reporting Frequency: Once per episode of treatmentOutcome: YesHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis outcome measure is to be submitted once per Treatment Episode for all patients with a functional deficit related to the elbow, wrist or hand. This is an outcome measure and
- [2023 # 024 Communication with the Physician or Other Clinician Managing On-going Care Post-Fracture for Men and Women Aged 50 Years and Older](https://healthmonix.com/mips_quality_measure/2023-024-communication-with-the-physician-or-other-clinician-managing-on-going-care-post-fracture-for-men-and-women-aged-50-years-and-older/) - CMS Measure ID: #24Collection Type: CQM Reporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted after each occurrence of a fracture during the performance period. It is anticipated that eligible clinicians who treat the fracture will submit this measure. Each occurrence of a
- [2023 # 493 Adult Immunization Status](https://healthmonix.com/mips_quality_measure/2023-493-adult-immunization-status/) - CMS Measure ID: #493Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: NewInstructionsThis measure is to be submitted a minimum of once per performance period for all patients 19 years of age and older on the date of the encounter. This measure may be submitted by Merit-based
- [2023 # 491  Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing Status in Colorectal Carcinoma, Endometrial, Gastroesophageal, or Small Bowel Carcinoma](https://healthmonix.com/mips_quality_measure/2023-491-mismatch-repair-mmr-or-microsatellite-instability-msi-biomarker-testing-status-in-colorectal-carcinoma-endometrial-gastroesophageal-or-small-bowel-carcinoma/) - CMS Measure ID: #491Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: NewInstructionsThis measure is to be submitted each time a primary colorectal, endometrial, gastroesophageal or small bowel carcinoma, biopsy or resection surgical pathology examination is performed during the performance period. This measure may be submitted by Merit-based Incentive Payment
- [2023 # 490  Appropriate Intervention of Immune-Related Diarrhea and/or Colitis in Patients Treated with Immune Checkpoint Inhibitors](https://healthmonix.com/mips_quality_measure/2023-490-appropriate-intervention-of-immune-related-diarrhea-and-or-colitis-in-patients-treated-with-immune-checkpoint-inhibitors/) - CMS Measure ID: #490Collection Type: CQMReporting Frequency: Once per episode of treatmentOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: NewInstructionsThis measure is to be submitted a minimum of once per episode for patients with a diagnosis of cancer and on immune checkpoint inhibitors and who have grade 2 or above diarrhea and/or grade 2
- [2023 # 488 Kidney Health Evaluation](https://healthmonix.com/mips_quality_measure/2023-488-kidney-health-evaluation/) - CMS Measure ID: #488Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: NewInstructionsThis measure is to be submitted a minimum of once per performance period for patients with a diagnosis of diabetes seen during the performance period. This measure may be submitted by Merit-based Incentive Payment System
- [2023 # 489 Adult Kidney Disease: Angiotensin Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy](https://healthmonix.com/mips_quality_measure/2023-489-adult-kidney-disease-angiotensin-converting-enzyme-ace-inhibitor-or-angiotensin-receptor-blocker-arb-therapy/) - CMS Measure ID: #489Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: NewInstructionsThis measure is to be submitted a minimum of once per performance period for patients with a diagnosis of CKD (Stages 1-5, not receiving Renal Replacement Therapy (RRT)) and proteinuria seen during the performance period.
- [2023 # 487 Screening for Social Drivers of Health](https://healthmonix.com/mips_quality_measure/2023-487-screening-for-social-drivers-of-health/) - CMS Measure ID: #487Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Person and Caregiver-Centered Experience OutcomesMeasure Age: NewInstructionsThis measure is to be submitted a minimum of once per performance period for patients seen during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians
- [2023 # 485 Psoriasis – Improvement in Patient-Reported Itch Severity](https://healthmonix.com/mips_quality_measure/2023-485-psoriasis-improvement-in-patient-reported-itch-severity/) - CMS Measure ID: #485Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: NewInstructionsThis outcome measure is to be submitted at each denominator eligible visit for patients with a diagnosis of psoriasis seen during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who
- [2023 # 486 Dermatitis – Improvement in Patient-Reported Itch Severity](https://healthmonix.com/mips_quality_measure/2023-486-dermatitis-improvement-in-patient-reported-itch-severity/) - CMS Measure ID: #486Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: NewInstructionsThis outcome measure is to be submitted each denominator eligible visit for patients with a diagnosis of dermatitis seen during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform
- [2023 # 478  Functional Status Change for Patients with Neck Impairments](https://healthmonix.com/mips_quality_measure/2023-478-functional-status-change-for-patients-with-neck-impairments/) - CMS Measure ID: #478Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Person and Caregiver-Centered Experience OutcomesMeasure Age: > 2 yearsInstructionsThis outcome measure is to be submitted once per Treatment Episode for all patients with a functional deficit related to the neck. This measure is intended for patients with neck impairments. This is an
- [2023 # 477 Multimodal Pain Management](https://healthmonix.com/mips_quality_measure/2023-477-multimodal-pain-management/) - CMS Measure ID: #477Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be reported each time a patient undergoes a selected surgical procedure during the reporting period. It is anticipated that Merit-based Incentive Payment System (MIPS) eligible anesthesia providers and clinicians who provide denominator-eligible
- [2023 # 471  Functional Status After Lumbar Surgery](https://healthmonix.com/mips_quality_measure/2023-471-functional-status-after-lumbar-surgery/) - CMS Measure ID: #471Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Person and Caregiver-Centered Experience OutcomesMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a patient undergoes a lumbar discectomy/laminectomy or fusion during the denominator identification period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians
- [2023 # 470  Functional Status After Primary Total Knee Replacement](https://healthmonix.com/mips_quality_measure/2023-470-functional-status-after-primary-total-knee-replacement/) - CMS Measure ID: #470Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Person and Caregiver-Centered Experience OutcomesMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a patient undergoes a total knee replacement during the denominator identification period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who
- [2023 # 468 Continuity of Pharmacotherapy for Opioid Use Disorder (OUD)](https://healthmonix.com/mips_quality_measure/2023-468-continuity-of-pharmacotherapy-for-opioid-use-disorder-oud/) - CMS Measure ID: #468Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all adults aged 18 years and older with pharmacotherapy for OUD seen during the denominator identification period. This measure
- [2023 # 465 Uterine Artery Embolization Technique: Documentation of Angiographic Endpoints and Interrogation of Ovarian Arteries](https://healthmonix.com/mips_quality_measure/2023-465-uterine-artery-embolization-technique-documentation-of-angiographic-endpoints-and-interrogation-of-ovarian-arteries/) - CMS Measure ID: #465Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a procedure for uterine artery embolization is performed during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality
- [2023 # 464 Otitis Media with Effusion: Systemic Antimicrobials - Avoidance of Inappropriate Use](https://healthmonix.com/mips_quality_measure/2023-464-otitis-media-with-effusion-systemic-antimicrobials-avoidance-of-inappropriate-use/) - CMS Measure ID: #464Collection Type: CQMReporting Frequency: Once per episode of treatmentOutcome: NoHigh Priority: YesNQS Domain: Person and Caregiver-Centered Experience OutcomesMeasure Age: > 2 yearsInstructionsThis measure is to be submitted once for each occurrence of otitis media with effusion (OME) in children seen during the performance period. Each unique occurrence is defined as a 90-day
- [2023 # 463 Prevention of Post-Operative Vomiting (POV) – Combination Therapy (Pediatrics)](https://healthmonix.com/mips_quality_measure/2023-463-prevention-of-post-operative-vomiting-pov-combination-therapy-pediatrics/) - CMS Measure ID: #463Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time any procedure including surgical, therapeutic or diagnostic under an inhalational general anesthetic is performed during the performance period. There is no diagnosis associated with this measure. It is anticipated
- [2023 # 461  Leg Pain After Lumbar Surgery](https://healthmonix.com/mips_quality_measure/2023-461-leg-pain-after-lumbar-surgery/) - CMS Measure ID: #461Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Person and Caregiver-Centered Experience OutcomesMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a patient undergoes a lumbar discectomy/laminectomy or fusion during the denominator identification period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians
- [2023 # 459  Back Pain After Lumbar Surgery](https://healthmonix.com/mips_quality_measure/2023-459-back-pain-after-lumbar-surgery/) - CMS Measure ID: #459Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Person and Caregiver-Centered Experience OutcomesMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a patient undergoes a lumbar discectomy/laminectomy or fusion during the denominator identification period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians
- [2023 # 457 Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score – better)](https://healthmonix.com/mips_quality_measure/2023-457-percentage-of-patients-who-died-from-cancer-admitted-to-hospice-for-less-than-3-days-lower-score-better/) - CMS Measure ID: #457Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients who died of cancer during the measurement year. It is anticipated that eligible clinicians who provide services for
- [2023 # 453  Percentage of Patients Who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life (lower score – better)](https://healthmonix.com/mips_quality_measure/2023-453-percentage-of-patients-who-died-from-cancer-receiving-systemic-cancer-directed-therapy-in-the-last-14-days-of-life-lower-score-better/) - CMS Measure ID: #453Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients who died of cancer during the measurement year. It is anticipated that eligible clinicians who provide services for
- [2023 # 452  Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies](https://healthmonix.com/mips_quality_measure/2023-452-patients-with-metastatic-colorectal-cancer-and-ras-kras-or-nras-gene-mutation-spared-treatment-with-anti-epidermal-growth-factor-receptor-egfr-monoclonal-antibodies/) - CMS Measure ID: #452Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted once per performance period for patients with colorectal cancer seen during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who
- [2023 # 451 RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy](https://healthmonix.com/mips_quality_measure/2023-451-ras-kras-and-nras-gene-mutation-testing-performed-for-patients-with-metastatic-colorectal-cancer-who-receive-anti-epidermal-growth-factor-receptor-egfr-monoclonal-antibody-therapy/) - CMS Measure ID: #451Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted once per performance period for patients with colorectal cancer seen during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians
- [2023 # 450 Appropriate Treatment for Patients with Stage I (T1c) – III HER2 Positive Breast Cancer](https://healthmonix.com/mips_quality_measure/2023-450-appropriate-treatment-for-patients-with-stage-i-t1c-iii-her2-positive-breast-cancer/) - CMS Measure ID: #450Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with breast cancer seen during the performance period. This measure may be submitted by Merit-based Incentive Payment System
- [2023 # 448 Appropriate Workup Prior to Endometrial Ablation](https://healthmonix.com/mips_quality_measure/2023-448-appropriate-workup-prior-to-endometrial-ablation/) - CMS Measure ID: #448Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a procedure for endometrial ablation is performed during the performance period. This measure is to be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the
- [2023 # 445  Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)](https://healthmonix.com/mips_quality_measure/2023-445-risk-adjusted-operative-mortality-for-coronary-artery-bypass-graft-cabg/) - CMS Measure ID: #445Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients undergoing isolated CABG during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible
- [2023 # 443  Non-Recommended Cervical Cancer Screening in Adolescent Females](https://healthmonix.com/mips_quality_measure/2023-443-non-recommended-cervical-cancer-screening-in-adolescent-females/) - CMS Measure ID: #443Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted once per performance period for female patients seen during the performance period. There is no diagnosis associated with this measure. This measure may be submitted by Merit-based Incentive
- [2023 # 441 Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)](https://healthmonix.com/mips_quality_measure/2023-441-ischemic-vascular-disease-ivd-all-or-none-outcome-measure-optimal-control/) - CMS Measure ID: #441Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all patients seen during the performance period. The most recent quality-data code submitted will be used for performance calculation.
- [2023 # 440  Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician](https://healthmonix.com/mips_quality_measure/2023-440-skin-cancer-biopsy-reporting-time-pathologist-to-clinician/) - CMS Measure ID: #440Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a biopsy is performed during the performance period. It is anticipated that Merit-based Incentive Payment System (MIPS) eligible clinicians providing the pathology services for procedures will submit
- [2023 # 439  Age Appropriate Screening Colonoscopy](https://healthmonix.com/mips_quality_measure/2023-439-age-appropriate-screening-colonoscopy/) - CMS Measure ID: #439Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Efficiency and Cost ReductionMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a colonoscopy is performed for all patients during the performance period. There is no diagnosis associated with this measure. This measure may be submitted by Merit-based Incentive
- [2023 # 436  Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques](https://healthmonix.com/mips_quality_measure/2023-436-radiation-consideration-for-adult-ct-utilization-of-dose-lowering-techniques/) - CMS Measure ID: #436Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a patient has a computed tomography scan during the performance period. There is no diagnosis associated with this measure. It is anticipated that eligible clinicians who provide the
- [2023 # 433  Proportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse Repair](https://healthmonix.com/mips_quality_measure/2023-433-proportion-of-patients-sustaining-a-bowel-injury-at-the-time-of-any-pelvic-organ-prolapse-repair/) - CMS Measure ID: #433Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a pelvic organ prolapse repair surgery is performed during the performance period ending November 30th. There is no diagnosis associated with this measure. This measure may be submitted by
- [2023 # 432 Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair](https://healthmonix.com/mips_quality_measure/2023-432-proportion-of-patients-sustaining-a-bladder-injury-at-the-time-of-any-pelvic-organ-prolapse-repair/) - CMS Measure ID: #432Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a prolapse organ repair surgery is performed during the performance period ending November 30th. There is no diagnosis associated with this measure. This measure may be submitted by Merit-based
- [2023 # 431 Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling](https://healthmonix.com/mips_quality_measure/2023-431-preventive-care-and-screening-unhealthy-alcohol-use-screening-brief-counseling/) - CMS Measure ID: #431Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Community, Population and Public HealthMeasure Age: > 2 yearsInstructionsThis measure is to be submitted once per performance period for patients seen during the performance period. This measure is intended to reflect the quality of services provided for preventive screening
- [2023 # 430 Prevention of Post-Operative Nausea and Vomiting (PONV) – Combination Therapy](https://healthmonix.com/mips_quality_measure/2023-430-prevention-of-post-operative-nausea-and-vomiting-ponv-combination-therapy/) - CMS Measure ID: #430Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time any procedure including surgical, therapeutic or diagnostic under an inhalational general anesthetic is performed during the performance period. There is no diagnosis associated with this measure. It is anticipated
- [2023 # 424 Perioperative Temperature Management](https://healthmonix.com/mips_quality_measure/2023-424-perioperative-temperature-management/) - CMS Measure ID: #424Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time any procedure including surgical, therapeutic or diagnostic is performed under general or neuraxial anesthesia during the performance period. There is no diagnosis associated with this measure. It is anticipated
- [2023 # 422 Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury](https://healthmonix.com/mips_quality_measure/2023-422-performing-cystoscopy-at-the-time-of-hysterectomy-for-pelvic-organ-prolapse-to-detect-lower-urinary-tract-injury/) - CMS Measure ID: #422Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a procedure is performed during the performance period for patients who undergo a hysterectomy for pelvic organ prolapse. This measure may be submitted by Merit-based Incentive Payment System (MIPS)
- [2023 # 421 Appropriate Assessment of Retrievable Inferior Vena Cava (IVC) Filters for Removal](https://healthmonix.com/mips_quality_measure/2023-421-appropriate-assessment-of-retrievable-inferior-vena-cava-ivc-filters-for-removal/) - CMS Measure ID: #422Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a procedure is performed during the performance period for patients who undergo a hysterectomy for pelvic organ prolapse. This measure may be submitted by Merit-based Incentive Payment System (MIPS)
- [2023 # 420 Varicose Vein Treatment with Saphenous Ablation: Outcome Survey](https://healthmonix.com/mips_quality_measure/2023-420-varicose-vein-treatment-with-saphenous-ablation-outcome-survey/) - CMS Measure ID: #420Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a saphenous ablation procedure is performed for the treatment of varicose veins during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible
- [2023 # 419 Overuse of Imaging for the Evaluation of Primary Headache](https://healthmonix.com/mips_quality_measure/2023-419-overuse-of-imaging-for-the-evaluation-of-primary-headache/) - CMS Measure ID: #419Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Efficiency and Cost ReductionMeasure Age: > 2 yearsInstructionsThis measure is to be submitted at each denominator eligible visit for patients with a diagnosis of primary headache during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible
- [2023 # 416  Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 through 17 Years](https://healthmonix.com/mips_quality_measure/2023-416-emergency-medicine-emergency-department-utilization-of-ct-for-minor-blunt-head-trauma-for-patients-aged-2-through-17-years/) - CMS Measure ID: #416Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Efficiency and Cost ReductionMeasure Age: > 2 yearsInstructionsThis measure is to be submitted for each denominator eligible visit for patients aged 2 through 17 years who present to the emergency department with a minor blunt head trauma during the performance period. It is anticipated
- [2023 # 415 Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older](https://healthmonix.com/mips_quality_measure/2023-415-emergency-medicine-emergency-department-utilization-of-ct-for-minor-blunt-head-trauma-for-patients-aged-18-years-and-older/) - CMS Measure ID: #415Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Efficiency and Cost ReductionMeasure Age: > 2 yearsInstructionsThis measure is to be submitted for each denominator eligible visit for patients aged 18 years and older who present to the emergency department with a minor blunt head trauma during the performance period. It
- [2023 # 413 Door to Puncture Time for Endovascular Stroke Treatment](https://healthmonix.com/mips_quality_measure/2023-413-door-to-puncture-time-for-endovascular-stroke-treatment/) - CMS Measure ID: #413Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a patient undergoes a procedure for treatment of a cerebrovascular accident (CVA) during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who
- [2023 # 410 Psoriasis: Clinical Response to Systemic Medications](https://healthmonix.com/mips_quality_measure/2023-410-psoriasis-clinical-response-to-systemic-medications/) - CMS Measure ID: #410Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: YesHigh Priority: YesNQS Domain: Person and Caregiver-Centered Experience OutcomesMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all patients during the performance period. The most recent denominator eligible encounter should be used to determine if
- [2023 # 409 Clinical Outcome Post-Endovascular Stroke Treatment](https://healthmonix.com/mips_quality_measure/2023-409-clinical-outcome-post-endovascular-stroke-treatment/) - CMS Measure ID: #409Collection Type: CQMReporting Frequency: Once per yearOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients undergoing an endovascular stroke intervention procedure during the performance period. This measure is intended to reflect the success of the
- [2023 # 406 Appropriate Follow-Up Imaging for Incidental Thyroid Nodules in Patients](https://healthmonix.com/mips_quality_measure/2023-406-appropriate-follow-up-imaging-for-incidental-thyroid-nodules-in-patients/) - CMS Measure ID: #406Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a patients undergoes a computed tomography or magnetic resonance imaging with an incidental thyroid nodule finding during the performance period. There is no diagnosis associated with this measure.
- [2023 # 405 Appropriate Follow-up Imaging for Incidental Abdominal  Lesions](https://healthmonix.com/mips_quality_measure/2023-405-appropriate-follow-up-imaging-for-incidental-abdominal-lesions/) - CMS Measure ID: #405Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a patient undergoes an imaging study with an incidental abdominal lesion finding during the performance period. There is no diagnosis associated with this measure. It is anticipated that
- [2023 # 404 Anesthesiology Smoking Abstinence](https://healthmonix.com/mips_quality_measure/2023-404-anesthesiology-smoking-abstinence/) - CMS Measure ID: #404Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time an elective surgery, diagnostic, or pain procedure is performed under anesthesia during the performance period. There is no diagnosis associated with this measure. It is anticipated that eligible
- [2023 # 402 Tobacco Use and Help with Quitting Among Adolescents](https://healthmonix.com/mips_quality_measure/2023-402-tobacco-use-and-help-with-quitting-among-adolescents/) - CMS Measure ID: #402Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Community, Population and Public HealthMeasure Age: > 2 yearsInstructionsThis measure is to be submitted once per performance period for patients seen during the performance period. This measure is intended to reflect the quality of services provided for preventive screening
- [2023 # 401 Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis](https://healthmonix.com/mips_quality_measure/2023-401-hepatitis-c-screening-for-hepatocellular-carcinoma-hcc-in-patients-with-cirrhosis/) - CMS Measure ID: #401Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all patients with a diagnosis of chronic hepatitis C cirrhosis seen during the performance period. This measure is intended
- [2023 # 400 One-Time Screening for Hepatitis C Virus (HCV) for all Patients](https://healthmonix.com/mips_quality_measure/2023-400-one-time-screening-for-hepatitis-c-virus-hcv-for-all-patients/) - CMS Measure ID: #400Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all patients >= 18 years of age seen during the performance period AND who were seen twice for any visits or
- [2023 # 398 Optimal Asthma Control](https://healthmonix.com/mips_quality_measure/2023-398-optimal-asthma-control/) - CMS Measure ID: #398Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all patients with a diagnosis of asthma seen during the performance period. This measure may be submitted by Merit-based
- [2023 # 397 Melanoma Reporting](https://healthmonix.com/mips_quality_measure/2023-397-melanoma-reporting/) - CMS Measure ID: #397Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a patient’s pathology report addresses specimens with a diagnosis of malignant cutaneous melanoma; however, only one quality data code (QDC) per date of service for a patient
- [2023 # 396 Lung Cancer Reporting (Resection Specimens)](https://healthmonix.com/mips_quality_measure/2023-396-lung-cancer-reporting-resection-specimens/) - CMS Measure ID: #396Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a patient’s lung pathology report addresses specimens with a diagnosis of non-small cell lung cancer; however, only one quality data code (QDC) per date of service for
- [2023 # 395 Lung Cancer Reporting (Biopsy/Cytology Specimens)](https://healthmonix.com/mips_quality_measure/2023-395-lung-cancer-reporting-biopsy-cytology-specimens/) - CMS Measure ID: #395Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a patient’s pathology report addresses specimens with a diagnosis of non-small cell lung cancer; however, only one quality-data code (QDC) per date of service for a patient
- [2023 # 394 Immunizations for Adolescents](https://healthmonix.com/mips_quality_measure/2023-394-immunizations-for-adolescents/) - CMS Measure ID: #394Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Community, Population and Public HealthMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients seen during the performance period. There is no diagnosis associated with this measure. Performance for this
- [2023 # 393 HRS-9: Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision](https://healthmonix.com/mips_quality_measure/2023-393-hrs-9-infection-within-180-days-of-cardiac-implantable-electronic-device-cied-implantation-replacement-or-revision/) - CMS Measure ID: #393Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: YesHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with a CIED device implantation, replacement, or revision performed from January 1, 2023 through June 30, 2023 of the
- [2023 # 392 HRS-12: Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation Ablation](https://healthmonix.com/mips_quality_measure/2023-392-hrs-12-cardiac-tamponade-and-or-pericardiocentesis-following-atrial-fibrillation-ablation/) - CMS Measure ID: #392Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: YesHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with atrial fibrillation ablation performed during the performance period. This measure may be submitted by Merit-based Incentive Payment System
- [2023 # 389 Cataract Surgery: Difference Between Planned and Final Refraction](https://healthmonix.com/mips_quality_measure/2023-389-cataract-surgery-difference-between-planned-and-final-refraction/) - CMS Measure ID: #389Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be calculated each time a cataract procedure is performed during the performance period. This measure is intended to reflect the quality of services provided for the patient receiving cataract surgery. Note: This
- [2023 # 387 Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users](https://healthmonix.com/mips_quality_measure/2023-387-annual-hepatitis-c-virus-hcv-screening-for-patients-who-are-active-injection-drug-users/) - CMS Measure ID: #387Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all patients, regardless of age, who are active injection drug users seen during the performance period. This measure may
- [2023 # 386 Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences](https://healthmonix.com/mips_quality_measure/2023-386-amyotrophic-lateral-sclerosis-als-patient-care-preferences/) - CMS Measure ID: #386Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Person and Caregiver-Centered Experience OutcomesMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with a diagnosis of ALS during the performance period. This measure may be submitted by Merit-based
- [2023 # 385 Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement Within 90 Days of Surgery](https://healthmonix.com/mips_quality_measure/2023-385-adult-primary-rhegmatogenous-retinal-detachment-surgery-visual-acuity-improvement-within-90-days-of-surgery/) - CMS Measure ID: #385Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be calculated each time a procedure for primary rhegmatogenous retinal detachment is performed during the performance period. This measure is intended to reflect the quality of services provided for the patient receiving
- [2023 # 384 Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room Within 90 Days of Surgery](https://healthmonix.com/mips_quality_measure/2023-384-adult-primary-rhegmatogenous-retinal-detachment-surgery-no-return-to-the-operating-room-within-90-days-of-surgery/) - CMS Measure ID: #384Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be calculated each time a procedure for primary rhegmatogenous retinal detachment is performed during the performance period. This measure is intended to reflect the quality of services provided for the patient receiving
- [2023 # 383 Adherence to Antipsychotic Medications for Individuals with Schizophrenia](https://healthmonix.com/mips_quality_measure/2023-383-adherence-to-antipsychotic-medications-for-individuals-with-schizophrenia/) - CMS Measure ID: #383Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all patients with a diagnosis of schizophrenia or schizoaffective disorder seen during the performance period. This measure may be submitted
- [2023 # 374 Closing the Referral Loop: Receipt of Specialist Report](https://healthmonix.com/mips_quality_measure/2023-374-closing-the-referral-loop-receipt-of-specialist-report/) - CMS Measure ID: #374Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for the first referral for all patients during the measurement period. This measure may be submitted by Merit-based Incentive
- [2023 # 370  Depression Remission at Twelve Months](https://healthmonix.com/mips_quality_measure/2023-370-depression-remission-at-twelve-months/) - CMS Measure ID: #370Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted once per performance period for patients with an encounter during the denominator identification period with a diagnosis of depression and an initial Patient Health Questionnaire – 9 item version (PHQ-9) or
- [2023 # 364 Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended Guidelines](https://healthmonix.com/mips_quality_measure/2023-364-optimizing-patient-exposure-to-ionizing-radiation-appropriateness-follow-up-ct-imaging-for-incidentally-detected-pulmonary-nodules-according-to-recommended-guidelines/) - CMS Measure ID: #364Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a procedure for a CT imaging with an incidental pulmonary nodule is performed during the performance period. There is no diagnosis associated with this measure. This measure
- [2023 # 360 Optimizing Patient Exposure to Ionizing Radiation: Count of Potential High Dose Radiation Imaging Studies: Computed Tomography (CT) and Cardiac Nuclear Medicine Studies](https://healthmonix.com/mips_quality_measure/2023-360-optimizing-patient-exposure-to-ionizing-radiation-count-of-potential-high-dose-radiation-imaging-studies-computed-tomography-ct-and-cardiac-nuclear-medicine-studies/) - CMS Measure ID: #360Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a procedure for a CT imaging report is performed during the performance period. There is no diagnosis associated with this measure. This measure may be submitted by Merit-based Incentive
- [2023 # 358 Patient-Centered Surgical Risk Assessment and Communication](https://healthmonix.com/mips_quality_measure/2023-358-patient-centered-surgical-risk-assessment-and-communication/) - CMS Measure ID: #358Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Person and Caregiver-Centered Experience OutcomesMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a procedure is performed during the performance period for patients who undergo non-emergency surgical procedures. There is no diagnosis associated with this measure. It is anticipated
- [2023 # 357 Surgical Site Infection (SSI)](https://healthmonix.com/mips_quality_measure/2023-357-surgical-site-infection-ssi/) - CMS Measure ID: #357Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a surgical procedure listed in the denominator is performed during the performance period. There is no diagnosis associated with this measure. This measure may be submitted by Merit-based
- [2023 # 356 Unplanned Hospital Readmission within 30 Days of Principal Procedure](https://healthmonix.com/mips_quality_measure/2023-356-unplanned-hospital-readmission-within-30-days-of-principal-procedure/) - CMS Measure ID: #356Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a surgical procedure listed in the denominator is performed during the performance period ending November 30th. There is no diagnosis associated with this measure. This measure may be
- [2023 # 355 Unplanned Reoperation within the 30 Day Postoperative Period](https://healthmonix.com/mips_quality_measure/2023-355-unplanned-reoperation-within-the-30-day-postoperative-period/) - CMS Measure ID: #355Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time an operative procedure listed in the denominator is performed during the performance period. There is no diagnosis associated with this measure. This measure may be submitted by Merit-based Incentive
- [2023 # 354 Anastomotic Leak Intervention](https://healthmonix.com/mips_quality_measure/2023-354-anastomotic-leak-intervention/) - CMS Measure ID: #354Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a procedure for anastomotic leak intervention following gastric bypass or colectomy surgery is performed during the performance period. There is no diagnosis associated with this measure. This measure may
- [2023 # 351 Total Knee or Hip Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation](https://healthmonix.com/mips_quality_measure/2023-351-total-knee-or-hip-replacement-venous-thromboembolic-and-cardiovascular-risk-evaluation/) - CMS Measure ID: #351Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a procedure for total knee or total hip replacement is performed during the performance period. There is no diagnosis associated with this measure. This measure may be submitted by
- [2023 # 350 Total Knee or Hip Replacement: Shared Decision-Making: Trial of Conservative (Nonsurgical) Therapy](https://healthmonix.com/mips_quality_measure/2023-350-total-knee-or-hip-replacement-shared-decision-making-trial-of-conservative-nonsurgical-therapy/) - CMS Measure ID: #350Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a procedure for total knee or total hip replacement is performed during the performance period. There is no diagnosis associated with this measure. This measure may be
- [2023 # 344 Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2)](https://healthmonix.com/mips_quality_measure/2023-344-rate-of-carotid-artery-stenting-cas-for-asymptomatic-patients-without-major-complications-discharged-to-home-by-post-operative-day-2/) - CMS Measure ID: #344Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a CAS is performed during the performance period. It is anticipated that eligible clinicians who provide services of CAS, as described in the measure, based on the services
- [2023 # 340 HIV Medical Visit Frequency](https://healthmonix.com/mips_quality_measure/2023-340-hiv-medical-visit-frequency/) - CMS Measure ID: #340Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Efficiency and Cost ReductionMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with HIV seen during the performance period. This measure is intended to reflect the quality of services
- [2023 # 338 HIV Viral Load Suppression](https://healthmonix.com/mips_quality_measure/2023-338-hiv-viral-load-suppression/) - CMS Measure ID: #338Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with HIV seen during the performance period. This measure is intended to reflect the quality of services provided
- [2023 # 336 Maternity Care: Postpartum Follow-Up and Care Coordination](https://healthmonix.com/mips_quality_measure/2023-336-maternity-care-postpartum-follow-up-and-care-coordination/) - CMS Measure ID: #336Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all patients seen for postpartum care before or at 12 weeks of giving birth during the performance period. This
- [2023 # 335 Maternity Care: Elective Delivery (Without Medical Indication) at < 39 Weeks (Overuse)](https://healthmonix.com/mips_quality_measure/2023-335-maternity-care-elective-delivery-without-medical-indication-at-39-weeks-overuse/) - CMS Measure ID: #335Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a procedure is performed for patients undergoing delivery by cesarean birth or induction of labor at less than 39 weeks of gestation during the performance period. This measure may
- [2023 # 332 Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use)](https://healthmonix.com/mips_quality_measure/2023-332-adult-sinusitis-appropriate-choice-of-antibiotic-amoxicillin-with-or-without-clavulanate-prescribed-for-patients-with-acute-bacterial-sinusitis-appropriate-use/) - CMS Measure ID: #332Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Efficiency and Cost ReductionMeasure Age: > 2 yearsInstructionsThis measure may be submitted based on the actions of the submitting eligible clinician who performs the quality action, described in the measure, based on services provided within measure-specific denominator coding. This
- [2023 # 331 Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse)](https://healthmonix.com/mips_quality_measure/2023-331-adult-sinusitis-antibiotic-prescribed-for-acute-viral-sinusitis-overuse/) - CMS Measure ID: #331Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Efficiency and Cost ReductionMeasure Age: > 2 yearsInstructionsThis measure may be submitted based on the actions of the submitting eligible clinician who performs the quality action, described in the measure, based on services provided within measure-specific denominator coding. This measure is to
- [2023 # 326 Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy](https://healthmonix.com/mips_quality_measure/2023-326-atrial-fibrillation-and-atrial-flutter-chronic-anticoagulation-therapy/) - CMS Measure ID: #326Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with nonvalvular AF or atrial flutter seen during the performance period. This measure may be submitted by Merit-based Incentive Payment
- [2023 # 324 Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk Patients](https://healthmonix.com/mips_quality_measure/2023-324-cardiac-stress-imaging-not-meeting-appropriate-use-criteria-testing-in-asymptomatic-low-risk-patients/) - CMS Measure ID: #324Collection Type: CQMReporting Frequency: Once per episode of treatmentOutcome: NoHigh Priority: YesNQS Domain: Efficiency and Cost ReductionMeasure Age: > 2 yearsInstructionsThis measure is to be submitted once per procedure of cardiac stress imaging (i.e., SPECT, MPI, ECHO, CCTA, and CMR) for patients seen during the performance period. There is no diagnosis associated
- [2023 # 322 Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low-Risk Surgery Patients](https://healthmonix.com/mips_quality_measure/2023-322-cardiac-stress-imaging-not-meeting-appropriate-use-criteria-preoperative-evaluation-in-low-risk-surgery-patients/) - CMS Measure ID: #322Collection Type: CQMReporting Frequency: Once per episode of treatmentOutcome: NoHigh Priority: YesNQS Domain: Efficiency and Cost ReductionMeasure Age: > 2 yearsInstructionsThis measure is to be submitted once per procedure of cardiac stress imaging (i.e., SPECT, MPI, ECHO, CCTA, CMR) for patients seen during the performance period. There is no diagnosis associated with
- [2023 # 320 Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients](https://healthmonix.com/mips_quality_measure/2023-320-appropriate-follow-up-interval-for-normal-colonoscopy-in-average-risk-patients/) - CMS Measure ID: #320Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients seen during the performance period. Performance for this measure is not limited to the performance period. This
- [2023 # 317 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented](https://healthmonix.com/mips_quality_measure/2023-317-preventive-care-and-screening-screening-for-high-blood-pressure-and-follow-up-documented/) - CMS Measure ID: #317Collection Type: CQMReporting Frequency: All VisitsOutcome: NoHigh Priority: NoNQS Domain: Community, Population and Public HealthMeasure Age: > 2 yearsInstructionsThis measure is to be submitted at each visit for patients seen during the measurement period. Merit-based Incentive Payment System (MIPS) eligible clinicians who submit the measure must perform the blood pressure screening at
- [2023 # 293 Rehabilitative Therapy Referral for Patients with Parkinson's Disease](https://healthmonix.com/mips_quality_measure/2023-293-rehabilitative-therapy-referral-for-patients-with-parkinsons-disease/) - CMS Measure ID: #293Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with a diagnosis of Parkinson’s disease seen during the performance period. This measure may be submitted by
- [2023 # 291 Parkinson’s Disease: Cognitive Impairment or Dysfunction Assessment for Patients with Parkinson's Disease](https://healthmonix.com/mips_quality_measure/2023-291-parkinsons-disease-cognitive-impairment-or-dysfunction-assessment-for-patients-with-parkinsons-disease/) - CMS Measure ID: #291Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with a diagnosis of Parkinson’s disease seen during the performance period. This measure may be submitted by Merit-based
- [2023 # 290 Assessment of Mood Disorders and Psychosis for Patients with Parkinson’s Disease](https://healthmonix.com/mips_quality_measure/2023-290-assessment-of-mood-disorders-and-psychosis-for-patients-with-parkinsons-disease/) - CMS Measure ID: #290Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with a diagnosis of Parkinson’s Disease seen during the performance period. This measure may be submitted by Merit-based
- [2023 # 288 Dementia: Education and Support of Caregivers for Patients with Dementia](https://healthmonix.com/mips_quality_measure/2023-288-dementia-education-and-support-of-caregivers-for-patients-with-dementia/) - CMS Measure ID: #288Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with a diagnosis of dementia seen during the performance period. This measure may be submitted by Merit-based
- [2023 # 286 Dementia: Safety Concern Screening and Follow-Up for Patients with Dementia](https://healthmonix.com/mips_quality_measure/2023-286-dementia-safety-concern-screening-and-follow-up-for-patients-with-dementia/) - CMS Measure ID: #286Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with a diagnosis of dementia seen during the performance period. This measure may be submitted by Merit-based Incentive Payment
- [2023 # 283 Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management](https://healthmonix.com/mips_quality_measure/2023-283-dementia-associated-behavioral-and-psychiatric-symptoms-screening-and-management/) - CMS Measure ID: #283Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with a diagnosis of dementia seen during the performance period. This measure may be submitted by Merit-based Incentive
- [2023 # 282 Dementia: Functional Status Assessment](https://healthmonix.com/mips_quality_measure/2023-282-dementia-functional-status-assessment/) - CMS Measure ID: #282Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with a diagnosis of dementia seen during the performance period. This measure may be submitted by Merit-based Incentive
- [2023 # 250 Radical Prostatectomy Pathology Reporting](https://healthmonix.com/mips_quality_measure/2023-250-radical-prostatectomy-pathology-reporting/) - CMS Measure ID: #250Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a radical prostatectomy surgical pathology examination is performed during the performance period for prostate patients. It is anticipated that eligible clinicians who examine prostate tissue specimens following resection
- [2023 # 279 Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy](https://healthmonix.com/mips_quality_measure/2023-279-sleep-apnea-assessment-of-adherence-to-positive-airway-pressure-therapy/) - CMS Measure ID: #279Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with sleep apnea seen during the performance period. This measure may be submitted by Merit-based Incentive Payment System
- [2023 # 277 Sleep Apnea: Severity Assessment at Initial Diagnosis](https://healthmonix.com/mips_quality_measure/2023-277-sleep-apnea-severity-assessment-at-initial-diagnosis/) - CMS Measure ID: #277Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with a diagnosis of sleep apnea seen during the performance period. This measure may be submitted by Merit-based
- [2023 # 275 Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy](https://healthmonix.com/mips_quality_measure/2023-275-inflammatory-bowel-disease-ibd-assessment-of-hepatitis-b-virus-hbv-status-before-initiating-anti-tnf-tumor-necrosis-factor-therapy/) - CMS Measure ID: #275Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all patients with a diagnosis of inflammatory bowel disease seen during the performance period. This measure may be submitted
- [2023 # 268 Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy](https://healthmonix.com/mips_quality_measure/2023-268-epilepsy-counseling-for-women-of-childbearing-potential-with-epilepsy/) - CMS Measure ID: #268Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with a diagnosis of epilepsy during the performance period. This measure may be submitted by Merit-based Incentive Payment
- [2023 # 264 Sentinel Lymph Node Biopsy for Invasive Breast Cancer](https://healthmonix.com/mips_quality_measure/2023-264-sentinel-lymph-node-biopsy-for-invasive-breast-cancer/) - CMS Measure ID: #264Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a procedure is performed during the performance period for patients age 18 years and older who are operated upon for invasive breast cancer that are clinically node negative
- [2023 # 261 Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness](https://healthmonix.com/mips_quality_measure/2023-261-referral-for-otologic-evaluation-for-patients-with-acute-or-chronic-dizziness/) - CMS Measure ID: #261Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all patients seen during the performance period who present with acute or chronic dizziness. This measure is intended
- [2023 # 260 Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2)](https://healthmonix.com/mips_quality_measure/2023-260-rate-of-carotid-endarterectomy-cea-for-asymptomatic-patients-without-major-complications-discharged-to-home-by-post-operative-day-2/) - CMS Measure ID: #260Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a CEA is performed during the performance period. It is anticipated that eligible clinicians who provide services of CEA, as described in the measure, based on the services provided
- [2023 # 259 Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #2)](https://healthmonix.com/mips_quality_measure/2023-259-rate-of-endovascular-aneurysm-repair-evar-of-small-or-moderate-non-ruptured-abdominal-aortic-aneurysms-aaa-without-major-complications-discharged-to-home-by-post-operative-day-2/) - CMS Measure ID: #259Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time an endovascular repair AAA is performed during the performance period. It is anticipated that eligible clinicians who provide services of AAA repair, as described in the measure, based on
- [2023 # 254 Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal Pain](https://healthmonix.com/mips_quality_measure/2023-254-ultrasound-determination-of-pregnancy-location-for-pregnant-patients-with-abdominal-pain/) - CMS Measure ID: #254Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a pregnant patient presents to the ED with a chief complaint of abdominal pain and/or vaginal bleeding during the performance period. It is anticipated that Merit-based Incentive Payment
- [2023 # 238 Use of High-Risk Medications in Older Adults](https://healthmonix.com/mips_quality_measure/2023-238-use-of-high-risk-medications-in-older-adults/) - CMS Measure ID: #238Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients seen during the performance period. There is no diagnosis associated with this measure. This measure may be submitted by
- [2023 # 236 Controlling High Blood Pressure](https://healthmonix.com/mips_quality_measure/2023-236-controlling-high-blood-pressure/) - CMS Measure ID: #236Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with hypertension seen during the performance period. The performance period for this measure is 12 months. The most recent
- [2023 # 226 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention](https://healthmonix.com/mips_quality_measure/2023-226-preventive-care-and-screening-tobacco-use-screening-and-cessation-intervention/) - CMS Measure ID: #226Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Community, Population and Public HealthMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients seen during the performance period. This measure is intended to reflect the quality of services provided
- [2023 # 221  Functional Status Change for Patients with Shoulder Impairments](https://healthmonix.com/mips_quality_measure/2023-221-functional-status-change-for-patients-with-shoulder-impairments/) - CMS Measure ID: #221Collection Type: CQMReporting Frequency: Once per episode of treatmentOutcome: YesHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis outcome measure is to be submitted once per Treatment Episode for all patients with a functional deficit related to the shoulder. This is an outcome measure and its calculation requires submitting
- [2023 # 220  Functional Status Change for Patients with Low Back Impairments](https://healthmonix.com/mips_quality_measure/2023-220-functional-status-change-for-patients-with-low-back-impairments/) - CMS Measure ID: #220Collection Type: CQMReporting Frequency: Once per episode of treatmentOutcome: YesHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis outcome measure is to be submitted once per Treatment Episode for all patients with a functional deficit related to the low back region. This is an outcome measure and its calculation
- [2023 # 219 Functional Status Change for Patients with Lower Leg, Foot or Ankle Impairments](https://healthmonix.com/mips_quality_measure/2023-219-functional-status-change-for-patients-with-lower-leg-foot-or-ankle-impairments/) - CMS Measure ID: #219Collection Type: CQMReporting Frequency: Once per episode of treatmentOutcome: YesHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis outcome measure is to be submitted once per Treatment Episode for all patients with a functional deficit related to the lower leg, foot or ankle. This is an outcome measure and
- [2023 # 218 Functional Status Change for Patients with Hip Impairments](https://healthmonix.com/mips_quality_measure/2023-218-functional-status-change-for-patients-with-hip-impairments/) - CMS Measure ID: #218Collection Type: CQMReporting Frequency: Once per episode of treatmentOutcome: YesHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis outcome measure is to be submitted once per Treatment Episode for all patients with a functional deficit related to the hip. This is an outcome measure and its calculation requires submitting
- [2023 # 249 Barrett's Esophagus](https://healthmonix.com/mips_quality_measure/2023-249-barretts-esophagus/) - CMS Measure ID: #249Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a patient’s esophageal surgical pathology report demonstrates Barrett’s Esophagus; however, only one quality data code (QDC) per date of service for a patient is required. This measure may
- [2023 # 243 Cardiac Rehabilitation Patient Referral from an Outpatient Setting](https://healthmonix.com/mips_quality_measure/2023-243-cardiac-rehabilitation-patient-referral-from-an-outpatient-setting/) - CMS Measure ID: #243Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all patients seen during the performance period who had a qualifying diagnosis within the previous 12 months and
- [2023 # 191 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery](https://healthmonix.com/mips_quality_measure/2023-191-cataracts-20-40-or-better-visual-acuity-within-90-days-following-cataract-surgery/) - CMS Measure ID: #191Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a procedure for uncomplicated cataract is performed during the performance period. This measure is intended to reflect the quality of services provided for the patients receiving uncomplicated cataract
- [2023 # 187 Stroke and Stroke Rehabilitation: Thrombolytic Therapy](https://healthmonix.com/mips_quality_measure/2023-187-stroke-and-stroke-rehabilitation-thrombolytic-therapy/) - CMS Measure ID: #187Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted for each episode of acute ischemic stroke for patients who arrive at the hospital within 3.5 hours of time last known well and for whom IV thrombolytic therapy was initiated
- [2023 # 185 Colonoscopy Interval for Patients with a History of Adenomatous Polyps – Avoidance of Inappropriate Use](https://healthmonix.com/mips_quality_measure/2023-185-colonoscopy-interval-for-patients-with-a-history-of-adenomatous-polyps-avoidance-of-inappropriate-use/) - CMS Measure ID: #185Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a surveillance colonoscopy is performed during the performance period. It is anticipated the eligible clinician who performs the listed procedures, as specified in the denominator coding, will
- [2023 # 182 Functional Outcome Assessment](https://healthmonix.com/mips_quality_measure/2023-182-functional-outcome-assessment/) - CMS Measure ID: #182Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each denominator eligible visit for patients seen during the 12 month performance period. The functional outcome assessment is required to be current as defined in the definition section. This
- [2023 # 217 Functional Status Change for Patients with Knee Impairments](https://healthmonix.com/mips_quality_measure/2023-217-functional-status-change-for-patients-with-knee-impairments/) - CMS Measure ID: #217Collection Type: CQMReporting Frequency: Once per episode of treatmentOutcome: YesHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis outcome measure is to be submitted once per Treatment Episode for all patients with a functional deficit related to the knee. This is an outcome measure, and its calculation requires submitting
- [2023 # 205 HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis](https://healthmonix.com/mips_quality_measure/2023-205-hiv-aids-sexually-transmitted-disease-screening-for-chlamydia-gonorrhea-and-syphilis/) - CMS Measure ID: #205Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with HIV/AIDS seen during the performance period. Only patients who had at least two visits during the performance
- [2023 # 181 Elder Maltreatment Screen and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/2023-181-elder-maltreatment-screen-and-follow-up-plan/) - CMS Measure ID: #181Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients seen during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who
- [2023 # 180 Rheumatoid Arthritis (RA): Glucocorticoid Management](https://healthmonix.com/mips_quality_measure/2023-180-rheumatoid-arthritis-ra-glucocorticoid-management/) - CMS Measure ID: #180Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with a diagnosis of RA who are seen during the performance period. This measure may be submitted by
- [2023 # 178 Rheumatoid Arthritis (RA): Functional Status Assessment](https://healthmonix.com/mips_quality_measure/2023-178-rheumatoid-arthritis-ra-functional-status-assessment/) - CMS Measure ID: #178Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with RA seen during the performance period. It is anticipated that eligible clinicians who provide care for patients
- [2023 # 177 Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity](https://healthmonix.com/mips_quality_measure/2023-177-rheumatoid-arthritis-ra-periodic-assessment-of-disease-activity/) - CMS Measure ID: #177Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with a diagnosis of RA seen during the performance period. This measure may be submitted by Merit-based Incentive
- [2023 # 176 Tuberculosis Screening Prior to First Course of Biologic and/or Immune Response Modifier Therapy](https://healthmonix.com/mips_quality_measure/2023-176-tuberculosis-screening-prior-to-first-course-of-biologic-and-or-immune-response-modifier-therapy/) - CMS Measure ID: #176Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients who are being considered or prescribed a first course of biologic and/or immune response modifier therapy seen during the
- [2023 # 168  Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration](https://healthmonix.com/mips_quality_measure/2023-168-coronary-artery-bypass-graft-cabg-surgical-re-exploration/) - CMS Measure ID: #168Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time an isolated CABG procedure is performed during the performance period. It is anticipated that eligible clinicians who provide services for isolated CABG will submit this measure. This measure
- [2023 # 167 Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure](https://healthmonix.com/mips_quality_measure/2023-167-coronary-artery-bypass-graft-cabg-postoperative-renal-failure/) - CMS Measure ID: #167Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time an isolated CABG procedure is performed during the performance period. It is anticipated that eligible clinicians who provide services for isolated CABG will submit this measure. This measure
- [2023 # 164 Coronary Artery Bypass Graft (CABG): Prolonged Intubation](https://healthmonix.com/mips_quality_measure/2023-164-coronary-artery-bypass-graft-cabg-prolonged-intubation/) - CMS Measure ID: #164Collection Type: CQMReporting Frequency: Every visitOutcome: YesHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time an isolated CABG procedure is performed during the performance period. It is anticipated that eligible clinicians who provide services for isolated CABG will submit this measure. This measure
- [2023 # 155 Falls: Plan of Care](https://healthmonix.com/mips_quality_measure/2023-155-falls-plan-of-care/) - CMS Measure ID: #155Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients seen during the performance period. There is no diagnosis associated with this measure. This measure is appropriate
- [2023 # 147 Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy](https://healthmonix.com/mips_quality_measure/2023-147-nuclear-medicine-correlation-with-existing-imaging-studies-for-all-patients-undergoing-bone-scintigraphy/) - CMS Measure ID: #147Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time bone scintigraphy is performed during the performance period. There is no diagnosis associated with this measure. It is anticipated that Merit-based Incentive Payment System (MIPS) eligible clinicians
- [2023 # 145 Radiology: Exposure Dose Indices Reported for Procedures Using Fluoroscopy](https://healthmonix.com/mips_quality_measure/2023-145-radiology-exposure-dose-indices-reported-for-procedures-using-fluoroscopy/) - CMS Measure ID: #145Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a procedure using fluoroscopy is performed in a hospital or outpatient setting during the performance period. There is no diagnosis associated with this measure. It is anticipated that eligible clinicians
- [2023 # 144 Oncology: Medical and Radiation – Plan of Care for Pain](https://healthmonix.com/mips_quality_measure/2023-144-oncology-medical-and-radiation-plan-of-care-for-pain/) - CMS Measure ID: #144Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Person and Caregiver-Centered Experience OutcomesMeasure Age: > 2 yearsInstructionsThis measure is to be submitted at each denominator eligible visit occurring during the performance period for patients with a diagnosis of cancer and in which pain is present who are seen during the performance period.
- [2023 # 143 Oncology: Medical and Radiation – Pain Intensity Quantified](https://healthmonix.com/mips_quality_measure/2023-143-oncology-medical-and-radiation-pain-intensity-quantified/) - CMS Measure ID: #143Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Person and Caregiver-Centered Experience OutcomesMeasure Age: > 2 yearsInstructionsThis measure is to be submitted at each denominator eligible visit occurring during the performance period for patients with a diagnosis of cancer who are seen during the performance period. It is anticipated that
- [2023 # 141 Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of Care](https://healthmonix.com/mips_quality_measure/2023-141-primary-open-angle-glaucoma-poag-reduction-of-intraocular-pressure-iop-by-15-or-documentation-of-a-plan-of-care/) - CMS Measure ID: #141Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: YesHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for glaucoma patients seen during the performance period. It is anticipated that eligible clinicians who provide the primary management
- [2023 # 138 Melanoma: Coordination of Care](https://healthmonix.com/mips_quality_measure/2023-138-melanoma-coordination-of-care/) - CMS Measure ID: #138Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted at each denominator eligible visit occurring during the performance period ending November 30th for melanoma patients seen during the performance period. It is anticipated that eligible clinicians providing care
- [2023 # 137 Melanoma: Continuity of Care – Recall System](https://healthmonix.com/mips_quality_measure/2023-137-melanoma-continuity-of-care-recall-system/) - CMS Measure ID: #137Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with a current diagnosis of melanoma or a history of melanoma seen during the performance period. It
- [2023 # 134 Preventive Care and Screening: Screening for Depression and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/2023-134-preventive-care-and-screening-screening-for-depression-and-follow-up-plan/) - CMS Measure ID: #134Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Community, Population and Public HealthMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients seen during the performance period. The most recent screening submitted will be used for performance calculation. This measure
- [2023 # 130 Documentation of Current Medications in the Medical Record](https://healthmonix.com/mips_quality_measure/2023-130-documentation-of-current-medications-in-the-medical-record/) - CMS Measure ID: #130Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Patient SafetyMeasure Age: > 2 yearsInstructionsThis measure is to be submitted at each denominator eligible visit during the 12 month performance period. Eligible clinicians meet the intent of this measure by making their best effort to document a current, complete and accurate
- [2023 # 128 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/2023-128-preventive-care-and-screening-body-mass-index-bmi-screening-and-follow-up-plan/) - CMS Measure ID: #128Collection Type: CQMReporting Frequency: Most Recent Visit(with 12 mo. exception)Outcome: NoHigh Priority: NoNQS Domain: Community, Population and Public HealthMeasure Age: > 2 yearsInstructionsThere is no diagnosis associated with this measure. This measure is to be submitted a minimum of once per performance period for patients seen during the performance period. This measure
- [2023 # 127  Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear](https://healthmonix.com/mips_quality_measure/2023-127-diabetes-mellitus-diabetic-foot-and-ankle-care-ulcer-prevention-evaluation-of-footwear/) - CMS Measure ID: #127Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with diabetes mellitus seen during the performance period. This measure may be submitted by non-medical doctor/doctor of osteopathic
- [2023 # 126 Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy – Neurological Evaluation](https://healthmonix.com/mips_quality_measure/2023-126-diabetes-mellitus-diabetic-foot-and-ankle-care-peripheral-neuropathy-neurological-evaluation/) - CMS Measure ID: #126Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with diabetes mellitus seen during the performance period. Evaluation of neurological status in patients with diabetes to assign
- [2023 # 118  Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF <= 40%)](https://healthmonix.com/mips_quality_measure/2023-118-coronary-artery-disease-cad-angiotensin-converting-enzyme-ace-inhibitor-or-angiotensin-receptor-blocker-arb-therapy-diabetes-or-left-ventricular-systolic-dysfunction-lvef/) - CMS Measure ID: #118Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all patients with CAD seen during the performance period. This measure may be submitted by Merit-based Incentive Payment System
- [2023 # 117 Diabetes: Eye Exam](https://healthmonix.com/mips_quality_measure/2023-117-diabetes-eye-exam/) - CMS Measure ID: #117Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with diabetes mellitus seen during the performance period. This measure may be submitted by Merit-based Incentive Payment System
- [2023 # 116  Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis](https://healthmonix.com/mips_quality_measure/2023-116-avoidance-of-antibiotic-treatment-for-acute-bronchitis-bronchiolitis/) - CMS Measure ID: #116Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Efficiency and Cost ReductionMeasure Age: > 2 yearsInstructionsThis measure is to be submitted at each occurrence of acute bronchitis/bronchiolitis during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS) eligible clinicians who perform the quality actions described
- [2023 # 113  Colorectal Cancer Screening](https://healthmonix.com/mips_quality_measure/2023-113-colorectal-cancer-screening/) - CMS Measure ID: #113Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients seen during the performance period. There is no diagnosis associated with this measure. Performance for this measure is
- [2023 # 112  Breast Cancer Screening](https://healthmonix.com/mips_quality_measure/2023-112-breast-cancer-screening/) - CMS Measure ID: #112Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for female patients seen during the performance period. There is no diagnosis associated with this measure. The patient should either
- [2023 # 110  Preventive Care and Screening: Influenza Immunization](https://healthmonix.com/mips_quality_measure/2023-110-preventive-care-and-screening-influenza-immunization/) - CMS Measure ID: #110Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Community, Population and Public HealthMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once for visits for patients seen between January and March for the 2022-2023 influenza season AND a minimum of once for visits
- [2023 # 104  Prostate Cancer: Combination Androgen Deprivation Therapy for High Risk or Very High Risk Prostate Cancer](https://healthmonix.com/mips_quality_measure/2023-104-prostate-cancer-combination-androgen-deprivation-therapy-for-high-risk-or-very-high-risk-prostate-cancer/) - CMS Measure ID: #104Collection Type: CQMReporting Frequency: Once per episode of treatmentOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted once per episode of radiation therapy for all male patients with prostate cancer who receive external beam radiotherapy to the prostate during the performance period. Each episode
- [2023 # 102  Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients](https://healthmonix.com/mips_quality_measure/2023-102-prostate-cancer-avoidance-of-overuse-of-bone-scan-for-staging-low-risk-prostate-cancer-patients/) - CMS Measure ID: #102Collection Type: CQMReporting Frequency: Once per episode of treatmentOutcome: NoHigh Priority: YesNQS Domain: Efficiency and Cost ReductionMeasure Age: > 2 yearsInstructionsThis measure is to be submitted once per performance period for patients with a diagnosis of prostate cancer at low (or very low) risk of recurrence who receive interstitial prostate brachytherapy, external
- [2023 # 093 Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy – Avoidance of Inappropriate Use](https://healthmonix.com/mips_quality_measure/2023-093-acute-otitis-externa-aoe-systemic-antimicrobial-therapy-avoidance-of-inappropriate-use/) - CMS Measure ID: #93Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Efficiency and Cost ReductionMeasure Age: > 2 yearsInstructionsThis measure may be submitted based on the actions of the submitting eligible clinician who performs the quality action, described in the measure, based on services provided within measure-specific denominator coding. This measure is to
- [2023 # 066  Appropriate Testing for Pharyngitis](https://healthmonix.com/mips_quality_measure/2023-066-appropriate-testing-for-pharyngitis/) - CMS Measure ID: #66Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Efficiency and Cost ReductionMeasure Age: > 2 yearsInstructionsThis measure is to be submitted once for each occurrence of pharyngitis during the performance period. Claims data will be analyzed to determine unique occurrences. This measure is intended to reflect the quality of services
- [2023 # 065 Appropriate Treatment for Upper Respiratory Infection (URI)](https://healthmonix.com/mips_quality_measure/2023-065-appropriate-treatment-for-upper-respiratory-infection-uri/) - CMS Measure ID: #65Collection Type: CQMReporting Frequency: Every visitOutcome: NoHigh Priority: YesNQS Domain: Efficiency and Cost ReductionMeasure Age: > 2 yearsInstructionsThis measure is to be submitted once for each occurrence of upper respiratory infection during the performance period. Claims data will be analyzed to determine unique occurrences. This measure may be submitted by Merit-based Incentive
- [2023 # 052  Chronic Obstructive Pulmonary Disease (COPD): Long-Acting Inhaled Bronchodilator Therapy](https://healthmonix.com/mips_quality_measure/2023-052-chronic-obstructive-pulmonary-disease-copd-long-acting-inhaled-bronchodilator-therapy/) - CMS Measure ID: #52Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all COPD patients seen during the performance period. This measure may be submitted by Merit-based Incentive Payment System (MIPS)
- [2023 # 050  Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older](https://healthmonix.com/mips_quality_measure/2023-050-urinary-incontinence-plan-of-care-for-urinary-incontinence-in-women-aged-65-years-and-older/) - CMS Measure ID: #50Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Person and Caregiver-Centered Experience OutcomesMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients seen during the performance period. This measure is appropriate for use in the ambulatory setting only.
- [2023 # 048  Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older](https://healthmonix.com/mips_quality_measure/2023-048-urinary-incontinence-assessment-of-presence-or-absence-of-urinary-incontinence-in-women-aged-65-years-and-older/) - CMS Measure ID: #48Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients seen during the performance period. This measure is appropriate for use in the ambulatory setting only and is
- [2023 # 047 Advance Care Plan](https://healthmonix.com/mips_quality_measure/2023-047-advance-care-plan/) - CMS Measure ID: #47Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients seen during the performance period. There is no diagnosis associated with this measure. This measure may be
- [2023 # 039 Screening for Osteoporosis for Women Aged 65-85 Years of Age](https://healthmonix.com/mips_quality_measure/2023-039-screening-for-osteoporosis-for-women-aged-65-85-years-of-age/) - CMS Measure ID: #39Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients seen during the performance period. Female patients aged 65-85 years of age should have a central DXA measurement
- [2023 # 019  Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care](https://healthmonix.com/mips_quality_measure/2023-019-diabetic-retinopathy-communication-with-the-physician-managing-ongoing-diabetes-care/) - CMS Measure ID: #19Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all patients with diabetic retinopathy seen during the performance period. It is anticipated that eligible clinicians who provide
- [2023 # 008  Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)](https://healthmonix.com/mips_quality_measure/2023-008-heart-failure-hf-beta-blocker-therapy-for-left-ventricular-systolic-dysfunction-lvsd/) - CMS Measure ID: #8Collection Type: CQMReporting Frequency: 1: Once per patient/year; 2: Every VisitOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted for all heart failure patients a minimum of once per performance period when seen in the outpatient setting AND submitted at each hospital discharge (99238*
- [2023 # 007  Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <= 40%)](https://healthmonix.com/mips_quality_measure/2023-007-coronary-artery-disease-cad-beta-blocker-therapy-prior-myocardial-infarction-mi-or-left-ventricular-systolic-dysfunction-lvef/) - CMS Measure ID: #7Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all patients with a diagnosis of CAD seen during the performance period. Only patients who had at least two
- [2023 # 006 Coronary Artery Disease (CAD): Antiplatelet Therapy](https://healthmonix.com/mips_quality_measure/2023-006-coronary-artery-disease-cad-antiplatelet-therapy/) - CMS Measure ID: #6Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for all patients with CAD seen during the performance period. This measure may be submitted by Merit-based Incentive Payment System
- [2023 # 005 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)](https://healthmonix.com/mips_quality_measure/2023-005-heart-failure-hf-angiotensin-converting-enzyme-ace-inhibitor-or-angiotensin-receptor-blocker-arb-or-angiotensin-receptor-neprilysin-inhibitor-arni-therapy-for-left-ventricular-sys/) - CMS Measure ID: #5Collection Type: CQMReporting Frequency: 1: Once per patient/year; 2: Every VisitOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted for all heart failure patients a minimum of once per performance period when seen in the outpatient setting AND submitted at each hospital discharge (99238*
- [2023 # 001  Diabetes: Hemoglobin A1c Poor Control](https://healthmonix.com/mips_quality_measure/2023-001-diabetes-hemoglobin-a1c-poor-control/) - CMS Measure ID: #1Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: YesNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients with diabetes seen during the performance period. The most recent quality-data code submitted will be used for performance
- [2023 APP Measure #321: CAHPS for MIPS Clinician/Group Survey](https://healthmonix.com/mips_quality_measure/2023-app-measure-321-cahps-for-mips-clinician-group-survey/) - Measure Type High Priority Measure? Collection Type(s) Patient Engagement/Experience yes CSV Measure Description The Consumer Assessment of Healthcare Providers and Systems (CAHPS) for MIPS Clinician/Group Survey is comprised of 10 Summary Survey Measures (SSMs) and measures patient experience of care within a group practice. The NQF endorsement status and endorsement id (if applicable) for each
- [2023 #479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for the Merit-Based Incentive Payment System (MIPS) Groups](https://healthmonix.com/mips_quality_measure/2023-479-hospital-wide-30-day-all-cause-unplanned-readmission-hwr-rate-for-the-merit-based-incentive-payment-system-mips-groups/) - CMS Measure ID: #479Collection Type: Administrative ClaimsOutcome: NoHigh Priority: YesMeasure Age: 1st year Measure Description The 30-day Hospital-Wide, All-Cause Unplanned Readmission (HWR) Rate for the Merit- based Incentive Payment System (MIPS) Groups measure is a risk-standardized readmission rate for beneficiaries age 65 or older who were hospitalized and experienced an unplanned readmission for any cause to a
- [2023 APP Measure #480: Risk Standardized All-Cause Unplanned Admissions for Multiple Chronic Conditions for ACOs](https://healthmonix.com/mips_quality_measure/2023-app-measure-480-risk-standardized-all-cause-unplanned-admissions-for-multiple-chronic-conditions-for-acos/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes Medicare Part B Claims, eCQM, CMSWeb Interface, MIPS CQM Measure Description This measure is a re-specified version of the measure, Hospital-level Risk-standardized Complication rate (RSCR) following Elective Primary Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA) (National Quality Forum 1550), which was developed for patients
- [2023 # 304 Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery](https://healthmonix.com/mips_quality_measure/2023-304-cataracts-patient-satisfaction-within-90-days-following-cataract-surgery/) - CMS Measure ID: #304Collection Type: CQMReporting Frequency: Every VisitOutcome: NoHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 years Instructions This measure is to be submitted each time a procedure for cataracts is performed during the performance period. This measure is intended to reflect the quality of services provided for the patient receiving cataract surgery.Note:
- [2023 # 483  Person-Centered Primary Care Measure Patient Reported Outcome Performance Measure (PCPCM PRO-PM)](https://healthmonix.com/mips_quality_measure/2023-483-person-centered-primary-care-measure-patient-reported-outcome-performance-measure-pcpcm-pro-pm/) - CMS Measure ID: #483Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: YesHigh Priority: YesNQS Domain: Person and Caregiver-Centered Experience OutcomesMeasure Age: NewInstructionsThis measure is to be submitted once per performance period. For each MIPS eligible clinician, group, subgroup*, virtual group, and APM Entity, a minimum of 30 PCPCM PRO instruments per clinician are needed
- [2023 # 482 Hemodialysis Vascular Access: Practitioner Level Long-term Catheter Rate](https://healthmonix.com/mips_quality_measure/2023-482-hemodialysis-vascular-access-practitioner-level-long-term-catheter-rate/) - CMS Measure ID: #482Collection Type: CQMReporting Frequency: Every VisitOutcome: YesHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: NewInstructionsThis measure is to be submitted a minimum of once per month for patients who used a catheter for three patient months or longer for vascular access as defined in CROWNWeb. This measure may be submitted by
- [2023 # 303  Cataracts: Improvement in Patient’s Visual Function within 90 Days Following Cataract Surgery](https://healthmonix.com/mips_quality_measure/2023-303-cataracts-improvement-in-patients-visual-function-within-90-days-following-cataract-surgery/) - CMS Measure ID: #303Collection Type: CQMReporting Frequency: Every VisitOutcome: YesHigh Priority: YesNQS Domain: Communication and Care CoordinationMeasure Age: > 2 yearsInstructionsThis measure is to be submitted each time a procedure for cataracts is performed during the performance period. This measure is intended to reflect the quality of services provided for the patient receiving cataract surgery.
- [2023 # ECPR51  Discharge Prescription of Naloxone after Opioid Poisoning or Overdose](https://healthmonix.com/mips_quality_measure/2023-ecpr51-discharge-prescription-of-naloxone-after-opioid-poisoning-or-overdose/) - Measure Title: Discharge Prescription of Naloxone after Opioid Poisoning or OverdoseDescription: Percentage of Opioid Poisoning or Overdose Patients Presenting to An Acute Care Facility Who Were Prescribed Naloxone at DischargeDenominator: Any patient evaluated by the Eligible Professional (E/M Codes 99217, 99234-99236,99238-99239, 99281-99285, 99291-99292) PLUS Diagnosis of opioid poisoning from heroin, methadone, morphine, opium, codeine, hydrocodone, or
- [2023 # 475  HIV Screening](https://healthmonix.com/mips_quality_measure/2023-475-hiv-screening/) - eCQM,MVP Title HIV Screening eCQM Identifier (Measure Authoring Tool) 349 eCQM Version Number 5.0.000 NQF Number Not Applicable GUID ed78899d-2375-4d68-aa63-58e1734f5694 Measurement Period January 1, 20XX through December 31, 20XX Measure Steward Centers for Disease Control and Prevention (CDC) Measure Developer Mathematica Endorsed By None Description Percentage of patients aged 15-65 at the start of the
- [2023 # 378 Children Who Have Dental Decay or Cavities](https://healthmonix.com/mips_quality_measure/2023-378-children-who-have-dental-decay-or-cavities/) - eCQM Title Children Who Have Dental Decay or Cavities eCQM Identifier (Measure Authoring Tool) 75 eCQM Version Number 11.0.000 NQF Number Not Applicable GUID 61947125-4376-4a7b-ab7a-ac2be9bd9138 Measurement Period January 1, 20XX through December 31, 20XX Measure Steward Centers for Medicare & Medicaid Services (CMS) Measure Developer National Committee for Quality Assurance Endorsed By None Description Percentage
- [2023 # 377 Functional Status Assessments for Heart Failure](https://healthmonix.com/mips_quality_measure/2023-377-functional-status-assessments-for-heart-failure/) - eCQM,MVP Title Functional Status Assessments for Heart Failure eCQM Identifier (Measure Authoring Tool) 90 eCQM Version Number 12.1.000 NQF Number Not Applicable GUID bb9b8ef7-0354-40e0-bec7-d6891b7df519 Measurement Period January 1, 20XX through December 31, 20XX Measure Steward Centers for Medicare & Medicaid Services (CMS) Measure Developer National Committee for Quality Assurance Endorsed By None Description Percentage of
- [2023 # 281 Dementia: Cognitive Assessment](https://healthmonix.com/mips_quality_measure/2023-281-dementia-cognitive-assessment/) - eCQM,MVP Title Dementia: Cognitive Assessment eCQM Identifier (Measure Authoring Tool) 149 eCQM Version Number 11.0.000 NQF Number 2872e GUID 7c443b9b-1ad1-4467-b527-defc445701ff Measurement Period January 1, 20XX through December 31, 20XX Measure Steward American Academy of Neurology Measure Developer American Academy of Neurology Measure Developer American Medical Association (AMA) Measure Developer PCPI(R) Foundation (PCPI[R]) Endorsed By National
- [2023 # 376  Functional Status Assessment for Total Hip Replacement](https://healthmonix.com/mips_quality_measure/2023-376-functional-status-assessment-for-total-hip-replacement/) - eCQM,MVP Title Functional Status Assessment for Total Hip Replacement eCQM Identifier (Measure Authoring Tool) 56 eCQM Version Number 11.0.000 NQF Number Not Applicable GUID 2f291003-3f2f-48af-bef9-e5aacb95ac3e Measurement Period January 1, 20XX through December 31, 20XX Measure Steward Centers for Medicare & Medicaid Services (CMS) Measure Developer National Committee for Quality Assurance Endorsed By None Description Percentage
- [2023 # HCPR24 Appropriate Utilization of Vancomycin for Cellulitis](https://healthmonix.com/mips_quality_measure/2023-hcpr24-appropriate-utilization-of-vancomycin-for-cellulitis/) - Measure Title: Appropriate Utilization of Vancomycin for CellulitisMeasure Description: Percentage of Patients with Cellulitis Who Did Not Receive Vancomycin Unless MRSA Infection or Risk for MRSA Infection Was IdentifiedDenominator: Any patient greater than or equal to 18 years of age evaluated by the Eligible Professional PLUS Admitted or Placed in Observation Status PLUS Diagnosis of Cellulitis (Transferred, eloped,
- [2023 # HCPR23 Avoidance of Echocardiogram and Carotid Ultrasound for Syncope](https://healthmonix.com/mips_quality_measure/2023-hcpr23-avoidance-of-echocardiogram-and-carotid-ultrasound-for-syncope/) - Measure Title: Avoidance of Echocardiogram and Carotid Ultrasound for SyncopeMeasure Description: Percentage of Patients Presenting with Syncope Who Did Not Have an Echocardiogram or Carotid Ultrasound OrderedDenominator: Any patient greater than or equal to 18 years of age evaluated by the Eligible Professional PLUS, Admitted or Placed in Observation Status PLUS Diagnosis of Syncope (Transferred, eloped, AMA or
- [2023 # HCPR20 Clostridium Difficile- Risk Assessment and Plan of Care](https://healthmonix.com/mips_quality_measure/2023-hcpr20-clostridium-difficile-risk-assessment-and-plan-of-care/) - Measure Title: Clostridium Difficile – Risk Assessment and Plan of CareMeasure Description: Percentage of Adult Patients Who Had a Risk Assessment for C. difficile Infection and, If High-Risk, Had a Plan of Care for C. difficile Completed on the Day Of or Day After Hospital AdmissionDenominator: Any patient greater or equal to 18 years of age evaluated by
- [2023 # HCPR17 Pressure Ulcers -Risk Assessment and Plan of Care](https://healthmonix.com/mips_quality_measure/2023-hcpr17-pressure-ulcers-risk-assessment-and-plan-of-care/) - Measure Title: Pressure Ulcers – Risk Assessment and Plan of CareMeasure Description: Percentage of Adult Post-acute Facility Patients That Had a Risk Assessment for Pressure Ulcers and a Plan of Care for Pressure Ulcer Prevention/Treatment CompletedDenominator: Adult patients greater than or equal to 18 years of age evaluated by the Eligible Professional in the Post-acute FacilityNumerator: Adult Post-acute Facility
- [2023 # HCPR16 Physicians Orders for Life-Sustaining Treatment (POLST)](https://healthmonix.com/mips_quality_measure/2023-hcpr16-physicians-orders-for-life-sustaining-treatment-polst/) - Measure Title: Physician’s Orders for Life-Sustaining Treatment (POLST) FormMeasure Description: Percentage of Patients Greater Than or Equal to 65 Years of Age with Physician’s Orders for Life-Sustaining Treatment (POLST) Forms CompletedDenominator: Adult patients greater than or equal to 65 years of age evaluated by the Eligible ProfessionalNumerator: Patients with a completed Physician’s Orders for Life-Sustaining Treatment (POLST) formDenominator Exclusions: NoneDenominator
- [2023 # ECPR56  Opioid Withdrawal: Initiation of Medication-Assisted Treatment (MAT) and Referral to Outpatient Opioid Treatment](https://healthmonix.com/mips_quality_measure/2023-ecpr56-opioid-withdrawal-initiation-of-medication-assisted-treatment-mat-and-referral-to-outpatient-opioid-treatment/) - Measure Title: Opioid Withdrawal: Initiation of Medication-Assisted Treatment (MAT) and Referral to Outpatient Opioid TreatmentMeasure Description: Percentage of Patients Presenting with Opioid Withdrawal Who Were Given Medication-Assisted Treatment and Referred to Outpatient Opioid TreatmentDenominator: Any patient greater than or equal to 18 years of age evaluated by the Eligible Professional with diagnosis of opioid abuse or dependence with
- [2023 # ECPR55  Avoidance of Long-Acting (LA) or Extended-Release (ER) Opiate Prescriptions and Opiate Prescriptions for Greater Than 3 Days Duration for Acute Pain](https://healthmonix.com/mips_quality_measure/2023-ecpr55-avoidance-of-long-acting-la-or-extended-release-er-opiate-prescriptions-and-opiate-prescriptions-for-greater-than-3-days-duration-for-acute-pain/) - Measure Title: Avoidance of Long-Acting (LA) or Extended-Release (ER) Opiate Prescriptions and Opiate Prescriptions for Greater Than 3 Days Duration for Acute PainMeasure Description: Percentage of Adult Patients Who Were Prescribed an Opiate Who Were Not Prescribed a Long-Acting (LA) or Extended-Release (ER) Formulation and for Whom the Prescription Duration Was Not Greater than 3 days for
- [2023 # ECPR52 Appropriate Treatment of Psychosis and Agitation in the Emergency Department](https://healthmonix.com/mips_quality_measure/2023-ecpr52-appropriate-treatment-of-psychosis-and-agitation-in-the-emergency-department/) - Measure Title: Appropriate Treatment of Psychosis and Agitation in the Emergency DepartmentMeasure Description: Percentage of Adult Patients With Psychosis or Agitation Who Were Ordered an Oral Antipsychotic Medication in the Emergency DepartmentDenominator: Any patient greater than or equal to 18 years of age evaluated by the Eligible Professional in the Emergency Department (ED) PLUS ED length of stay
- [2023 # AQI73  Prevention of Arterial Line-Related Bloodstream Infections](https://healthmonix.com/mips_quality_measure/2023-aqi73-prevention-of-arterial-line-related-bloodstream-infections/) - Measure Title: Prevention of Arterial Line-Related Bloodstream InfectionsDescription: Percentage of patients, regardless of age, who undergo placement of a peripheral intra-arterial catheter for whom the arterial line was inserted with all indicated elements of sterile barrier technique, hand hygiene, skin preparation and, if ultrasound is used, sterile ultrasound techniques followed.This measure will consist of three performance
- [2023 # ECPR46 Avoidance of Opiate Prescriptions for Low Back Pain or Migraines](https://healthmonix.com/mips_quality_measure/2023-ecpr46-avoidance-of-opiate-prescriptions-for-low-back-pain-or-migraines/) - Measure Title: Avoidance of Opiate Prescriptions for Low Back Pain or MigrainesDescription: Percentage of Patients with Low Back Pain and/or Migraines Who Were Not Prescribed an OpiateDenominator: Any patient ≥ 18 years of age evaluated by the Eligible Professional (E/M Codes 99202-99205, 99212-99215, 99281- 99285, 99291-99292 AND Place of Service Indicator: 11, 19, 20, 22 or 23) PLUS
- [2023 # ECPR39  Avoid Head CT for Patients with Uncomplicated Syncope](https://healthmonix.com/mips_quality_measure/2023-ecpr39-avoid-head-ct-for-patients-with-uncomplicated-syncope/) - Measure Title: Avoid Head CT for Patients with Uncomplicated SyncopeDescription: Percentage of Adult Syncope Patients Who Did Not Receive a Head CT Scan Ordered by the ProviderDenominator: Any patient ≥18 years of age evaluated by the Eligible Professional in the Emergency Department or Urgent Care Clinic (E/M Codes 99202-99205, 99212-99215, 99281- 99285, & 99291-99292 AND Place of
- [2023 # AQI72 Perioperative Anemia Management](https://healthmonix.com/mips_quality_measure/2023-aqi72-perioperative-anemia-management/) - Measure Title: Perioperative Anemia ManagementDescription: Percentage of patients, aged 18 years and older, undergoing elective total joint arthroplasty who were screened for anemia preoperatively AND, if positive, have documentation that one or more of the following management strategies were used prior to PACU discharge. Management strategies include one or more of the following: Cell salvage techniques
- [2023 # AQI69 Intraoperative Antibiotic Redosing](https://healthmonix.com/mips_quality_measure/2023-aqi69-intraoperative-antibiotic-redosing/) - Measure Title: Intraoperative Antibiotic Redosing Description: Percentage of patients, aged 18 years and older, who received preoperative antibiotic prophylaxis within 60 minutes prior to incision (if fluoroquinolone or vancomycin, two hours) and undergo a procedure greater than two hours duration who received intraoperative antibiotic redosing at a maximum interval of two half-lives of the selected prophylactic antibiotic.Denominator: All
- [2023 # AQI48 Patient-Reported Experience with Anesthesia](https://healthmonix.com/mips_quality_measure/2023-aqi48-patient-reported-experience-with-anesthesia/) - Measure Title: Patient-Reported Experience with AnesthesiaDescription: Percentage of patients, aged 18 and older, who were surveyed on their patient experience and satisfaction with anesthesia care and who reported a positive experience.This measure will consist of two performance rates:AQI48a: Percentage of patients, aged 18 and older, who were surveyed on their patient experience and satisfaction with anesthesia careAQI48b:
- [2023 # ACEP59 Chest Pain: Avoidance of admission for adult patients with low-risk chest pain](https://healthmonix.com/mips_quality_measure/2023-acep59-chest-pain-avoidance-of-admission-for-adult-patients-with-low-risk-chest-pain/) - Measure Title: Chest Pain – Avoidance of admission for adult patients with low-risk chest painDescription: Percentage of adult patients who came to the Emergency Department with low-risk chest pain and were dischargedDenominator: All adult patients 35-64 years of age with an ED diagnosis of chest painNumerator: All adult patients 35-64 years of age with an ED diagnosis of chest
- [2023 # MBHR16 Comprehensive Cognitive Assessment Assists with Differential Diagnosis](https://healthmonix.com/mips_quality_measure/2023-mbhr16-comprehensive-cognitive-assessment-assists-with-differential-diagnosis/) - Measure Title: Comprehensive Cognitive Assessment Assists with Differential DiagnosisDescription: Percentage of patients, regardless of age, referred for evaluation due to concerns for cognitive impairment for whom 1) a standardized valid assessment of cognition was performed and 2) results of assessment informed determination of diagnosis or further clarified etiological factors of cognitive impairment or complaints.Denominator: All patients, regardless
- [2023 # MBHR15 Consideration of Cultural-Linguistic and Demographic Factors in Cognitive Assessment](https://healthmonix.com/mips_quality_measure/2023-mbhr15-consideration-of-cultural-linguistic-and-demographic-factors-in-cognitive-assessment/) - Measure Title: Consideration of Cultural-Linguistic and Demographic Factors in Cognitive AssessmentDescription: Percentage of patients, regardless of age, referred for evaluation due to concerns for cognitive changes or difficulties for whom 1) a standardized valid assessment of cognition was performed and 2) interpretation of results included consideration of appropriate and relevant cultural-linguistic and demographic factors.Denominator: All patients, regardless
- [2023 # MBHR14 Sleep Quality Sleep Response at 3-months](https://healthmonix.com/mips_quality_measure/2023-mbhr14-sleep-quality-sleep-response-at-3-months/) - Measure Title: Sleep Quality Sleep Response at 3-monthsDescription: Percentage of patients 18 years and older who reported sleep quality concerns (e.g., insomnia) with documentation of a standardized tool AND demonstrated a response to treatment at three months (+/- 60 days) after index visit.This measure relies on the Insomnia Severity Index assessment tool, which can be foundhere.Denominator: Patients
- [2023 # MBHR13 Social Role Functioning Assessment utilizing PROMIS Adult Ability to Participate in Social Roles and Activities](https://healthmonix.com/mips_quality_measure/2023-mbhr13-social-role-functioning-assessment-utilizing-promis-adult-ability-to-participate-in-social-roles-and-activities/) - Measure Title: Social Role Functioning Assessment utilizing PROMIS Adult Ability to Participate in Social Roles and ActivitiesDescription: The percentage of adult patients (18 years of age or older) who report concerns related to their psychosocial function and who have completed a standardized assessment utilizing the PROMIS Adult Ability to Participate in Social Roles and Activities during measurement period.This
- [2023 # MBHR18  Provision of Feedback Following a Cognitive or Mental Status Assessment with Documentation of Understanding of Test Results and Subsequent Healthcare Plan with Timely Transmission of Results](https://healthmonix.com/mips_quality_measure/2023-mbhr18-provision-of-feedback-following-a-cognitive-or-mental-status-assessment-with-documentation-of-understanding-of-test-results-and-subsequent-healthcare-plan-with-timely-transmission-of-re/) - Measure Title: Provision of Feedback Following a Cognitive or Mental Status Assessment with Documentation of Understanding of Test Results and Subsequent Healthcare Plan with Timely Transmission of ResultsDescription: Percentage of patients, regardless of age, who received a standardized cognitive or mental status assessment followed by provision of feedback regarding test results and associated recommendations, who acknowledged understanding
- [2023 # MBHR11 Cognitive Assessment with Counseling on Safety and Potential Risk](https://healthmonix.com/mips_quality_measure/2023-mbhr11-cognitive-assessment-with-counseling-on-safety-and-potential-risk/) - Measure Title: Cognitive Assessment with Counseling on Safety and Potential RiskDescription: Percentage of patients, regardless of age, referred for evaluation due to concerns for cognitive impairment for whom 1) a standardized valid assessment of cognition was performed and 2) reporting of results included counseling on safety and potential risks.To see additional details, please view the workflow diagram
- [2023 # MBHR10 Symptom Improvement in adults with ADHD](https://healthmonix.com/mips_quality_measure/2023-mbhr10-symptom-improvement-in-adults-with-adhd/) - Measure Title: Symptom Improvement in adults with ADHDDescription: The percentage of adult patients (18 years of age or older) with a diagnosis of ADHD who show a reduction in symptoms of 25% on the Adult ADHD Self-Report Scale (ASRS-v1.1)- 18 item self-report scale of ADHD symptoms within 2 to 10 months after initially reporting significant symptoms. There
- [2023 # MBHR09 Outcome monitoring of ADHD functional impairment in children and youth](https://healthmonix.com/mips_quality_measure/2023-mbhr09-outcome-monitoring-of-adhd-functional-impairment-in-children-and-youth/) - Measure Title: Outcome monitoring of ADHD functional impairment in children and youthDescription: Percentage of children aged 4 through 18 years, with a diagnosis of attention deficit/hyperactivity disorder (ADHD), who demonstrate a change score of 0.25 or greater on the Weiss Functional Impairment Rating Scale - Parent Report (WFIRS-P) within 2 to 10 months after an initial positive finding
- [2023 # MBHR08 Alcohol Use Disorder Outcome Response](https://healthmonix.com/mips_quality_measure/2023-mbhr08-alcohol-use-disorder-outcome-response/) - Measure Title: Alcohol Use Disorder Outcome ResponseDescription: The percentage of adult patients (18 years of age or older) who report problems with drinking alcohol (e.g., can be noted through a screening measure such as the AUDIT-C as described in MIPS Clinical Quality Measure Quality ID #431 aka NQF 2152 or other drug/alcohol screeners such as the DAST
- [2023 # MBHR07 Posttraumatic Stress Disorder (PTSD) Outcome Assessment for Adults and Children](https://healthmonix.com/mips_quality_measure/2023-mbhr07-posttraumatic-stress-disorder-ptsd-outcome-assessment-for-adults-and-children/) - Measure Title: Posttraumatic Stress Disorder (PTSD) Outcome Assessment for Adults and ChildrenDescription: The percentage of patients with a history of a traumatic event (i.e., an experience that was unusually or especially frightening, horrible, or traumatic) who report symptoms consistent with PTSD for at least one month following the traumatic event AND with documentation of a standardized symptom
- [2023 # MBHR05 Monitoring for psychosocial problems among children and youth](https://healthmonix.com/mips_quality_measure/2023-mbhr05-monitoring-for-psychosocial-problems-among-children-and-youth/) - Measure Title:Monitoring for psychosocial problems among children and youthDescription: Percentage of children from 3 to 17 years of age who are receiving a psychiatric or behavioral health intake visit AND who demonstrated a reliable change in parent-reported problem behaviors 2 to 10 months after initial positive screen for externalizing and internalizing behavior problems. This measure relies on
- [2023 # MBHR03 Pain Interference Response utilizing PROMIS](https://healthmonix.com/mips_quality_measure/2023-mbhr03-pain-interference-response-utilizing-promis/) - Measure Title: Pain Interference Response utilizing PROMISDescription: The percentage of adult patients (18 years of age or older) who report chronic pain issues and demonstrated a response to treatment at one month from the index score.To see additional details, please view the workflow diagram for this measure: View diagramThis measure relies on the PROMIS Pain Interference assessment tool,
- [2023 # MBHR01 Use of Anxiety Severity](https://healthmonix.com/mips_quality_measure/2023-mbhr01-use-of-anxiety-severity/) - Measure Title: Use of Anxiety SeverityDescription: The percentage of adult patients (18 years and older) with an anxiety disorder diagnosis (e.g., generalized anxiety disorder, social anxiety disorder, or panic disorder) who have completed a standardized tool (e.g., GAD-7, BAI) during measurement period.This measure relies on the GAD-7 assessment tool, which can be foundhere.Denominator: Patients aged ≥ 18
- [2023 # IROMS20  Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with arm, shoulder, or hand injury](https://healthmonix.com/mips_quality_measure/2023-iroms20-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-in-improvement-in-pain-score-measured-via-the-numeric-pain-rating/) - Measure Title: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with arm, shoulder, or hand injury.Measure Description: The proportion of patients failing to achieve an MCID of two (2) points or more improvement
- [2023 # IROMS19  Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with arm, shoulder, and hand injury measured via the validated Disability of Arm Shoulder and Hand (DASH) score, Quick Disability of Arm Shoulder and Hand (QDASH) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID](https://healthmonix.com/mips_quality_measure/2023-iroms19-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-to-indicate-functional-improvement-in-rehabilitation-of-patients-w/) - Measure Title: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with arm, shoulder, and hand injury measured via the validated Disability of Arm Shoulder and Hand (DASH) score, Quick Disability of Arm Shoulder and Hand (QDASH) score, or equivalent instrument
- [2023 # IROMS18  Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with low back pain](https://healthmonix.com/mips_quality_measure/2023-iroms18-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-in-improvement-in-pain-score-measured-via-the-numeric-pain-rating/) - Measure Title: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with low back pain.Measure Description: The proportion of patients failing to achieve an MCID of two (2) points or more improvement in the
- [2023 # IROMS17  Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation patients with low back pain measured via the validated Modified Low Back Pain Disability Questionnaire (MDQ) score](https://healthmonix.com/mips_quality_measure/2023-iroms17-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-to-indicate-functional-improvement-in-rehabilitation-patients-with/) - Measure Title: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation patients with low back pain measured via the validated Modified Low Back Pain Disability Questionnaire (MDQ) score.Measure Description: The proportion of patients failing to achieve an MCID of six (6) points or more
- [2023 # IROMS16  Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with neck pain/injury](https://healthmonix.com/mips_quality_measure/2023-iroms16-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-in-improvement-in-pain-score-measured-via-the-numeric-pain-rating/) - Measure Title: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with neck pain/injury.Measure Description: The proportion of patients failing to achieve an MCID of two (2) points or more improvement in the NPRS
- [2023 # IROMS15/KEET01  Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with neck pain/injury measured via the validated Neck Disability Index (NDI)](https://healthmonix.com/mips_quality_measure/2023-iroms15-keet01-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-to-indicate-functional-improvement-in-rehabilitation-of-pat/) - Measure Title: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with neck pain/injury measured via the validated Neck Disability Index (NDI).Measure Description: The proportion of patients failing to achieve an MCID of seven and a half (7.5) points or more improvement
- [2023 # IROMS14  Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with hip, leg or ankle (lower extremity except knee) injury](https://healthmonix.com/mips_quality_measure/2023-iroms14-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-in-improvement-in-pain-score-measured-via-the-numeric-pain-rating/) - Measure Title: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with hip, leg or ankle (lower extremity except knee) injury.Measure Description: The proportion of patients failing to achieve an MCID of two (2)
- [2023 # IROMS13  Failure to Progress (FTP): Proportion of patients not achieving a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with hip, leg or ankle injuries using the validated Lower Extremity Function Scale (LEFS) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID](https://healthmonix.com/mips_quality_measure/2023-iroms13-failure-to-progress-ftp-proportion-of-patients-not-achieving-a-minimal-clinically-important-difference-mcid-to-indicate-functional-improvement-in-rehabilitation-of-patients-with-h/) - Measure Title: Failure to Progress (FTP): Proportion of patients not achieving a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with hip, leg or ankle injuries using the validated Lower Extremity Function Scale (LEFS) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published
- [2023 # IROMS12  Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with knee injury pain](https://healthmonix.com/mips_quality_measure/2023-iroms12-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-in-improvement-in-pain-score-measured-via-the-numeric-pain-rating/) - Measure Title: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation patients with knee injury pain.Measure Description: The proportion of patients failing to achieve MCID of two (2) points or more improvement in the NPRS
- [2023 # IROMS11  Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in knee rehabilitation of patients with knee injury measured via their validated Knee Outcome Survey (KOS) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID](https://healthmonix.com/mips_quality_measure/2023-iroms11-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-to-indicate-functional-improvement-in-knee-rehabilitation-of-patie/) - Measure Title: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in knee rehabilitation of patients with knee injury measured via their validated Knee Outcome Survey (KOS) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID.Measure
- [2023 # HM07  Functional Status Change for Patients with Vestibular Dysfunction](https://healthmonix.com/mips_quality_measure/2023-hm07-functional-status-change-for-patients-with-vestibular-dysfunction/) - Measure Title: Functional Status Change for Patients with Vestibular DysfunctionMeasure Description: Percentage of patients aged 14 years and older diagnosed with vestibular dysfunction who achieve a Minimal Clinically Important Difference (MCID) as measured via the validated Dizziness Handicap Inventory or equivalent instrument to indicate functional, emotional, and physical improvement· Submission Age Criteria 1: Patients aged 14-17 years
- [2023 # 481 Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer](https://healthmonix.com/mips_quality_measure/2023-481-intravesical-bacillus-calmette-guerin-for-non-muscle-invasive-bladder-cancer/) - eCQM Title Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer eCQM Identifier (Measure Authoring Tool) 646 eCQM Version Number 3.0.000 NQF Number Not Applicable GUID 224b1722-aef9-4e7f-97f8-284267fc1b00 Measurement Period January 1, 20XX through December 31, 20XX Measure Steward Oregon Urology Measure Developer Oregon Urology Endorsed By None Description Percentage of patients initially diagnosed with non-muscle invasive bladder
- [2023 # 379 Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists](https://healthmonix.com/mips_quality_measure/2023-379-primary-caries-prevention-intervention-as-offered-by-primary-care-providers-including-dentists/) - eCQM Title Primary Caries Prevention Intervention as Offered by Dentists eCQM Identifier (Measure Authoring Tool) 74 eCQM Version Number 12.0.000 NQF Number Not Applicable GUID 0b81b6ba-3b30-41bf-a2f3-95bdc9f558f2 Measurement Period January 1, 20XX through December 31, 20XX Measure Steward Centers for Medicare & Medicaid Services (CMS) Measure Developer National Committee for Quality Assurance Endorsed By None Description
- [2023 # 382 Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment](https://healthmonix.com/mips_quality_measure/2023-382-child-and-adolescent-major-depressive-disorder-mdd-suicide-risk-assessment/) - eCQM Title Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment eCQM Identifier (Measure Authoring Tool) 177 eCQM Version Number 11.0.000 NQF Number 1365e GUID 848d09de-7e6b-43c4-bedd-5a2957ccffe3 Measurement Period January 1, 20XX through December 31, 20XX Measure Steward Mathematica Measure Developer Mathematica Measure Developer American Medical Association (AMA) Measure Developer PCPI(R) Foundation (PCPI[R]) Endorsed By
- [2023 # 462  Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy](https://healthmonix.com/mips_quality_measure/2023-462-bone-density-evaluation-for-patients-with-prostate-cancer-and-receiving-androgen-deprivation-therapy/) - eCQM Title Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy eCQM Identifier (Measure Authoring Tool) 645 eCQM Version Number 6.0.000 NQF Number Not Applicable GUID 977b302e-cdf3-4ba2-8020-5e099d93ad18 Measurement Period January 1, 20XX through December 31, 20XX Measure Steward Oregon Urology Measure Developer Oregon Urology Endorsed By None Description Patients determined as
- [2023 # 472 Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture](https://healthmonix.com/mips_quality_measure/2023-472-appropriate-use-of-dxa-scans-in-women-under-65-years-who-do-not-meet-the-risk-factor-profile-for-osteoporotic-fracture/) - eCQM Title Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture eCQM Identifier (Measure Authoring Tool) 249 eCQM Version Number 5.0.000 NQF Number 3475e GUID a3ce125d-c238-42ce-862e-dba0055dfc66 Measurement Period January 1, 20XX through December 31, 20XX Measure Steward Centers for Medicare & Medicaid Services
- [2023 # 476  Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia](https://healthmonix.com/mips_quality_measure/2023-476-urinary-symptom-score-change-6-12-months-after-diagnosis-of-benign-prostatic-hyperplasia/) - eCQM Title Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia eCQM Identifier (Measure Authoring Tool) 771 eCQM Version Number 4.0.000 NQF Number Not Applicable GUID 1c05c6c0-8099-4270-83ce-292cf6e35c51 Measurement Period January 1, 20XX through December 31, 20XX Measure Steward Large Urology Group Practice Association (LUGPA) Measure Developer Large Urology Group Practice Association (LUGPA)
- [2023 # 375  Functional Status Assessment for Total Knee Replacement](https://healthmonix.com/mips_quality_measure/2023-375-functional-status-assessment-for-total-knee-replacement/) - eCQM Title Functional Status Assessment for Total Knee Replacement eCQM Identifier (Measure Authoring Tool) 66 eCQM Version Number 11.0.000 NQF Number Not Applicable GUID be8d9655-1194-46ef-b43e-4b1d0c36ab71 Measurement Period January 1, 20XX through December 31, 20XX Measure Steward Centers for Medicare & Medicaid Services (CMS) Measure Developer National Committee for Quality Assurance Endorsed By None Description Percentage
- [2023 # 366  Follow-Up Care for Children Prescribed ADHD Medication (ADD)](https://healthmonix.com/mips_quality_measure/2023-366-follow-up-care-for-children-prescribed-adhd-medication-add/) - eCQM Title Follow-Up Care for Children Prescribed ADHD Medication (ADD) eCQM Identifier (Measure Authoring Tool) 136 eCQM Version Number 12.0.000 NQF Number Not Applicable GUID 703cc49b-b653-4885-80e8-245a057f5ae9 Measurement Period January 1, 20XX through December 31, 20XX Measure Steward National Committee for Quality Assurance Measure Developer National Committee for Quality Assurance Endorsed By None Description Percentage of
- [2023 # 318 Falls: Screening for Future Fall Risk](https://healthmonix.com/mips_quality_measure/2023-318-falls-screening-for-future-fall-risk/) - eCQM Title Falls: Screening for Future Fall Risk eCQM Identifier (Measure Authoring Tool) 139 eCQM Version Number 11.0.000 NQF Number Not Applicable GUID bc5b4a57-b964-4399-9d40-667c896f31ea Measurement Period January 1, 20XX through December 31, 20XX Measure Steward National Committee for Quality Assurance Measure Developer National Committee for Quality Assurance Measure Developer American Medical Association (AMA) Measure Developer
- [2023 # 309 Cervical Cancer Screening](https://healthmonix.com/mips_quality_measure/2023-309-cervical-cancer-screening/) - eCQM Title Cervical Cancer Screening eCQM Identifier (Measure Authoring Tool) 124 eCQM Version Number 11.0.000 NQF Number Not Applicable GUID 42e7e489-790f-427a-a1a6-d6e807f65a6d Measurement Period January 1, 20XX through December 31, 20XX Measure Steward National Committee for Quality Assurance Measure Developer National Committee for Quality Assurance Endorsed By None Description Percentage of women 21-64 years of age
- [2023 # 310 Chlamydia Screening for Women](https://healthmonix.com/mips_quality_measure/2023-310-chlamydia-screening-for-women/) - eCQM Title Chlamydia Screening in Women eCQM Identifier (Measure Authoring Tool) 153 eCQM Version Number 11.0.000 NQF Number Not Applicable GUID c9930664-be3d-4ffe-ae4a-5cf4933ecb89 Measurement Period January 1, 20XX through December 31, 20XX Measure Steward National Committee for Quality Assurance Measure Developer National Committee for Quality Assurance Endorsed By None Description Percentage of women 16-24 years of
- [2023 # 305 Initiation and Engagement of Alcohol and Other Drug Dependence Treatment](https://healthmonix.com/mips_quality_measure/2023-305-initiation-and-engagement-of-alcohol-and-other-drug-dependence-treatment/) - eCQM Title Initiation and Engagement of Substance Use Disorder Treatment eCQM Identifier (Measure Authoring Tool) 137 eCQM Version Number 11.0.000 NQF Number Not Applicable GUID c3657d72-21b4-4675-820a-86c7fe293bf5 Measurement Period January 1, 20XX through December 31, 20XX Measure Steward National Committee for Quality Assurance Measure Developer National Committee for Quality Assurance Endorsed By None Description Percentage of
- [2023 # 009  Anti-depressant Medication Management](https://healthmonix.com/mips_quality_measure/2023-9-anti-depressant-medication-management/) - eCQM Title Anti-depressant Medication Management eCQM Identifier (Measure Authoring Tool) 128 eCQM Version Number 11.1.000 NQF Number Not Applicable GUID 8924f2b3-ec06-4650-b634-d70a53dee577 Measurement Period January 1, 20XX through December 31, 20XX Measure Steward National Committee for Quality Assurance Measure Developer National Committee for Quality Assurance Endorsed By None Description Percentage of patients 18 years of age
- [2023 # 012  Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation](https://healthmonix.com/mips_quality_measure/2023-12-primary-open-angle-glaucoma-poag-optic-nerve-evaluation/) - eCQM Title Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation eCQM Identifier (Measure Authoring Tool) 143 eCQM Version Number 11.0.000 NQF Number 0086e GUID db9d9f09-6b6a-4749-a8b2-8c1fdb018823 Measurement Period January 1, 20XX through December 31, 20XX Measure Steward American Academy of Ophthalmology Measure Developer American Academy of Ophthalmology Measure Developer American Medical Association (AMA) Measure Developer PCPI(R) Foundation
- [2023 # 107 Adult Major Depressive Disorder (MDD): Suicide Risk Assessment](https://healthmonix.com/mips_quality_measure/2023-107-adult-major-depressive-disorder-mdd-suicide-risk-assessment/) - eCQM Title Adult Major Depressive Disorder (MDD): Suicide Risk Assessment eCQM Identifier (Measure Authoring Tool) 161 eCQM Version Number 11.0.000 NQF Number 0104e GUID 60176fbf-bfdc-4892-9c9e-604f206553c8 Measurement Period January 1, 20XX through December 31, 20XX Measure Steward Mathematica Measure Developer Mathematica Measure Developer American Medical Association (AMA) Measure Developer PCPI(R) Foundation (PCPI[R]) Endorsed By National Quality
- [2023 # 239 Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents](https://healthmonix.com/mips_quality_measure/2023-239-weight-assessment-and-counseling-for-nutrition-and-physical-activity-for-children-and-adolescents/) - eCQM Title Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents eCQM Identifier (Measure Authoring Tool) 155 eCQM Version Number 11.0.000 NQF Number Not Applicable GUID 0b63f730-25d6-4248-b11f-8c09c66a04eb Measurement Period January 1, 20XX through December 31, 20XX Measure Steward National Committee for Quality Assurance Measure Developer National Committee for Quality Assurance Endorsed By None
- [2023 # 240 Childhood Immunization Status](https://healthmonix.com/mips_quality_measure/2023-240-childhood-immunization-status/) - eCQM Title Childhood Immunization Status eCQM Identifier (Measure Authoring Tool) 117 eCQM Version Number 11.0.000 NQF Number Not Applicable GUID b2802b7a-3580-4be8-9458-921aea62b78c Measurement Period January 1, 20XX through December 31, 20XX Measure Steward National Committee for Quality Assurance Measure Developer National Committee for Quality Assurance Endorsed By None Description Percentage of children 2 years of age
- [2023 # 014  Age-Related Macular Degeneration (AMD): Dilated Macular Examination](https://healthmonix.com/mips_quality_measure/2023-014-age-related-macular-degeneration-amd-dilated-macular-examination/) - CMS Measure ID: #14Collection Type: CQMReporting Frequency: Once per patient per yearOutcome: NoHigh Priority: NoNQS Domain: Effective Clinical CareMeasure Age: > 2 yearsInstructionsThis measure is to be submitted a minimum of once per performance period for patients seen during the performance period. It is anticipated that eligible clinicians who provide the primary management of patients
- [2021 MIPS Measure #443: Non-Recommended Cervical Cancer Screening in Adolescent Females](https://healthmonix.com/mips_quality_measure/2023-443-non-recommended-cervical-cancer-screening-in-adolescent-females/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description The percentage of adolescent females 16–20 years of age who were screened unnecessarily for cervical cancer
- [2021 MIPS Measure #304: Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery](https://healthmonix.com/mips_quality_measure/2021-mips-measure-304-cataracts-patient-satisfaction-within-90-days-following-cataract-surgery/) - Measure Type High Priority Measure? Collection Type(s) Patient Engagement/Experience yes MIPS CQM Measure Description Percentage of patients aged 18 years and older who had cataract surgery and were satisfied with their care within 90 days following the cataract surgery, based on completion of the Consumer Assessment of Healthcare Providers and Systems Surgical Care Survey
- [2021 MIPS Measure #303: Cataracts: Improvement in Patient’s Visual Function within 90 Days Following Cataract Surgery](https://healthmonix.com/mips_quality_measure/2021-mips-measure-303-cataracts-improvement-in-patients-visual-function-within-90-days-following-cataract-surgery/) - Measure Type High Priority Measure? Collection Type(s) Patient Reported Outcome yes MIPS CQM Measure Description Percentage of patients aged 18 years and older who had cataract surgery and had improvement in visual function achieved within 90 days following the cataract surgery, based on completing a pre-operative and post-operative visual function survey Instructions This measure
- [2022 #484 Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions](https://healthmonix.com/mips_quality_measure/2022-484-clinician-and-clinician-group-risk-standardized-hospital-admission-rates-for-patients-with-multiple-chronic-conditions/) - CMS Measure ID: #484Collection Type: Administrative Claimsstrong>Outcome: NoHigh Priority: Yesstrong>Measure Age: 1st year Measure Description The measure is an annual risk-standardized rate of acute, unplanned hospital admissions among Medicare Fee-for-Service (FFS) patients aged 65 years and older with multiple chronic conditions (MCCs; i.e., two or more of nine qualifying chronic conditions). The measure is adjusted for age,
- [2022 #479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for the Merit-Based Incentive Payment System (MIPS) Groups](https://healthmonix.com/mips_quality_measure/2022-479-hospital-wide-30-day-all-cause-unplanned-readmission-hwr-rate-for-the-merit-based-incentive-payment-system-mips-groups/) - CMS Measure ID: #479Collection Type: Administrative ClaimsOutcome: NoHigh Priority: YesMeasure Age: 1st year Measure Description The 30-day Hospital-Wide, All-Cause Unplanned Readmission (HWR) Rate for the Merit- based Incentive Payment System (MIPS) Groups measure is a risk-standardized readmission rate for beneficiaries age 65 or older who were hospitalized and experienced an unplanned readmission for any cause to a
- [2022 Measure #  001 Diabetes: Hemoglobin A1c Poor Control](https://healthmonix.com/mips_quality_measure/2022-measure-001-diabetes-hemoglobin-a1c-poor-control/) - Measure Type High Priority Measure? Collection Type(s) Intermediate Outcome yes Medicare Part B Claims, eCQM, CMS Web Interface, MIPS CQM Measure Description Percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the measurement period. Instructions This measure is to be submitted a minimum of once per performance period
- [2022 Measure #  005 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)](https://healthmonix.com/mips_quality_measure/2022-measure-005-heart-failure-hf-angiotensin-converting-enzyme-ace-inhibitor-or-angiotensin-receptor-blocker-arb-or-angiotensin-receptor-neprilysin-inhibitor-arni-therapy-for-left-ventric/) - Measure Type High Priority Measure? Collection Type(s) Process no eCQM, MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB or ARNI therapy either within a 12-month
- [2022 MIPS Measure #366: Follow-Up Care for Children Prescribed ADHD Medication (ADD)](https://healthmonix.com/mips_quality_measure/2022-mips-measure-366-follow-up-care-for-children-prescribed-adhd-medication-add/) - Description Percentage of children 6-12 years of age and newly dispensed a medication for attention-deficit/hyperactivity disorder (ADHD) who had appropriate follow-up care. Two rates are reported. a. Percentage of children who had one follow-up visit with a practitioner with prescribing authority during the 30-Day Initiation Phase. b. Percentage of children who remained on ADHD medication
- [2022 HM9: Functional Benefit of a Cochlear Implant](https://healthmonix.com/mips_quality_measure/2022-hm9-functional-benefit-of-a-cochlear-implant/) - Measure Description Percentage of patients aged 18 years and older, who are evaluated for hearing loss and complete a hearing loss self-assessment tool that indicated an impact of hearing-related quality of life (QoL), and if diagnosed with a bilateral moderate to profound sensorineural hearing loss (SNHL) and less than 60% open set speech recognition are
- [2022 HM12: Outcomes of Treatment of Benign Paroxysmal Positional Vertigo](https://healthmonix.com/mips_quality_measure/2022-hm12-outcomes-of-treatment-of-benign-paroxysmal-positional-vertigo/) - Measure Description Percentage of patients aged 18 years and older, who report benign paroxysmal positional vertigo (BPPV)-related symptoms and are screened with a dizziness assessment questionnaire and undergo positional nystagmus testing AND, if diagnosed or identified with BPPV, received a BPPV-related care plan and vestibular intervention(s) or treatment(s) AND who have an improvement in nystagmus
- [2022 Measure #  478 Functional Status Change for Patients with Neck Impairments](https://healthmonix.com/mips_quality_measure/2022-measure-478-functional-status-change-for-patients-with-neck-impairments/) - Measure Type High Priority Measure? Collection Type(s) Patient Reported Outcome yes MIPS CQMs SpecificationsMeasure A patient-reported outcome measure of risk-adjusted change in functional status for patients 14 years+ with neck impairments. The change in functional status (FS) is assessed using the FOTO Neck FS patient-reported outcome measure (PROM). The measure is adjusted to patient characteristics
- [2022 MIPS Measure #476: Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia](https://healthmonix.com/mips_quality_measure/2022-mips-measure-476-urinary-symptom-score-change-6-12-months-after-diagnosis-of-benign-prostatic-hyperplasia/) - Description Percentage of patients with an office visit within the measurement period and with a new diagnosis of clinically significant Benign Prostatic Hyperplasia who have International Prostate Symptoms Score (IPSS) or American Urological Association (AUA) Symptom Index (SI) documented at time of diagnosis and again 6-12 months later with an improvement of 3 points Initial
- [2022 MIPS Measure #475: HIV Screening](https://healthmonix.com/mips_quality_measure/2022-mips-measure-475-hiv-screening/) - Description Percentage of patients aged 15-65 at the start of the measurement period who were between 15-65 years old when tested for HIV Initial Population Patients 15 to 65 years of age at the start of the measurement period AND who had at least one outpatient visit during the measurement period Denominator Equals Initial Population
- [2022 MIPS Measure #472: Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture](https://healthmonix.com/mips_quality_measure/2022-mips-measure-472-appropriate-use-of-dxa-scans-in-women-under-65-years-who-do-not-meet-the-risk-factor-profile-for-osteoporotic-fracture/) - Description Percentage of female patients 50 to 64 years of age without select risk factors for osteoporotic fracture who received an order for a dual-energy x-ray absorptiometry (DXA) scan during the measurement period Initial Population Female patients ages 50 to 64 years with an encounter during the measurement period Denominator Equals Initial Population Denominator Exclusions
- [2022 Measure #471 Functional Status After Lumbar Discectomy/Laminectomy](https://healthmonix.com/mips_quality_measure/2022-measure-471-functional-status-after-lumbar-discectomy-laminectomy/) - Measure Type High Priority Measure? Collection Type(s) Patient Reported Outcome yes MIPS CQM Measure Description For patients age 18 and older who had lumbar discectomy/laminectomy procedure, functional status is rated by the patient as less than or equal to 22 OR an improvement of 30 points or greater on the Oswestry Disability Index (ODI version
- [2022 MIPS Measure # 462: Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy](https://healthmonix.com/mips_quality_measure/2022-mips-measure-462-bone-density-evaluation-for-patients-with-prostate-cancer-and-receiving-androgen-deprivation-therapy/) - Description Patients determined as having prostate cancer who are currently starting or undergoing androgen deprivation therapy (ADT), for an anticipated period of 12 months or greater and who receive an initial bone density evaluation. The bone density evaluation must be prior to the start of ADT or within 3 months of the start of ADT.
- [2021 MIPS Measure #457: Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score – better)](https://healthmonix.com/mips_quality_measure/2021-mips-measure-457-percentage-of-patients-who-died-from-cancer-admitted-to-hospice-for-less-than-3-days-lower-score-better/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Proportion of patients who died from cancer, and admitted to hospice and spent less than 3 days there
- [2022 Measure #  457 Percentage of Patients Who Died from Cancer Admitted to Hospice for Less than 3 days (lower score – better)](https://healthmonix.com/mips_quality_measure/2022-measure-457-percentage-of-patients-who-died-from-cancer-admitted-to-hospice-for-less-than-3-days-lower-score-better/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Proportion of patients who died from cancer, and admitted to hospice and spent less than 3 days there Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source, connecting you to
- [2022 Measure #  453 Percentage of Patients Who Died from Cancer Receiving Chemotherapy in the Last 14 Days of Life (lower score – better)](https://healthmonix.com/mips_quality_measure/2022-measure-453-percentage-of-patients-who-died-from-cancer-receiving-chemotherapy-in-the-last-14-days-of-life-lower-score-better/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients who died from cancer receiving chemotherapy in the last 14 days of life. Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source, connecting you to the latest
- [2022 Measure #  452 Patients with Metastatic Colorectal Cancer and RAS (KRAS or NRAS) Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies](https://healthmonix.com/mips_quality_measure/2022-measure-452-patients-with-metastatic-colorectal-cancer-and-ras-kras-or-nras-gene-mutation-spared-treatment-with-anti-epidermal-growth-factor-receptor-egfr-monoclonal-antibodies/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of adult patients (aged 18 or over) with metastatic colorectal cancer and RAS (KRAS or NRAS) gene mutation spared treatment with anti-EGFR monoclonal antibodies Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a
- [2022 Measure #  451 RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy](https://healthmonix.com/mips_quality_measure/2022-measure-451-ras-kras-and-nras-gene-mutation-testing-performed-for-patients-with-metastatic-colorectal-cancer-who-receive-anti-epidermal-growth-factor-receptor-egfr-monoclonal-antibody-ther/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of adult patients (aged 18 or over) with metastatic colorectal cancer who receive anti-epidermal growth factor receptor monoclonal antibody therapy for whom RAS (KRAS and NRAS) gene mutation testing was performed Stay up to date with the latest news regarding MACRA
- [2022 Measure #  450 Appropriate Treatment for Patients with Stage I (T1c) – III HER2 Positive Breast Cancer](https://healthmonix.com/mips_quality_measure/2022-measure-450-appropriate-treatment-for-patients-with-stage-i-t1c-iii-her2-positive-breast-cancer/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of female patients aged 18 to 70 with stage I (T1c) – III HER2 positive breast cancer for whom appropriate treatment is initiated Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free
- [2022 MIPS Measure #382: Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment](https://healthmonix.com/mips_quality_measure/2022-mips-measure-382-child-and-adolescent-major-depressive-disorder-mdd-suicide-risk-assessment/) - Description Percentage of patient visits for those patients aged 6 through 17 years with a diagnosis of major depressive disorder with an assessment for suicide risk Initial Population All patient visits for those patients aged 6 through 17 years with a diagnosis of major depressive disorder Denominator Equals Initial Population Denominator Exclusions None Numerator Patient
- [2022 MIPS Measure #379: Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists](https://healthmonix.com/mips_quality_measure/2022-mips-measure-379-primary-caries-prevention-intervention-as-offered-by-primary-care-providers-including-dentists/) - Description Percentage of children, 6 months - 20 years of age, who received a fluoride varnish application during the measurement period Initial Population Children, 6 months - 20 years of age, with a visit during the measurement period Denominator Equals Initial Population Denominator Exclusions Exclude patients who are in hospice care for any part of
- [2022 MIPS Measure #378: Children Who Have Dental Decay or Cavities](https://healthmonix.com/mips_quality_measure/2022-mips-measure-378-children-who-have-dental-decay-or-cavities/) - Description Percentage of children, 6 months - 20 years of age at the start of the measurement period, who have had tooth decay or cavities during the measurement period Initial Population Children, 6 months - 20 years of age, with a clinical oral evaluation during the measurement period Denominator Equals Initial Population Denominator Exclusions Exclude
- [2022 MIPS Measure #376: Functional Status Assessment for Total Hip Replacement](https://healthmonix.com/mips_quality_measure/2022-mips-measure-376-functional-status-assessment-for-total-hip-replacement/) - Description Percentage of patients 18 years of age and older who received an elective primary total hip arthroplasty (THA) and completed a functional status assessment within 90 days prior to the surgery and in the 270-365 days after the surgery Initial Population Patients 19 years of age and older who had a primary total hip
- [2022 MIPS Measure #375: Functional Status Assessment for Total Knee Replacement](https://healthmonix.com/mips_quality_measure/2022-mips-measure-375-functional-status-assessment-for-total-knee-replacement/) - Description Percentage of patients 18 years of age and older who received an elective primary total knee arthroplasty (TKA) and completed a functional status assessment within 90 days prior to the surgery and in the 270-365 days after the surgery Initial Population Patients 19 years of age and older who had a primary total knee
- [2022 MIPS Measure # 318: Falls: Screening for Future Fall Risk](https://healthmonix.com/mips_quality_measure/2022-mips-measure-318-falls-screening-for-future-fall-risk/) - Description Percentage of patients 65 years of age and older who were screened for future fall risk during the measurement period Initial Population Patients aged 65 years and older with a visit during the measurement period Denominator Equals Initial Population Denominator Exclusions Exclude patients who are in hospice care for any part of the measurement
- [2022 MIPS Measure #310: Chlamydia Screening for Women](https://healthmonix.com/mips_quality_measure/2022-mips-measure-310-chlamydia-screening-for-women/) - Description Percentage of women 16-24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement period Initial Population Women 16 to 24 years of age who are sexually active and who had a visit in the measurement period Denominator Equals Initial Population Denominator Exclusions
- [2022 Measure #  288 Dementia: Education and Support of Caregivers for Patients with Dementia](https://healthmonix.com/mips_quality_measure/2022-measure-288-dementia-education-and-support-of-caregivers-for-patients-with-dementia/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients with dementia whose caregiver(s) were provided with education on dementia disease management and health behavior changes AND were referred to additional resources for support in the last 12 months Stay up to date with the latest news regarding MACRA
- [2022 Measure #  286 Dementia: Safety Concern Screening and Follow-Up for Patients with Dementia](https://healthmonix.com/mips_quality_measure/2022-measure-286-dementia-safety-concern-screening-and-follow-up-for-patients-with-dementia/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients with dementia or their caregiver(s) for whom there was a documented safety concerns screening in two domains of risk: 1) dangerousness to self or others and 2) environmental risks; and if safety concerns screening was positive in the last
- [2022 Measure #  283 Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management](https://healthmonix.com/mips_quality_measure/2022-measure-283-dementia-associated-behavioral-and-psychiatric-symptoms-screening-and-management/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients with dementia for whom there was a documented screening for behavioral and psychiatric symptoms, including depression, and for whom, if symptoms screening was positive, there was also documentation of recommendations for management in the last 12 months Stay up
- [2022 Measure #  282 Dementia: Functional Status Assessment](https://healthmonix.com/mips_quality_measure/2022-measure-282-dementia-functional-status-assessment/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients with dementia for whom an assessment of functional status was performed at least once in the last 12 months. Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news
- [2022 MIPS Measure #281: Dementia: Cognitive Assessment](https://healthmonix.com/mips_quality_measure/2022-mips-measure-281-dementia-cognitive-assessment/) - Description Percentage of patients, regardless of age, with a diagnosis of dementia for whom an assessment of cognition is performed and the results reviewed at least once within a 12-month period Initial Population All patients, regardless of age, with a diagnosis of dementia Denominator Equals Initial Population Denominator Exclusions None Numerator Patients for whom an
- [2022 Measure #  279 Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy](https://healthmonix.com/mips_quality_measure/2022-measure-279-sleep-apnea-assessment-of-adherence-to-positive-airway-pressure-therapy/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of visits for patients aged 18 years and older with a diagnosis of obstructive sleep apnea who were prescribed positive airway pressure therapy who had documentation that adherence to positive airway pressure therapy was objectively measured Stay up to date with
- [2022 Measure #  277 Sleep Apnea: Severity Assessment at Initial Diagnosis](https://healthmonix.com/mips_quality_measure/2022-measure-277-sleep-apnea-severity-assessment-at-initial-diagnosis/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of obstructive sleep apnea who had an apnea hypopnea index (AHI) or a respiratory disturbance index (RDI) measured at the time of initial diagnosis Stay up to date with the latest
- [2022 Measure #  275 Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy](https://healthmonix.com/mips_quality_measure/2022-measure-275-inflammatory-bowel-disease-ibd-assessment-of-hepatitis-b-virus-hbv-status-before-initiating-anti-tnf-tumor-necrosis-factor-therapy/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients with a diagnosis of inflammatory bowel disease (IBD) who had Hepatitis B Virus (HBV) status assessed and results interpreted prior to initiating anti-TNF (tumor necrosis factor) therapy Stay up to date with the latest news regarding MACRA and MIPS.
- [2022 Measure #  268 Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy](https://healthmonix.com/mips_quality_measure/2022-measure-268-epilepsy-counseling-for-women-of-childbearing-potential-with-epilepsy/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, MIPS CQM Measure Description Percentage of all patients of childbearing potential (12 years and older) diagnosed with epilepsy who were counseled at least once a year about how epilepsy and its treatment may affect contraception and pregnancy Stay up to date with
- [2022 Measure #  265 Biopsy Follow-Up](https://healthmonix.com/mips_quality_measure/2022-measure-265-biopsy-follow-up/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of new patients whose biopsy results have been reviewed and communicated to the primary care/referring physician and patient. Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source, connecting you
- [2022 Measure #  264 Sentinel Lymph Node Biopsy for Invasive Breast Cancer](https://healthmonix.com/mips_quality_measure/2022-measure-264-sentinel-lymph-node-biopsy-for-invasive-breast-cancer/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description The percentage of clinically node negative (clinical stage T1N0M0 or T2N0M0) breast cancer patients before or after neoadjuvant systemic therapy, who undergo a sentinel lymph node (SLN) procedure Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix
- [2022 Measure #  261 Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness](https://healthmonix.com/mips_quality_measure/2022-measure-261-referral-for-otologic-evaluation-for-patients-with-acute-or-chronic-dizziness/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged birth and older referred to a physician (preferably a physician specially trained in disorders of the ear) for an otologic evaluation subsequent to an audiologic evaluation after presenting with acute or chronic dizziness. Stay
- [2022 Measure #  260 Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2)](https://healthmonix.com/mips_quality_measure/2022-measure-260-rate-of-carotid-endarterectomy-cea-for-asymptomatic-patients-without-major-complications-discharged-to-home-by-post-operative-day-2/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2 Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source, connecting you to the
- [2022 Measure #  259 Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #2)](https://healthmonix.com/mips_quality_measure/2022-measure-259-rate-of-endovascular-aneurysm-repair-evar-of-small-or-moderate-non-ruptured-abdominal-aortic-aneurysms-aaa-without-major-complications-discharged-to-home-by-post-operative-day/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percent of patients undergoing endovascular repair of small or moderate non-ruptured infrarenal abdominal aortic aneurysms (AAA) that do not experience a major complication (discharged to home no later than post-operative day #2) Stay up to date with the latest news regarding MACRA
- [2022 Measure #  258 Rate of Open Repair of Small or Moderate Non-Ruptured Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #7)](https://healthmonix.com/mips_quality_measure/2022-measure-258-rate-of-open-repair-of-small-or-moderate-non-ruptured-abdominal-aortic-aneurysms-aaa-without-major-complications-discharged-to-home-by-post-operative-day-7/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percent of patients undergoing open repair of small or moderate sized non-ruptured infrarenal abdominal aortic aneurysms who do not experience a major complication (discharge to home no later than post-operative day #7) Stay up to date with the latest news regarding MACRA
- [2022 Measure #  254 Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal Pain](https://healthmonix.com/mips_quality_measure/2022-measure-254-ultrasound-determination-of-pregnancy-location-for-pregnant-patients-with-abdominal-pain/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, MIPS CQM Measure Description Percentage of pregnant female patients aged 14 to 50 who present to the emergency department (ED) with a chief complaint of abdominal pain or vaginal bleeding who receive a trans-abdominal or trans-vaginal ultrasound to determine pregnancy location Stay
- [2022 Measure #  250 Radical Prostatectomy Pathology Reporting](https://healthmonix.com/mips_quality_measure/2022-measure-250-radical-prostatectomy-pathology-reporting/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, MIPS CQM Measure Description Percentage of radical prostatectomy pathology reports that include the pT category, the pN category, the Gleason score and a statement about margin status Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor
- [2022 Measure #  249 Barrett's Esophagus](https://healthmonix.com/mips_quality_measure/2022-measure-249-barretts-esophagus/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, MIPS CQM Measure Description Percentage of esophageal biopsy reports that document the presence of Barrett’s mucosa that also include a statement about dysplasia Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly
- [2022 Measure #  243 Cardiac Rehabilitation Patient Referral from an Outpatient Setting](https://healthmonix.com/mips_quality_measure/2022-measure-243-cardiac-rehabilitation-patient-referral-from-an-outpatient-setting/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients evaluated in an outpatient setting who within the previous 12 months have experienced an acute myocardial infarction (MI), coronary artery bypass graft (CABG) surgery, a percutaneous coronary intervention (PCI), cardiac valve surgery, or cardiac transplantation, or who have chronic
- [2022 MIPS Measure #239: Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents](https://healthmonix.com/mips_quality_measure/2022-mips-measure-239-weight-assessment-and-counseling-for-nutrition-and-physical-activity-for-children-adolescents/) - Description Percentage of patients 3-17 years of age who had an outpatient visit with a Primary Care Physician (PCP) or Obstetrician/Gynecologist (OB/GYN) and who had evidence of the following during the measurement period. Three rates are reported. Percentage of patients with height, weight, and body mass index (BMI) percentile documentation Percentage of patients with counseling
- [2022 Measure #  238 Use of High-Risk Medications in Older Adults](https://healthmonix.com/mips_quality_measure/2022-measure-238-use-of-high-risk-medications-in-older-adults/) - Measure Type High Priority Measure? Collection Type(s) Process yes eCQM, MIPS CQM Measure Description Percentage of patients 65 years of age and older who were ordered at least two high-risk medications from the same drug class Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly
- [2022 Measure #  236 Controlling High Blood Pressure](https://healthmonix.com/mips_quality_measure/2022-measure-236-controlling-high-blood-pressure/) - Measure Type High Priority Measure? Collection Type(s) Intermediate Outcome yes Medicare Part B Claims, eCQM, CMS Web Interface, MIPS CQM Measure Description Percentage of patients 18-85 years of age who had a diagnosis of essential hypertension starting before and continuing into, or starting during the first six months of the measurement period, and whose most
- [2022 Measure #  226 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention](https://healthmonix.com/mips_quality_measure/2022-measure-226-preventive-care-and-screening-tobacco-use-screening-and-cessation-intervention/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, eCQM, CMS Web Interface, MIPS CQM Measure Description Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within the measurement period AND who received tobacco cessation intervention on the date of the encounter
- [2022 Measure #  222 Functional Status Change for Patients with Elbow, Wrist or Hand Impairments](https://healthmonix.com/mips_quality_measure/2022-measure-222-functional-status-change-for-patients-with-elbow-wrist-or-hand-impairments/) - DENOMINATOR NOTE: *Signifies that this CPT Category I code is a non-covered service under the Medicare Part B Physician Fee Schedule (PFS). These non-covered services should be counted in the denominator population for MIPS CQMs.
- [2022 Measure #  221 Functional Status Change for Patients with Shoulder Impairments](https://healthmonix.com/mips_quality_measure/2022-measure-221-functional-status-change-for-patients-with-shoulder-impairments/) - Measure Type High Priority Measure? Collection Type(s) Patient Reported Outcome yes MIPS CQM Measure Description A patient-reported outcome measure of risk-adjusted change in functional status for patients 14 years+ with shoulder impairments. The change in functional status (FS) is assessed using the FOTO Shoulder FS patient-reported outcome measure (PROM). The measure is adjusted to patient
- [2022 Measure #  220 Functional Status Change for Patients with Low Back Impairments](https://healthmonix.com/mips_quality_measure/2022-measure-220-functional-status-change-for-patients-with-low-back-impairments/) - Measure Type High Priority Measure? Collection Type(s) Patient Reported Outcome yes MIPS CQM Measure Description A patient-reported outcome measure of risk-adjusted change in functional status for patients 14 years+ with low back impairments. The change in functional status (FS) is assessed using the FOTO Low Back FS patient-reported outcome measure (PROM). The measure is adjusted
- [2022 Measure #  219 Functional Status Change for Patients with Lower Leg, Foot or Ankle Impairments](https://healthmonix.com/mips_quality_measure/2022-measure-219-functional-status-change-for-patients-with-lower-leg-foot-or-ankle-impairments/) - Measure Type High Priority Measure? Collection Type(s) Patient Reported Outcome yes MIPS CQM Measure Description A patient-reported outcome measure of risk-adjusted change in functional status for patients 14 years+ with foot, ankle or lower leg impairments. The change in functional status (FS) is assessed using the FOTO Lower Extremity Physical Function (LEPF) patient- reported outcome
- [2022 Measure #  218 Functional Status Change for Patients with Hip Impairments](https://healthmonix.com/mips_quality_measure/2022-measure-218-functional-status-change-for-patients-with-hip-impairments/) - Measure Type High Priority Measure? Collection Type(s) Patient Reported Outcome yes MIPS CQM Measure Description A patient-reported outcome measure of risk-adjusted change in functional status for patients 14 years+ with hip impairments. The change in functional status (FS) is assessed using the FOTO Lower Extremity Physical Function (LEPF) patient-reported outcome measure (PROM) . The measure
- [2022 Measure #  205 HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis](https://healthmonix.com/mips_quality_measure/2022-measure-205-hiv-aids-sexually-transmitted-disease-screening-for-chlamydia-gonorrhea-and-syphilis/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 13 years and older with a diagnosis of HIV/AIDS for whom chlamydia, gonorrhea, and syphilis screenings were performed at least once since the diagnosis of HIV infection Stay up to date with the latest news regarding MACRA and
- [2022 Measure #  191 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery](https://healthmonix.com/mips_quality_measure/2022-measure-191-cataracts-20-40-or-better-visual-acuity-within-90-days-following-cataract-surgery/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes eCQM, MIPS CQM Measure Description Percentage of cataract surgeries for patients aged 18 years and older with a diagnosis of uncomplicated cataract and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near) achieved
- [2022 Measure #  187 Stroke and Stroke Rehabilitation: Thrombolytic Therapy](https://healthmonix.com/mips_quality_measure/2022-measure-187-stroke-and-stroke-rehabilitation-thrombolytic-therapy/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of acute ischemic stroke who arrive at the hospital within two hours of time last known well and for whom IV t-PA was initiated within three hours of time last known
- [2022 Measure #  185 Colonoscopy Interval for Patients with a History of Adenomatous Polyps – Avoidance of Inappropriate Use](https://healthmonix.com/mips_quality_measure/2022-measure-185-colonoscopy-interval-for-patients-with-a-history-of-adenomatous-polyps-avoidance-of-inappropriate-use/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older receiving a surveillance colonoscopy, with a history of prior adenomatous polyp(s) in previous colonoscopy findings, which had an interval of 3 or more years since their last colonoscopy. Stay up to date with the
- [2022 Measure #  182 Functional Outcome Assessment](https://healthmonix.com/mips_quality_measure/2022-measure-182-functional-outcome-assessment/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of visits for patients aged 18 years and older with documentation of a current functional outcome assessment using a standardized functional outcome assessment tool on the date of the encounter AND documentation of a care plan based
- [2022 Measure #  181 Elder Maltreatment Screen and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/2022-measure-181-elder-maltreatment-screen-and-follow-up-plan/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged 65 years and older with a documented elder maltreatment screen using an Elder Maltreatment Screening tool on the date of encounter AND a documented follow-up plan on the date of the positive screen Stay
- [2022 Measure #  180 Rheumatoid Arthritis (RA): Glucocorticoid Management](https://healthmonix.com/mips_quality_measure/2022-measure-180-rheumatoid-arthritis-ra-glucocorticoid-management/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have been assessed for glucocorticoid use and, for those on prolonged doses of prednisone ≥ 10 mg daily (or equivalent) with improvement or no change in
- [2022 Measure #  178 Rheumatoid Arthritis (RA): Functional Status Assessment](https://healthmonix.com/mips_quality_measure/2022-measure-178-rheumatoid-arthritis-ra-functional-status-assessment/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) for whom a functional status assessment was performed at least once within 12 months. Stay up to date with the latest news regarding MACRA and MIPS. The
- [2022 Measure #  177 Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity](https://healthmonix.com/mips_quality_measure/2022-measure-177-rheumatoid-arthritis-ra-periodic-assessment-of-disease-activity/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have an assessment of disease activity using an ACR-preferred RA disease activity assessment tool at ≥50% of encounters for RA for each patient during the measurement
- [2022 Measure #  176 Tuberculosis Screening Prior to First Course Biologic Therapy](https://healthmonix.com/mips_quality_measure/2022-measure-176-tuberculosis-screening-prior-to-first-course-biologic-therapy/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description If a patient has been newly prescribed a biologic disease-modifying anti-rheumatic drug (DMARD) therapy, then the medical record should indicate TB testing in the preceding 12-month period. Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor
- [2022 Measure #  168 Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration](https://healthmonix.com/mips_quality_measure/2022-measure-168-coronary-artery-bypass-graft-cabg-surgical-re-exploration/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percentage of patients aged 18 years and older undergoing isolated CABG surgery who require a return to the operating room (OR) during the current hospitalization for mediastinal bleeding with or without tamponade, graft occlusion, valve dysfunction, or other cardiac reason. Stay up
- [2022 Measure #  167 Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure](https://healthmonix.com/mips_quality_measure/2022-measure-167-coronary-artery-bypass-graft-cabg-postoperative-renal-failure/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older undergoing isolated CABG surgery (without pre-existing renal failure) who develop postoperative renal failure or require dialysis. Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly
- [2022 Measure #  164 Coronary Artery Bypass Graft (CABG): Prolonged Intubation](https://healthmonix.com/mips_quality_measure/2022-measure-164-coronary-artery-bypass-graft-cabg-prolonged-intubation/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older undergoing isolated CABG surgery who require postoperative intubation > 24 hours. Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source, connecting you
- [2022 Measure #  155 Falls: Plan of Care](https://healthmonix.com/mips_quality_measure/2022-measure-155-falls-plan-of-care/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged 65 years and older with a history of falls that had a plan of care for falls documented within 12 months Stay up to date with the latest news regarding MACRA and MIPS. The
- [2022 Measure #  147 Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy](https://healthmonix.com/mips_quality_measure/2022-measure-147-nuclear-medicine-correlation-with-existing-imaging-studies-for-all-patients-undergoing-bone-scintigraphy/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of final reports for all patients, regardless of age, undergoing bone scintigraphy that include physician documentation of correlation with existing relevant imaging studies (e.g., x-ray, MRI, CT, etc.) that were performed Stay up to date with the
- [2022 Measure #  145 Radiology: Exposure Dose Indices or Exposure Time and Number of Images Reported for Procedures Using Fluoroscopy](https://healthmonix.com/mips_quality_measure/2022-measure-145-radiology-exposure-dose-indices-or-exposure-time-and-number-of-images-reported-for-procedures-using-fluoroscopy/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Final reports for procedures using fluoroscopy that document radiation exposure indices, or exposure time and number of fluorographic images (if radiation exposure indices are not available) Stay up to date with the latest news regarding MACRA and MIPS.
- [2022 Measure #  143 Oncology: Medical and Radiation – Pain Intensity Quantified](https://healthmonix.com/mips_quality_measure/2022-measure-143-oncology-medical-and-radiation-pain-intensity-quantified/) - Measure Type High Priority Measure? Collection Type(s) Process yes eCQM, MIPS CQM Measure Description Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified. Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is
- [2022 Measure #  141 Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of Care](https://healthmonix.com/mips_quality_measure/2022-measure-141-primary-open-angle-glaucoma-poag-reduction-of-intraocular-pressure-iop-by-15-or-documentation-of-a-plan-of-care/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of primary open-angle glaucoma (POAG) whose glaucoma treatment has not failed (the most recent IOP was reduced by at least 15% from the pre-intervention level) OR if
- [2022 Measure #  138 Melanoma: Coordination of Care](https://healthmonix.com/mips_quality_measure/2022-measure-138-melanoma-coordination-of-care/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patient visits, regardless of age, with a new occurrence of melanoma that have a treatment plan documented in the chart that was communicated to the physician(s) providing continuing care within one month of diagnosis Stay up to date with the
- [2022 Measure #  134 Preventive Care and Screening: Screening for Depression and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/2022-measure-134-preventive-care-and-screening-screening-for-depression-and-follow-up-plan/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, eCQM, CMS Web Interface, MIPS CQM Measure Description Percentage of patients aged 12 years and older screened for depression on the date of the encounter or 14 days prior to the date of the encounter using an age appropriate standardized depression screening
- [2022 Measure #  130 Documentation of Current Medications in the Medical Record](https://healthmonix.com/mips_quality_measure/2022-measure-130-documentation-of-current-medications-in-the-medical-record/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, eCQM, MIPS CQM Measure Description Percentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter.
- [2022 Measure #  128 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/2022-measure-128-preventive-care-and-screening-body-mass-index-bmi-screening-and-follow-up-plan/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, eCQM, MIPS CQM Measure Description Percentage of patients aged 18 years and older with a BMI documented during the current encounter or during the previous twelve months AND with a BMI outside of normal parameters, a follow-up plan is documented during the
- [2022 Measure #  127 Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear](https://healthmonix.com/mips_quality_measure/2022-measure-127-diabetes-mellitus-diabetic-foot-and-ankle-care-ulcer-prevention-evaluation-of-footwear/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who were evaluated for proper footwear and sizing Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news
- [2022 Measure #  126 Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy – Neurological Evaluation](https://healthmonix.com/mips_quality_measure/2022-measure-126-diabetes-mellitus-diabetic-foot-and-ankle-care-peripheral-neuropathy-neurological-evaluation/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who had a neurological examination of their lower extremities within 12 months Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is
- [2022 Measure #  119 Diabetes: Medical Attention for Nephropathy](https://healthmonix.com/mips_quality_measure/2022-measure-119-diabetes-medical-attention-for-nephropathy/) - Measure Type High Priority Measure? Collection Type(s) Process no eCQM, MIPS CQM Measure Description The percentage of patients 18-75 years of age with diabetes who had a nephropathy screening test or evidence of nephropathy during the measurement period. Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a
- [2022 Measure #  118 Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy -- Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)](https://healthmonix.com/mips_quality_measure/2022-measure-118-coronary-artery-disease-cad-angiotensin-converting-enzyme-ace-inhibitor-or-angiotensin-receptor-blocker-arb-therapy-diabetes-or-left-ventricular-systolic-dysfunction-lve/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period who also have diabetes OR a current or prior Left Ventricular Ejection Fraction (LVEF) < 40% who were prescribed ACE inhibitor
- [2022 Measure #  117 Diabetes: Eye Exam](https://healthmonix.com/mips_quality_measure/2022-measure-117-diabetes-eye-exam/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, eCQM, MIPS CQM Measure Description Percentage of patients 18-75 years of age with diabetes and an active diagnosis of retinopathy in any part of the measurement period who had a retinal or dilated eye exam by an eye care professional during the
- [2022 Measure #  116 Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis](https://healthmonix.com/mips_quality_measure/2022-measure-116-avoidance-of-antibiotic-treatment-for-acute-bronchitis-bronchiolitis/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description The percentage of adults 18–64 years of age with a diagnosis of acute bronchitis who were not prescribed or dispensed an antibiotic prescription Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly
- [2022 Measure #  113 Colorectal Cancer Screening](https://healthmonix.com/mips_quality_measure/2022-measure-113-colorectal-cancer-screening/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, eCQM, CMS Web Interface, MIPS CQM Measure Description Percentage of patients 50-75 years of age who had appropriate screening for colorectal cancer. Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news
- [2022 Measure #  112 Breast Cancer Screening](https://healthmonix.com/mips_quality_measure/2022-measure-112-breast-cancer-screening/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, eCQM, CMS Web Interface, MIPS CQM Measure Description Percentage of women 50 – 74 years of age who had a mammogram to screen for breast cancer in the 27 months prior to the end of the measurement period. Stay up to date
- [2022 Measure #  111 Pneumococcal Vaccination Status for Older Adults](https://healthmonix.com/mips_quality_measure/2022-measure-111-pneumococcal-vaccination-status-for-older-adults/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, eCQM, MIPS CQM Measure Description Percentage of patients 66 years of age and older who have ever received a pneumococcal vaccine Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source,
- [2022 Measure #  110 Preventive Care and Screening: Influenza Immunization](https://healthmonix.com/mips_quality_measure/2022-measure-110-preventive-care-and-screening-influenza-immunization/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, eCQM, CMS Web Interface, MIPS CQM Measure Description Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization Stay up
- [2022 MIPS Measure #107: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment](https://healthmonix.com/mips_quality_measure/2022-mips-measure-107-adult-major-depressive-disorder-mdd-suicide-risk-assessment/) - Description All patient visits during which a new diagnosis of MDD or a new diagnosis of recurrent MDD was identified for patients aged 18 years and older with a suicide risk assessment completed during the visit Initial Population Patient visits during which a new diagnosis of MDD, single or recurrent episode, was identified Denominator Equals
- [2022 Measure #  104 Prostate Cancer: Combination Androgen Deprivation Therapy for High Risk or Very High Risk Prostate Cancer](https://healthmonix.com/mips_quality_measure/2022-measure-104-prostate-cancer-combination-androgen-deprivation-therapy-for-high-risk-or-very-high-risk-prostate-cancer/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients, regardless of age, with a diagnosis of prostate cancer at high or very high risk of recurrence receiving external beam radiotherapy to the prostate who were prescribed androgen deprivation therapy in combination with external beam radiotherapy to the prostate
- [2022 Measure #  102 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients](https://healthmonix.com/mips_quality_measure/2022-measure-102-prostate-cancer-avoidance-of-overuse-of-bone-scan-for-staging-low-risk-prostate-cancer-patients/) - Measure Type High Priority Measure? Collection Type(s) Process yes eCQM, MIPS CQM Measure Description Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan
- [2022 Measure #  093 Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy – Avoidance of Inappropriate Use](https://healthmonix.com/mips_quality_measure/2022-measure-093-acute-otitis-externa-aoe-systemic-antimicrobial-therapy-avoidance-of-inappropriate-use/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged 2 years and older with a diagnosis of AOE who were not prescribed systemic antimicrobial therapy Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free
- [2022 Measure #  076 Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections](https://healthmonix.com/mips_quality_measure/2022-measure-076-prevention-of-central-venous-catheter-cvc-related-bloodstream-infections/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients, regardless of age, who undergo central venous catheter (CVC) insertion for whom CVC was inserted with all elements of maximal sterile barrier technique, hand hygiene, skin preparation and, if ultrasound is used, sterile ultrasound techniques
- [2022 Measure #  066 Appropriate Testing for Pharyngitis](https://healthmonix.com/mips_quality_measure/2022-measure-066-appropriate-testing-for-pharyngitis/) - Measure Type High Priority Measure? Collection Type(s) Process yes eCQM, MIPS CQM Measure Description The percentage of episodes for patients 3 years and older with a diagnosis of pharyngitis that resulted in an antibiotic dispensing event and a group A streptococcus (strep) test Stay up to date with the latest news regarding MACRA and MIPS.
- [2022 Measure #  065 Appropriate Treatment for Upper Respiratory Infection (URI)](https://healthmonix.com/mips_quality_measure/2022-measure-065-appropriate-treatment-for-upper-respiratory-infection-uri/) - Measure Type High Priority Measure? Collection Type(s) Process yes eCQM, MIPS CQM Measure Description Percentage of episodes for patients 3 months of age and older with a diagnosis of upper respiratory infection (URI) that did not result in an antibiotic dispensing event Stay up to date with the latest news regarding MACRA and MIPS. The
- [2022 Measure #  052 Chronic Obstructive Pulmonary Disease (COPD) Long-Acting Inhaled Bronchodilator Therapy](https://healthmonix.com/mips_quality_measure/2022-measure-052-chronic-obstructive-pulmonary-disease-copd-long-acting-inhaled-bronchodilator-therapy/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of COPD (FEV1/FVC < 70%) and who have an FEV1 less than 60% predicted and have symptoms who were prescribed an long-acting inhaled bronchodilator Stay up to
- [2022 Measure #  477 Multimodal Pain Management](https://healthmonix.com/mips_quality_measure/2022-measure-477-multimodal-pain-management/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQMs SpecificationsMeasure Measure Description Percentage of patients, aged 18 years and older, undergoing selected surgical procedures that were managed with multimodal pain medicine Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source, connecting
- [2022 Measure #  473 Leg Pain After Lumbar Fusion](https://healthmonix.com/mips_quality_measure/2022-measure-473-leg-pain-after-lumbar-fusion/) - Measure Type High Priority Measure? Collection Type(s) Patient Reported Outcome yes MIPS CQM Measure Description For patients 18 years of age or older who had a lumbar fusion procedure, leg pain is rated by the patient as less than or equal to 3.0 OR an improvement of 5.0 points or greater on the Visual Analog
- [2022 Measure #  470 Functional Status After Primary Total Knee Replacement](https://healthmonix.com/mips_quality_measure/2022-measure-470-functional-status-after-primary-total-knee-replacement/) - Measure Type High Priority Measure? Collection Type(s) Patient Reported Outcome yes MIPS CQM Measure Description For patients age 18 and older who had a primary total knee replacement procedure, functional status is rated by the patient as greater than or equal to 37 on the Oxford Knee Score (OKS) or a 71 or greater on
- [2022 Measure #  469 Functional Status After Lumbar Fusion](https://healthmonix.com/mips_quality_measure/2022-measure-469-functional-status-after-lumbar-fusion/) - Measure Type High Priority Measure? Collection Type(s) Patient Reported Outcome yes MIPS CQM Measure Description For patients 18 years of age and older who had a lumbar fusion procedure, functional status is rated by the patient as less than or equal to 22 OR an improvement of 30 points or greater on the Oswestry Disability
- [2022 Measure #  468 Continuity of Pharmacotherapy for Opioid Use Disorder (OUD)](https://healthmonix.com/mips_quality_measure/2022-measure-468-continuity-of-pharmacotherapy-for-opioid-use-disorder-oud/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of adults aged 18 years and older with pharmacotherapy for opioid use disorder (OUD) who have at least 180 days of continuous treatment Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free
- [2022 Measure #  465 Uterine Artery Embolization Technique: Documentation of Angiographic Endpoints and Interrogation of Ovarian Arteries](https://healthmonix.com/mips_quality_measure/2022-measure-465-uterine-artery-embolization-technique-documentation-of-angiographic-endpoints-and-interrogation-of-ovarian-arteries/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description The percentage of patients with documentation of angiographic endpoints of embolization AND the documentation of embolization strategies in the presence of unilateral or bilateral absent uterine arteries Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor
- [2022 Measure #  464 Otitis Media with Effusion: Systemic Antimicrobials](https://healthmonix.com/mips_quality_measure/2022-measure-464-otitis-media-with-effusion-systemic-antimicrobials/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients aged 2 months through 12 years with a diagnosis of OME who were not prescribed systemic antimicrobials Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source, connecting
- [2022 Measure #  463 Prevention of Post-Operative Vomiting (POV) – Combination Therapy (Pediatrics)](https://healthmonix.com/mips_quality_measure/2022-measure-463-prevention-of-post-operative-vomiting-pov-combination-therapy-pediatrics/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients aged 3 through 17 years, who undergo a procedure under general anesthesia in which an inhalational anesthetic is used for maintenance AND who have two or more risk factors for post-operative vomiting (POV), who receive combination therapy consisting of
- [2022 Measure #  461 Leg Pain After Lumbar Discectomy/ Laminotomy](https://healthmonix.com/mips_quality_measure/2022-measure-461-leg-pain-after-lumbar-discectomy-laminotomy/) - Measure Type High Priority Measure? Collection Type(s) Patient Reported Outcome yes MIPS CQM Measure Description For patients 18 years of age or older who had a lumbar discectomy/laminectomy procedure, leg pain is rated by the patients as less than or equal to 3.0 OR an improvement of 5.0 points or greater on the Visual Analog
- [2022 Measure #  460 Back Pain After Lumbar Fusion](https://healthmonix.com/mips_quality_measure/2022-measure-460-back-pain-after-lumbar-fusion/) - Measure Type High Priority Measure? Collection Type(s) Patient Reported Outcome yes MIPS CQM Measure Description For patients 18 years of age or older who had a lumbar fusion procedure, back pain is rated by the patient as less than or equal to 3.0 OR an improvement of 5.0 points or greater on the Visual Analog
- [2022 Measure #  459 Back Pain After Lumbar Discectomy/Laminotomy](https://healthmonix.com/mips_quality_measure/2022-measure-459-back-pain-after-lumbar-discectomy-laminotomy/) - Measure Type High Priority Measure? Collection Type(s) Patient Reported Outcome yes MIPS CQM Measure Description For patients 18 years of age or older who had a lumbar discectomy/laminectomy procedure, back pain is rated by the patients as less than or equal to 3.0 OR an improvement of 5.0 points or greater on the Visual Analog
- [2022 Measure #  455 Percentage of Patients Who Died from Cancer Admitted to the Intensive Care Unit (ICU) in the Last 30 Days of Life (lower score – better)](https://healthmonix.com/mips_quality_measure/2022-measure-455-percentage-of-patients-who-died-from-cancer-admitted-to-the-intensive-care-unit-icu-in-the-last-30-days-of-life-lower-score-better/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percentage of patients who died from cancer admitted to the ICU in the last 30 days of life. Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source, connecting you to
- [2022 Measure #  448 Appropriate Workup Prior to Endometrial Ablation](https://healthmonix.com/mips_quality_measure/2022-measure-448-appropriate-workup-prior-to-endometrial-ablation/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients, aged 18 years and older, who undergo endometrial sampling or hysteroscopy with biopsy and results are documented before undergoing an endometrial ablation. Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a
- [2022 Measure #  445 Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)](https://healthmonix.com/mips_quality_measure/2022-measure-445-risk-adjusted-operative-mortality-for-coronary-artery-bypass-graft-cabg/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percent of patients aged 18 years and older undergoing isolated CABG who die, including both all deaths occurring during the hospitalization in which the CABG was performed, even if after 30 days, and those deaths occurring after discharge from the hospital, but
- [2022 Measure #  443 Non-Recommended Cervical Cancer Screening in Adolescent Females](https://healthmonix.com/mips_quality_measure/2022-measure-443-non-recommended-cervical-cancer-screening-in-adolescent-females/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description The percentage of adolescent females 16–20 years of age who were screened unnecessarily for cervical cancer Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source, connecting you to the latest
- [2022 Measure #  441 Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)](https://healthmonix.com/mips_quality_measure/2022-measure-441-ischemic-vascular-disease-ivd-all-or-none-outcome-measure-optimal-control/) - Measure Type High Priority Measure? Collection Type(s) Intermediate Outcome yes MIPS CQM Measure Description The IVD All-or-None Measure is one outcome measure (optimal control). The measure contains four goals. All four goals within a measure must be reached in order to meet that measure. The numerator for the all-or-none measure should be collected from the
- [2022 Measure #  439 Age Appropriate Screening Colonoscopy](https://healthmonix.com/mips_quality_measure/2022-measure-439-age-appropriate-screening-colonoscopy/) - Measure Type High Priority Measure? Collection Type(s) Efficiency yes MIPS CQM Measure Description The percentage of screening colonoscopies performed in patients greater than or equal to 86 years of age from January 1 to December 31 Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly
- [2022 Measure #  438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease](https://healthmonix.com/mips_quality_measure/2022-measure-438-statin-therapy-for-the-prevention-and-treatment-of-cardiovascular-disease/) - Measure Type High Priority Measure? Collection Type(s) Process no , eCQM, CMS Web Interface, MIPS CQM Measure Description Percentage of the following patients - all considered at high risk of cardiovascular events - who were prescribed or were on statin therapy during the measurement period:•All patients who were previously diagnosed with or currently have an
- [2022 Measure #  436 Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques](https://healthmonix.com/mips_quality_measure/2022-measure-436-radiation-consideration-for-adult-ct-utilization-of-dose-lowering-techniques/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, MIPS CQM Measure Description Percentage of final reports for patients aged 18 years and older undergoing CT with documentation that one or more of the following dose reduction techniques were used: Automated exposure control Adjustment of the mA and/or kV according to
- [2022 Measure #  433 Proportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse Repair](https://healthmonix.com/mips_quality_measure/2022-measure-433-proportion-of-patients-sustaining-a-bowel-injury-at-the-time-of-any-pelvic-organ-prolapse-repair/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percentage of patients undergoing surgical repair of pelvic organ prolapse that is complicated by a bowel injury at the time of index surgery that is recognized intraoperatively or within 30 days after surgery Stay up to date with the latest news regarding
- [2022 Measure #  432 Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair](https://healthmonix.com/mips_quality_measure/2022-measure-432-proportion-of-patients-sustaining-a-bladder-injury-at-the-time-of-any-pelvic-organ-prolapse-repair/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percentage of patients undergoing pelvic organ prolapse repairs who sustain an injury to the bladder recognized either during or within 30 days after surgery Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free
- [2022 Measure #  431 Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling](https://healthmonix.com/mips_quality_measure/2022-measure-431-preventive-care-and-screening-unhealthy-alcohol-use-screening-brief-counseling/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 12 months AND who received brief counseling if identified as an unhealthy alcohol user Stay up
- [2022 Measure #  430 Prevention of Post-Operative Nausea and Vomiting (PONV) – Combination Therapy](https://healthmonix.com/mips_quality_measure/2022-measure-430-prevention-of-post-operative-nausea-and-vomiting-ponv-combination-therapy/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients, aged 18 years and older, who undergo a procedure under an inhalational general anesthetic, AND who have three or more risk factors for post-operative nausea and vomiting (PONV), who receive combination therapy consisting of at least two prophylactic pharmacologic
- [2022 Measure #  425 Photodocumentation of Cecal Intubation](https://healthmonix.com/mips_quality_measure/2022-measure-425-photodocumentation-of-cecal-intubation/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, MIPS CQM Measure Description The rate of screening and surveillance colonoscopies for which photodocumentation of at least two landmarks of cecal intubation is performed to establish a complete examination Stay up to date with the latest news regarding MACRA and MIPS. The
- [2022 Measure #  424 Perioperative Temperature Management](https://healthmonix.com/mips_quality_measure/2022-measure-424-perioperative-temperature-management/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percentage of patients, regardless of age, who undergo surgical or therapeutic procedures under general or neuraxial anesthesia of 60 minutes duration or longer for whom at least one body temperature greater than or equal to 35.5 degrees Celsius (or 95.9 degrees Fahrenheit)
- [2022 Measure #  047 Advance Care Plan](https://healthmonix.com/mips_quality_measure/2022-measure-047-advance-care-plan/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record or documentation in the medical record that an advance care plan was discussed but the
- [2022 Measure #  422 Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury](https://healthmonix.com/mips_quality_measure/2022-measure-422-performing-cystoscopy-at-the-time-of-hysterectomy-for-pelvic-organ-prolapse-to-detect-lower-urinary-tract-injury/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients who undergo cystoscopy to evaluate for lower urinary tract injury at the time of hysterectomy for pelvic organ prolapse Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is
- [2022 Measure #  421 Appropriate Assessment of Retrievable Inferior Vena Cava Filters for Removal](https://healthmonix.com/mips_quality_measure/2022-measure-421-appropriate-assessment-of-retrievable-inferior-vena-cava-filters-for-removal/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients in whom a retrievable IVC filter is placed who, within 3 months post-placement, have a documented assessment for the appropriateness of continued filtration, device removal or the inability to contact the patient with at least two attempts Stay up
- [2022 Measure #  420 Varicose Vein Treatment with Saphenous Ablation: Outcome Survey](https://healthmonix.com/mips_quality_measure/2022-measure-420-varicose-vein-treatment-with-saphenous-ablation-outcome-survey/) - Measure Type High Priority Measure? Collection Type(s) Patient Reported Outcome yes MIPS CQM Measure Description Percentage of patients treated for varicose veins (CEAP C2-S) who are treated with saphenous ablation (with or without adjunctive tributary treatment) that report an improvement on a disease specific patient reported outcome survey instrument after treatment Stay up to date
- [2022 Measure #  419 Overuse of Imaging for the Evaluation of Primary Headache](https://healthmonix.com/mips_quality_measure/2022-measure-419-overuse-of-imaging-for-the-evaluation-of-primary-headache/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients for whom imaging of the head (CT or MRI) is obtained for the evaluation of primary headache when clinical indications are not present Stay up to date with the latest news regarding MACRA and MIPS.
- [2022 Measure #  418 Osteoporosis Management in Women Who Had a Fracture](https://healthmonix.com/mips_quality_measure/2022-measure-418-osteoporosis-management-in-women-who-had-a-fracture/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, MIPS CQM Measure Description The percentage of women age 50-85 who suffered a fracture in the six months prior to the performance period through June 30 of the performance period and who either had a bone mineral density test or received a
- [2022 Measure #  416 Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 through 17 Years](https://healthmonix.com/mips_quality_measure/2022-measure-416-emergency-medicine-emergency-department-utilization-of-ct-for-minor-blunt-head-trauma-for-patients-aged-2-through-17-years/) - Measure Type High Priority Measure? Collection Type(s) Efficiency yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of emergency department visits for patients aged 2 through 17 years who presented with a minor blunt head trauma who had a head CT for trauma ordered by an emergency care provider who are classified as low
- [2022 Measure #  415 Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older](https://healthmonix.com/mips_quality_measure/2022-measure-415-emergency-medicine-emergency-department-utilization-of-ct-for-minor-blunt-head-trauma-for-patients-aged-18-years-and-older/) - Measure Type High Priority Measure? Collection Type(s) Efficiency yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of emergency department visits for patients aged 18 years and older who presented with a minor blunt head trauma who had a head CT for trauma ordered by an emergency care clinician who have an indication for
- [2022 Measure #  413 Door to Puncture Time for Endovascular Stroke Treatment](https://healthmonix.com/mips_quality_measure/2022-measure-413-door-to-puncture-time-for-endovascular-stroke-treatment/) - Measure Type High Priority Measure? Collection Type(s) Intermediate Outcome yes MIPS CQM Measure Description Percentage of patients undergoing endovascular stroke treatment who have a door to puncture time of 90 minutes or less. Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source, connecting
- [2022 Measure #  410 Psoriasis: Clinical Response to Systemic Medications](https://healthmonix.com/mips_quality_measure/2022-measure-410-psoriasis-clinical-response-to-systemic-medications/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of psoriasis vulgaris patients receiving systemic medication who meet minimal physician-or patient-reported disease activity levels. It is implied that establishment and maintenance of an established minimum level of disease control as measured by physician-and/or patient-reported outcomes will
- [2022 Measure #  409 Clinical Outcome Post-Endovascular Stroke Treatment](https://healthmonix.com/mips_quality_measure/2022-measure-409-clinical-outcome-post-endovascular-stroke-treatment/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percentage of patients with a Modified Rankin Score (mRS) score of 0 to 2 at 90 days following endovascular stroke intervention. Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source,
- [2022 Measure #  406 Appropriate Follow-Up Imaging for Incidental Thyroid Nodules in Patients](https://healthmonix.com/mips_quality_measure/2022-measure-406-appropriate-follow-up-imaging-for-incidental-thyroid-nodules-in-patients/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of final reports for computed tomography (CT), CT angiography (CTA) or magnetic resonance imaging (MRI) or magnetic resonance angiogram (MRA) studies of the chest or neck for patients aged 18 years and older with no known thyroid
- [2022 Measure #  405 Appropriate Follow-up Imaging for Incidental Abdominal  Lesions](https://healthmonix.com/mips_quality_measure/2022-measure-405-appropriate-follow-up-imaging-for-incidental-abdominal-lesions/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of final reports for imaging studies for patients aged 18 years and older with one or more of the following noted incidentally with a specific recommendation for no follow‐up imaging recommended based on radiological findings:• Cystic renal
- [2022 Measure #  404 Anesthesiology Smoking Abstinence](https://healthmonix.com/mips_quality_measure/2022-measure-404-anesthesiology-smoking-abstinence/) - Measure Type High Priority Measure? Collection Type(s) Intermediate Outcome yes MIPS CQM Measure Description The percentage of current smokers who abstain from cigarettes prior to anesthesia on the day of elective surgery or procedure Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source,
- [2022 Measure #  402 Tobacco Use and Help with Quitting Among Adolescents](https://healthmonix.com/mips_quality_measure/2022-measure-402-tobacco-use-and-help-with-quitting-among-adolescents/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description The percentage of adolescents 12 to 20 years of age with a primary care visit during the measurement year for whom tobacco use status was documented and received help with quitting if identified as a tobacco user Stay up to date with
- [2022 Measure #  401 Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis](https://healthmonix.com/mips_quality_measure/2022-measure-401-hepatitis-c-screening-for-hepatocellular-carcinoma-hcc-in-patients-with-cirrhosis/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis who underwent imaging with either ultrasound, contrast enhanced CT or MRI for hepatocellular carcinoma (HCC) at least once within the 12-month submission period Stay up to
- [2022 Measure #  400 One-Time Screening for Hepatitis C Virus (HCV) for all Patients](https://healthmonix.com/mips_quality_measure/2022-measure-400-one-time-screening-for-hepatitis-c-virus-hcv-for-all-patients/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older with one or more of the following: a history of injection drug use, receipt of a blood transfusion prior to 1992, receiving maintenance hemodialysis, OR birthdate in the years 1945-1965 who received one-time screening
- [2022 Measure #  398 Optimal Asthma Control](https://healthmonix.com/mips_quality_measure/2022-measure-398-optimal-asthma-control/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Composite measure of the percentage of pediatric and adult patients whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools and not at risk for exacerbation Stay up to date with the latest news regarding MACRA
- [2022 Measure #  397 Melanoma Reporting](https://healthmonix.com/mips_quality_measure/2022-measure-397-melanoma-reporting/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Pathology reports for primary malignant cutaneous melanoma that include the pT category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors. Stay up to date with the latest
- [2022 Measure #  396 Lung Cancer Reporting (Resection Specimens)](https://healthmonix.com/mips_quality_measure/2022-measure-396-lung-cancer-reporting-resection-specimens/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Pathology reports based on lung resection specimens with a diagnosis of primary lung carcinoma that include the pT category, pN category and for non-small cell lung cancer (NSCLC), histologic type. Stay up to date with the latest news
- [2022 Measure #  395 Lung Cancer Reporting (Biopsy/Cytology Specimens)](https://healthmonix.com/mips_quality_measure/2022-measure-395-lung-cancer-reporting-biopsy-cytology-specimens/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Pathology reports based on lung biopsy and/or cytology specimens with a diagnosis of primary non-small cell lung cancer classified into specific histologic type following the International Association for the Study of Lung Cancer (IASLC) guidance or classified as
- [2022 Measure #  394 Immunizations for Adolescents](https://healthmonix.com/mips_quality_measure/2022-measure-394-immunizations-for-adolescents/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description The percentage of adolescents 13 years of age who had one dose of meningococcal vaccine (serogroups A, C, W, Y), one tetanus, diphtheria toxoids and acellular pertussis (Tdap) vaccine, and have completed the human papillomavirus (HPV) vaccine series by their 13th birthday.
- [2022 Measure #  393 HRS-9: Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision](https://healthmonix.com/mips_quality_measure/2022-measure-393-hrs-9-infection-within-180-days-of-cardiac-implantable-electronic-device-cied-implantation-replacement-or-revision/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Infection rate following CIED device implantation, replacement, or revision Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source, connecting you to the latest updates in the value-based care industry. Instructions
- [2022 Measure #  392 HRS-12: Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation Ablation](https://healthmonix.com/mips_quality_measure/2022-measure-392-hrs-12-cardiac-tamponade-and-or-pericardiocentesis-following-atrial-fibrillation-ablation/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Rate of cardiac tamponade and/or pericardiocentesis following atrial fibrillation ablation. This measure is submitted as four rates stratified by age and gender: Submission Age Criteria 1: Females 18-64 years of age Submission Age Criteria 2: Males 18-64 years of age Submission Age
- [2022 Measure #  391 Follow-up After Hospitalization for Mental Illness (FUH)](https://healthmonix.com/mips_quality_measure/2022-measure-391-follow-up-after-hospitalization-for-mental-illness-fuh/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description The percentage of discharges for patients 6 years of age and older who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and who had a follow-up visit with a mental health provider. Two rates are submitted: The percentage
- [2022 Measure #  389 Cataract Surgery: Difference Between Planned and Final Refraction](https://healthmonix.com/mips_quality_measure/2022-measure-389-cataract-surgery-difference-between-planned-and-final-refraction/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percentage of patients aged 18 years and older who had cataract surgery performed and who achieved a final refraction within +/- 1.0 diopters of their planned (target) refraction Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix
- [2022 Measure #  387 Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users](https://healthmonix.com/mips_quality_measure/2022-measure-387-annual-hepatitis-c-virus-hcv-screening-for-patients-who-are-active-injection-drug-users/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients, regardless of age, who are active injection drug users who received screening for HCV infection within the 12-month reporting period Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly
- [2022 Measure #  386 Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences](https://healthmonix.com/mips_quality_measure/2022-measure-386-amyotrophic-lateral-sclerosis-als-patient-care-preferences/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients diagnosed with Amyotrophic Lateral Sclerosis (ALS) who were offered assistance in planning for end of life issues (e.g., advance directives, invasive ventilation, hospice) at least once annually Stay up to date with the latest news regarding MACRA and MIPS.
- [2022 Measure #  385 Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement Within 90 Days of Surgery](https://healthmonix.com/mips_quality_measure/2022-measure-385-adult-primary-rhegmatogenous-retinal-detachment-surgery-visual-acuity-improvement-within-90-days-of-surgery/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Patients aged 18 years and older who had surgery for primary rhegmatogenous retinal detachment and achieved an improvement in their visual acuity, from their preoperative level, within 90 days of surgery in the operative eye Stay up to date with the latest
- [2021 MIPS Measure #385: Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement Within 90 Days of Surgery](https://healthmonix.com/mips_quality_measure/2021-mips-measure-385-adult-primary-rhegmatogenous-retinal-detachment-surgery-visual-acuity-improvement-within-90-days-of-surgery/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Patients aged 18 years and older who had surgery for primary rhegmatogenous retinal detachment and achieved an improvement in their visual acuity, from their preoperative level, within 90 days of surgery in the operative eye Instructions This measure is to be
- [2022 Measure #  384 Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room Within 90 Days of Surgery](https://healthmonix.com/mips_quality_measure/2022-measure-384-adult-primary-rhegmatogenous-retinal-detachment-surgery-no-return-to-the-operating-room-within-90-days-of-surgery/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Patients aged 18 years and older who had surgery for primary rhegmatogenous retinal detachment who did not require a return to the operating room within 90 days of surgery Stay up to date with the latest news regarding MACRA and MIPS. The
- [2022 Measure #  383 Adherence to Antipsychotic Medications for Individuals with Schizophrenia](https://healthmonix.com/mips_quality_measure/2022-measure-383-adherence-to-antipsychotic-medications-for-individuals-with-schizophrenia/) - Measure Type High Priority Measure? Collection Type(s) Intermediate Outcome yes MIPS CQM Measure Description Percentage of individuals at least 18 years of age as of the beginning of the performance period with schizophrenia or schizoaffective disorder who had at least two prescriptions filled for any antipsychotic medication and who had a Proportion of Days Covered
- [2022 Measure #  374 Closing the Referral Loop: Receipt of Specialist Report](https://healthmonix.com/mips_quality_measure/2022-measure-374-closing-the-referral-loop-receipt-of-specialist-report/) - Measure Type High Priority Measure? Collection Type(s) Process yes eCQM, MIPS CQM Measure Description Percentage of patients with referrals, regardless of age, for which the referring provider receives a report from the provider to whom the patient was referred Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is
- [2022 Measure #  370 Depression Remission at Twelve Months](https://healthmonix.com/mips_quality_measure/2022-measure-370-depression-remission-at-twelve-months/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes eCQM, CMS Web Interface, MIPS CQM Measure Description The percentage of adolescent patients 12 to 17 years of age and adult patients 18 years of age or older with major depression or dysthymia who reached remission 12 months (+/- 60 days) after an index event date.
- [2022 Measure #  048 Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older](https://healthmonix.com/mips_quality_measure/2022-measure-048-urinary-incontinence-assessment-of-presence-or-absence-of-urinary-incontinence-in-women-aged-65-years-and-older/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, MIPS CQM Measure Description Percentage of female patients aged 65 years and older who were assessed for the presence or absence of urinary incontinence within 12 months Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor
- [2022 Measure #  364 Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended Guidelines](https://healthmonix.com/mips_quality_measure/2022-measure-364-optimizing-patient-exposure-to-ionizing-radiation-appropriateness-follow-up-ct-imaging-for-incidentally-detected-pulmonary-nodules-according-to-recommended-guidelines/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of final reports for CT imaging studies with a finding of an incidental pulmonary nodule for patients aged 35 years and older that contain an impression or conclusion that includes a recommended interval and modality for follow-up (e.g., type of imaging
- [2022 Measure #  360 Optimizing Patient Exposure to Ionizing Radiation: Count of Potential High Dose Radiation Imaging Studies: Computed Tomography (CT) and Cardiac Nuclear Medicine Studies](https://healthmonix.com/mips_quality_measure/2022-measure-360-optimizing-patient-exposure-to-ionizing-radiation-count-of-potential-high-dose-radiation-imaging-studies-computed-tomography-ct-and-cardiac-nuclear-medicine-studies/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of computed tomography (CT) and cardiac nuclear medicine (myocardial perfusion studies) imaging reports for all patients, regardless of age, that document a count of known previous CT (any type of CT) and cardiac nuclear medicine (myocardial perfusion) studies that the patient
- [2022 Measure #  039 Screening for Osteoporosis for Women Aged 65-85 Years of Age](https://healthmonix.com/mips_quality_measure/2022-measure-039-screening-for-osteoporosis-for-women-aged-65-85-years-of-age/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, MIPS CQM Measure Description Percentage of female patients aged 65-85 years of age who ever had a central dual-energy X-ray absorptiometry (DXA) to check for osteoporosis Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is
- [2022 Measure #  358 Patient-Centered Surgical Risk Assessment and Communication](https://healthmonix.com/mips_quality_measure/2022-measure-358-patient-centered-surgical-risk-assessment-and-communication/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients who underwent a non-emergency surgery who had their personalized risks of postoperative complications assessed by their surgical team prior to surgery using a clinical data-based, patient-specific risk calculator and who received personal discussion of those risks with the surgeon
- [2022 Measure #  357 Surgical Site Infection (SSI)](https://healthmonix.com/mips_quality_measure/2022-measure-357-surgical-site-infection-ssi/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percentage of patients aged 18 years and older who had a surgical site infection (SSI) Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source, connecting you to the latest updates
- [2022 Measure #  356 Unplanned Hospital Readmission within 30 Days of Principal Procedure](https://healthmonix.com/mips_quality_measure/2022-measure-356-unplanned-hospital-readmission-within-30-days-of-principal-procedure/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percentage of patients aged 18 years and older who had an unplanned hospital readmission within 30 days of principal procedure Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source, connecting
- [2022 Measure #  355 Unplanned Reoperation within the 30 Day Postoperative Period](https://healthmonix.com/mips_quality_measure/2022-measure-355-unplanned-reoperation-within-the-30-day-postoperative-period/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percentage of patients aged 18 years and older who had any unplanned reoperation within the 30 day postoperative period Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source, connecting you
- [2022 Measure #  354 Anastomotic Leak Intervention](https://healthmonix.com/mips_quality_measure/2022-measure-354-anastomotic-leak-intervention/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percentage of patients aged 18 years and older who required an anastomotic leak intervention following gastric bypass or colectomy surgery Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source, connecting
- [2022 Measure #  351 Total Knee or Hip Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation](https://healthmonix.com/mips_quality_measure/2022-measure-351-total-knee-or-hip-replacement-venous-thromboembolic-and-cardiovascular-risk-evaluation/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients regardless of age undergoing a total knee or total hip replacement who are evaluated for the presence or absence of venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., History of Deep Vein Thrombosis
- [2022 Measure #  350 Total Knee or Hip Replacement: Shared Decision-Making: Trial of Conservative (Non-surgical) Therapy](https://healthmonix.com/mips_quality_measure/2022-measure-350-total-knee-or-hip-replacement-shared-decision-making-trial-of-conservative-non-surgical-therapy/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients regardless of age undergoing a total knee or total hip replacement with documented shared decision- making with discussion of conservative (non-surgical) therapy (e.g., non-steroidal anti-inflammatory drug (NSAIDs), analgesics, weight loss, exercise, injections) prior to the procedure. Stay up to
- [2022 Measure #  344 Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2)](https://healthmonix.com/mips_quality_measure/2022-measure-344-rate-of-carotid-artery-stenting-cas-for-asymptomatic-patients-without-major-complications-discharged-to-home-by-post-operative-day-2/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percent of asymptomatic patients undergoing CAS who are discharged to home no later than post-operative day #2 Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free weekly news source, connecting you to the
- [2022 Measure #  340 HIV Medical Visit Frequency](https://healthmonix.com/mips_quality_measure/2022-measure-340-hiv-medical-visit-frequency/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients, regardless of age with a diagnosis of HIV who had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits Stay up to date
- [2022 Measure #  024 Communication with the Physician or Other Clinician Managing On-going Care Post-Fracture for Men and Women Aged 50 Years and Older](https://healthmonix.com/mips_quality_measure/2022-measure-024-communication-with-the-physician-or-other-clinician-managing-on-going-care-post-fracture-for-men-and-women-aged-50-years-and-older/)
- [2022 Measure #  338 HIV Viral Load Suppression](https://healthmonix.com/mips_quality_measure/2022-measure-338-hiv-viral-load-suppression/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description The percentage of patients, regardless of age, with a diagnosis of HIV with a HIV viral load less than 200 copies/mL at last HIV viral load test during the measurement year Stay up to date with the latest news regarding MACRA and
- [2022 Measure #  336 Maternity Care: Postpartum Follow-Up and Care Coordination](https://healthmonix.com/mips_quality_measure/2022-measure-336-maternity-care-postpartum-follow-up-and-care-coordination/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients, regardless of age, who gave birth during a 12-month period who were seen for postpartum care before or at 12 weeks of giving birth and received the following at a postpartum visit: breast-feeding evaluation and education, postpartum depression screening,
- [2022 Measure #  335 Maternity Care: Elective Delivery (Without Medical Indication) at < 39 Weeks (Overuse)](https://healthmonix.com/mips_quality_measure/2022-measure-335-maternity-care-elective-delivery-without-medical-indication-at-39-weeks-overuse/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percentage of patients, regardless of age, who gave birth during a 12-month period, delivered a live singleton at < 39 weeks of gestation, and had elective deliveries (without medical indication) by cesarean birth or induction of labor. Stay up to date with
- [2022 Measure #  332 Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use)](https://healthmonix.com/mips_quality_measure/2022-measure-332-adult-sinusitis-appropriate-choice-of-antibiotic-amoxicillin-with-or-without-clavulanate-prescribed-for-patients-with-acute-bacterial-sinusitis-appropriate-use/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of acute bacterial sinusitis that were prescribed amoxicillin, with or without clavulanate, as a first line antibiotic at the time of diagnosis Stay up to date with the latest news regarding
- [2022 Measure #  008 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)](https://healthmonix.com/mips_quality_measure/2022-measure-008-heart-failure-hf-beta-blocker-therapy-for-left-ventricular-systolic-dysfunction-lvsd/) - Measure Type High Priority Measure? Collection Type(s) Process no eCQM, MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed beta-blocker therapy either within a 12 month period when seen in
- [2022 Measure #  007 Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)](https://healthmonix.com/mips_quality_measure/2022-measure-007-coronary-artery-disease-cad-beta-blocker-therapy-prior-myocardial-infarction-mi-or-left-ventricular-systolic-dysfunction-lvef-40/) - Measure Type High Priority Measure? Collection Type(s) Process no eCQM, MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period who also have a prior MI or a current or prior LVEF < 40% who were prescribed beta-blocker therapy. Stay
- [2022 Measure #  331 Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse)](https://healthmonix.com/mips_quality_measure/2022-measure-331-adult-sinusitis-antibiotic-prescribed-for-acute-viral-sinusitis-overuse/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients, aged 18 years and older, with a diagnosis of acute viral sinusitis who were prescribed an antibiotic within 10 days after onset of symptoms Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor
- [2022 Measure #  326 Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy](https://healthmonix.com/mips_quality_measure/2022-measure-326-atrial-fibrillation-and-atrial-flutter-chronic-anticoagulation-therapy/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged 18 years and older with atrial fibrillation (AF) or atrial flutter who were prescribed an FDA-approved oral anticoagulant drug for the prevention of thromboembolism during the measurement period. Stay up to date with the latest
- [2022 Measure #  324 Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk Patients](https://healthmonix.com/mips_quality_measure/2022-measure-324-cardiac-stress-imaging-not-meeting-appropriate-use-criteria-testing-in-asymptomatic-low-risk-patients/) - Measure Type High Priority Measure? Collection Type(s) Efficiency yes MIPS CQM Measure Description Percentage of all stress single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), stress echocardiogram (ECHO), cardiac computed tomography angiography (CCTA), and cardiovascular magnetic resonance (CMR) performed in asymptomatic, low coronary heart disease (CHD) risk patients 18 years and older for initial
- [2022 Measure #  323 Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI)](https://healthmonix.com/mips_quality_measure/2022-measure-323-cardiac-stress-imaging-not-meeting-appropriate-use-criteria-routine-testing-after-percutaneous-coronary-intervention-pci/) - Measure Type High Priority Measure? Collection Type(s) Efficiency yes MIPS CQM Measure Description Percentage of all stress single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), stress echocardiogram (ECHO), cardiac computed tomography angiography (CCTA), and cardiovascular magnetic resonance (CMR) performed in patients aged 18 years and older routinely after percutaneous coronary intervention (PCI), with reference
- [2022 Measure #  322 Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low-Risk Surgery Patients](https://healthmonix.com/mips_quality_measure/2022-measure-322-cardiac-stress-imaging-not-meeting-appropriate-use-criteria-preoperative-evaluation-in-low-risk-surgery-patients/) - Measure Type High Priority Measure? Collection Type(s) Efficiency yes MIPS CQM Measure Description Percentage of stress single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), stress echocardiogram (ECHO), cardiac computed tomography angiography (CCTA), or cardiac magnetic resonance (CMR) performed in low-risk surgery patients 18 years or older for preoperative evaluation during the 12-month submission period
- [2022 Measure #  320 Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients](https://healthmonix.com/mips_quality_measure/2022-measure-320-appropriate-follow-up-interval-for-normal-colonoscopy-in-average-risk-patients/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged 50 to 75 years of age receiving a screening colonoscopy without biopsy or polypectomy who had a recommended follow-up interval of at least 10 years for repeat colonoscopy documented in their colonoscopy report Stay
- [2022 MIPS Measure #309: Cervical Cancer Screening](https://healthmonix.com/mips_quality_measure/2022-mips-measure-309-cervical-cancer-screening/) - Description Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria: Women age 21-64 who had cervical cytology performed within the last 3 years Women age 30-64 who had cervical human papillomavirus (HPV) testing performed within the last 5 years Initial Population Women 23-64 years of
- [2022 Measure #  006 Coronary Artery Disease (CAD): Antiplatelet Therapy](https://healthmonix.com/mips_quality_measure/2022-measure-006-coronary-artery-disease-cad-antiplatelet-therapy/) - Measure Type High Priority Measure? Collection Type(s) Process no eCQM, MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease (CAD) seen within a 12 month period who were prescribed aspirin or clopidogrel Stay up to date with the latest news regarding MACRA and MIPS. The
- [2022 MIPS Measure #305: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment](https://healthmonix.com/mips_quality_measure/2022-mips-measure-305-initiation-and-engagement-of-alcohol-and-other-drug-dependence-treatment/) - Description Percentage of patients 13 years of age and older with a new episode of alcohol or other drug abuse or (AOD) dependence who received the following. Two rates are reported. a. Percentage of patients who initiated treatment including either an intervention or medication for the treatment of AOD abuse or dependence within 14 days
- [2022 Measure #  293 Rehabilitative Therapy Referral for Patients with Parkinson’s Disease](https://healthmonix.com/mips_quality_measure/2022-measure-293-rehabilitative-therapy-referral-for-patients-with-parkinsons-disease/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of all patients with a diagnosis of Parkinson’s Disease who were referred to physical, occupational, speech, or recreational therapy once during the measurement period. Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a
- [2022 Measure #  291 Parkinson’s Disease: Cognitive Impairment or Dysfunction Assessment for Patients with Parkinson's Disease](https://healthmonix.com/mips_quality_measure/2022-measure-291-parkinsons-disease-cognitive-impairment-or-dysfunction-assessment-for-patients-with-parkinsons-disease/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of all patients with a diagnosis of Parkinson’s Disease [PD] who were assessed for cognitive impairment or dysfunction once during the measurement period. Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a free
- [2022 Measure #  290 Assessment of Mood Disorders and Psychosis for Patients with Parkinson’s Disease](https://healthmonix.com/mips_quality_measure/2022-measure-290-assessment-of-mood-disorders-and-psychosis-for-patients-with-parkinsons-disease/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of all patients with a diagnosis of Parkinson’s Disease [PD] who were assessed for depression, anxiety, apathy, AND psychosis once during the measurement period. Stay up to date with the latest news regarding MACRA and MIPS. The Healthmonix Advisor is a
- [2022 Measure #  217 Functional Status Change for Patients with Knee Impairments](https://healthmonix.com/mips_quality_measure/2022-measure-217-functional-status-change-for-patients-with-knee-impairments/) - Measure Type High Priority Measure? Collection Type(s) Patient Reported Outcome yes MIPS CQM Measure Description A patient-reported outcome measure of risk-adjusted change in functional status for patients aged 14 years+ with knee impairments. The change in functional status (FS) is assessed using the FOTO Lower Extremity Physical Function (LEPF) patient-reported outcome measure (PROM). The measure
- [2022 Measure #  144 Oncology: Medical and Radiation – Plan of Care for Pain](https://healthmonix.com/mips_quality_measure/2022-measure-144-oncology-medical-and-radiation-plan-of-care-for-pain/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of visits for patients, regardless of age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy who report having pain with a documented plan of care to address pain Stay up to date with the latest news regarding MACRA
- [2022 Measure #  440 Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician](https://healthmonix.com/mips_quality_measure/2022-measure-440-skin-cancer-biopsy-reporting-time-pathologist-to-clinician/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of biopsies with a diagnosis of cutaneous Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), or melanoma (including in situ disease) in which the pathologist communicates results to the clinician within 7 days from the time when the tissue specimen
- [2022 Measure #  317 Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented](https://healthmonix.com/mips_quality_measure/2022-measure-317-preventive-care-and-screening-screening-for-high-blood-pressure-and-follow-up-documented/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, eCQM, MIPS CQM Measure Description Percentage of patient visits for patients aged 18 years and older seen during the measurement period who were screened for high blood pressure AND a recommended follow-up plan is documented, as indicated, if blood pressure is elevated
- [2022 Measure #  137 Melanoma: Continuity of Care – Recall System](https://healthmonix.com/mips_quality_measure/2022-measure-137-melanoma-continuity-of-care-recall-system/) - Measure Type High Priority Measure? Collection Type(s) Structure yes MIPS CQM Measure Description Percentage of patients, regardless of age, with a current diagnosis of melanoma or a history of melanoma whose information was entered, at least once within a 12 month period, into a recall system that includes: A target date for the next complete
- [2022 Measure #  014 Age-Related Macular Degeneration (AMD): Dilated Macular Examination](https://healthmonix.com/mips_quality_measure/2022-measure-014-age-related-macular-degeneration-amd-dilated-macular-examination/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged 50 years and older with a diagnosis of age-related macular degeneration (AMD) who had a dilated macular examination performed which included documentation of the presence or absence of macular thickening or geographic atrophy or
- [2022 Measure #  019 Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care](https://healthmonix.com/mips_quality_measure/2022-measure-019-diabetic-retinopathy-communication-with-the-physician-managing-ongoing-diabetes-care/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, eCQM, MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed with documented communication to the physician who manages the ongoing care of the patient
- [2022 Measure #  050 Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older](https://healthmonix.com/mips_quality_measure/2022-measure-050-urinary-incontinence-plan-of-care-for-urinary-incontinence-in-women-aged-65-years-and-older/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of female patients aged 65 years and older with a diagnosis of urinary incontinence with a documented plan of care for urinary incontinence at least once within 12 months Stay up to date with the latest news
- [2021 MIPS Measure #440: Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma (SCC): Biopsy Reporting Time – Pathologist to Clinician](https://healthmonix.com/mips_quality_measure/2021-mips-measure-440-basal-cell-carcinoma-bcc-squamous-cell-carcinoma-scc-biopsy-reporting-time-pathologist-to-clinician/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of biopsies with a diagnosis of cutaneous Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), or melanoma (including in situ disease) in which the pathologist communicates results to the clinician within 7 days from the time when the tissue
- [2021 MIPS Measure #024: Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older](https://healthmonix.com/mips_quality_measure/2021-mips-measure-024-communication-with-the-physician-or-other-clinician-managing-on-going-care-post-fracture-for-men-and-women-aged-50-years-and-older/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CLINICAL QUALITY MEASURES (CQMS) Measure Description Percentage of patients aged 50 years and older treated for a fracture with documentation of communication, between the physician treating the fracture and the physician or other clinician managing the patient’s on-going care, that a fracture occurred and
- [MBHR13 Social Role Functioning Assessment utilizing PROMIS Adult Ability to Participate in Social Roles and Activities](https://healthmonix.com/mips_quality_measure/mbhr13-social-role-functioning-assessment-utilizing-promis-adult-ability-to-participate-in-social-roles-and-activities/) - Measure Title Social Role Functioning Assessment utilizing PROMIS Adult Ability to Participate in Social Roles and Activities Measure Description The percentage of adult patients (18 years of age or older) who report concerns related to their psychosocial function and who have completed a standardized assessment utilizing the PROMIS Adult Ability to Participate in Social Roles
- [MBHR12 Provision of Feedback Following a Cognitive or Mental Status Assessment with Documentation of Understanding of Test Results and Subsequent Healthcare Plan](https://healthmonix.com/mips_quality_measure/mbhr12-provision-of-feedback-following-a-cognitive-or-mental-status-assessment-with-documentation-of-understanding-of-test-results-and-subsequent-healthcare-plan/) - Measure Title: Provision of Feedback Following a Cognitive or Mental Status Assessment with Documentation of Understanding of Test Results and Subsequent Healthcare Plan Measure Description: Percentage of patients, regardless of age, who received a standardized cognitive or mental status assessment followed by provision of feedback regarding test results and associated recommendations, who acknowledged understanding of
- [2022 QCDR Measure: Functional Status Change for Patients with Vestibular Dysfunction](https://healthmonix.com/mips_quality_measure/2022-qcdr-measure-functional-status-change-for-patients-with-vestibular-dysfunction/) - Measure ID HM7 Measure Title Functional Status Change for Patients with Vestibular Dysfunction Measure Description Percentage of patients aged 14 years and older diagnosed with vestibular dysfunction who achieve a Minimal Clinically Important Difference (MCID) to indicate functional, emotional, and physical improvement Submission Age Criteria 1: Patients aged 14-17 years of age Submission Age Criteria
- [MBHR17 Improved Efficiency: Time Interval for reporting results of cognitive assessment](https://healthmonix.com/mips_quality_measure/mbhr17-improved-efficiency-time-interval-for-reporting-results-of-cognitive-assessment/) - Measure Title Improved Efficiency: Time Interval for reporting results of cognitive assessment Measure Description: Percentage of patients, regardless of age, for which the referring provider or patient receives reporting of assessment results within 14 days of the completion of assessment. Denominator Number of patients, regardless of age, who were referred for a cognitive or mental
- [MBHR16 Comprehensive Cognitive Assessment Assists with Differential Diagnosis](https://healthmonix.com/mips_quality_measure/mbhr16-comprehensive-cognitive-assessment-assists-with-differential-diagnosis/) - Measure Title Comprehensive Cognitive Assessment Assists with Differential Diagnosis Measure Description Percentage of patients, regardless of age, referred for evaluation due to concerns for cognitive impairment for whom 1) a standardized valid assessment of cognition was performed and 2) results of assessment informed determination of diagnosis or further clarified etiological factors of cognitive impairment or
- [MBHR15 Consideration of Cultural-Linguistic and Demographic Factors in Cognitive Assessment](https://healthmonix.com/mips_quality_measure/mbhr15-consideration-of-cultural-linguistic-and-demographic-factors-in-cognitive-assessment/) - Measure Title Consideration of Cultural-Linguistic and Demographic Factors in Cognitive Assessment. Measure Description Percentage of patients, regardless of age, referred for evaluation due to concerns for cognitive changes or difficulties for whom 1) a standardized valid assessment of cognition was performed and 2) interpretation of results included consideration of appropriate and relevant cultural-linguistic and demographic
- [MBHR14 Sleep Quality Response at 3-months](https://healthmonix.com/mips_quality_measure/mbhr14-sleep-quality-response-at-3-months/) - Measure TitleSleep Quality Response at 3-months Measure DescriptionPercentage of patients 18 years and older who reported sleep quality concerns (e.g., insomnia) with documentation of a standardized tool AND demonstrated a response to treatment at three months (+/- 60 days) after index visit. Denominator DENOMINATOR: Patients aged >= 18 years of age ANDPatient Encounter CPT codes:0362T,
- [HCPR16 Physician’s Orders for Life-Sustaining Treatment (POLST) Form](https://healthmonix.com/mips_quality_measure/hcpr16-physicians-orders-for-life-sustaining-treatment-polst-form/) - Measure ID HCPR16 Measure Title Physician’s Orders for Life-Sustaining Treatment (POLST) Form Measure Description Percentage of Patients Greater Than or Equal to 65 Years of Age with Physician’s Orders for Life-Sustaining Treatment (POLST) Forms Completed Denominator Adult patients greater than or equal to 65 years of age evaluated by the Eligible Professional Numerator Patients with
- [HCPR17 Pressure Ulcers – Risk Assessment and Plan of Care](https://healthmonix.com/mips_quality_measure/hcpr17-pressure-ulcers-risk-assessment-and-plan-of-care/) - Measure ID HCPR17 Measure Title Pressure Ulcers – Risk Assessment and Plan of Care Measure Description Percentage of Adult Post-acute Facility Patients That Had a Risk Assessment for Pressure Ulcers and a Plan of Care for Pressure Ulcer Prevention/Treatment Completed Denominator Adult patients greater than or equal to 18 years of age evaluated by the
- [HCPR18 Unintentional Weight Loss – Risk Assessment and Plan of Care](https://healthmonix.com/mips_quality_measure/hcpr18-unintentional-weight-loss-risk-assessment-and-plan-of-care/) - Measure ID HCPR18 Measure Title Unintentional Weight Loss – Risk Assessment and Plan of Care Measure Description Percentage of Adult Post-acute Facility Patients that Had a Risk Assessment for Unintentional Weight Loss and a Plan of Care for Unintentional Weight Loss Documented by Provider Denominator Adult patients greater than or equal to 18 years evaluated
- [HCPR23 Avoidance of Echocardiogram and Carotid Ultrasound for Syncope](https://healthmonix.com/mips_quality_measure/hcpr23-avoidance-of-echocardiogram-and-carotid-ultrasound-for-syncope/) - Measure ID HCPR23 Measure Title Avoidance of Echocardiogram and Carotid Ultrasound for Syncope Measure Description Percentage of Patients Presenting with Syncope Who Did Not Have an Echocardiogram or Carotid Ultrasound Ordered Denominator Any patient greater than or equal to 18 years of age evaluated by the Eligible Professional PLUS, Admitted or Placed in Observation Status
- [HCPR24 Appropriate Utilization of Vancomycin for Cellulitis](https://healthmonix.com/mips_quality_measure/hcpr24-appropriate-utilization-of-vancomycin-for-cellulitis/) - Measure ID HCPR24 Measure Title Appropriate Utilization of Vancomycin for Cellulitis Measure Description Percentage of Patients with Cellulitis Who Did Not Receive Vancomycin Unless MRSA Infection or Risk for MRSA Infection Was Identified Denominator Any patient greater than or equal to 18 years of age evaluated by the Eligible Professional PLUS Admitted or Placed in
- [ACEP59 Chest Pain – Avoidance of admission for adult patients with low-risk chest pain.](https://healthmonix.com/mips_quality_measure/acep59-chest-pain-avoidance-of-admission-for-adult-patients-with-low-risk-chest-pain/) - Measure ID ACEP59 Measure Title Chest Pain – Avoidance of admission for adult patients with low-risk chest pain. Measure Description Percentage of adult patients who came to the Emergency Department with low-risk chest pain and were discharged Denominator All adult patients 35-64 years of age with an ED diagnosis of chest pain Numerator All adult
- [ACEP61 Avoidance of Chest X-ray in pediatric patients with Asthma, Bronchiolitis or Croup](https://healthmonix.com/mips_quality_measure/acep61-avoidance-of-chest-x-ray-in-pediatric-patients-with-asthma-bronchiolitis-or-croup/) - Measure ID ACEP61 Measure Title Avoidance of Chest X-ray in pediatric patients with Asthma, Bronchiolitis or Croup Measure Description Percentage of ED visits for pediatric patients with Asthma, Bronchiolitis or Croup for whom a Chest X-ray was ordered/performed. Denominator All patients aged 18 years or less coming to the Emergency Department with a diagnosis of
- [ACEP19 Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older](https://healthmonix.com/mips_quality_measure/acep19-emergency-medicine-emergency-department-utilization-of-ct-for-minor-blunt-head-trauma-for-patients-aged-18-years-and-older/) - Measure ID ACEP19 Measure Title Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older Measure Description Percentage of emergency department visits for patients aged 18 years and older who presented with a minor blunt head trauma who had a head CT for trauma ordered by
- [ACEP50 ED Median Time from ED arrival to ED departure for all Adult Patients](https://healthmonix.com/mips_quality_measure/acep50-ed-median-time-from-ed-arrival-to-ed-departure-for-all-adult-patients/) - Measure ID ACEP50 Measure Title ED Median Time from ED arrival to ED departure for all Adult Patients Measure Description Time (in minutes) from ED arrival to ED departure for all Adult Patients Denominator All Emergency Department encounters for patients aged 18 years and older with documented discharge disposition Numerator Time (in minutes) from ED
- [ACQR12 ABCDEF Bundle - Early mobility for ICU patients](https://healthmonix.com/mips_quality_measure/acqr12-abcdef-bundle-early-mobility-for-icu-patients/) - Measure ID ACQR12 Measure Title ABCDEF Bundle - Early mobility for ICU patients Measure Description Patients admitted to the intensive care unit (ICU) for > or = 4 days should be included in an early mobility program (E of ABCDEF Bundle) to improve their recovery process. Denominator All Patients >= 18 years of age on
- [ACQR13 Sepsis: Hour One bundle](https://healthmonix.com/mips_quality_measure/acqr13-sepsis-hour-one-bundle/) - Measure ID ACQR13 Measure Title Sepsis: Hour One bundle Measure Description Surviving Sepsis Campaign's Hour One bundle initiation in patients with Sepsis and acute organ dysfunction Denominator All patients 18 years of age or greater being admitted with sepsis and acute organ dysfunction Numerator Patients that had the Surviving Sepsis Campaign Hour One Bundle INITIATED
- [ACQR16 COPD Exacerbation or CHF Exacerbation requiring Hospital Admission: Palliative Care Evaluation](https://healthmonix.com/mips_quality_measure/acqr16-copd-exacerbation-or-chf-exacerbation-requiring-hospital-admission-palliative-care-evaluation/) - Measure ID ACQR16 Measure Title COPD Exacerbation or CHF Exacerbation requiring Hospital Admission: Palliative Care Evaluation Measure Description Patients admitted with 2 or more COPD exacerbations in 12 months or a single admission for COPD with hypercapnic respiratory failure, or being discharged to a SNF or LTACH should receive an evaluation from a palliative care
- [AQI69 Intraoperative Antibiotic Redosing](https://healthmonix.com/mips_quality_measure/aqi69-intraoperative-antibiotic-redosing/) - Measure ID AQI69 Measure Title Intraoperative Antibiotic Redosing Measure Description Percentage of patients, aged 18 years and older, who received preoperative antibiotic prophylaxis within 60 minutes prior to incision (if fluoroquinolone or vancomycin, two hours) and undergo a procedure greater than two hours duration who received intraoperative antibiotic redosing at a maximum interval of two
- [AQI73 Prevention of Arterial Line-Related Bloodstream Infections](https://healthmonix.com/mips_quality_measure/aqi73-prevention-of-arterial-line-related-bloodstream-infections/) - Measure ID AQI73 Measure Title Prevention of Arterial Line-Related Bloodstream Infections Measure Description Percentage of patients, regardless of age, who undergo placement of a peripheral intra-arterial catheter for whom the arterial line was inserted with all indicated elements of sterile barrier technique, hand hygiene, skin preparation and, if ultrasound is used, sterile ultrasound techniques followed.
- [AQI72 Perioperative Anemia Management](https://healthmonix.com/mips_quality_measure/aqi72-perioperative-anemia-management/) - Measure ID AQI72 Measure Title Perioperative Anemia Management Measure Description Percentage of patients, aged 18 years and older, undergoing elective total joint arthroplasty who were screened for anemia preoperatively AND, if positive, have documentation that one or more of the following management strategies were used prior to PACU discharge. Management strategies include one or more
- [ECPR39 Avoid Head CT for Patients with Uncomplicated Syncope](https://healthmonix.com/mips_quality_measure/ecpr39-avoid-head-ct-for-patients-with-uncomplicated-syncope/) - Measure ID ECPR39 Measure Title Avoid Head CT for Patients with Uncomplicated Syncope Measure Description Percentage of Adult Syncope Patients Who Did Not Receive a Head CT Scan Ordered by the Provider Denominator Any patient greater than or equal to 18 years of age evaluated by the Eligible Professional in the Emergency Department or Urgent
- [ECPR41 Rh Status Evaluation and Treatment of Pregnant Women at Risk of Fetal Blood Exposure](https://healthmonix.com/mips_quality_measure/ecpr41-rh-status-evaluation-and-treatment-of-pregnant-women-at-risk-of-fetal-blood-exposure/) - Measure ID ECPR41 Measure Title Rh Status Evaluation and Treatment of Pregnant Women at Risk of Fetal Blood Exposure Measure Description Percentage of Women Aged 14-50 Years at Risk of Fetal Blood Exposure Who Had Their Rh Status Evaluated in the Emergency Department (ED) and Received Rh-Immunoglobulin (Rhogam) if Rh-negative Denominator Any Female Patient greater
- [ECPR46 Avoidance of Opiates for Low Back Pain or Migraines](https://healthmonix.com/mips_quality_measure/ecpr46-avoidance-of-opiates-for-low-back-pain-or-migraines/) - Measure ID ECPR46 Measure Title Avoidance of Opiates for Low Back Pain or Migraines Measure Description Percentage of Patients with Low Back Pain and/or Migraines Who Were Not Prescribed an Opiate Denominator Any patient greater than or equal to 18 years of age evaluated by the Eligible Professional PLUS Diagnosis of low back pain OR
- [ECPR51 Discharge Prescription of Naloxone after Opioid Poisoning or Overdose](https://healthmonix.com/mips_quality_measure/ecpr51-discharge-prescription-of-naloxone-after-opioid-poisoning-or-overdose/) - Measure ID ECPR51 Measure Title Discharge Prescription of Naloxone after Opioid Poisoning or Overdose Measure Description Percentage of Opioid Poisoning or Overdose Patients Presenting to An Acute Care Facility Who Were Prescribed Naloxone at Discharge Denominator Any patient evaluated by the Eligible Professional in the acute care setting PLUS diagnoses of opioid poisoning from heroin,
- [ECPR52 Appropriate Treatment of Psychosis and Agitation in the Emergency Department](https://healthmonix.com/mips_quality_measure/ecpr52-appropriate-treatment-of-psychosis-and-agitation-in-the-emergency-department/) - Measure ID ECPR52 Measure Title Appropriate Treatment of Psychosis and Agitation in the Emergency Department Measure Description Percentage of Adult Patients With Psychosis or Agitation Who Were Ordered an Oral Antipsychotic Medication in the Emergency Department Denominator Any patient greater than or equal to 18 years of age evaluated by the Eligible Professional in the
- [ECPR57 Clinician Reporting of Loss of Consciousness to State Department of Public Health or Department of Motor Vehicles](https://healthmonix.com/mips_quality_measure/ecpr57-clinician-reporting-of-loss-of-consciousness-to-state-department-of-public-health-or-department-of-motor-vehicles/) - Measure ID ECPR57 Measure Title Clinician Reporting of Loss of Consciousness to State Department of Public Health or Department of Motor Vehicles Measure Description Percentage of Patients At Risk for Recurrent Loss of Consciousness For Whom Loss of Consciousness Information Was Submitted to Department of Public Health or Department of Motor Vehicles Denominator Any patient
- [ECPR55 Avoidance of Long-Acting (LA) or Extended-Release (ER) Opiate Prescriptions and Opiate Prescriptions for Greater Than 3 Days Duration for Acute Pain](https://healthmonix.com/mips_quality_measure/ecpr55-avoidance-of-long-acting-la-or-extended-release-er-opiate-prescriptions-and-opiate-prescriptions-for-greater-than-3-days-duration-for-acute-pain/) - Measure ID ECPR55 Measure Title Avoidance of Long-Acting (LA) or Extended-Release (ER) Opiate Prescriptions and Opiate Prescriptions for Greater Than 3 Days Duration for Acute Pain Measure Description Percentage of Adult Patients Who Were Prescribed an Opiate Who Were Not Prescribed a Long-Acting (LA) or Extended-Release (ER) Formulation and for Whom the Prescription Duration Was
- [ECPR56 Opioid Withdrawal: Initiation of Medication-Assisted Treatment (MAT) and Referral to Outpatient Opioid Treatment](https://healthmonix.com/mips_quality_measure/ecpr56-opioid-withdrawal-initiation-of-medication-assisted-treatment-mat-and-referral-to-outpatient-opioid-treatment/) - Measure ID ECPR56 Measure Title Opioid Withdrawal: Initiation of Medication-Assisted Treatment (MAT) and Referral to Outpatient Opioid Treatment Measure Description Percentage of Patients Presenting with Opioid Withdrawal Who Were Given Medication-Assisted Treatment and Referred to Outpatient Opioid Treatment Denominator Any patient greater than or equal to 18 years of age evaluated by the Eligible Professional with diagnosis of opioid abuse or dependence with withdrawal (Transferred, eloped, AMA or expired patients are excluded)
- [HCPR14 Venous Thromboembolism (VTE) Prophylaxis](https://healthmonix.com/mips_quality_measure/hcpr14-venous-thromboembolism-vte-prophylaxis/) - Measure ID HCPR14 Measure Title Venous Thromboembolism (VTE) Prophylaxis Measure Description Percentage of Adult Patients Who Had VTE Prophylaxis Ordered at the Time of Admission OR Have Documentation of Reason for No VTE Prophylaxis Denominator Inpatients greater than or equal to 18 years of age, evaluated by the Eligible Professional AND LOS between 2 days
- [MBHR01 Use of Anxiety Severity Measure](https://healthmonix.com/mips_quality_measure/mbhr01-use-of-anxiety-severity-measure/) - Measure Title Use of Anxiety Severity Measure Measure Description The percentage of adult patients (18 years and older) with an anxiety disorder diagnosis (e.g., generalized anxiety disorder, social anxiety disorder, or panic disorder) who have completed a standardized tool (e.g., GAD-7, BAI) during measurement period. Denominator Patients aged ≥ 18 years on date
- [MBHR02 Anxiety Response at 6-months](https://healthmonix.com/mips_quality_measure/mbhr02-anxiety-response-at-6-months/) - Measure Title Anxiety Response at 6-months Measure Description The percentage of adult patients (18 years of age or older) with an anxiety disorder (e.g., generalized anxiety disorder, social anxiety disorder, or panic disorder) who demonstrated a response to treatment (GAD-7 score at least 25% less than score at index event) at 6-months (+/- 60
- [MBHR03 Pain Interference Response utilizing PROMIS](https://healthmonix.com/mips_quality_measure/mbhr03-pain-interference-response-utilizing-promis/) - Measure Title Pain Interference Response utilizing PROMIS Measure Description The percentage of adult patients (18 years of age or older) who report chronic pain issues and demonstrated a response to treatment at one month from the index score. Denominator Adult patients (18 years of age or older) who report chronic pain issues
- [MBHR05 Monitoring for psychosocial problems among children and youth](https://healthmonix.com/mips_quality_measure/mbhr05-monitoring-for-psychosocial-problems-among-children-and-youth/) - Measure Title Monitoring for psychosocial problems among children and youth Measure Description Percentage of children from 3 to 17 years of age who are receiving a psychiatric or behavioral health intake visit AND who demonstrated a reliable change in parent-reported problem behaviors 2 to 10 months after initial positive screen for externalizing and internalizing
- [MBHR07 Posttraumatic Stress Disorder (PTSD) Outcome Assessment for Adults and Children](https://healthmonix.com/mips_quality_measure/mbhr07-posttraumatic-stress-disorder-ptsd-outcome-assessment-for-adults-and-children/) - Measure Title Posttraumatic Stress Disorder (PTSD) Outcome Assessment for Adults and Children Measure Description The percentage of patients with a history of a traumatic event (i.e., an experience that was unusually or especially frightening, horrible, or traumatic) who report symptoms consistent with PTSD for at least one month following the traumatic event AND with
- [MBHR08 Alcohol Use Disorder Outcome Response](https://healthmonix.com/mips_quality_measure/mbhr08-alcohol-use-disorder-outcome-response/) - Measure Title Alcohol Use Disorder Outcome Response Measure Description The percentage of adult patients (18 years of age or older) who report problems with drinking alcohol (e.g., can be noted through a screening measure such as the AUDIT-C as described in MIPS Clinical Quality Measure Quality ID #431 aka NQF 2152 or other drug/alcohol
- [MBHR09 Outcome monitoring of ADHD functional impairment in children and youth](https://healthmonix.com/mips_quality_measure/mbhr09-outcome-monitoring-of-adhd-functional-impairment-in-children-and-youth/) - Measure Title Outcome monitoring of ADHD functional impairment in children and youth Measure Description Percentage of children aged 4 through 18 years, with a diagnosis of attention deficit/hyperactivity disorder (ADHD), who demonstrate a change score of 0.25 or greater on the Weiss Functional Impairment Rating Scale - Parent Report (WFIRS-P) within 2 to 10 months
- [MBHR10 Symptom Improvement in adults with ADHD](https://healthmonix.com/mips_quality_measure/mbhr10-symptom-improvement-in-adults-with-adhd/) - Measure Title Symptom Improvement in adults with ADHD Measure Description The percentage of adult patients (18 years of age or older) with a diagnosis of ADHD who show a reduction in symptoms of 25% on the Adult ADHD Self-Report Scale (ASRS-v1.1)- 18 item self-report scale of ADHD symptoms within 2 to 10 months after initially
- [MBHR11 Cognitive Assessment with Counseling on Safety and Potential Risk](https://healthmonix.com/mips_quality_measure/mbhr11-cognitive-assessment-with-counseling-on-safety-and-potential-risk/) - Measure Title Cognitive Assessment with Counseling on Safety and Potential Risk Measure Description Percentage of patients, regardless of age, referred for evaluation due to concerns for cognitive impairment for whom 1) a standardized valid assessment of cognition was performed and 2) reporting of results included counseling on safety and potential risks. Denominator All patients,
- [2022 QCDR Measure: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with knee injury measured via their validated Knee Outcome Survey (KOS) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID](https://healthmonix.com/mips_quality_measure/2022-qcdr-measure-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-to-indicate-functional-improvement-in-rehabilitation-of-patient/) - KNEE INJURY FUNCTIONAL IMPROVEMENT Measure ID IROMS11 Measure Title Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with knee injury measured via their validated Knee Outcome Survey (KOS) score, or equivalent instrument which has undergone peer reviewed published validation
- [2022 QCDR Measure: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation of patients with knee injury](https://healthmonix.com/mips_quality_measure/2022-qcdr-measure-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-in-improvement-in-pain-score-measured-via-the-numeric-pain-rat/) - KNEE INJURY NPRS Measure ID IROMS12 Measure Title Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation of patients with knee injury. Measure Description The proportion of patients failing to achieve an MCID
- [2022 QCDR Measure: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with hip, leg, or ankle injuries using the validated Lower Extremity Function Scale (LEFS) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID](https://healthmonix.com/mips_quality_measure/2022-qcdr-measure-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-to-indicate-functional-improvement-in-rehabilitation-of-patient-2/) - HIP, LEG OR ANKLE INJURY FUNCTIONA IMPROVEMENT Measure ID IROMS13 Measure Title Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with hip, leg, or ankle injuries using the validated Lower Extremity Function Scale (LEFS) score, or equivalent instrument which
- [2022 QCDR Measure: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation of patients with hip, leg, or ankle (lower extremity except knee) injury](https://healthmonix.com/mips_quality_measure/2022-qcdr-measure-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-in-improvement-in-pain-score-measured-via-the-numeric-pain-rat-2/) - HIP, LEG OR ANKLE INJURY NPRS Measure ID IROMS14 Measure Title Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation of patients with hip, leg, or ankle (lower extremity except knee) injury. Measure
- [2022 QCDR Measure: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with neck pain/injury measured via their validated Neck Disability Index (NDI) score](https://healthmonix.com/mips_quality_measure/2022-qcdr-measure-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-to-indicate-functional-improvement-in-rehabilitation-of-patient-3/) - NECK PAIN/INJURY FUNCTIONAL IMPROVEMENT Measure ID IROMS15 Measure Title Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with neck pain/injury measured via their validated Neck Disability Index (NDI) score. Measure Description The proportion of patients failing to achieve an
- [2022 QCDR Measure: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation of patients with neck pain/injury](https://healthmonix.com/mips_quality_measure/2022-qcdr-measure-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-in-improvement-in-pain-score-measured-via-the-numeric-pain-rat-3/) - NECK PAIN/INJURY NPRS Measure ID IROMS16 Measure Title Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation of patients with neck pain/injury. Measure Description The proportion of patients failing to achieve an MCID
- [2022 QCDR Measure: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with low back pain measured via their validated Modified Low Back Pain Disability Questionnaire (MDQ) score](https://healthmonix.com/mips_quality_measure/2022-qcdr-measure-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-to-indicate-functional-improvement-in-rehabilitation-of-patient-4/) - LOW BACK PAIN FUNCTIONAL IMPROVEMENT Measure ID IROMS17 Measure Title Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with low back pain measured via their validated Modified Low Back Pain Disability Questionnaire (MDQ) score. Measure Description The proportion of
- [2022 QCDR Measure: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation of patients with low back pain](https://healthmonix.com/mips_quality_measure/2022-qcdr-measure-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-in-improvement-in-pain-score-measured-via-the-numeric-pain-rat-4/) - LOW BACK PAIN NPRS Measure ID IROMS18 Measure Title Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation of patients with low back pain. Measure Description The proportion of patients failing to achieve
- [2022 QCDR Measure: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with arm, shoulder, or hand injury measured via their validated Disability of the Arm, Shoulder and Hand (DASH) score, Quick Disability of the Arm, Shoulder and Hand (QDASH) score, or equivalent instrument which has undergone peer reviewed published validation and demonstrates a peer reviewed published MCID](https://healthmonix.com/mips_quality_measure/2022-qcdr-measure-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-to-indicate-functional-improvement-in-rehabilitation-of-patient-5/) - ARM, SHOULDER, AND HAND INJURY FUNCTIONAL IMPROVEMENT Measure ID IROMS19 Measure Title Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) to indicate functional improvement in rehabilitation of patients with arm, shoulder, or hand injury measured via their validated Disability of the Arm, Shoulder and Hand (DASH) score,
- [2022 QCDR Measure: Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation of patients with arm, shoulder, or hand injury](https://healthmonix.com/mips_quality_measure/2022-qcdr-measure-failure-to-progress-ftp-proportion-of-patients-failing-to-achieve-a-minimal-clinically-important-difference-mcid-in-improvement-in-pain-score-measured-via-the-numeric-pain-rat-5/) - ARM, SHOULDER, AND HAND INJURY NPRS Measure ID IROMS20 Measure Title Failure to Progress (FTP): Proportion of patients failing to achieve a Minimal Clinically Important Difference (MCID) in improvement in pain score, measured via the Numeric Pain Rating Scale (NPRS), in rehabilitation of patients with arm, shoulder, or hand injury. Measure Description The proportion of
- [2021 APP Measure #480: Risk Standardized All-Cause Unplanned Admissions for Multiple Chronic Conditions for ACOs](https://healthmonix.com/mips_quality_measure/2021-app-measure-480-risk-standardized-all-cause/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes Medicare Part B Claims, eCQM, CMSWeb Interface, MIPS CQM Measure Description This measure is a re-specified version of the measure, Hospital-level Risk-standardized Complication rate (RSCR) following Elective Primary Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA) (National Quality Forum 1550), which was developed for patients
- [2022 MIPS Measure #9: Anti-depressant Medication Management](https://healthmonix.com/mips_quality_measure/2022-mips-measure-9-anti-depressant-medication-management/) - Description Percentage of patients 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression, and who remained on an antidepressant medication treatment. Two rates are reported. a. Percentage of patients who remained on an antidepressant medication for at least 84 days (12 weeks). b. Percentage of patients
- [2022 MIPS Measure #261: Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness](https://healthmonix.com/mips_quality_measure/clone-of-2021-mips-measure-261-referral-for-otologic-evaluation-for-patients-with-acute-or-chronic-dizziness/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged birth and older referred to a physician (preferably a physician specially trained in disorders of the ear) for an otologic evaluation subsequent to an audiologic evaluation after presenting with acute or chronic dizziness. Instructions
- [2022 MIPS Measure #181: Elder Maltreatment Screen and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/clone-of-2021-mips-measure-181-elder-maltreatment-screen-and-follow-up-plan/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged 65 years and older with a documented elder maltreatment screen using an Elder Maltreatment Screening tool on the date of encounter AND a documented follow-up plan on the date of the positive screen Instructions
- [2022 MIPS Measure #155: Falls: Plan of Care](https://healthmonix.com/mips_quality_measure/clone-of-2021-mips-measure-155-falls-plan-of-care/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged 65 years and older with a history of falls that had a plan of care for falls documented within 12 months Instructions This measure is to be submitted a minimum of once per performance
- [2022 Measure #134: Preventive Care and Screening: Screening for Depression and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/clone-of-2021-measure-134-preventive-care-and-screening-screening-for-depression-and-follow-up-plan/) - Measure Type High Priority Measure? Collection Type(s) eCQM/CQM no Medicare Part B Claims, eCQM, CMSWeb Interface, MIPS CQM Measure Description Percentage of patients aged 12 years and older screened for depression on the date of the encounter or 14 days prior to the date of the encounter using an age appropriate standardized depression screening tool
- [2022 HM11: Outcomes of Treatment of Subjective Tinnitus](https://healthmonix.com/mips_quality_measure/clone-of-2021-hm11-outcomes-of-treatment-of-subjective-tinnitus/) - Measure Description Percentage of patients aged 18 years and older who are screened for bothersome subjective tinnitus AND, if patient reports symptoms, assessed with clinical evaluation for tinnitus severity and impact on hearing-related quality of life (HRQoL) using a validated self-assessment tool AND, if identified with tinnitus that impacts the patients HRQoL, receive a tinnitus-related
- [2021 HM11: Outcomes of Treatment of Subjective Tinnitus](https://healthmonix.com/mips_quality_measure/2021-hm11-outcomes-of-treatment-of-subjective-tinnitus/) - Measure Description Percentage of patients aged 18 years and older who are screened for bothersome subjective tinnitus AND, if patient reports symptoms, assessed with clinical evaluation for tinnitus severity and impact on hearing-related quality of life (HRQoL) using a validated self-assessment tool AND, if identified with tinnitus that impacts the patients HRQoL, receive a tinnitus-related
- [2022 HM10: Outcomes of Hearing Loss Treatment](https://healthmonix.com/mips_quality_measure/clone-of-2021-hm10-outcomes-of-hearing-loss-treatment/) - Measure Description Percentage of patients aged 50 years and older, who are screened with a hearing loss self-assessment tool that indicated an impact on hearing-related QoL AND if diagnosed with a mild or greater hearing loss in at least one ear or identified with a hearing loss, receive an audiologic care plan and hearing loss
- [2022 MIPS Measure #12: Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation](https://healthmonix.com/mips_quality_measure/2022-mips-measure-12-primary-open-angle-glaucoma-poag-optic-nerve-evaluation/) - Description Percentage of patients aged 18 years and older with a diagnosis of primary open-angle glaucoma (POAG) who have an optic nerve head evaluation during one or more visits within 12 months Initial Population All patients aged 18 years and older with a diagnosis of primary open-angle glaucoma Denominator Equals Initial Population Denominator Exclusions None
- [2022 MIPS Measure # TBD: Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer](https://healthmonix.com/mips_quality_measure/2022-mips-measure-tbd-intravesical-bacillus-calmette-guerin-for-non-muscle-invasive-bladder-cancer/) - Description Percentage of patients initially diagnosed with non-muscle invasive bladder cancer and who received intravesical Bacillus-Calmette-Guerin (BCG) within 6 months of bladder cancer staging. Initial Population All patients initially diagnosed with T1, Tis or high grade Ta non-muscle invasive bladder cancer and a qualified encounter in the measurement period. Denominator Equals Initial population Denominator Exclusions
- [2021 MIPS Measure #418: Osteoporosis Management in Women Who Had a Fracture](https://healthmonix.com/mips_quality_measure/2021-mips-measure-418-osteoporosis-management-in-women-who-had-a-fracture/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, MIPS CQM Measure Description The percentage of women age 50-85 who suffered a fracture in the six months prior to the performance period through June 30 of the performance period and who either had a bone mineral density test or received a
- [2021 MIPS Measure #370: Depression Remission at Twelve Months](https://healthmonix.com/mips_quality_measure/2021-mips-measure-370-depression-remission-at-twelve-months/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes eCQM, CMSWeb Interface, MIPS CQM Measure Description The percentage of adolescent patients 12 to 17 years of age and adult patients 18 years of age or older with major depression or dysthymia who reached remission 12 months (+/- 60 days) after an index event date. Instructions
- [2021 QCDR Measure #008: Functional Status Change for Patients With Lower Extremity Functional Status Deficit](https://healthmonix.com/mips_quality_measure/2021-qcdr-measure-008-functional-status-change-for-patients-with-lower-extremity-functional-status-deficit/) - Measure Title Functional Status Change for Patients With Lower Extremity Functional Status Deficit Measure Description Percentage of patients aged 18 years or older with a functional deficit related to the lower extremity who achieve a Minimal Clinically Important Difference (MCID) in Lower Extremity Functional Scale (LEFS) score that indicates a functional improvement greater than zero.
- [2021 QCDR Measure #007: Functional Status Change for Patients with Vestibular Dysfunction](https://healthmonix.com/mips_quality_measure/2021-qcdr-measure-007-functional-status-change-for-patients-with-vestibular-dysfunction/) - Measure Title Functional Status Change for Patients with Vestibular Dysfunction Measure Description Percentage of patients aged 14 years and older diagnosed with vestibular dysfunction who achieve a Minimal Clinically Important Difference (MCID) as measured via the validated Dizziness Handicap Inventory or equivalent instrument to indicate functional, emotional, and physical improvement· Submission Age Criteria 1: Patients
- [2021 QCDR Measure #006: Functional Status Change for Patients With Low Back Functional Status Deficit](https://healthmonix.com/mips_quality_measure/2021-qcdr-measure-006-functional-status-change-for-patients-with-low-back-functional-status-deficit/) - Measure Title Functional Status Change for Patients With Low Back Functional Status Deficit Measure Description Percentage of patients aged 18 years or older with a functional deficit related to the low back who achieve a Minimal Clinically Important Difference (MCID) in the Modified Oswestry Low Back Pain Questionnaire (ODI) or equivalent score that indicates a
- [2021 QCDR Measure #005: Functional Status Change for Patients With Neck Functional Status Deficit](https://healthmonix.com/mips_quality_measure/2021-qcdr-measure-005-functional-status-change-for-patients-with-neck-functional-status-deficit/) - Measure Title Functional Status Change for Patients With Neck Functional Status Deficit Measure Description Percentage of patients aged 18 years or older with a functional deficit related to the neck who achieve a Minimal Clinically Important Difference (MCID) in the Neck Disability Index (NDI) or equivalent score that indicates a functional improvement greater than zero.
- [2021 QCDR Measure #004: Functional Status Change for Patients With Upper-limb Functional Status Deficit](https://healthmonix.com/mips_quality_measure/2021-qcdr-measure-004-functional-status-change-for-patients-with-upper-limb-functional-status-deficit/) - Measure Title Functional Status Change for Patients With Upper-limb Functional Status Deficit Measure Description Percentage of patients aged 13 years or older with a functional deficit related to the upper-limb who achieve a Minimal Clinically Important Difference (MCID) in QuickDASH or equivalent score that indicates a functional improvement greater than zero. Two rates will be
- [2021 Measure #321: CAHPS for MIPS Clinician/Group Survey](https://healthmonix.com/mips_quality_measure/2021-mips-measure-321-cahps-for-mips-clinician-group-survey/) - Measure Type High Priority Measure? Collection Type(s) Survey yes CSV Measure Description The Consumer Assessment of Healthcare Providers and Systems (CAHPS) for MIPS Clinician/Group Survey is comprised of 10 Summary Survey Measures (SSMs) and measures patient experience of care within a group practice. The NQF endorsement status and endorsement id (if applicable) for each SSM
- [2021 Measure #236: Controlling High Blood Pressure](https://healthmonix.com/mips_quality_measure/2021-mips-measure-236-controlling-high-blood-pressure/) - Measure Type High Priority Measure? Collection Type(s) eCQM/CQM yes Medicare Part B Claims, eCQM, CMSWeb Interface, MIPS CQM Measure Description Percentage of patients 18 - 85 years of age who had a diagnosis of hypertension overlapping the measurement period or the year prior to the measurement period, and whose most recent blood pressure was adequately
- [2021 Measure #134: Preventive Care and Screening: Screening for Depression and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/2021-mips-measure-134-preventive-care-and-screening-screening-for-depression-and-follow-up-plan/) - Measure Type High Priority Measure? Collection Type(s) eCQM/CQM no Medicare Part B Claims, eCQM, CMSWeb Interface, MIPS CQM Measure Description Percentage of patients aged 12 years and older screened for depression on the date of the encounter or 14 days prior to the date of the encounter using an age appropriate standardized depression screening tool
- [2021 Measure #001: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%)](https://healthmonix.com/mips_quality_measure/2021-mips-measure-001-diabetes-hemoglobin-a1c-hba1c-poor-control-9/) - Measure Type High Priority Measure? Collection Type(s) eCQM/CQM yes Medicare Part B Claims, eCQM, CMSWeb Interface, MIPS CQM Measure Description Percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the measurement period. Instructions This measure is to be submitted a minimum of once per performance period for patients
- [2021 APP Measure #479: Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for the Merit-Based Incentive Payment System (MIPS) Groups](https://healthmonix.com/mips_quality_measure/2021-app-measure-479-hospital-wide-incentive/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes Medicare Part B Claims, eCQM, CMSWeb Interface, MIPS CQM Measure Description This measure is a re-specified version of the measure, Risk-adjusted readmission rate (RARR) of unplanned readmission within 30 days of hospital discharge for any condition (NQF 1789), which was developed for patients 65 years and
- [2021 HM12: Outcomes of Treatment of Benign Paroxysmal Positional Vertigo](https://healthmonix.com/mips_quality_measure/2021-hm12-outcomes-of-treatment-of-benign-paroxysmal-positional-vertigo/) - Measure Description Percentage of patients aged 18 years and older, who report benign paroxysmal positional vertigo (BPPV)-related symptoms and are screened with a dizziness assessment questionnaire and undergo positional nystagmus testing AND, if diagnosed or identified with BPPV, received a BPPV-related care plan and vestibular intervention(s) or treatment(s) AND who have an improvement in nystagmus
- [2021 HM9: Functional Benefit of a Cochlear Implant](https://healthmonix.com/mips_quality_measure/2021-hm9-functional-benefit-of-a-cochlear-implant/) - Measure Description Percentage of patients aged 18 years and older, who are evaluated for hearing loss and complete a hearing loss self-assessment tool that indicated an impact of hearing-related quality of life (QoL), and if diagnosed with a bilateral moderate to profound sensorineural hearing loss (SNHL) and less than 60% open set speech recognition are
- [2021 MIPS Measure #431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling](https://healthmonix.com/mips_quality_measure/2021-mips-measure-431-preventive-care-and-screening-unhealthy-alcohol-use-screening-brief-counseling/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 12 months AND who received brief counseling if identified as an unhealthy alcohol user
- [2021 MIPS Measure #318: Falls: Screening for Future Fall Risk](https://healthmonix.com/mips_quality_measure/2021-mips-measure-318-falls-screening-for-future-fall-risk/) - Measure Type High Priority Measure? Collection Type(s) Process yes , eCQM, CMSWeb Interface, Measure Description Percentage of patients 65 years of age and older who were screened for future fall risk during the measurement period
- [2021 MIPS Measure #261: Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness](https://healthmonix.com/mips_quality_measure/2021-mips-measure-261-referral-for-otologic-evaluation-for-patients-with-acute-or-chronic-dizziness/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged birth and older referred to a physician (preferably a physician specially trained in disorders of the ear) for an otologic evaluation subsequent to an audiologic evaluation after presenting with acute or chronic dizziness.
- [2021 MIPS Measure #226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention](https://healthmonix.com/mips_quality_measure/2021-mips-measure-226-preventive-care-and-screening-tobacco-use-screening-and-cessation-intervention/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, eCQM, CMSWeb Interface, MIPS CQM Measure Description Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 12 months AND who received tobacco cessation intervention if identified as a tobacco user
- [2021 MIPS Measure #181: Elder Maltreatment Screen and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/2021-mips-measure-181-elder-maltreatment-screen-and-follow-up-plan/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged 65 years and older with a documented elder maltreatment screen using an Elder Maltreatment Screening tool on the date of encounter AND a documented follow-up plan on the date of the positive screen Instructions
- [2021 MIPS Measure #155: Falls: Plan of Care](https://healthmonix.com/mips_quality_measure/2021-mips-measure-155-falls-plan-of-care/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged 65 years and older with a history of falls that had a plan of care for falls documented within 12 months Instructions This measure is to be submitted a minimum of once per performance
- [2021 MIPS Measure #154: Falls: Risk Assessment](https://healthmonix.com/mips_quality_measure/2021-mips-measure-154-falls-risk-assessment/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, MIPS CQM Measure Description Percentage of patients aged 65 years and older with a history of falls that had a risk assessment for falls completed within 12 months Instructions This measure is to be submitted a minimum of once per performance period
- [2021 MIPS Measure #130: Documentation of Current Medications in the Medical Record](https://healthmonix.com/mips_quality_measure/2021-mips-measure-130-documentation-of-current-medications-in-the-medical-record/) - Measure Type High Priority Measure? Collection Type(s) Process yes Medicare Part B Claims, eCQM, MIPS CQM Measure Description Percentage of visits for patients aged 18 years and older for which the eligible professional or eligible clinician attests to documenting a list of current medications using all immediate resources available on the date of the encounter.
- [2021 HCPR20: Clostridium Difficile – Risk Assessment and Plan of Care](https://healthmonix.com/mips_quality_measure/2021-hcpr20-clostridium-difficile-risk-assessment-and-plan-of-care/) - Measure Description Percentage of Adult Patients Who Had a Risk Assessment for C. difficile Infection and, If High-Risk, Had a Plan of Care for C. difficile Completed on the Day Of or Day After Hospital Admission Denominator Any patient ≥ 18 years of age evaluated by the Eligible Professional (E/M Codes 99221- 99223, 99231- 99233,
- [2021 HCPR17: Pressure Ulcers – Risk Assessment and Plan of Care](https://healthmonix.com/mips_quality_measure/2021-hcpr17-pressure-ulcers-risk-assessment-and-plan-of-care/) - Measure Description Percentage of Adult Post-acute Facility Patients That Had a Risk Assessment for Pressure Ulcers and a Plan of Care for Pressure Ulcer Prevention/Treatment Completed Denominator Adult patients aged ≥ 18 years evaluated by the Eligible Professional in the Post-acute Facility (E/M Codes 99304-99310, 99315, 99316) Numerator Adult Post-acute Facility Patients that Had a
- [2021 HCPR14: Venous Thromboembolism (VTE) Prophylaxis](https://healthmonix.com/mips_quality_measure/2021-hcpr14-venous-thromboembolism-vte-prophylaxis/) - Measure Description Percentage of Adult Patients Who Had VTE Prophylaxis Ordered at the Time of Admission OR Have Documentation of Reason for No VTE Prophylaxis Denominator Inpatients ≥ 18 years of age evaluated by the Eligible Professional (E/M Codes 99221- 99223, 99231-99233, 99238-99239, 99291-99292 AND Place of Service Indicator: 21) PLUS LOS ≥ 2 days
- [2021 HCPR18: Unintentional Weight Loss – Risk Assessment and Plan of Care](https://healthmonix.com/mips_quality_measure/2021-hcpr18-unintentional-weight-loss-risk-assessment-and-plan-of-care/) - Measure Description Percentage of Adult Post-acute Facility Patients that Had a Risk Assessment for Unintentional Weight Loss and a Plan of Care for Unintentional Weight Loss Documented by Provider Denominator Adult patients aged ≥ 18 years evaluated by the Eligible Professional in the Post-acute Facility (E/M Codes 99304-99310, 99315, 99316) Numerator Adult Post-acute Facility Patients
- [2021 MIPS Measure #401: Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis](https://healthmonix.com/mips_quality_measure/2021-mips-measure-401-hepatitis-c-screening-for-hepatocellular-carcinoma-hcc-in-patients-with-cirrhosis/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis who underwent imaging with either ultrasound, contrast enhanced CT or MRI for hepatocellular carcinoma (HCC) at least once within the 12-month submission period Instructions This measure
- [2021 MIPS Measure #391: Follow-Up After Hospitalization for Mental Illness (FUH)](https://healthmonix.com/mips_quality_measure/2021-mips-measure-391-follow-up-after-hospitalization-for-mental-illness-fuh/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description The percentage of discharges for patients 6 years of age and older who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and who had a follow-up visit with a mental health practitioner. Two rates are submitted: The percentage
- [2021 MIPS Measure #374: Closing the Referral Loop: Receipt of Specialist Report](https://healthmonix.com/mips_quality_measure/2021-mips-measure-374-closing-the-referral-loop-receipt-of-specialist-report/) - Measure Type High Priority Measure? Collection Type(s) Process yes eCQM, MIPS CQM Measure Description Percentage of patients with referrals, regardless of age, for which the referring provider receives a report from the provider to whom the patient was referred Instructions This measure is to be submitted a minimum of once per performance period for all
- [2021 MIPS Measure #342: Pain Brought Under Control Within 48 Hours](https://healthmonix.com/mips_quality_measure/2021-mips-measure-342-pain-brought-under-control-within-48-hours/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Patients aged 18 and older who report being uncomfortable because of pain at the initial assessment (after admission to palliative care services) who report pain was brought to a comfortable level within 48 hours Instructions This measure is to be submitted a
- [2021 MIPS Measure #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented](https://healthmonix.com/mips_quality_measure/2021-mips-measure-317-preventive-care-and-screening-screening-for-high-blood-pressure-and-follow-up-documented/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, eCQM, MIPS CQM Measure Description Percentage of patient visits for patients aged 18 years and older seen during the measurement period who were screened for high blood pressure AND a recommended follow-up plan is documented, as indicated, if blood pressure is pre-hypertensive
- [2021 MIPS Measure #288: Dementia: Education and Support of Caregivers for Patients with Dementia](https://healthmonix.com/mips_quality_measure/2021-mips-measure-288-dementia-education-and-support-of-caregivers-for-patients-with-dementia/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients with dementia whose caregiver(s) were provided with education on dementia disease management and health behavior changes AND were referred to additional resources for support in the last 12 months Instructions This measure is to be submitted a minimum of
- [2021 MIPS Measure #286: Dementia: Safety Concern Screening and Follow-Up for Patients with Dementia](https://healthmonix.com/mips_quality_measure/2021-mips-measure-286-dementia-safety-concern-screening-and-follow-up-for-patients-with-dementia/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients with dementia or their caregiver(s) for whom there was a documented safety concerns screening in two domains of risk: 1) dangerousness to self or others and 2) environmental risks; and if safety concerns screening was positive in the last
- [2021 MIPS Measure #283: Dementia Associated Behavioral and Psychiatric Symptoms Screening and Management](https://healthmonix.com/mips_quality_measure/2021-mips-measure-283-dementia-associated-behavioral-and-psychiatric-symptoms-screening-and-management/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients with dementia for whom there was a documented screening for behavioral and psychiatric symptoms, including depression, and for whom, if symptoms screening was positive, there was also documentation of recommendations for management in the last 12 months Instructions This
- [2021 MIPS Measure #282: Dementia: Functional Status Assessment](https://healthmonix.com/mips_quality_measure/2021-mips-measure-282-dementia-functional-status-assessment/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients with dementia for whom an assessment of functional status was performed at least once in the last 12 months. Instructions This measure is to be submitted a minimum of once per performance period for patients with a diagnosis of
- [2021 MIPS Measure #128: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan](https://healthmonix.com/mips_quality_measure/2021-mips-measure-128-preventive-care-and-screening-body-mass-index-bmi-screening-and-follow-up-plan/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, eCQM, MIPS CQM Measure Description Percentage of patients aged 18 years and older with a BMI documented during the current encounter or during the previous twelve months AND with a BMI outside of normal parameters, a follow-up plan is documented during the
- [2021 MIPS Measure #111: Pneumococcal Vaccination Status for Older Adults](https://healthmonix.com/mips_quality_measure/2021-mips-measure-111-pneumococcal-vaccination-status-for-older-adults/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, eCQM, MIPS CQM Measure Description Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine Instructions This measure is to be submitted a minimum of once per performance period for patients seen during the performance period.
- [2021 MIPS Measure #110: Preventive Care and Screening: Influenza Immunization](https://healthmonix.com/mips_quality_measure/2021-mips-measure-110-preventive-care-and-screening-influenza-immunization/) - Measure Type High Priority Measure? Collection Type(s) Process no Medicare Part B Claims, eCQM, CMSWeb Interface, MIPS CQM Measure Description Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization Instructions This measure
- [2021 AQI70: Prevention of Arterial Line Related Bloodstream Infections](https://healthmonix.com/mips_quality_measure/2021-aqi70-prevention-of-arterial-line-related-bloodstream-infections/) - Measure Description Percentage of patients, regardless of age, who undergo placement of a peripheral intra-arterial catheter for whom the arterial line was inserted with all indicated elements of sterile barrier technique, hand hygiene, skin preparation and, if ultrasound is used, sterile ultrasound techniques followed. This measure will consist of two performance rates: a. Percentage of
- [2021 AQI71: Ambulatory Glucose Management](https://healthmonix.com/mips_quality_measure/2021-aqi71-ambulatory-glucose-management/) - Measure Description Percentage of diabetic patients, aged 18 years and older, who receive an office-based or ambulatory surgery whose blood glucose level is appropriately managed throughout the perioperative period. The measure consists of four performance rates: a. Percentage of patients, aged 18 years and older, with a current diagnosis of diabetes mellitus receiving anesthesia services
- [2021 AQI72: Perioperative Anemia Management](https://healthmonix.com/mips_quality_measure/2021-aqi72-perioperative-anemia-management/) - Measure Description Percentage of patients, aged 18 years and older, undergoing elective total joint arthroplasty who were screened for anemia preoperatively AND, if positive, have documentation that one or more of the following management strategies were used prior to PACU discharge. Denominator Patients, aged 18 years and older, undergoing elective total joint arthroplasty. Denominator Note:
- [2021 AQI69: Intraoperative Antibiotic Redosing](https://healthmonix.com/mips_quality_measure/2021-aqi69-intraoperative-antibiotic-redosing/) - Measure Description Percentage of patients, aged 18 years and older, who received preoperative antibiotic prophylaxis within 60 minutes prior to incision (if fluoroquinolone or vancomycin, two hours) and undergo a procedure greater than two hours duration who received intraoperative antibiotic redosing at a maximum interval of two half-lives of the selected prophylactic antibiotic. Denominator All
- [2021 AQI57: Safe Opioid Prescribing Practices](https://healthmonix.com/mips_quality_measure/2021-aqi57-safe-opioid-prescribing-practices/) - Measure Description Percentage of patients, aged 18 years and older, prescribed opioid medications for longer than six weeks’ duration for whom ALL of the following opioid prescribing best practices are followed: Chemical dependency screening (includes laboratory testing and/or questionnaire) within the immediate 6 months prior to the encounter Co-prescription of naloxone or documented discussion regarding
- [2021 AQI55: Team-Based Implementation of a Care-and-Communication Bundle for ICU Patients](https://healthmonix.com/mips_quality_measure/2021-aqi55-team-based-implementation-of-a-care-and-communication-bundle-for-icu-patients/) - Measure Description Percentage of patients, regardless of age, who are admitted to an intensive care unit (ICU) for ≥48 hours and who received critical care services who have documentation by managing physician of attempted or actual identification of a surrogate decision maker, an advance directive, and the patient’s preference for cardiopulmonary resuscitation, within 48 hours
- [2021 HCPR16: Physician’s Orders for Life-Sustaining Treatment (POLST) Form](https://healthmonix.com/mips_quality_measure/2021-hcpr16-physicians-orders-for-life-sustaining-treatment-polst-form/) - Measure Description Percentage of Patients Aged 65 Years and Older with Physician’s Orders for Life-Sustaining Treatment (POLST) Forms Completed Denominator Adult patients aged ≥ 65 years evaluated by the Eligible Professional (E/M Codes 99221-99223, 99231-99233, 99238-99239, 99291-99292, 99304-99310, 99315, 99316) Numerator Patients with a completed Physician’s Orders for Life-Sustaining Treatment (POLST) form Definitions: Physician’s Orders
- [2021 ECPR54: Avoidance of Co-Prescribing of Opioid Analgesic and Benzodiazepine](https://healthmonix.com/mips_quality_measure/2021-ecpr54-avoidance-of-co-prescribing-of-opioid-analgesic-and-benzodiazepine/) - Measure Description Percentage of Patients Who Were Not Concurrently Prescribed Opioid Analgesic and Benzodiazepine Medications Denominator Any patient ≥ 18 years of age evaluated by the Eligible Professional Transferred, eloped or AMA patients are excluded (V0700) Numerator Patients Who Were Concurrently Prescribed Opioid Analgesic and Benzodiazepine Medications Performance Met (VE278): Opioid Analgesic AND Benzodiazepine NOT
- [2021 ECPR52: Appropriate Treatment of Psychosis and Agitation in the Emergency Department](https://healthmonix.com/mips_quality_measure/2021-ecpr52-appropriate-treatment-of-psychosis-and-agitation-in-the-emergency-department/) - Measure Description Percentage of Adult Patients With Psychosis or Agitation Who Were Ordered an Oral Antipsychotic Medication in the Emergency Department Denominator Any patient ≥ 18 years of age evaluated by the Eligible Professional in the Emergency Department (99281-99285 & 99291-99292 AND Place of Service Indicator: 23) PLUS Emergency department length of stay of 4
- [2021 ECPR51: Discharge Prescription of Naloxone after Opioid Poisoning or Overdose](https://healthmonix.com/mips_quality_measure/2021-ecpr51-discharge-prescription-of-naloxone-after-opioid-poisoning-or-overdose/) - Measure Description Percentage of Opioid Poisoning or Overdose Patients Presenting to An Acute Care Facility Who Were Prescribed Naloxone at Discharge Denominator Any patient evaluated by the Eligible Professional (E/M Codes 99217, 99234-99236, 99238-99239, 99281-99285, 99291-99292) PLUS Diagnosis of opioid poisoning from heroin, methadone, morphine, opium, codeine, hydrocodone, or another opioid substance ICD-10: T40.0X1A, T40.0X1D,
- [2021 ECPR46: Avoidance of Opiates for Low Back Pain or Migraines](https://healthmonix.com/mips_quality_measure/2021-ecpr46-avoidance-of-opiates-for-low-back-pain-or-migraines/) - Measure Description Percentage of Patients with Low Back Pain and/or Migraines Who Were Not Prescribed an Opiate Denominator Any patient ≥ 18 years of age evaluated by the Eligible Professional in the Emergency Department or Urgent Care Clinic (E/M Codes 99201-99205, 99212-99215, 99281- 99285, 99291-99292 AND Place of Service Indicator: 11, 19, 20, 22 or
- [2021 ECPR39: Avoid Head CT for Patients with Uncomplicated Syncope](https://healthmonix.com/mips_quality_measure/2021-ecpr39-avoid-head-ct-for-patients-with-uncomplicated-syncope/) - Measure Description Percentage of Adult Syncope Patients Who Did Not Receive a Head CT Scan Ordered by the Provider Denominator Any patient ≥18 years of age evaluated by the Eligible Professional in the Emergency Department or Urgent Care Clinic (E/M Codes 99201-99205, 99212-99215, 99281- 99285, & 99291-99292 AND Place of Service Indicator: 11, 19, 20,
- [2021 ECPR41: Rh Status Evaluation and Treatment of Pregnant Women at Risk of Fetal Blood Exposure](https://healthmonix.com/mips_quality_measure/2021-ecpr41-rh-status-evaluation-and-treatment-of-pregnant-women-at-risk-of-fetal-blood-exposure/) - Measure Description Percentage of Women Aged 14-50 Years at Risk of Fetal Blood Exposure Who Had Their Rh Status Evaluated in the Emergency Department (ED) and Received Rh-Immunoglobulin (Rhogam) if Rh-negative Denominator Any Female Patient > 14 Years of Age and < 51 Years of Age Evaluated by the Eligible Professional in the ED (E/M
- [2021 ECPR40: Initiation of the Initial Sepsis Bundle](https://healthmonix.com/mips_quality_measure/2021-ecpr40-initiation-of-the-initial-sepsis-bundle/) - Measure Description Percentage of Adult Emergency Department Patients Diagnosed with Severe Sepsis or Septic Shock That Have Initiation of the Initial Sepsis Bundle Denominator Any patient > 18 years of age evaluated by the Eligible Professional in the Emergency Department (E/M Codes 99281-99285 & 99291-99292 AND Place of Service Indicator: 23) PLUS ED diagnosis of
- [2021 MBHR Measure: Posttraumatic Stress Disorder (PTSD) Screening and Outcome Assessment](https://healthmonix.com/mips_quality_measure/2021-mbhr-measure-posttraumatic-stress-disorder-ptsd-screening-and-outcome-assessment/) - QCDR Name: MBHR Mental and Behavioral Health Registry Measure Title Posttraumatic Stress Disorder (PTSD) Screening and Outcome Assessment NQS Domain Effective Clinical Care Measure ID MBHR7 NQF ID N/A Measure Type Patient Reported Outcome (PRO) High Priority? Yes Description The percentage of patients with a history of a traumatic event (i.e., an experience that was
- [2021 MBHR Measure: Social Role Functioning Outcome utilizing PROMIS](https://healthmonix.com/mips_quality_measure/2021-mbhr-measure-social-role-functioning-outcome-utilizing-promis/) - QCDR Name: MBHR Mental and Behavioral Health Registry Measure Title Social Role Functioning Outcome utilizing PROMIS NQS Domain Effective Clinical Care Measure ID MBHR4 NQF ID N/A Measure Type Patient Reported Outcome (PRO) High Priority? Yes Description The percentage of adult patients (18 years of age or older) with a mood or anxiety disorder who
- [2021 MBHR Measure: Pain Interference Response utilizing PROMIS](https://healthmonix.com/mips_quality_measure/2021-mbhr-measure-pain-interference-response-utilizing-promis/) - QCDR Name: MBHR Mental and Behavioral Health Registry Measure Title Pain Interference Response utilizing PROMIS NQS Domain Effective Clinical Care Measure ID MBHR3 NQF ID N/A Measure Type Patient Reported Outcome (PRO) High Priority? Yes Description The percentage of adult patients (18 years of age or older) who report pain issues and demonstrated a response
- [2021 MIPS Measure #126: Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy – Neurological Evaluation](https://healthmonix.com/mips_quality_measure/2021-mips-measure-126-diabetes-mellitus-diabetic-foot-and-ankle-care-peripheral-neuropathy-neurological-evaluation/) - Measure Type High Priority Measure? Collection Type(s) Process no MIPS CQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who had a neurological examination of their lower extremities within 12 months
- [2021 MIPS Measure #185: Colonoscopy Interval for Patients with a History of Adenomatous Polyps– Avoidance of Inappropriate Use](https://healthmonix.com/mips_quality_measure/2021-mips-measure-185-colonoscopy-interval-for-patients-with-a-history-of-adenomatous-polyps-avoidance-of-inappropriate-use/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Percentage of patients aged 18 years and older receiving a surveillance colonoscopy, with a history of a prior adenomatous polyp(s) in previous colonoscopy findings, which had an interval of 3 or more years since their last colonoscopy Instructions INSTRUCTIONS: This measure
- [2021 MIPS Measure #168: Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration](https://healthmonix.com/mips_quality_measure/2021-mips-measure-168-coronary-artery-bypass-graft-cabg-surgical-re-exploration/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percentage of patients aged 18 years and older undergoing isolated CABG surgery who require a return to the operating room (OR) during the current hospitalization for mediastinal bleeding with or without tamponade, graft occlusion, valve dysfunction, or other cardiac reason. Instructions
- [2021 MIPS Measure #167: Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure](https://healthmonix.com/mips_quality_measure/2021-mips-measure-167-coronary-artery-bypass-graft-cabg-postoperative-renal-failure/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percentage of patients aged 18 years and older undergoing isolated CABG surgery (without pre-existing renal failure) who develop postoperative renal failure or require dialysis. Instructions This measure is to be submitted each time an isolated CABG procedure is performed during the
- [2021 MIPS Measure #164: Coronary Artery Bypass Graft (CABG): Prolonged Intubation](https://healthmonix.com/mips_quality_measure/2021-mips-measure-164-coronary-artery-bypass-graft-cabg-prolonged-intubation/) - Measure Type High Priority Measure? Collection Type(s) Outcome yes MIPS CQM Measure Description Percentage of patients aged 18 years and older undergoing isolated CABG surgery who require postoperative intubation > 24 hours. Instructions This measure is to be submitted each time an isolated CABG procedure is performed during the performance period. It is anticipated that
- [2021 MIPS Measure #009: Anti-Depressant Medication Management](https://healthmonix.com/mips_quality_measure/2021-mips-measure-009-anti-depressant-medication-management/) - Measure Type High Priority Measure? Collection Type(s) Process no eCQM Measure Description Percentage of patients 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression, and who remained on an antidepressant medication treatment. Two rates are reported.a. Percentage of patients who remained on an antidepressant medication
- [2021 MIPS Measure #262: Image Confirmation of Successful Excision of Image-Localized Breast Lesion](https://healthmonix.com/mips_quality_measure/2021-mips-measure-262-image-confirmation-of-successful-excision-of-image-localized-breast-lesion/) - Measure Type High Priority Measure? Collection Type(s) Process yes MIPS CQM Measure Description Image confirmation of lesion(s) targeted for image guided excisional biopsy or image guided partial mastectomy in patients with nonpalpable, image-detected breast lesion(s). Lesions may include: microcalcifications, mammographic or sonographic mass or architectural distortion, focal suspicious abnormalities on magnetic resonance imaging (MRI)
- [2021 MIPS Measure #305: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment](https://healthmonix.com/mips_quality_measure/2021-mips-measure-305-initiation-and-engagement-of-alcohol-and-other-drug-dependence-treatment/) - Measure Type High Priority Measure? Collection Type(s) Process no eCQM Measure Description Percentage of patients 13 years of age and older with a new episode of alcohol and other drug (AOD) dependence who received the following. Two rates are reported.a. Percentage of patients who initiated treatment within 14 days of the diagnosisb. Percentage of
- [2021 MIPS Measure #281: Dementia: Cognitive Assessment](https://healthmonix.com/mips_quality_measure/2021-mips-measure-281-dementia-cognitive-assessment/) - Measure Type High Priority Measure? Collection Type(s) Process no eCQM Measure Description Percentage of patients, regardless of age, with a diagnosis of dementia for whom an assessment of cognition is performed and the results reviewed at least once within a 12-month period
- [2021 MIPS Measure #240: Childhood Immunization Status](https://healthmonix.com/mips_quality_measure/2021-mips-measure-240-childhood-immunization-status/) - Measure Type High Priority Measure? Collection Type(s) Process no eCQM Measure Description Percentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DTaP); three polio (IPV), one measles, mumps and rubella (MMR); three H influenza type B (HiB); three hepatitis B (Hep B); one chicken pox (VZV); four pneumococcal
- [2021 MIPS Measure #239: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents](https://healthmonix.com/mips_quality_measure/2021-mips-measure-239-weight-assessment-and-counseling-for-nutrition-and-physical-activity-for-children-and-adolescents/) - Measure Type High Priority Measure? Collection Type(s) Process no eCQM Measure Description Percentage of patients 3-17 years of age who had an outpatient visit with a Primary Care Physician (PCP) or Obstetrician/Gynecologist (OB/GYN) and who had evidence of the following during the measurement period. Three rates are reported.• Percentage of patients with height, weight,
- [2021 MIPS Measure #107: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment](https://healthmonix.com/mips_quality_measure/2021-mips-measure-107-adult-major-depressive-disorder-mdd-suicide-risk-assessment/) - Measure Type High Priority Measure? Collection Type(s) Process no eCQM Measure Description Percentage of patients aged 18 years and older with a diagnosis of major depressive disorder (MDD) with a suicide risk assessment completed during the visit in which a new diagnosis or recurrent episode was identified
- [2021 QCDR Measure #003: Pain Interference Response utilizing PROMIS](https://healthmonix.com/mips_quality_measure/2021-qcdr-measure-003-pain-interference-response-utilizing-promis/) - Measure Title Pain Interference Response utilizing PROMIS Measure Description The percentage of adult patients (18 years of age or older) who report pain issues and demonstrated a response to treatment at one month from the index score Denominator Adult patients (18 years of age or older) who report pain issues as significantly impacting their life
- [2021 MIPS Measure #476: International Prostate Symptom Score (IPSS) or American Urological Association-Symptom Index (AUA-SI) Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia](https://healthmonix.com/mips_quality_measure/2021-mips-measure-476-international-prostate-symptom-score-ipss-or-american-urological-association-symptom-index-aua-si-change-6-12-months-after-diagnosis-of-benign-prostatic-hyperplasia/) - Measure Type High Priority Measure? Collection Type(s) Patient Reported Outcome yes eCQM Measure Description Percentage of patients with an office visit within the measurement period and with a new diagnosis of clinically significant Benign Prostatic Hyperplasia who have International Prostate Symptoms Score (IPSS) or American Urological Association (AUA) Symptom Index (SI) documented at time

## MIPS Improvement Activities

- [2023 MIPS Improvement Activity IA_PSPA_30: PCI Bleeding Campaign](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_30-pci-bleeding-campaign/) - Activity Description Participation in the PCI Bleeding Campaign which is a national quality improvement program that provides infrastructure for a learning network and offers evidence-based resources and tools to reduce avoidable bleeding associated with patients who receive a percutaneous coronary intervention (PCI). The program uses a patient-centered and team-based approach, leveraging evidence-based best practices to
- [2023 MIPS Improvement Activity IA_PSPA_6: Consultation of the Prescription Drug Monitoring program](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_6-consultation-of-the-prescription-drug-monitoring-program/) - Activity Description Review the history of controlled substance prescriptions for 90 percent* of patients using state prescription drug monitoring program (PDMP) data prior to the issuance of a Controlled Substance Schedule II (CSII) opioid prescription lasting longer than 3 days. *Apply exceptions for patients receiving palliative and hospice care. Activity ID Activity Weighting Sub-Category Name
- [2023 MIPS Improvement Activity IA_PSPA_20: Leadership engagement in regular guidance and demonstrated commitment for implementing practice improvement changes](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_20-leadership-engagement-in-regular-guidance-and-demonstrated-commitment-for-implementing-practice-improvement-changes/) - Activity Description Ensure full engagement of clinical and administrative leadership in practice improvement that could include one or more of the following: • Make responsibility for guidance of practice change a component of clinical and administrative leadership roles; • Allocate time for clinical and administrative leadership for practice improvement efforts, including participation in regular team
- [2023 MIPS Improvement Activity IA_PM_7: Use of QCDR for feedback reports that incorporate population health](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_7-use-of-qcdr-for-feedback-reports-that-incorporate-population-health/) - Activity Description Use of a QCDR to generate regular feedback reports that summarize local practice patterns and treatment outcomes, including for vulnerable populations. Activity ID Activity Weighting Sub-Category Name IA_PM_7 High Population Management Objective & Validation Documentation N/A
- [2023 MIPS Improvement Activity IA_BE_7: Participation in a QCDR, that promotes use of patient engagement tools.](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_be_7-participation-in-a-qcdr-that-promotes-use-of-patient-engagement-tools/) - Activity Description Participation in a Qualified Clinical Data Registry (QCDR), that promotes patient engagement, including: • Use of processes and tools that engage patients for adherence to treatment plans; • Implementation of patient self-action plans; • Implementation of shared clinical decision making capabilities; or • Use of QCDR patient experience data to inform and advance
- [2023 MIPS Improvement Activity IA_BE_8: Participation in a QCDR, that promotes collaborative learning network opportunities that are interactive.](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_be_8-participation-in-a-qcdr-that-promotes-collaborative-learning-network-opportunities-that-are-interactive/) - Activity Description Participation in a QCDR, that promotes collaborative learning network opportunities that are interactive. Activity ID Activity Weighting Sub-Category Name IA_BE_8 Medium Beneficiary Engagement Objective & Validation Documentation N/A
- [2023 MIPS Improvement Activity IA_BMH_12: Promoting Clinician Well-Being](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_bmh_12-promoting-clinician-well-being/) - Activity Description Develop and implement programs to support clinician well-being and resilience—for example, through relationship-building opportunities, leadership development plans, or creation of a team within a practice to address clinician well-being—using one of the following approaches: • Completion of clinician survey on clinician well-being with subsequent implementation of an improvement plan based on the results
- [2023 MIPS Improvement Activity IA_BMH_13: Obtain or Renew an Approved Waiver for Provision of Buprenorphine as Medication-Assisted Treatment for Opioid Use Disorder](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_bmh_13-obtain-or-renew-an-approved-waiver-for-provision-of-buprenorphine-as-medication-assisted-treatment-for-opioid-use-disorder/) - Activity Description Complete any required training and obtain or renew an approved waiver for provision of medication-assisted treatment of opioid use disorders using buprenorphine. Note: This activity may be selected once for low-capacity waivers, as these do not expire, and once every 3 years for the expanded waiver, in keeping with renewal requirements. Activity ID
- [2023 MIPS Improvement Activity IA_PCMH: Electronic submission of Patient Centered Medical Home accreditation](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pcmh-electronic-submission-of-patient-centered-medical-home-accreditation/) - Activity Description N/A Activity ID Activity Weighting Sub-Category Name IA_PCMH N/A Objective & Validation Documentation Objective: Obtaining Patient-Centered Medical Home™ certification drives significant and sustainable practice improvements including population care quality, efficiency, and improved patient satisfaction all directly linked to better health outcomes. Validation Documentation: Evidence of meeting performance standards and expectations pertaining to the
- [2023 MIPS Improvement Activity IA_BMH_9: Unhealthy Alcohol Use for Patients with Co-occurring Conditions of Mental Health and Substance Abuse and Ambulatory Care Patients](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_bmh_9-unhealthy-alcohol-use-for-patients-with-co-occurring-conditions-of-mental-health-and-substance-abuse-and-ambulatory-care-patients/) - Activity Description Individual MIPS eligible clinicians or groups must regularly engage in integrated prevention and treatment interventions, including screening and brief counseling (for example: NQF #2152) for patients with co-occurring conditions of mental health and substance abuse. MIPS eligible clinicians would attest that 60 percent for the CY 2018 Quality Payment Program performance period, and
- [2023 MIPS Improvement Activity IA_BMH_10: Completion of Collaborative Care Management Training Program](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_bmh_10-completion-of-collaborative-care-management-training-program/) - Activity Description To receive credit for this activity, MIPS eligible clinicians must complete a collaborative care management training program, such as the American Psychiatric Association (APA) Collaborative Care Model training program available to the public, in order to implement a collaborative care management approach that provides comprehensive training in the integration of behavioral health into
- [2023 MIPS Improvement Activity IA_BMH_11: Implementation of a Trauma-Informed Care (TIC) Approach to Clinical Practice](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_bmh_11-implementation-of-a-trauma-informed-care-tic-approach-to-clinical-practice/) - Activity Description Create and implement a plan for trauma-informed care (TIC) that recognizes the potential impact of trauma experiences on patients and takes steps to mitigate the effects of adverse events in order to avoid re-traumatizing or triggering past trauma. Actions in this plan may include, but are not limited to, the following: • Incorporate
- [2023 MIPS Improvement Activity IA_BMH_7: Implementation of Integrated Patient Centered Behavioral Health Model](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_bmh_7-implementation-of-integrated-patient-centered-behavioral-health-model/) - Activity Description Offer integrated behavioral health services to support patients with behavioral health needs who also have conditions such as dementia or other poorly controlled chronic illnesses. The services could include one or more of the following: • Use evidence-based treatment protocols and treatment to goal where appropriate; • Use evidence-based screening and case finding
- [2023 MIPS Improvement Activity IA_BMH_8: Electronic Health Record Enhancements for BH data capture](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_bmh_8-electronic-health-record-enhancements-for-bh-data-capture/) - Activity Description Enhancements to an electronic health record to capture additional data on behavioral health (BH) populations and use that data for additional decision-making purposes (e.g., capture of additional BH data results in additional depression screening for at-risk patient not previously identified). Activity ID Activity Weighting Sub-Category Name IA_BMH_8 Medium Behavioral and Mental Health Objective
- [2023 MIPS Improvement Activity IA_BMH_4: Depression screening](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_bmh_4-depression-screening/) - Activity Description Depression screening and follow-up plan: Regular engagement of MIPS eligible clinicians or groups in integrated prevention and treatment interventions, including depression screening and follow-up plan (refer to NQF #0418) for patients with co-occurring conditions of behavioral or mental health conditions. Activity ID Activity Weighting Sub-Category Name IA_BMH_4 Medium Behavioral and Mental Health Objective
- [2023 MIPS Improvement Activity IA_BMH_5: MDD prevention and treatment interventions](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_bmh_5-mdd-prevention-and-treatment-interventions/) - Activity Description Major depressive disorder: Regular engagement of MIPS eligible clinicians or groups in integrated prevention and treatment interventions, including suicide risk assessment (refer to NQF #0104) for mental health patients with co-occurring conditions of behavioral or mental health conditions. Activity ID Activity Weighting Sub-Category Name IA_BMH_5 Medium Behavioral and Mental Health Objective & Validation
- [2023 MIPS Improvement Activity IA_BMH_6: Implementation of co-location PCP and MH services](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_bmh_6-implementation-of-co-location-pcp-and-mh-services/) - Activity Description Integration facilitation and promotion of the colocation of mental health and substance use disorder services in primary and/or non-primary clinical care settings. Activity ID Activity Weighting Sub-Category Name IA_BMH_6 High Behavioral and Mental Health Objective & Validation Documentation Objective: Integrate mental health and substance use disorder services with primary and/or non-primary clinical care
- [2023 MIPS Improvement Activity IA_BMH_1: Diabetes screening](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_bmh_1-diabetes-screening/) - Activity Description Diabetes screening for people with schizophrenia or bipolar disease who are using antipsychotic medication. Activity ID Activity Weighting Sub-Category Name IA_BMH_1 Medium Behavioral and Mental Health Objective & Validation Documentation Objective: Improve rates of screening for patients with schizophrenia or bipolar disorder, who have higher risk or higher prevalence of diabetes relative to
- [2023 MIPS Improvement Activity IA_BMH_2: Tobacco use](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_bmh_2-tobacco-use/) - Activity Description Tobacco use: Regular engagement of MIPS eligible clinicians or groups in integrated prevention and treatment interventions, including tobacco use screening and cessation interventions (refer to NQF #0028) for patients with co-occurring conditions of behavioral or mental health and at risk factors for tobacco dependence. Activity ID Activity Weighting Sub-Category Name IA_BMH_2 Medium Behavioral
- [2023 MIPS Improvement Activity IA_ERP_5: Implementation of a Laboratory Preparedness Plan](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_erp_5-implementation-of-a-laboratory-preparedness-plan/) - Activity Description Develop, implement, update, and maintain a preparedness plan for a laboratory intended to support continued or expanded patient care during COVID-19 or another public health emergency. The plan should address how the laboratory would maintain or expand patient access to health care services to improve beneficiary health outcomes and reduce healthcare disparities. For
- [2023 MIPS Improvement Activity IA_ERP_6: COVID-19 Vaccine Achievement for Practice Staff](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_erp_6-covid-19-vaccine-achievement-for-practice-staff/) - Activity Description Demonstrate that the MIPS eligible clinician’s practice has maintained or achieved a rate of 100% of office staff staying up to date with COVID vaccines according to the Centers for Disease Control and Prevention (https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html). Please note that those who are determined to have a medical contraindication specified by CDC recommendations are excluded
- [2023 MIPS Improvement Activity IA_ERP_2: Participation in a 60-day or greater effort to support domestic or international humanitarian needs](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_erp_2-participation-in-a-60-day-or-greater-effort-to-support-domestic-or-international-humanitarian-needs/) - Activity Description Participation in domestic or international humanitarian volunteer work. Activities that simply involve registration are not sufficient. MIPS eligible clinicians and groups attest to domestic or international humanitarian volunteer work for a period of a continuous 60 days or greater. Activity ID Activity Weighting Sub-Category Name IA_ERP_2 High Emergency Response & Preparedness Objective &
- [2023 MIPS Improvement Activity IA_ERP_3: COVID-19 Clinical Data Reporting with or without Clinical Trial](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_erp_3-covid-19-clinical-data-reporting-with-or-without-clinical-trial/) - Activity Description To receive credit for this improvement activity, a MIPS eligible clinician or group must: (1) participate in a COVID-19 clinical trial utilizing a drug or biological product to treat a patient with a COVID-19 infection and report their findings through a clinical data repository or clinical data registry for the duration of their
- [2023 MIPS Improvement Activity IA_ERP_4: Implementation of a Personal Protective Equipment (PPE) Plan](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_erp_4-implementation-of-a-personal-protective-equipment-ppe-plan/) - Activity Description Implement a plan to acquire, store, maintain, and replenish supplies of personal protective equipment (PPE) for all clinicians or other staff who are in physical proximity to patients. In accordance with guidance from the Centers for Disease Control and Prevention (CDC) the PPE plan should address: • Conventional capacity: PPE controls that should
- [2023 MIPS Improvement Activity IA_AHE_12: Practice Improvements that Engage Community Resources to Address Drivers of Health](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_ahe_12-practice-improvements-that-engage-community-resources-to-address-drivers-of-health/) - Activity Description Select and screen for drivers of health that are relevant for the eligible clinician’s population using evidence-based tools. If possible, use a screening tool that is health IT-enabled and includes standards-based, coded questions/fields for the capture of data. After screening, address identified drivers of health through at least one of the following: •
- [2023 MIPS Improvement Activity IA_ERP_1: Participation on Disaster Medical Assistance Team, registered for 6 months](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_erp_1-participation-on-disaster-medical-assistance-team-registered-for-6-months/) - Activity Description Participation in Disaster Medical Assistance Teams, or Community Emergency Responder Teams. Activities that simply involve registration are not sufficient. MIPS eligible clinicians and MIPS eligible clinician groups must be registered for a minimum of 6 months as a volunteer for disaster or emergency response. Activity ID Activity Weighting Sub-Category Name IA_ERP_1 Medium Emergency
- [2023 MIPS Improvement Activity IA_AHE_9: Implement Food Insecurity and Nutrition Risk Identification and Treatment Protocols](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_ahe_9-implement-food-insecurity-and-nutrition-risk-identification-and-treatment-protocols/) - Activity Description Create or improve, and then implement, protocols for identifying and providing appropriate support to: a) patients with or at risk for food insecurity, and b) patients with or at risk for poor nutritional status. (Poor nutritional status is sometimes referred to as clinical malnutrition or undernutrition and applies to people who are overweight
- [2023 MIPS Improvement Activity IA_AHE_10: Adopt Certified Health Information Technology for Security Tags for Electronic Health Record Data](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_ahe_10-adopt-certified-health-information-technology-for-security-tags-for-electronic-health-record-data/) - Activity Description Use security labeling services available in certified Health Information Technology (IT) for electronic health record (EHR) data to facilitate data segmentation. Certification criteria for security tags may be found in the ONC Health IT Certification Program at 45 CFR 170.315(b)(7) and (b)(8). Activity ID Activity Weighting Sub-Category Name IA_AHE_10 Medium Achieving Health Equity
- [2023 MIPS Improvement Activity IA_AHE_11: Create and Implement a Plan to Improve Care for Lesbian, Gay, Bisexual, Transgender, and Queer Patients](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_ahe_11-create-and-implement-a-plan-to-improve-care-for-lesbian-gay-bisexual-transgender-and-queer-patients/) - Activity Description Create and implement a plan to improve care for lesbian, gay, bisexual, transgender, and queer (LGBTQ+) patients by understanding and addressing health disparities for this population. The plan may include an analysis of sexual orientation and gender identity (SO/GI) data to identify disparities in care for LGBTQ+ patients. Actions to implement this activity
- [2023 MIPS Improvement Activity IA_AHE_7: Comprehensive Eye Exams](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_ahe_7-comprehensive-eye-exams/) - Activity Description To receive credit for this activity, MIPS eligible clinicians must promote the importance of a comprehensive eye exam, which may be accomplished by any one or more of the following: • providing literature, • facilitating a conversation about this topic using resources such as the “Think About Your Eyes” campaign, • referring patients
- [2023 MIPS Improvement Activity IA_AHE_8: Create and Implement an Anti-Racism Plan](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_ahe_8-create-and-implement-an-anti-racism-plan/) - Activity Description Create and implement an anti-racism plan using the CMS Disparities Impact Statement or other anti-racism planning tools. The plan should include a clinic-wide review of existing tools and policies, such as value statements or clinical practice guidelines, to ensure that they include and are aligned with a commitment to anti-racism and an understanding
- [2023 MIPS Improvement Activity IA_AHE_3: Promote use of Patient-Reported Outcome Tools](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_ahe_3-promote-use-of-patient-reported-outcome-tools/) - Activity Description Demonstrate performance of activities for employing patient-reported outcome (PRO) tools and corresponding collection of PRO data such as the use of PHQ-2 or PHQ-9, PROMIS instruments, patient reported Wound-Quality of Life (QoL), patient reported Wound Outcome, and patient reported Nutritional Screening. Activity ID Activity Weighting Sub-Category Name IA_AHE_3 High Achieving Health Equity Objective
- [2023 MIPS Improvement Activity IA_AHE_5: MIPS Eligible Clinician Leadership in Clinical Trials or CBPR](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_ahe_5-mips-eligible-clinician-leadership-in-clinical-trials-or-cbpr/) - Activity Description Lead clinical trials, research alliances, or community-based participatory research (CBPR) that identify tools, research, or processes that focus on minimizing disparities in healthcare access, care quality, affordability, or outcomes. Research could include addressing health-related social needs like food insecurity, housing insecurity, transportation barriers, utility needs, and interpersonal safety. Activity ID Activity Weighting Sub-Category
- [2023 MIPS Improvement Activity IA_AHE_6: Provide Education Opportunities for New Clinicians](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_ahe_6-provide-education-opportunities-for-new-clinicians/) - Activity Description MIPS eligible clinicians acting as a preceptor for clinicians-in-training (such as medical residents/fellows, medical students, physician assistants, nurse practitioners, or clinical nurse specialists) and accepting such clinicians for clinical rotations in community practices in small, underserved, or rural areas. Activity ID Activity Weighting Sub-Category Name IA_AHE_6 High Achieving Health Equity Objective & Validation
- [2023 MIPS Improvement Activity IA_PSPA_33: Application of CDC’s Training for Healthcare Providers on Lyme Disease](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_33-application-of-cdcs-training-for-healthcare-providers-on-lyme-disease/) - Activity Description Apply the Centers for Disease Control and Prevention’s (CDC) Training for Healthcare Providers on Lyme Disease using clinical decision support (CDS). CDS for Lyme disease should be built directly into the clinician workflow and support decision making for a specific patient at the point of care. Specific examples of how the guideline could
- [2023 MIPS Improvement Activity IA_AHE_1: Enhance Engagement of Medicaid and Other Underserved Populations](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_ahe_1-enhance-engagement-of-medicaid-and-other-underserved-populations/) - Activity Description To improve responsiveness of care for Medicaid and other underserved patients: use time-to-treat data (i.e., data measuring the time between clinician identifying a need for an appointment and the patient having a scheduled appointment) to identify patterns by which care or engagement with Medicaid patients or other groups of underserved patients has not
- [2023 MIPS Improvement Activity IA_PSPA_29: Consulting Appropriate Use Criteria (AUC) Using Clinical Decision Support when Ordering Advanced Diagnostic Imaging](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_29-consulting-appropriate-use-criteria-auc-using-clinical-decision-support-when-ordering-advanced-diagnostic-imaging/) - Activity Description Clinicians attest that they are consulting specified applicable AUC through a qualified clinical decision support mechanism for all applicable imaging services furnished in an applicable setting, paid for under an applicable payment system, and ordered on or after January 1, 2018. This activity is for clinicians that are early adopters of the Medicare
- [2023 MIPS Improvement Activity IA_PSPA_31: Patient Medication Risk Education](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_31-patient-medication-risk-education/) - Activity Description In order to receive credit for this activity, MIPS eligible clinicians must provide both written and verbal education regarding the risks of concurrent opioid and benzodiazepine use for patients who are prescribed both benzodiazepines and opioids. Education must be completed for at least 75% of qualifying patients and occur: (1) at the time
- [2023 MIPS Improvement Activity IA_PSPA_32: Use of CDC Guideline for Clinical Decision Support to Prescribe Opioids for Chronic Pain via Clinical Decision Support](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_32-use-of-cdc-guideline-for-clinical-decision-support-to-prescribe-opioids-for-chronic-pain-via-clinical-decision-support/) - Activity Description In order to receive credit for this activity, MIPS eligible clinicians must utilize the Centers for Disease Control (CDC) Guideline for Prescribing Opioids for Chronic Pain via clinical decision support (CDS). For CDS to be most effective, it needs to be built directly into the clinician workflow and support decision making on a
- [2023 MIPS Improvement Activity IA_PSPA_27: Invasive Procedure or Surgery Anticoagulation Medication Management](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_27-invasive-procedure-or-surgery-anticoagulation-medication-management/) - Activity Description For an anticoagulated patient undergoing a planned invasive procedure for which interruption in anticoagulation is anticipated, including patients taking vitamin K antagonists (warfarin), target specific oral anticoagulants (such as apixaban, dabigatran, and rivaroxaban), and heparins/low molecular weight heparins, documentation, including through the use of electronic tools, that the plan for anticoagulation management in
- [2023 MIPS Improvement Activity IA_PSPA_28: Completion of an Accredited Safety or Quality Improvement Program](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_28-completion-of-an-accredited-safety-or-quality-improvement-program/) - Activity Description Completion of an accredited performance improvement continuing medical education (CME) program that addresses performance or quality improvement according to the following criteria: • The activity must address a quality or safety gap that is supported by a needs assessment or problem analysis, or must support the completion of such a needs assessment as
- [2023 MIPS Improvement Activity IA_PSPA_23: Completion of CDC Training on Antibiotic Stewardship](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_23-completion-of-cdc-training-on-antibiotic-stewardship/) - Activity Description Completion of all modules of the Centers for Disease Control and Prevention antibiotic stewardship course. Note: This activity may be selected once every 4 years, to avoid duplicative information given that some of the modules may change on a year by year basis but over 4 years there would be a reasonable expectation
- [2023 MIPS Improvement Activity IA_PSPA_25: Cost Display for Laboratory and Radiographic Orders](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_25-cost-display-for-laboratory-and-radiographic-orders/) - Activity Description Implementation of a cost display for laboratory and radiographic orders, such as costs that can be obtained through the Medicare clinical laboratory fee schedule. Activity ID Activity Weighting Sub-Category Name IA_PSPA_25 Medium Patient Safety & Practice Assessment Objective & Validation Documentation Objective: Help eligible ordering clinicians easily obtain information on the cost of
- [2023 MIPS Improvement Activity lA_PSPA_26: Communication of Unscheduled Visit for Adverse Drug Event and Nature of Event](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-la_pspa_26-communication-of-unscheduled-visit-for-adverse-drug-event-and-nature-of-event/) - Activity Description A MIPS eligible clinician providing unscheduled care (such as an emergency room, urgent care, or other unplanned encounter) attests that, for greater than 75 percent of case visits that result from a clinically significant adverse drug event, the MIPS eligible clinician provides information, including through the use of health IT to the patient’s
- [2023 MIPS Improvement Activity IA_PSPA_21: Implementation of fall screening and assessment programs](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_21-implementation-of-fall-screening-and-assessment-programs/) - Activity Description Implementation of fall screening and assessment programs to identify patients at risk for falls and address modifiable risk factors (e.g., Clinical decision support/prompts in the electronic health record that help manage the use of medications, such as benzodiazepines, that increase fall risk). Activity ID Activity Weighting Sub-Category Name IA_PSPA_21 Medium Patient Safety &
- [2023 MIPS Improvement Activity IA_PSPA_22: CDC Training on CDC's Guideline for Prescribing Opioids for Chronic Pain](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_22-cdc-training-on-cdcs-guideline-for-prescribing-opioids-for-chronic-pain/) - Activity Description Completion of all the modules of the Centers for Disease Control and Prevention (CDC) course “Applying CDC’s Guideline for Prescribing Opioids” that reviews the 2016 “Guideline for Prescribing Opioids for Chronic Pain.” Note: This activity may be selected once every 4 years, to avoid duplicative information given that some of the modules may
- [2023 MIPS Improvement Activity IA_PSPA_17: Implementation of analytic capabilities to manage total cost of care for practice population](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_17-implementation-of-analytic-capabilities-to-manage-total-cost-of-care-for-practice-population/) - Activity Description In order to receive credit for this activity, a MIPS eligible clinician must conduct or build the capacity to conduct analytic activities to manage total cost of care for the practice population. Examples of these activities could include: 1.) Train appropriate staff on interpretation of cost and utilization information; 2.) Use available data
- [2023 MIPS Improvement Activity IA_PSPA_18: Measurement and improvement at the practice and panel level](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_18-measurement-and-improvement-at-the-practice-and-panel-level/) - Activity Description Measure and improve quality at the practice and panel level, such as the American Board of Orthopaedic Surgery (ABOS) Physician Scorecards that could include one or more of the following: • Regularly review measures of quality, utilization, patient satisfaction and other measures; and/or • Use relevant data sources to create benchmarks and goals
- [2023 MIPS Improvement Activity IA_PSPA_19: Implementation of formal quality improvement methods, practice changes or other practice improvement processes](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_19-implementation-of-formal-quality-improvement-methods-practice-changes-or-other-practice-improvement-processes/) - Activity Description Adopt a formal model for quality improvement and create a culture in which all staff, including leadership, actively participates in improvement activities that could include one or more of the following, such as: • Participation in multisource feedback; • Train all staff in quality improvement methods; • Integrate practice change/quality improvement into staff
- [2023 MIPS Improvement Activity IA_PSPA_13: Participation in Joint Commission Evaluation Initiative](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_13-participation-in-joint-commission-evaluation-initiative/) - Activity Description Participation in Joint Commission Ongoing Professional Practice Evaluation initiative Activity ID Activity Weighting Sub-Category Name IA_PSPA_13 Medium Patient Safety & Practice Assessment Objective & Validation Documentation Objective: Implement the Joint Commission’s Ongoing Professional Practice Evaluation with goal of identifying negative practice trends earlier. Validation Documentation: Evidence of participation in the Joint Commission’s Ongoing
- [2023 MIPS Improvement Activity IA_PSPA_15: Implementation of an ASP](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_15-implementation-of-an-asp/) - Activity Description Leadership of an Antimicrobial Stewardship Program (ASP) that includes implementation of an ASP that measures the appropriate use of antibiotics for several different conditions (such as but not limited to upper respiratory infection treatment in children, diagnosis of pharyngitis, bronchitis treatment in adults) according to clinical guidelines for diagnostics and therapeutics. Specific activities
- [2023 MIPS Improvement Activity IA_PSPA_16: Use of decision support and standardized treatment protocols](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_16-use-of-decision-support-and-standardized-treatment-protocols/) - Activity Description Use decision support and standardized treatment protocols to manage workflow in the team to meet patient needs. Activity ID Activity Weighting Sub-Category Name IA_PSPA_16 Medium Patient Safety & Practice Assessment Objective & Validation Documentation Objective: Help eligible clinicians align diagnoses and treatment plans with up-to-date, evidence-based standards and guidelines as part of routine
- [2023 MIPS Improvement Activity IA_PSPA_9: Completion of the AMA STEPS Forward program](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_9-completion-of-the-ama-steps-forward-program/) - Activity Description Completion of the American Medical Association’s STEPS Forward program. Activity ID Activity Weighting Sub-Category Name IA_PSPA_9 Medium Patient Safety & Practice Assessment Objective & Validation Documentation Objective: Gain the knowledge to "improve practice efficiency and ultimately enhance patient care, physician satisfaction and practice sustainability" (from https://edhub.ama-assn.org/steps-forward/pages/About). Validation Documentation: Evidence of completion of American
- [2023 MIPS Improvement Activity IA_PSPA_12: Participation in private payer CPIA](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_12-participation-in-private-payer-cpia/) - Activity Description Participation in designated private payer clinical practice improvement activities. Activity ID Activity Weighting Sub-Category Name IA_PSPA_12 Medium Patient Safety & Practice Assessment Objective & Validation Documentation Objective: Improve the quality of care provided, and health outcomes for patients, by participating in improvement activities designated by private payers. Validation Documentation: Evidence of participation in
- [2023 MIPS Improvement Activity IA_PSPA_4: Administration of the AHRQ Survey of Patient Safety Culture](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_4-administration-of-the-ahrq-survey-of-patient-safety-culture/) - Activity Description Administration of the AHRQ Survey of Patient Safety Culture and submission of data to the comparative database (refer to AHRQ Survey of Patient Safety Culture website http://www.ahrq.gov/professionals/quality-patient-safety/patientsafetyculture/index.html). Note: This activity may be selected once every 4 years, to avoid duplicative information given that some of the modules may change on a year by
- [2023 MIPS Improvement Activity IA_PSPA_7: Use of QCDR data for ongoing practice assessment and improvements](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_7-use-of-qcdr-data-for-ongoing-practice-assessment-and-improvements/) - Activity Description Participation in a Qualified Clinical Data Registry (QCDR) and use of QCDR data for ongoing practice assessment and improvements in patient safety, including: • Performance of activities that promote use of standard practices, tools, and processes for quality improvement (for example, documented preventive health efforts, like screening and vaccinations) that can be shared
- [2023 MIPS Improvement Activity IA_PSPA_8: Use of patient safety tools](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_8-use-of-patient-safety-tools/) - Activity Description In order to receive credit for this activity, a MIPS eligible clinician must use tools that assist specialty practices in tracking specific measures that are meaningful to their practice. Some examples of tools that could satisfy this activity are: a surgical risk calculator; evidence based protocols, such as Enhanced Recovery After Surgery (ERAS)
- [2023 MIPS Improvement Activity IA_PSPA_1: Participation in an AHRQ-listed patient safety organization](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_1-participation-in-an-ahrq-listed-patient-safety-organization/) - Activity Description Participation in an AHRQ-listed patient safety organization. Activity ID Activity Weighting Sub-Category Name IA_PSPA_1 Medium Patient Safety & Practice Assessment Objective & Validation Documentation Objective: Adopt and implement Patient Safety Organization (PSO) methodologies through data collection, analysis, reporting, and education to promote the quantifiable reduction of avoidable medical errors and deficiencies identified in
- [2023 MIPS Improvement Activity IA_PSPA_2: Participation in MOC Part IV](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_2-participation-in-moc-part-iv/) - Activity Description In order to receive credit for this activity, a MIPS eligible clinician must participate in Maintenance of Certification (MOC) Part IV. Maintenance of Certification (MOC) Part IV requires clinicians to perform monthly activities across practice to regularly assess performance by reviewing outcomes addressing identified areas for improvement and evaluating the results. Some examples
- [2023 MIPS Improvement Activity IA_PSPA_3: Participate in IHI Training/Forum Event; National Academy of Medicine, AHRQ Team STEPPS® or other similar activity](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pspa_3-participate-in-ihi-training-forum-event-national-academy-of-medicine-ahrq-team-stepps-or-other-similar-activity/) - Activity Description For MIPS eligible clinicians not participating in Maintenance of Certification (MOC) Part IV, new engagement for MOC Part IV, such as the Institute for Healthcare Improvement (IHI) Training/Forum Event; National Academy of Medicine, Agency for Healthcare Research and Quality (AHRQ) Team STEPPS®, or the American Board of Family Medicine (ABFM) Performance in Practice
- [2023 MIPS Improvement Activity IA_BE_25: Drug Cost Transparency](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_be_25-drug-cost-transparency/) - Activity Description Provide counseling to patients and/or their caregivers regarding: costs of medications using a real time benefit tool (RTBT) which provides to the prescriber real-time patient-specific formulary and benefit information for drugs, including cost-sharing for a beneficiary. Activity ID Activity Weighting Sub-Category Name IA_BE_25 High Beneficiary Engagement Objective & Validation Documentation Objective: Help patients
- [2023 MIPS Improvement Activity IA_BE_24: Financial Navigation Program](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_be_24-financial-navigation-program/) - Activity Description In order to receive credit for this activity, MIPS eligible clinicians must attest that their practice provides financial counseling to patients or their caregiver about costs of care and an exploration of different payment options. The MIPS eligible clinician may accomplish this by working with other members of their practice (for example, financial
- [2023 MIPS Improvement Activity IA_BE_23: Integration of patient coaching practices between visits](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_be_23-integration-of-patient-coaching-practices-between-visits/) - Activity Description Provide coaching between visits with follow-up on care plan and goals. Activity ID Activity Weighting Sub-Category Name IA_BE_23 Medium Beneficiary Engagement Objective & Validation Documentation Objective: Provide additional direct support to patients in achieving their goals, thus improving patient satisfaction, adherence to plans, and health outcomes. Validation Documentation: Documented use of coaching provided
- [2023 MIPS Improvement Activity IA_BE_22: Improved practices that engage patients pre-visit](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_be_22-improved-practices-that-engage-patients-pre-visit/) - Activity Description Implementation of workflow changes that engage patients prior to the visit, such as a pre-visit development of a shared visit agenda with the patient, or targeted pre-visit laboratory testing that will be resulted and available to the MIPS eligible clinician to review and discuss during the patient’s appointment. Activity ID Activity Weighting Sub-Category
- [2023 MIPS Improvement Activity IA_BE_16: Promote Self-management in Usual Care](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_be_16-promote-self-management-in-usual-care/) - Activity Description To help patients self-manage their care, incorporate culturally and linguistically tailored evidence-based techniques for promoting self-management into usual care, and provide patients with tools and resources for self-management. Examples of evidence-based techniques to use in usual care include: goal setting with structured follow-up, Teach-back methods, action planning, assessment of need for self-management (for
- [2023 MIPS Improvement Activity IA_BE_19: Use group visits for common chronic conditions (e.g., diabetes)](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_be_19-use-group-visits-for-common-chronic-conditions-e-g-diabetes/) - Activity Description Use group visits for common chronic conditions (e.g., diabetes). Activity ID Activity Weighting Sub-Category Name IA_BE_19 Medium Beneficiary Engagement Objective & Validation Documentation Objective: Give patients with common chronic conditions opportunities to learn about self-management topics and discuss shared concerns while improving efficiency in the delivery of quality care. Validation Documentation: Documented use
- [2023 MIPS Improvement Activity IA_BE_14: Engage patients and families to guide improvement in the system of care](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_be_14-engage-patients-and-families-to-guide-improvement-in-the-system-of-care/) - Activity Description Engage patients and families to guide improvement in the system of care by leveraging digital tools for ongoing guidance and assessments outside the encounter, including the collection and use of patient data for return-to-work and patient quality of life improvement. Platforms and devices that collect patient-generated health data (PGHD) must do so with
- [2023 MIPS Improvement Activity IA_BE_15: Engagement of patients, family and caregivers in developing a plan of care](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_be_15-engagement-of-patients-family-and-caregivers-in-developing-a-plan-of-care/) - Activity Description Engage patients, family, and caregivers in developing a plan of care and prioritizing their goals for action, documented in the electronic health record (EHR) technology. Activity ID Activity Weighting Sub-Category Name IA_BE_15 Medium Beneficiary Engagement Objective & Validation Documentation Objective: Increase engagement with patients, family, and caregivers and ensure care provided aligns with
- [2023 MIPS Improvement Activity IA_BE_5: Enhancements/regular updates to practice websites/tools that also include considerations for patients with cognitive disabilities](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_be_5-enhancements-regular-updates-to-practice-websites-tools-that-also-include-considerations-for-patients-with-cognitive-disabilities/) - Activity Description Enhancements and ongoing regular updates and use of websites/tools that include consideration for compliance with section 508 of the Rehabilitation Act of 1973 or for improved design for patients with cognitive disabilities. Refer to the CMS website on Section 508 of the Rehabilitation Act https://www.cms.gov/Research-Statistics-Data-and-Systems/CMS-Information-Technology/Section508/index.html?redirect=/InfoTechGenInfo/07_Section508.asp that requires that institutions receiving federal funds solicit,
- [2023 MIPS Improvement Activity IA_BE_6: Regularly Assess Patient Experience of Care and Follow Up on Findings](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_be_6-regularly-assess-patient-experience-of-care-and-follow-up-on-findings/) - Activity Description Collect and follow up on patient experience and satisfaction data. This activity also requires follow-up on findings of assessments, including the development and implementation of improvement plans. To fulfill the requirements of this activity, MIPS eligible clinicians can use surveys (e.g., Consumer Assessment of Healthcare Providers and Systems Survey), advisory councils, or other
- [2023 MIPS Improvement Activity IA_BE_12: Use evidence-based decision aids to support shared decision-making](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_be_12-use-evidence-based-decision-aids-to-support-shared-decision-making/) - Activity Description Use evidence-based decision aids to support shared decision-making. Activity ID Activity Weighting Sub-Category Name IA_BE_12 Medium Beneficiary Engagement Objective & Validation Documentation Objective: Increase use of evidence-based decision aids to encourage shared decision-making with beneficiaries. Validation Documentation: Documented use of evidence-based decision aids to support shared decision-making, a collaborative process aimed at improving
- [2023 MIPS Improvement Activity IA_BE_3: Engagement with QIN-QIO to implement self-management training programs](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_be_3-engagement-with-qin-qio-to-implement-self-management-training-programs/) - Activity Description Engagement with a Quality Innovation Network-Quality Improvement Organization, which may include participation in self-management training programs such as diabetes. Activity ID Activity Weighting Sub-Category Name IA_BE_3 Medium Beneficiary Engagement Objective & Validation Documentation Objective: Become more equipped to help patients self-manage their chronic conditions. Validation Documentation: Evidence of Quality Innovation Network-Quality Improvement Organization
- [2023 MIPS Improvement Activity IA_BE_4: Engagement of patients through implementation of improvements in patient portal](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_be_4-engagement-of-patients-through-implementation-of-improvements-in-patient-portal/) - Activity Description To receive credit for this activity, MIPS eligible clinicians must provide access to an enhanced patient/caregiver portal that allows users (patients or caregivers and their clinicians) to engage in bidirectional information exchange. The primary use of this portal should be clinical and not administrative. Examples of the use of such a portal include,
- [2023 MIPS Improvement Activity IA_CC_19: Tracking of clinician's relationship to and responsibility for a patient by reporting MACRA patient relationship codes](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_cc_19-tracking-of-clinicians-relationship-to-and-responsibility-for-a-patient-by-reporting-macra-patient-relationship-codes/) - Activity Description To receive credit for this improvement activity, a MIPS eligible clinician must attest that they reported MACRA patient relationship codes (PRC) using the applicable HCPCS modifiers on 50 percent or more of their Medicare claims for a minimum of a continuous 90-day period within the performance period. Reporting the PRC modifiers enables the
- [2023 MIPS Improvement Activity IA_BE_1: Use of certified EHR to capture patient reported outcomes](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_be_1-use-of-certified-ehr-to-capture-patient-reported-outcomes/) - Activity Description To improve patient access, perform activities beyond routine care that enable capture of patient reported outcomes (for example, related to functional status, symptoms and symptom burden, health behaviors, or patient experience) or patient activation measures (that is, measures of patient involvement in their care) through use of certified electronic health record technology, and
- [2023 MIPS Improvement Activity IA_CC_18: Relationship-Centered Communication](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_cc_18-relationship-centered-communication/) - Activity Description In order to receive credit for this activity, MIPS eligible clinicians must participate in a minimum of eight hours of training on relationship-centered care tenets such as making effective open-ended inquiries; eliciting patient stories and perspectives; listening and responding with empathy; using the ART (ask, respond, tell) communication technique to engage patients, and
- [2023 MIPS Improvement Activity IA_CC_16: Primary Care Physician and Behavioral Health Bilateral Electronic Exchange of
Information for Shared Patients](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_cc_16-primary-care-physician-and-behavioral-health-bilateral-electronic-exchange-ofinformation-for-shared-patients/) - Activity Description The primary care and behavioral health practices use the same electronic health record system for shared patients or have an established bidirectional flow of primary care and behavioral health records. Activity ID Activity Weighting Sub-Category Name IA_CC_16 Medium Care Coordination Objective & Validation Documentation Objective: Improve whole-person care by establishing bidirectional communication between
- [2023 MIPS Improvement Activity IA_CC_17: Patient Navigator Program](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_cc_17-patient-navigator-program/) - Activity Description Implement a Patient Navigator Program that offers evidence-based resources and tools to reduce avoidable hospital readmissions, utilizing a patient-centered and team-based approach, leveraging evidence-based best practices to improve care for patients by making hospitalizations less stressful, and the recovery period more supportive by implementing quality improvement strategies. Activity ID Activity Weighting Sub-Category Name
- [2023 MIPS Improvement Activity IA_CC_15: PSH Care Coordination](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_cc_15-psh-care-coordination/) - Activity Description Participation in a Perioperative Surgical Home (PSH) that provides a patient-centered, physician-led, interdisciplinary, and team-based system of coordinated patient care, which coordinates care from pre-procedure assessment through the acute care episode, recovery, and post-acute care. This activity allows for reporting of strategies and processes related to care coordination of patients receiving surgical or
- [2023 MIPS Improvement Activity IA_CC_12: Care coordination agreements that promote improvements in patient tracking across settings](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_cc_12-care-coordination-agreements-that-promote-improvements-in-patient-tracking-across-settings/) - Activity Description Establish effective care coordination and active referral management that could include one or more of the following: • Establish care coordination agreements with frequently used consultants that set expectations for documented flow of information and MIPS eligible clinician or MIPS eligible clinician group expectations between settings. Provide patients with information that sets their
- [2023 MIPS Improvement Activity IA_CC_13: Practice improvements to align with OpenNotes principles](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_cc_13-practice-improvements-to-align-with-opennotes-principles/) - Activity Description Adherence to the principles described in the OpenNotes initiative (https://www.opennotes.org) to ensure that patients have full access to their patient information to guide patient care. Activity ID Activity Weighting Sub-Category Name IA_CC_13 Medium Care Coordination Objective & Validation Documentation Objective: Utilize a program or process that provides an open exchange of necessary patient
- [2023 MIPS Improvement Activity IA_CC_11: Care transition standard operational improvements](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_cc_11-care-transition-standard-operational-improvements/) - Activity Description Establish standard operations to manage transitions of care that could include one or more of the following: • Establish formalized lines of communication with local settings in which empaneled patients receive care to ensure documented flow of information and seamless transitions in care; and/or • Partner with community or hospital-based transitional care services.
- [2023 MIPS Improvement Activity IA_CC_9: Implementation of practices/processes for developing regular individual care plans](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_cc_9-implementation-of-practices-processes-for-developing-regular-individual-care-plans/) - Activity Description Implementation of practices/processes, including a discussion on care, to develop regularly updated individual care plans for at-risk patients that are shared with the beneficiary or caregiver(s). Individual care plans should include consideration of a patient’s goals and priorities, as well as desired outcomes of care. Activity ID Activity Weighting Sub-Category Name IA_CC_9 Medium
- [2023 MIPS Improvement Activity IA_CC_10: Care transition documentation practice improvements](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_cc_10-care-transition-documentation-practice-improvements/) - Activity Description In order to receive credit for this activity, a MIPS eligible clinician must document practices/processes for care transition with documentation of how a MIPS eligible clinician or group carried out an action plan for the patient with the patient’s preferences in mind (that is, a “patient-centered” plan) during the first 30 days following
- [2023 MIPS Improvement Activity IA_CC_2: Implementation of improvements that contribute to more timely communication of test results](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_cc_2-implementation-of-improvements-that-contribute-to-more-timely-communication-of-test-results/) - Activity Description Timely communication of test results defined as timely identification of abnormal test results with timely follow-up. Activity ID Activity Weighting Sub-Category Name IA_CC_2 Medium Care Coordination Objective & Validation Documentation Objective: Reduce risk of patient harm that occurs when abnormal test results are not delivered in a timely way. Validation Documentation: Evidence of
- [2023 MIPS Improvement Activity IA_CC_7: Regular training in care coordination](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_cc_7-regular-training-in-care-coordination/) - Activity Description Implementation of regular care coordination training. Activity ID Activity Weighting Sub-Category Name IA_CC_7 Medium Care Coordination Objective & Validation Documentation Objective: Utilize preferred practice patterns within your practice to improve care coordination. Validation Documentation: Evidence of participation in/implementation of regular care coordination training within the attestation period. Include the following element: 1) Care
- [2023 MIPS Improvement Activity IA_CC_8: Implementation of documentation improvements for practice/process improvements](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_cc_8-implementation-of-documentation-improvements-for-practice-process-improvements/) - Activity Description Implementation of practices/processes that document care coordination activities (e.g., a documented care coordination encounter that tracks all clinical staff involved and communications from date patient is scheduled for outpatient procedure through day of procedure). Activity ID Activity Weighting Sub-Category Name IA_CC_8 Medium Care Coordination Objective & Validation Documentation Objective: Develop and utilize processes
- [2023 MIPS Improvement Activity IA_PM_20: Glycemic Referring Services](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_20-glycemic-referring-services/) - Activity Description For at-risk outpatient Medicare beneficiaries, individual MIPS eligible clinicians and groups must attest to implementation of systematic preventive approaches in clinical practice for at least 60 percent for the CY 2018 performance period and 75 percent in future years, of medical records with documentation of referring eligible patients with prediabetes to a CDC-recognized
- [2023 MIPS Improvement Activity IA_PM_21: Advance Care Planning](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_21-advance-care-planning/) - Activity Description Implementation of practices/processes to develop advance care planning that includes: documenting the advance care plan or living will within the medical record, educating clinicians about advance care planning motivating them to address advance care planning needs of their patients, and how these needs can translate into quality improvement, educating clinicians on approaches and
- [2023 MIPS Improvement Activity IA_CC_1: Implementation of use of specialist reports back to referring clinician or group to close referral loop](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_cc_1-implementation-of-use-of-specialist-reports-back-to-referring-clinician-or-group-to-close-referral-loop/) - Activity Description Performance of regular practices that include providing specialist reports back to the referring individual MIPS eligible clinician or group to close the referral loop or where the referring individual MIPS eligible clinician or group initiates regular inquiries to specialist for specialist reports which could be documented or noted in the EHR technology. Activity
- [2023 MIPS Improvement Activity IA_PM_18: Provide Clinical-Community Linkages](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_18-provide-clinical-community-linkages/) - Activity Description Engaging community health workers to provide a comprehensive link to community resources through family-based services focusing on success in health, education, and self-sufficiency. This activity supports individual MIPS eligible clinicians or groups that coordinate with primary care and other clinicians, engage and support patients, use of health information technology, and employ quality measurement
- [2023 MIPS Improvement Activity IA_PM_19: Glycemic Screening Services](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_19-glycemic-screening-services/) - Activity Description For at-risk outpatient Medicare beneficiaries, individual MIPS eligible clinicians and groups must attest to implementation of systematic preventive approaches in clinical practice for at least 60 percent for the 2018 performance period and 75 percent in future years, of electronic medical records with documentation of screening patients for abnormal blood glucose according to
- [2023 MIPS Improvement Activity IA_PM_15: Implementation of episodic care management practice improvements](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_15-implementation-of-episodic-care-management-practice-improvements/) - Activity Description Provide episodic care management, including management across transitions and referrals that could include one or more of the following: • Routine and timely follow-up to hospitalizations, ED visits and stays in other institutional settings, including symptom and disease management, and medication reconciliation and management; and/or • Managing care intensively through new diagnoses, injuries
- [2023 MIPS Improvement Activity IA_PM_16: Implementation of medication management practice improvements](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_16-implementation-of-medication-management-practice-improvements/) - Activity Description Manage medications to maximize efficiency, effectiveness and safety that could include one or more of the following: • Reconcile and coordinate medications and provide medication management across transitions of care settings and eligible clinicians or groups; • Integrate a pharmacist into the care team; and/or • Conduct periodic, structured medication reviews. Activity ID
- [2023 MIPS Improvement Activity IA_PM_17: Participation in Population Health Research](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_17-participation-in-population-health-research/) - Activity Description Participation in federally and/or privately funded research that identifies interventions, tools, or processes that can improve a targeted patient population. Activity ID Activity Weighting Sub-Category Name IA_PM_17 Medium Population Management Objective & Validation Documentation Objective: Contribute to the development of evidence-based interventions, tools, or processes for improving health outcomes. Validation Documentation: Evidence supporting
- [2023 MIPS Improvement Activity IA_PM_12: Population empanelment](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_12-population-empanelment/) - Activity Description Empanel (assign responsibility for) the total population, linking each patient to a MIPS eligible clinician or group or care team. Empanelment is a series of processes that assign each active patient to a MIPS eligible clinician or group and/or care team, confirm assignment with patients and clinicians, and use the resultant patient panels
- [2023 MIPS Improvement Activity IA_PM_13: Chronic care and preventative care management for empaneled patients](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_13-chronic-care-and-preventative-care-management-for-empaneled-patients/) - Activity Description In order to receive credit for this activity, a MIPS eligible clinician must manage chronic and preventive care for empaneled patients (that is, patients assigned to care teams for the purpose of population health management), which could include one or more of the following actions: • Provide patients annually with an opportunity for development
- [2023 MIPS Improvement Activity IA_PM_14: Implementation of methodologies for improvements in longitudinal care management for high risk patients](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_14-implementation-of-methodologies-for-improvements-in-longitudinal-care-management-for-high-risk-patients/) - Activity Description Provide longitudinal care management to patients at high risk for adverse health outcome or harm that could include one or more of the following: • Use a consistent method to assign and adjust global risk status for all empaneled patients to allow risk stratification into actionable risk cohorts. Monitor the risk-stratification method and
- [2023 MIPS Improvement Activity IA_PM_5: Engagement of community for health status improvement](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_5-engagement-of-community-for-health-status-improvement/) - Activity Description Take steps to improve health status of communities, such as collaborating with key partners and stakeholders to implement evidenced-based practices to improve a specific chronic condition. Refer to the local Quality Improvement Organization (QIO) for additional steps to take for improving health status of communities as there are many steps to select from
- [2023 MIPS Improvement Activity IA_PM_6: Use of toolsets or other resources to close healthcare disparities across communities](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_6-use-of-toolsets-or-other-resources-to-close-healthcare-disparities-across-communities/) - Activity Description Address inequities in health outcomes by using population health data analysis tools to identify health inequities in the community and practice and assess options for effective and relevant interventions such as Population Health Toolkit or other resources identified by the clinician, practice, or by CMS. Based on this information, create, refine, and implement
- [2023 MIPS Improvement Activity IA_PM_11: Regular review practices in place on targeted patient population needs](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_11-regular-review-practices-in-place-on-targeted-patient-population-needs/) - Activity Description Implement regular reviews of targeted patient population needs, such as structured clinical case reviews, which include access to reports that show unique characteristics of MIPS eligible clinician's patient population, identification of underserved patients, and how clinical treatment needs are being tailored, if necessary, to address unique needs and what resources in the community
- [2023 MIPS Improvement Activity IA_PM_3: RHC, IHS or FQHC quality improvement activities](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_3-rhc-ihs-or-fqhc-quality-improvement-activities/) - Activity Description Participating in a Rural Health Clinic (RHC), Indian Health Service Medium Management (IHS), or Federally Qualified Health Center in ongoing engagement activities that contribute to more formal quality reporting, and that include receiving quality data back for broader quality improvement and benchmarking improvement which will ultimately benefit patients. Participation in Indian Health Service,
- [2023 MIPS Improvement Activity IA_PM_4: Glycemic management services](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_4-glycemic-management-services/) - Activity Description For outpatient Medicare beneficiaries with diabetes and who are prescribed antidiabetic agents (e.g., insulin, sulfonylureas), MIPS eligible clinicians and groups must attest to having: For the first performance year, at least 60 percent of medical records with documentation of an individualized glycemic treatment goal that: a) Takes into account patient-specific factors, including, at
- [2023 MIPS Improvement Activity IA_EPA_5: Participation in User Testing of the Quality Payment Program Website (https://qpp.cms.gov/)](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_epa_5-participation-in-user-testing-of-the-quality-payment-program-website-https-qpp-cms-gov/) - Activity Description User participation in the Quality Payment Program website testing is an activity for eligible clinicians who have worked with CMS to provide substantive, timely, and responsive input to improve the CMS Quality Payment Program website through product user-testing that enhances system and program accessibility, readability and responsiveness as well as providing feedback for
- [2023 MIPS Improvement Activity IA_EPA_6: Create and Implement a Language Access Plan](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_epa_6-create-and-implement-a-language-access-plan/) - Activity Description Create and implement a language access plan to address communication barriers for individuals with limited English proficiency. The language access plan must align with standards for communication and language assistance defined in the National Standards for Culturally and Linguistically Appropriate Services (CLAS) in Health and Health Care (https://thinkculturalhealth.hhs.gov/clas). Activity ID Activity Weighting Sub-Category
- [2023 MIPS Improvement Activity IA_PM_2: Anticoagulant management improvements](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_pm_2-anticoagulant-management-improvements/) - Activity Description Individual MIPS eligible clinicians and groups who prescribe anti-coagulation medications (including, but not limited to oral Vitamin K antagonist therapy, including warfarin or other coagulation cascade inhibitors) must attest that for 75 percent of their ambulatory care patients receiving these medications are being managed with support from one or more of the following
- [2023 MIPS Improvement Activity IA_EPA_2: Use of telehealth services that expand practice access](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_epa_2-use-of-telehealth-services-that-expand-practice-access/) - Activity Description Create and implement a standardized process for providing telehealth services to expand access to care. Activity ID Activity Weighting Sub-Category Name IA_EPA_2 Medium Expanded Practice Access Objective & Validation Documentation Objective: Improve health outcomes by expanding patient access to telehealth services that are delivered through standardized processes. Validation Documentation: Evidence of the creation
- [2023 MIPS Improvement Activity IA_EPA_3: Collection and use of patient experience and satisfaction data on access](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_epa_3-collection-and-use-of-patient-experience-and-satisfaction-data-on-access/) - Activity Description Collection of patient experience and satisfaction data on access to care and development of an improvement plan, such as outlining steps for improving communications with patients to help understanding of urgent access needs. Activity ID Activity Weighting Sub-Category Name IA_EPA_3 Medium Expanded Practice Access Objective & Validation Documentation Objective: Develop an improvement plan
- [2023 MIPS Improvement Activity IA_EPA_4: Additional improvements in access as a result of QIN/QIO TA](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_epa_4-additional-improvements-in-access-as-a-result-of-qin-qio-ta/) - Activity Description As a result of Quality Innovation Network-Quality Improvement Organization technical assistance, performance of additional activities that improve access to services or improve care coordination (for example, investment of on-site diabetes educator). Activity ID Activity Weighting Sub-Category Name IA_EPA_4 Medium Expanded Practice Access Objective & Validation Documentation Objective: Use learnings from engagement with Quality
- [2022 MIPS Improvement Activity IA_PCMH: Electronic submission of Patient Centered Medical Home accreditation](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pcmh-electronic-submission-of-patient-centered-medical-home-accreditation/) - Activity Description N/A Activity ID Activity Weighting Sub-Category Name IA_PCMH N/A Objective Obtaining Patient-Centered Medical Home™ certification drives significant and sustainable practice improvements including population care quality, efficiency, and improved patient satisfaction all directly linked to better health outcomes. Validation Evidence of meeting performance standards and expectations pertaining to the Patient-Centered Medical Home™ model. Include
- [2022 MIPS Improvement Activity IA_ERP_3: COVID-19 Clinical Data Reporting with or without Clinical Trial](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_erp_3-covid-19-clinical-data-reporting-with-or-without-clinical-trial/) - Activity Description To receive credit for this improvement activity, a MIPS eligible clinician or group must: (1) participate in a COVID-19 clinical trial utilizing a drug or biological product to treat a patient with a COVID-19 infection and report their findings through a clinical data repository or clinical data registry for the duration of their
- [2023 MIPS Improvement Activity IA_EPA_1: Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record](https://healthmonix.com/mips_ia/2023-mips-improvement-activity-ia_epa_1-provide-24-7-access-to-mips-eligible-clinicians-or-groups-who-have-real-time-access-to-patients-medical-record/) - Activity Description Provide 24/7 access to MIPS eligible clinicians, groups, or care teams for advice about urgent care (e.g., MIPS eligible clinician and care team access to medical record, cross-coverage with access to medical record, or protocol-driven nurse line with access to medical record) that could include one or more of the following: • Expanded
- [2022 MIPS Improvement Activity IA_BMH_10: Completion of Collaborative Care Management Training Program](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_bmh_10-completion-of-collaborative-care-management-training-program/) - Activity Description To receive credit for this activity, MIPS eligible clinicians must complete a collaborative care management training program, such as the American Psychiatric Association (APA) Collaborative Care Model training program available to the public, in order to implement a collaborative care management approach that provides comprehensive training in the integration of behavioral health into
- [2022 MIPS Improvement Activity IA_BMH_11: Implementation of a Trauma-Informed Care (TIC) Approach to Clinical Practice](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_bmh_11-implementation-of-a-trauma-informed-care-tic-approach-to-clinical-practice/) - Activity Description Create and implement a plan for trauma-informed care (TIC) that recognizes the potential impact of trauma experiences on patients and takes steps to mitigate the effects of adverse events in order to avoid re-traumatizing or triggering past trauma. Actions in this plan may include, but are not limited to, the following: Incorporate trauma-informed
- [2022 MIPS Improvement Activity IA_BMH_12: Promoting Clinician Well-Being](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_bmh_12-promoting-clinician-well-being/) - Activity Description Develop and implement programs to support clinician well-being and resilience—for example, through relationship-building opportunities, leadership development plans, or creation of a team within a practice to address clinician well-being—using one of the following approaches: Completion of clinician survey on clinician well-being with subsequent implementation of an improvement plan based on the results of
- [2022 MIPS Improvement Activity IA_BMH_8: Electronic Health Record Enhancements for BH data capture](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_bmh_8-electronic-health-record-enhancements-for-bh-data-capture/) - Activity Description Enhancements to an electronic health record to capture additional data on behavioral health (BH) populations and use that data for additional decision-making purposes (e.g., capture of additional BH data results in additional depression screening for at-risk patient not previously identified). Activity ID Activity Weighting Sub-Category Name IA_BMH_8 Medium Behavioral and Mental Health Objective
- [2022 MIPS Improvement Activity IA_BMH_9: Unhealthy Alcohol Use for Patients with Co-occurring Conditions of Mental Health and Substance Abuse and Ambulatory Care Patients](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_bmh_9-unhealthy-alcohol-use-for-patients-with-co-occurring-conditions-of-mental-health-and-substance-abuse-and-ambulatory-care-patients/) - Activity Description Individual MIPS eligible clinicians or groups must regularly engage in integrated prevention and treatment interventions, including screening and brief counseling (for example: NQF #2152) for patients with co-occurring conditions of mental health and substance abuse. MIPS eligible clinicians would attest that 60 percent for the CY 2018 Quality Payment Program performance period, and
- [2022 MIPS Improvement Activity IA_BMH_6: Implementation of co-location PCP and MH services](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_bmh_6-implementation-of-co-location-pcp-and-mh-services/) - Activity Description Integration facilitation and promotion of the colocation of mental health and substance use disorder services in primary and/or non-primary clinical care settings. Activity ID Activity Weighting Sub-Category Name IA_BMH_6 High Behavioral and Mental Health Objective Integrate mental health and substance use disorder services with primary and/or non-primary clinical care through the co-location and
- [2022 MIPS Improvement Activity IA_BMH_7: Implementation of Integrated Patient Centered Behavioral Health Model](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_bmh_7-implementation-of-integrated-patient-centered-behavioral-health-model/) - Activity Description Offer integrated behavioral health services to support patients with behavioral health needs who also have conditions such as dementia or other poorly controlled chronic illnesses. The services could include one or more of the following: Use evidence-based treatment protocols and treatment to goal where appropriate; Use evidence-based screening and case finding strategies to
- [2022 MIPS Improvement Activity IA_BMH_4: Depression screening](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_bmh_4-depression-screening/) - Activity Description Depression screening and follow-up plan: Regular engagement of MIPS eligible clinicians or groups in integrated prevention and treatment interventions, including depression screening and follow-up plan (refer to NQF #0418) for patients with co-occurring conditions of behavioral or mental health conditions. Activity ID Activity Weighting Sub-Category Name IA_BMH_4 Medium Behavioral and Mental Health Objective
- [2022 MIPS Improvement Activity IA_BMH_5: MDD prevention and treatment interventions](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_bmh_5-mdd-prevention-and-treatment-interventions/) - Activity Description Major depressive disorder: Regular engagement of MIPS eligible clinicians or groups in integrated prevention and treatment interventions, including suicide risk assessment (refer to NQF #0104) for mental health patients with co-occurring conditions of behavioral or mental health conditions. Activity ID Activity Weighting Sub-Category Name IA_BMH_5 Medium Behavioral and Mental Health Objective Increase patient-centered
- [2022 MIPS Improvement Activity IA_BMH_1: Diabetes screening](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_bmh_1-diabetes-screening/) - Activity Description Diabetes screening for people with schizophrenia or bipolar disease who are using antipsychotic medication. Activity ID Activity Weighting Sub-Category Name IA_BMH_1 Medium Behavioral and Mental Health Objective Improve rates of screening for patients with schizophrenia or bipolar disorder, who have higher risk or higher prevalence of diabetes relative to the general population, thus
- [2022 MIPS Improvement Activity IA_BMH_2: Tobacco use](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_bmh_2-tobacco-use/) - Activity Description Tobacco use: Regular engagement of MIPS eligible clinicians or groups in integrated prevention and treatment interventions, including tobacco use screening and cessation interventions (refer to NQF #0028) for patients with co-occurring conditions of behavioral or mental health and at risk factors for tobacco dependence. Activity ID Activity Weighting Sub-Category Name IA_BMH_2 Medium Behavioral
- [2022 MIPS Improvement Activity IA_ERP_4: Implementation of a Personal Protective Equipment (PPE) Plan](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_erp_4-implementation-of-a-personal-protective-equipment-ppe-plan/) - Activity Description Implement a plan to acquire, store, maintain, and replenish supplies of personal protective equipment (PPE) for all clinicians or other staff who are in physical proximity to patients. In accordance with guidance from the Centers for Disease Control and Prevention (CDC) the PPE plan should address: Conventional capacity: PPE controls that should be
- [2022 MIPS Improvement Activity IA_ERP_5: Implementation of a Laboratory Preparedness Plan](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_erp_5-implementation-of-a-laboratory-preparedness-plan/) - Activity Description Develop, implement, update, and maintain a preparedness plan for a laboratory intended to support continued or expanded patient care during COVID-19 or another public health emergency. The plan should address how the laboratory would maintain or expand patient access to health care services to improve beneficiary health outcomes and reduce healthcare disparities. For
- [2022 MIPS Improvement Activity IA_AHE_9: Implement Food Insecurity and Nutrition Risk Identification and Treatment Protocols](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_ahe_9-implement-food-insecurity-and-nutrition-risk-identification-and-treatment-protocols/) - Activity Description Create or improve, and then implement, protocols for identifying and providing appropriate support to: a) patients with or at risk for food insecurity, and b) patients with or at risk for poor nutritional status. (Poor nutritional status is sometimes referred to as clinical malnutrition or undernutrition and applies to people who are overweight
- [2022 MIPS Improvement Activity IA_ERP_1: Participation on Disaster Medical Assistance Team, registered for 6 months.](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_erp_1-participation-on-disaster-medical-assistance-team-registered-for-6-months/) - Activity Description Participation in Disaster Medical Assistance Teams, or Community Emergency Responder Teams. Activities that simply involve registration are not sufficient. MIPS eligible clinicians and MIPS eligible clinician groups must be registered for a minimum of 6 months as a volunteer for disaster or emergency response. Activity ID Activity Weighting Sub-Category Name IA_ERP_1 Medium Emergency
- [2022 MIPS Improvement Activity IA_ERP_2: Participation in a 60-day or greater effort to support domestic or international humanitarian needs.](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_erp_2-participation-in-a-60-day-or-greater-effort-to-support-domestic-or-international-humanitarian-needs/) - Activity Description Participation in domestic or international humanitarian volunteer work. Activities that simply involve registration are not sufficient. MIPS eligible clinicians and groups attest to domestic or international humanitarian volunteer work for a period of a continuous 60 days or greater. Activity ID Activity Weighting Sub-Category Name IA_ERP_2 High Emergency Response & Preparedness Objective Provide
- [2022 MIPS Improvement Activity IA_AHE_6: Provide Education Opportunities for New Clinicians](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_ahe_6-provide-education-opportunities-for-new-clinicians/) - Activity Description MIPS eligible clinicians acting as a preceptor for clinicians-in-training (such as medical residents/fellows, medical students, physician assistants, nurse practitioners, or clinical nurse specialists) and accepting such clinicians for clinical rotations in community practices in small, underserved, or rural areas. Activity ID Activity Weighting Sub-Category Name IA_AHE_6 High Achieving Health Equity Objective Provide clinicians-in-training
- [2022 MIPS Improvement Activity IA_AHE_7: Comprehensive Eye Exams](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_ahe_7-comprehensive-eye-exams/) - Activity Description To receive credit for this activity, MIPS eligible clinicians must promote the importance of a comprehensive eye exam, which may be accomplished by any one or more of the following: providing literature facilitating a conversation about this topic using resources such as the “Think About Your Eyes” campaign, referring patients to resources providing
- [2022 MIPS Improvement Activity IA_AHE_8: Create and Implement an Anti-Racism Plan](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_ahe_8-create-and-implement-an-anti-racism-plan/) - Activity Description Create and implement an anti-racism plan using the CMS Disparities Impact Statement or other anti-racism planning tools. The plan should include a clinic-wide review of existing tools and policies, such as value statements or clinical practice guidelines, to ensure that they include and are aligned with a commitment to anti-racism and an understanding
- [2022 MIPS Improvement Activity IA_AHE_1: Enhance Engagement of Medicaid and Other Underserved Populations](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_ahe_1-enhance-engagement-of-medicaid-and-other-underserved-populations/) - Activity Description To improve responsiveness of care for Medicaid and other underserved patients: use time-to-treat data (i.e., data measuring the time between clinician identifying a need for an appointment and the patient having a scheduled appointment) to identify patterns by which care or engagement with Medicaid patients or other groups of underserved patients has not
- [2022 MIPS Improvement Activity IA_AHE_3: Promote use of Patient-Reported Outcome Tools](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_ahe_3-promote-use-of-patient-reported-outcome-tools/) - Activity Description Demonstrate performance of activities for employing patient-reported outcome (PRO) tools and corresponding collection of PRO data such as the use of PHQ-2 or PHQ-9, PROMIS instruments, patient reported Wound-Quality of Life (QoL), patient reported Wound Outcome, and patient reported Nutritional Screening. Activity ID Activity Weighting Sub-Category Name IA_AHE_3 High Achieving Health Equity Objective
- [2022 MIPS Improvement Activity IA_AHE_5: MIPS Eligible Clinician Leadership in Clinical Trials or CBPR](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_ahe_5-mips-eligible-clinician-leadership-in-clinical-trials-or-cbpr/) - Activity Description Lead clinical trials, research alliances, or community-based participatory research (CBPR) that identify tools, research, or processes that focus on minimizing disparities in healthcare access, care quality, affordability, or outcomes. Research could include addressing health-related social needs like food insecurity, housing insecurity, transportation barriers, utility needs, and interpersonal safety. Activity ID Activity Weighting Sub-Category
- [2022 MIPS Improvement Activity IA_PSPA_32: Use of CDC Guideline for Clinical Decision Support to Prescribe Opioids for Chronic Pain via Clinical Decision Support](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_32-use-of-cdc-guideline-for-clinical-decision-support-to-prescribe-opioids-for-chronic-pain-via-clinical-decision-support/) - Activity Description In order to receive credit for this activity, MIPS eligible clinicians must utilize the Centers for Disease Control (CDC) Guideline for Prescribing Opioids for Chronic Pain via clinical decision support (CDS). For CDS to be most effective, it needs to be built directly into the clinician workflow and support decision making on a
- [2022 MIPS Improvement Activity IA_PSPA_33: Application of CDC’s Training for Healthcare Providers on Lyme Disease](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_33-application-of-cdcs-training-for-healthcare-providers-on-lyme-disease/) - Activity Description Apply the Centers for Disease Control and Prevention’s (CDC) Training for Healthcare Providers on Lyme Disease using clinical decision support (CDS). CDS for Lyme disease should be built directly into the clinician workflow and support decision making for a specific patient at the point of care. Specific examples of how the guideline could
- [2022 MIPS Improvement Activity IA_PSPA_29: Consulting Appropriate Use Criteria (AUC) Using Clinical Decision Support when Ordering Advanced Diagnostic Imaging](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_29-consulting-appropriate-use-criteria-auc-using-clinical-decision-support-when-ordering-advanced-diagnostic-imaging/) - Activity Description Clinicians attest that they are consulting specified applicable AUC through a qualified clinical decision support mechanism for all applicable imaging services furnished in an applicable setting, paid for under an applicable payment system, and ordered on or after January 1, 2018. This activity is for clinicians that are early adopters of the Medicare
- [2022 MIPS Improvement Activity IA_PSPA_30: PCI Bleeding Campaign](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_30-pci-bleeding-campaign/) - Activity Description Participation in the PCI Bleeding Campaign which is a national quality improvement program that provides infrastructure for a learning network and offers evidence-based resources and tools to reduce avoidable bleeding associated with patients who receive a percutaneous coronary intervention (PCI). The program uses a patient-centered and team-based approach, leveraging evidence-based best practices to
- [2022 MIPS Improvement Activity IA_PSPA_31: Patient Medication Risk Education](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_31-patient-medication-risk-education/) - Activity Description In order to receive credit for this activity, MIPS eligible clinicians must provide both written and verbal education regarding the risks of concurrent opioid and benzodiazepine use for patients who are prescribed both benzodiazepines and opioids. Education must be completed for at least 75% of qualifying patients and occur: (1) at the time
- [2022 MIPS Improvement Activity IA_PSPA_27: Invasive Procedure or Surgery Anticoagulation Medication Management](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_27-invasive-procedure-or-surgery-anticoagulation-medication-management/) - Activity Description For an anticoagulated patient undergoing a planned invasive procedure for which interruption in anticoagulation is anticipated, including patients taking vitamin K antagonists (warfarin), target specific oral anticoagulants (such as apixaban, dabigatran, and rivaroxaban), and heparins/low molecular weight heparins, documentation, including through the use of electronic tools, that the plan for anticoagulation management in
- [2022 MIPS Improvement Activity IA_PSPA_28: Completion of an Accredited Safety or Quality Improvement Program](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_28-completion-of-an-accredited-safety-or-quality-improvement-program/) - Activity Description Completion of an accredited performance improvement continuing medical education (CME) program that addresses performance or quality improvement according to the following criteria: The activity must address a quality or safety gap that is supported by a needs assessment or problem analysis, or must support the completion of such a needs assessment as part
- [2022 MIPS Improvement Activity lA_PSPA_26: Communication of Unscheduled Visit for Adverse Drug Event and Nature of Event](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-la_pspa_26-communication-of-unscheduled-visit-for-adverse-drug-event-and-nature-of-event/) - Activity Description A MIPS eligible clinician providing unscheduled care (such as an emergency room, urgent care, or other unplanned encounter) attests that, for greater than 75 percent of case visits that result from a clinically significant adverse drug event, the MIPS eligible clinician provides information, including through the use of health IT to the patient’s
- [2022 MIPS Improvement Activity IA_PSPA_23: Completion of CDC Training on Antibiotic Stewardship](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_23-completion-of-cdc-training-on-antibiotic-stewardship/) - Activity Description Completion of all modules of the Centers for Disease Control and Prevention antibiotic stewardship course. Note: This activity may be selected once every 4 years, to avoid duplicative information given that some of the modules may change on a year by year basis but over 4 years there would be a reasonable expectation
- [2022 MIPS Improvement Activity IA_PSPA_25: Cost Display for Laboratory and Radiographic Orders](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_25-cost-display-for-laboratory-and-radiographic-orders/) - Activity Description Implementation of a cost display for laboratory and radiographic orders, such as costs that can be obtained through the Medicare clinical laboratory fee schedule. Activity ID Activity Weighting Sub-Category Name IA_PSPA_25 Medium Patient Safety and Practice Assessment Objective Help eligible ordering clinicians easily obtain information on the cost of laboratory and radiography orders,
- [2022 MIPS Improvement Activity IA_PSPA_20: Leadership engagement in regular guidance and demonstrated commitment for implementing practice improvement changes](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_20-leadership-engagement-in-regular-guidance-and-demonstrated-commitment-for-implementing-practice-improvement-changes/) - Activity Description Ensure full engagement of clinical and administrative leadership in practice improvement that could include one or more of the following: Make responsibility for guidance of practice change a component of clinical and administrative leadership roles; Allocate time for clinical and administrative leadership for practice improvement efforts, including participation in regular team meetings; and/or
- [2022 MIPS Improvement Activity IA_PSPA_21: Implementation of fall screening and assessment programs](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_21-implementation-of-fall-screening-and-assessment-programs/) - Activity Description Implementation of fall screening and assessment programs to identify patients at risk for falls and address modifiable risk factors (e.g., Clinical decision support/prompts in the electronic health record that help manage the use of medications, such as benzodiazepines, that increase fall risk). Activity ID Activity Weighting Sub-Category Name IA_PSPA_21 Medium Patient Safety and
- [2022 MIPS Improvement Activity IA_PSPA_22: CDC Training on CDC's Guideline for Prescribing Opioids for Chronic Pain](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_22-cdc-training-on-cdcs-guideline-for-prescribing-opioids-for-chronic-pain/) - Activity Description Completion of all the modules of the Centers for Disease Control and Prevention (CDC) course “Applying CDC’s Guideline for Prescribing Opioids” that reviews the 2016 “Guideline for Prescribing Opioids for Chronic Pain.” Note: This activity may be selected once every 4 years, to avoid duplicative information given that some of the modules may
- [2022 MIPS Improvement Activity IA_PSPA_18: Measurement and improvement at the practice and panel level](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_18-measurement-and-improvement-at-the-practice-and-panel-level/) - Activity Description Measure and improve quality at the practice and panel level, such as the American Board of Orthopaedic Surgery (ABOS) Physician Scorecards that could include one or more of the following: Regularly review measures of quality, utilization, patient satisfaction and other measures; and/or Use relevant data sources to create benchmarks and goals for performance
- [2022 MIPS Improvement Activity IA_PSPA_19: Implementation of formal quality improvement methods, practice changes or other practice improvement processes](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_19-implementation-of-formal-quality-improvement-methods-practice-changes-or-other-practice-improvement-processes/) - Activity Description Adopt a formal model for quality improvement and create a culture in which all staff actively participates in improvement activities that could include one or more of the following, such as: Participation in multisource feedback; Train all staff in quality improvement methods; Integrate practice change/quality improvement into staff duties; Engage all staff in
- [2022 MIPS Improvement Activity IA_PSPA_15: Implementation of an ASP](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_15-implementation-of-an-asp/) - Activity Description Leadership of an Antimicrobial Stewardship Program (ASP) that includes implementation of an ASP that measures the appropriate use of antibiotics for several different conditions (such as but not limited to upper respiratory infection treatment in children, diagnosis of pharyngitis, bronchitis treatment in adults) according to clinical guidelines for diagnostics and therapeutics. Specific activities
- [2022 MIPS Improvement Activity IA_PSPA_16: Use of decision support and standardized treatment protocols](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_16-use-of-decision-support-and-standardized-treatment-protocols/) - Activity Description Use decision support and standardized treatment protocols to manage workflow in the team to meet patient needs. Activity ID Activity Weighting Sub-Category Name IA_PSPA_16 Medium Patient Safety and Practice Assessment Objective Help eligible clinicians align diagnoses and treatment plans with up-to-date, evidence-based standards and guidelines as part of routine care, thus improving the
- [2022 MIPS Improvement Activity IA_PSPA_17: Implementation of analytic capabilities to manage total cost of care for practice population](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_17-implementation-of-analytic-capabilities-to-manage-total-cost-of-care-for-practice-population/) - Activity Description In order to receive credit for this activity, a MIPS eligible clinician must conduct or build the capacity to conduct analytic activities to manage total cost of care for the practice population. Examples of these activities could include: Train appropriate staff on interpretation of cost and utilization information; Use available data regularly to
- [2022 MIPS Improvement Activity IA_PSPA_12: Participation in private payer CPIA](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_12-participation-in-private-payer-cpia/) - Activity Description Participation in designated private payer clinical practice improvement activities. Activity ID Activity Weighting Sub-Category Name IA_PSPA_12 Medium Patient Safety & Practice Assessment Objective Improve the quality of care provided, and health outcomes for patients, by participating in improvement activities designated by private payers. Validation Evidence of participation in private payer clinical practice improvement
- [2022 MIPS Improvement Activity IA_PSPA_13: Participation in Joint Commission Evaluation Initiative](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_13-participation-in-joint-commission-evaluation-initiative/) - Activity Description Participation in Joint Commission Ongoing Professional Practice Evaluation initiative Activity ID Activity Weighting Sub-Category Name IA_PSPA_13 Medium Patient Safety & Practice Assessment Objective Implement the Joint Commission’s Ongoing Professional Practice Evaluation with goal of identifying negative practice trends earlier. Validation Evidence of participation in the Joint Commission’s Ongoing Professional Practice Evaluation (OPPE) initiative.
- [2022 MIPS Improvement Activity IA_PSPA_8: Use of patient safety tools](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_8-use-of-patient-safety-tools/) - Activity Description In order to receive credit for this activity, a MIPS eligible clinician must use tools that assist specialty practices in tracking specific measures that are meaningful to their practice. Some examples of tools that could satisfy this activity are: a surgical risk calculator; evidence based protocols, such as Enhanced Recovery After Surgery (ERAS)
- [2022 MIPS Improvement Activity IA_PSPA_9: Completion of the AMA STEPS Forward program](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_9-completion-of-the-ama-steps-forward-program/) - Activity Description Completion of the American Medical Association’s STEPS Forward program. Activity ID Activity Weighting Sub-Category Name IA_PSPA_9 Medium Patient Safety & Practice Assessment Objective Gain the knowledge to "improve practice efficiency and ultimately enhance patient care, physician satisfaction and practice sustainability" (from edhub.ama-assn.org). Validation Evidence of completion of American Medical Association’s (AMA’s) STEPS Forward
- [2022 MIPS Improvement Activity IA_PSPA_10: Completion of training and receipt of approved waiver for provision of opioid medication-assisted treatments](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_10-completion-of-training-and-receipt-of-approved-waiver-for-provision-of-opioid-medication-assisted-treatments/) - Activity Description Completion of training and obtaining an approved waiver for provision of medication -assisted treatment of opioid use disorders using buprenorphine. Activity ID Activity Weighting Sub-Category Name IA_PSPA_10 Medium Patient Safety & Practice Assessment Objective Become better equipped to help patients overcome their opioid use disorders and, with certification, become a trusted source of
- [2022 MIPS Improvement Activity IA_PSPA_4: Administration of the AHRQ Survey of Patient Safety Culture](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_4-administration-of-the-ahrq-survey-of-patient-safety-culture/) - Activity Description Administration of the AHRQ Survey of Patient Safety Culture and submission of data to the comparative database (refer to AHRQ Survey of Patient Safety Culture website www.ahrq.gov). Note: This activity may be selected once every 4 years, to avoid duplicative information given that some of the modules may change on a year by
- [2022 MIPS Improvement Activity IA_PSPA_6: Consultation of the Prescription Drug Monitoring program](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_6-consultation-of-the-prescription-drug-monitoring-program/) - Activity Description Review the history of controlled substance prescriptions for 90 percent* of patients using state prescription drug monitoring program (PDMP) data prior to the issuance of a Controlled Substance Schedule II (CSII) opioid prescription lasting longer than 3 days. *Apply exceptions for patients receiving palliative and hospice care. Activity ID Activity Weighting Sub-Category Name
- [2022 MIPS Improvement Activity IA_PSPA_7: Use of QCDR data for ongoing practice assessment and improvements](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_7-use-of-qcdr-data-for-ongoing-practice-assessment-and-improvements/) - Activity Description Participation in a Qualified Clinical Data Registry (QCDR) and use of QCDR data for ongoing practice assessment and improvements in patient safety, including: Performance of activities that promote use of standard practices, tools and processes for quality improvement (for example, documented preventative screening and vaccinations that can be shared across MIPS eligible clinician
- [2022 MIPS Improvement Activity IA_PSPA_3: Participate in IHI Training/Forum Event; National Academy of Medicine, AHRQ Team STEPPS® or other similar activity.](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_3-participate-in-ihi-training-forum-event-national-academy-of-medicine-ahrq-team-stepps-or-other-similar-activity/) - Activity Description For MIPS eligible clinicians not participating in Maintenance of Certification (MOC) Part IV, new engagement for MOC Part IV, such as the Institute for Healthcare Improvement (IHI) Training/Forum Event; National Academy of Medicine, Agency for Healthcare Research and Quality (AHRQ) Team STEPPS®, or the American Board of Family Medicine (ABFM) Performance in Practice
- [2022 MIPS Improvement Activity IA_PSPA_2: Participation in MOC Part IV](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_2-participation-in-moc-part-iv/) - Activity Description In order to receive credit for this activity, a MIPS eligible clinician must participate in Maintenance of Certification (MOC) Part IV. Maintenance of Certification (MOC) Part IV requires clinicians to perform monthly activities across practice to regularly assess performance by reviewing outcomes addressing identified areas for improvement and evaluating the results. Some examples
- [2022 MIPS Improvement Activity IA_BE_24: Financial Navigation Program](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_be_24-financial-navigation-program/) - Activity Description In order to receive credit for this activity, MIPS eligible clinicians must attest that their practice provides financial counseling to patients or their caregiver about costs of care and an exploration of different payment options. The MIPS eligible clinician may accomplish this by working with other members of their practice (for example, financial
- [2022 MIPS Improvement Activity IA_BE_25: Drug Cost Transparency](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_be_25-drug-cost-transparency/) - Activity Description Provide counseling to patients and/or their caregivers regarding: costs of medications using a real time benefit tool (RTBT) which provides to the prescriber real-time patient-specific formulary and benefit information for drugs, including cost-sharing for a beneficiary. Activity ID Activity Weighting Sub-Category Name IA_BE_25 High Beneficiary Engagement Objective Help patients navigate the stress and
- [2022 MIPS Improvement Activity IA_PSPA_1: Participation in an AHRQ-listed patient safety organization.](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pspa_1-participation-in-an-ahrq-listed-patient-safety-organization/) - Activity Description Participation in an AHRQ-listed patient safety organization. Activity ID Activity Weighting Sub-Category Name IA_PSPA_1 Medium Patient Safety & Practice Assessment Objective Adopt and implement Patient Safety Organization (PSO) methodologies through data collection, analysis, reporting, and education to promote the quantifiable reduction of avoidable medical errors and deficiencies identified in the quality of care
- [2022 MIPS Improvement Activity IA_BE_22: Improved practices that engage patients pre-visit](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_be_22-improved-practices-that-engage-patients-pre-visit/) - Activity Description Implementation of workflow changes that engage patients prior to the visit, such as a pre-visit development of a shared visit agenda with the patient, or targeted pre-visit laboratory testing that will be resulted and available to the MIPS eligible clinician to review and discuss during the patient’s appointment. Activity ID Activity Weighting Sub-Category
- [2022 MIPS Improvement Activity IA_BE_23: Integration of patient coaching practices between visits](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_be_23-integration-of-patient-coaching-practices-between-visits/) - Activity Description Provide coaching between visits with follow-up on care plan and goals. Activity ID Activity Weighting Sub-Category Name IA_BE_23 Medium Beneficiary Engagement Objective Provide additional direct support to patients in achieving their goals, thus improving patient satisfaction, adherence to plans, and health outcomes. Validation Documented use of coaching provided between visits with follow-up on
- [2022 MIPS Improvement Activity IA_BE_15: Engagement of patients, family and caregivers in developing a plan of care](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_be_15-engagement-of-patients-family-and-caregivers-in-developing-a-plan-of-care/) - Activity Description Engage patients, family, and caregivers in developing a plan of care and prioritizing their goals for action, documented in the electronic health record (EHR) technology. Activity ID Activity Weighting Sub-Category Name IA_BE_15 Medium Beneficiary Engagement Objective Increase engagement with patients, family, and caregivers and ensure care provided aligns with their priorities and needs.
- [2022 MIPS Improvement Activity IA_BE_16: Promote Self-management in Usual Care](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_be_16-promote-self-management-in-usual-care/) - Activity Description To help patients self-manage their care, incorporate culturally and linguistically tailored evidence-based techniques for promoting self-management into usual care, and provide patients with tools and resources for self-management. Examples of evidence-based techniques to use in usual care include: goal setting with structured follow-up, Teach-back methods, action planning, assessment of need for self-management (for
- [2022 MIPS Improvement Activity IA_BE_19: Use group visits for common chronic conditions (e.g., diabetes).](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_be_19-use-group-visits-for-common-chronic-conditions-e-g-diabetes/) - Activity Description Use group visits for common chronic conditions (e.g., diabetes). Activity ID Activity Weighting Sub-Category Name IA_BE_19 Medium Beneficiary Engagement Objective Give patients with common chronic conditions opportunities to learn about self-management topics and discuss shared concerns while improving efficiency in the delivery of quality care. Validation Documented use of group visits for chronic
- [2022 MIPS Improvement Activity IA_BE_8: Participation in a QCDR, that promotes collaborative learning network opportunities that are interactive.](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_be_8-participation-in-a-qcdr-that-promotes-collaborative-learning-network-opportunities-that-are-interactive/) - Activity Description Participation in a QCDR, that promotes collaborative learning network opportunities that are interactive. Activity ID Activity Weighting Sub-Category Name IA_BE_8 Medium Beneficiary Engagement Objective Increase involvement of interactive collaborative learning networks with support of qualified clinical data registry (QCDR) promotion and feedback reports. Validation Evidence of participation in a QCDR that promotes interactive
- [2022 MIPS Improvement Activity IA_BE_12: Use evidence-based decision aids to support shared decision-making.](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_be_12-use-evidence-based-decision-aids-to-support-shared-decision-making/) - Activity Description Use evidence-based decision aids to support shared decision-making. Activity ID Activity Weighting Sub-Category Name IA_BE_12 Medium Beneficiary Engagement Objective Increase use of evidence-based decision aids to encourage shared decision-making with beneficiaries. Validation Documented use of evidence-based decision aids to support shared decision-making, a collaborative process aimed at improving beneficiary-clinician communication and informed consent
- [2022 MIPS Improvement Activity IA_BE_14: Engage patients and families to guide improvement in the system of care.](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_be_14-engage-patients-and-families-to-guide-improvement-in-the-system-of-care/) - Activity Description Engage patients and families to guide improvement in the system of care by leveraging digital tools for ongoing guidance and assessments outside the encounter, including the collection and use of patient data for return-to-work and patient quality of life improvement. Platforms and devices that collect patient-generated health data (PGHD) must do so with
- [2022 MIPS Improvement Activity IA_BE_6: Regularly Assess Patient Experience of Care and Follow Up on Findings](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_be_6-regularly-assess-patient-experience-of-care-and-follow-up-on-findings/) - Activity Description Collect and follow up on patient experience and satisfaction data. This activity also requires follow-up on findings of assessments, including the development and implementation of improvement plans. To fulfill the requirements of this activity, MIPS eligible clinicians can use surveys (e.g., Consumer Assessment of Healthcare Providers and Systems Survey), advisory councils, or other
- [2022 MIPS Improvement Activity IA_BE_7: Participation in a QCDR, that promotes use of patient engagement tools.](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_be_7-participation-in-a-qcdr-that-promotes-use-of-patient-engagement-tools/) - Activity Description Participation in a Qualified Clinical Data Registry (QCDR), that promotes patient engagement, including: Use of processes and tools that engage patients for adherence to treatment plans; Implementation of patient self-action plans; Implementation of shared clinical decision making capabilities; or Use of QCDR patient experience data to inform and advance improvements in beneficiary engagement.
- [2022 MIPS Improvement Activity IA_BE_3: Engagement with QIN-QIO to implement self-management training programs](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_be_3-engagement-with-qin-qio-to-implement-self-management-training-programs/) - Activity Description Engagement with a Quality Innovation Network-Quality Improvement Organization, which may include participation in self-management training programs such as diabetes. Activity ID Activity Weighting Sub-Category Name IA_BE_3 Medium Beneficiary Engagement Objective Become more equipped to help patients self-manage their chronic conditions. Validation Evidence of Quality Innovation Network-Quality Improvement Organization (QIN-QIO) relationship to implement self-management
- [2022 MIPS Improvement Activity IA_BE_4: Engagement of patients through implementation of improvements in patient portal](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_be_4-engagement-of-patients-through-implementation-of-improvements-in-patient-portal/) - Activity Description To receive credit for this activity, MIPS eligible clinicians must provide access to an enhanced patient/caregiver portal that allows users (patients or caregivers and their clinicians) to engage in bidirectional information exchange. The primary use of this portal should be clinical and not administrative. Examples of the use of such a portal include,
- [2022 MIPS Improvement Activity IA_BE_5: Enhancements/regular updates to practice websites/tools that also include considerations for patients with cognitive disabilities](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_be_5-enhancements-regular-updates-to-practice-websites-tools-that-also-include-considerations-for-patients-with-cognitive-disabilities/) - Activity Description Enhancements and ongoing regular updates and use of websites/tools that include consideration for compliance with section 508 of the Rehabilitation Act of 1973 or for improved design for patients with cognitive disabilities. Refer to the CMS website on Section 508 of the Rehabilitation Act that requires that institutions receiving federal funds solicit, procure,
- [2022 MIPS Improvement Activity IA_CC_19: Tracking of clinician's relationship to and responsibility for a patient by reporting MACRA patient relationship codes.](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_cc_19-tracking-of-clinicians-relationship-to-and-responsibility-for-a-patient-by-reporting-macra-patient-relationship-codes/) - Activity Description To receive credit for this improvement activity, a MIPS eligible clinician must attest that they reported MACRA patient relationship codes (PRC) using the applicable HCPCS modifiers on 50 percent or more of their Medicare claims for a minimum of a continuous 90-day period within the performance period. Reporting the PRC modifiers enables the
- [2022 MIPS Improvement Activity IA_BE_1: Use of certified EHR to capture patient reported outcomes](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_be_1-use-of-certified-ehr-to-capture-patient-reported-outcomes/) - Activity Description To improve patient access, perform activities beyond routine care that enable capture of patient reported outcomes (for example, related to functional status, symptoms and symptom burden, health behaviors, or patient experience) or patient activation measures (that is, measures of patient involvement in their care) through use of certified electronic health record technology, and
- [2022 MIPS Improvement Activity IA_CC_18: Relationship-Centered Communication](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_cc_18-relationship-centered-communication/) - Activity Description In order to receive credit for this activity, MIPS eligible clinicians must participate in a minimum of eight hours of training on relationship-centered care tenets such as making effective open-ended inquiries; eliciting patient stories and perspectives; listening and responding with empathy; using the ART (ask, respond, tell) communication technique to engage patients, and
- [2022 MIPS Improvement Activity IA_CC_17: Patient Navigator Program](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_cc_17-patient-navigator-program/) - Activity Description Implement a Patient Navigator Program that offers evidence-based resources and tools to reduce avoidable hospital readmissions, utilizing a patient-centered and team-based approach, leveraging evidence-based best practices to improve care for patients by making hospitalizations less stressful, and the recovery period more supportive by implementing quality improvement strategies. Activity ID Activity Weighting Sub-Category Name
- [2022 MIPS Improvement Activity IA_CC_15: PSH Care Coordination](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_cc_15-psh-care-coordination/) - Activity Description Participation in a Perioperative Surgical Home (PSH) that provides a patient-centered, physician-led, interdisciplinary, and team-based system of coordinated patient care, which coordinates care from pre-procedure assessment through the acute care episode, recovery, and post-acute care. This activity allows for reporting of strategies and processes related to care coordination of patients receiving surgical or
- [2022 MIPS Improvement Activity IA_CC_16: Primary Care Physician and Behavioral Health Bilateral Electronic Exchange of
Information for Shared Patients](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_cc_16-primary-care-physician-and-behavioral-health-bilateral-electronic-exchange-ofinformation-for-shared-patients/) - Activity Description The primary care and behavioral health practices use the same electronic health record system for shared patients or have an established bidirectional flow of primary care and behavioral health records. Activity ID Activity Weighting Sub-Category Name IA_CC_16 Medium Care Coordination Objective Improve whole-person care by establishing bidirectional communication between eligible primary care clinicians
- [2022 MIPS Improvement Activity IA_CC_12: Care coordination agreements that promote improvements in patient tracking across settings](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_cc_12-care-coordination-agreements-that-promote-improvements-in-patient-tracking-across-settings/) - Activity Description Establish effective care coordination and active referral management that could include one or more of the following: Establish care coordination agreements with frequently used consultants that set expectations for documented flow of information and MIPS eligible clinician or MIPS eligible clinician group expectations between settings. Provide patients with information that sets their expectations
- [2022 MIPS Improvement Activity IA_CC_13: Practice improvements for bilateral exchange of patient information](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_cc_13-practice-improvements-for-bilateral-exchange-of-patient-information/) - Activity Description Ensure that there is bilateral exchange of necessary patient information to guide patient care, such as Open Notes, that could include one or more of the following: Participate in a Health Information Exchange if available; and/or Use structured referral notes. Activity ID Activity Weighting Sub-Category Name IA_CC_13 Medium Care Coordination Objective Utilize a
- [2022 MIPS Improvement Activity IA_CC_14: Practice improvements that engage community resources to support patient health goals](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_cc_14-practice-improvements-that-engage-community-resources-to-support-patient-health-goals/) - Activity Description Select and screen for the health-related social needs (HRSN) that are relevant for your patient population using tools that have been tested with underserved populations. If possible, use a screening tool that is health IT-enabled and includes standards-based, coded question/field for the capture of data. After screening, address HRSNs identified through at least
- [2022 MIPS Improvement Activity IA_CC_10: Care transition documentation practice improvements](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_cc_10-care-transition-documentation-practice-improvements/) - Activity Description In order to receive credit for this activity, a MIPS eligible clinician must document practices/processes for care transition with documentation of how a MIPS eligible clinician or group carried out an action plan for the patient with the patient’s preferences in mind (that is, a “patient-centered” plan) during the first 30 days following
- [2022 MIPS Improvement Activity IA_CC_11: Care transition standard operational improvements](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_cc_11-care-transition-standard-operational-improvements/) - Activity Description Establish standard operations to manage transitions of care that could include one or more of the following: Establish formalized lines of communication with local settings in which empaneled patients receive care to ensure documented flow of information and seamless transitions in care; and/or Partner with community or hospital-based transitional care services. Activity ID
- [2022 MIPS Improvement Activity IA_CC_7: Regular training in care coordination](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_cc_7-regular-training-in-care-coordination/) - Activity Description Implementation of regular care coordination training. Activity ID Activity Weighting Sub-Category Name IA_CC_7 Medium Care Coordination Objective Utilize preferred practice patterns within your practice to improve care coordination. Validation Evidence of participation in/implementation of regular care coordination training within the attestation period. Include the following element: Care coordination training – Examples include availability
- [2022 MIPS Improvement Activity IA_CC_8: Implementation of documentation improvements for practice/process improvements](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_cc_8-implementation-of-documentation-improvements-for-practice-process-improvements/) - Activity Description Implementation of practices/processes that document care coordination activities (e.g., a documented care coordination encounter that tracks all clinical staff involved and communications from date patient is scheduled for outpatient procedure through day of procedure). Activity ID Activity Weighting Sub-Category Name IA_CC_8 Medium Care Coordination Objective Develop and utilize processes that improve care coordination
- [2022 MIPS Improvement Activity IA_CC_9: Implementation of practices/processes for developing regular individual care plans](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_cc_9-implementation-of-practices-processes-for-developing-regular-individual-care-plans/) - Activity Description Implementation of practices/processes, including a discussion on care, to develop regularly updated individual care plans for at-risk patients that are shared with the beneficiary or caregiver(s). Individual care plans should include consideration of a patient’s goals and priorities, as well as desired outcomes of care. Activity ID Activity Weighting Sub-Category Name IA_CC_9 Medium
- [2022 MIPS Improvement Activity IA_PM_21: Advance Care Planning](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_21-advance-care-planning/) - Activity Description Implementation of practices/processes to develop advance care planning that includes: documenting the advance care plan or living will within the medical record, educating clinicians about advance care planning motivating them to address advance care planning needs of their patients, and how these needs can translate into quality improvement, educating clinicians on approaches and
- [2022 MIPS Improvement Activity IA_CC_1: Implementation of use of specialist reports back to referring clinician or group to close referral loop](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_cc_1-implementation-of-use-of-specialist-reports-back-to-referring-clinician-or-group-to-close-referral-loop/) - Activity Description Performance of regular practices that include providing specialist reports back to the referring individual MIPS eligible clinician or group to close the referral loop or where the referring individual MIPS eligible clinician or group initiates regular inquiries to specialist for specialist reports which could be documented or noted in the EHR technology. Activity
- [2022 MIPS Improvement Activity IA_CC_2: Implementation of improvements that contribute to more timely communication of test results](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_cc_2-implementation-of-improvements-that-contribute-to-more-timely-communication-of-test-results/) - Activity Description Timely communication of test results defined as timely identification of abnormal test results with timely follow-up. Activity ID Activity Weighting Sub-Category Name IA_CC_2 Medium Care Coordination Objective Reduce risk of patient harm that occurs when abnormal test results are not delivered in a timely way. Validation Evidence of a process that reduces the
- [2022 MIPS Improvement Activity IA_PM_19: Glycemic Screening Services](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_19-glycemic-screening-services/) - Activity Description For at-risk outpatient Medicare beneficiaries, individual MIPS eligible clinicians and groups must attest to implementation of systematic preventive approaches in clinical practice for at least 60 percent for the 2018 performance period and 75 percent in future years, of electronic medical records with documentation of screening patients for abnormal blood glucose according to
- [2022 MIPS Improvement Activity IA_PM_20: Glycemic Referring Services](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_20-glycemic-referring-services/) - Activity Description For at-risk outpatient Medicare beneficiaries, individual MIPS eligible clinicians and groups must attest to implementation of systematic preventive approaches in clinical practice for at least 60 percent for the CY 2018 performance period and 75 percent in future years, of medical records with documentation of referring eligible patients with prediabetes to a CDC-recognized
- [2022 MIPS Improvement Activity IA_PM_16: Implementation of medication management practice improvements](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_16-implementation-of-medication-management-practice-improvements/) - Activity Description Manage medications to maximize efficiency, effectiveness and safety that could include one or more of the following: Reconcile and coordinate medications and provide medication management across transitions of care settings and eligible clinicians or groups; Integrate a pharmacist into the care team; and/or Conduct periodic, structured medication reviews. Activity ID Activity Weighting Sub-Category
- [2022 MIPS Improvement Activity IA_PM_17: Participation in Population Health Research](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_17-participation-in-population-health-research/) - Activity Description Participation in federally and/or privately funded research that identifies interventions, tools, or processes that can improve a targeted patient population. Activity ID Activity Weighting Sub-Category Name IA_PM_17 Medium Population Management Objective Contribute to the development of evidence-based interventions, tools, or processes for improving health outcomes. Validation Evidence supporting participation in a federally and/or
- [2022 MIPS Improvement Activity IA_PM_18: Provide Clinical-Community Linkages](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_18-provide-clinical-community-linkages/) - Activity Description Engaging community health workers to provide a comprehensive link to community resources through family-based services focusing on success in health, education, and self-sufficiency. This activity supports individual MIPS eligible clinicians or groups that coordinate with primary care and other clinicians, engage and support patients, use of health information technology, and employ quality measurement
- [2022 MIPS Improvement Activity IA_PM_15: Implementation of episodic care management practice improvements](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_15-implementation-of-episodic-care-management-practice-improvements/) - Activity Description Provide episodic care management, including management across transitions and referrals that could include one or more of the following: Routine and timely follow-up to hospitalizations, ED visits and stays in other institutional settings, including symptom and disease management, and medication reconciliation and management; and/or Managing care intensively through new diagnoses, injuries and exacerbations
- [2022 MIPS Improvement Activity IA_PM_14: Implementation of methodologies for improvements in longitudinal care management for high risk patients](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_14-implementation-of-methodologies-for-improvements-in-longitudinal-care-management-for-high-risk-patients/) - Activity Description Provide longitudinal care management to patients at high risk for adverse health outcome or harm that could include one or more of the following: Use a consistent method to assign and adjust global risk status for all empaneled patients to allow risk stratification into actionable risk cohorts. Monitor the risk-stratification method and refine
- [2022 MIPS Improvement Activity IA_PM_11: Regular review practices in place on targeted patient population needs](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_11-regular-review-practices-in-place-on-targeted-patient-population-needs/) - Activity Description Implement regular reviews of targeted patient population needs, such as structured clinical case reviews, which include access to reports that show unique characteristics of MIPS eligible clinician's patient population, identification of underserved patients, and how clinical treatment needs are being tailored, if necessary, to address unique needs and what resources in the community
- [2022 MIPS Improvement Activity IA_PM_12: Population empanelment](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_12-population-empanelment/) - Activity Description Empanel (assign responsibility for) the total population, linking each patient to a MIPS eligible clinician or group or care team. Empanelment is a series of processes that assign each active patient to a MIPS eligible clinician or group and/or care team, confirm assignment with patients and clinicians, and use the resultant patient panels
- [2022 MIPS Improvement Activity IA_PM_13: Chronic care and preventative care management for empaneled patients](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_13-chronic-care-and-preventative-care-management-for-empaneled-patients/) - Activity Description In order to receive credit for this activity, a MIPS eligible clinician must manage chronic and preventive care for empaneled patients (that is, patients assigned to care teams for the purpose of population health management), which could include one or more of the following actions: Provide patients annually with an opportunity for development
- [2022 MIPS Improvement Activity IA_PM_6: Use of toolsets or other resources to close healthcare disparities across communities](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_6-use-of-toolsets-or-other-resources-to-close-healthcare-disparities-across-communities/) - Activity Description Address inequities in health outcomes by using population health data analysis tools to identify health inequities in the community and practice and assess options for effective and relevant interventions such as Population Health Toolkit or other resources identified by the clinician, practice, or by CMS. Based on this information, create, refine, and implement
- [2022 MIPS Improvement Activity IA_PM_7: Use of QCDR for feedback reports that incorporate population health](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_7-use-of-qcdr-for-feedback-reports-that-incorporate-population-health/) - Activity Description Use of a QCDR to generate regular feedback reports that summarize local practice patterns and treatment outcomes, including for vulnerable populations. Activity ID Activity Weighting Sub-Category Name IA_PM_7 High Population Management Objective Increase knowledge of practice patterns and treatment outcomes to better serve patients, including vulnerable populations. Validation Evidence of use of qualified
- [2022 MIPS Improvement Activity IA_PM_4: Glycemic management services](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_4-glycemic-management-services/) - Activity Description For outpatient Medicare beneficiaries with diabetes and who are prescribed antidiabetic agents (e.g., insulin, sulfonylureas), MIPS eligible clinicians and groups must attest to having: For the first performance year, at least 60 percent of medical records with documentation of an individualized glycemic treatment goal that: Takes into account patient-specific factors, including, at least
- [2022 MIPS Improvement Activity IA_PM_5: Engagement of community for health status improvement](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_5-engagement-of-community-for-health-status-improvement/) - Activity Description Take steps to improve health status of communities, such as collaborating with key partners and stakeholders to implement evidenced-based practices to improve a specific chronic condition. Refer to the local Quality Improvement Organization (QIO) for additional steps to take for improving health status of communities as there are many steps to select from
- [2022 MIPS Improvement Activity IA_PM_2: Anticoagulant management improvements](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_2-anticoagulant-management-improvements/) - Activity Description Individual MIPS eligible clinicians and groups who prescribe anti-coagulation medications (including, but not limited to oral Vitamin K antagonist therapy, including warfarin or other coagulation cascade inhibitors) must attest that for 75 percent of their ambulatory care patients receiving these medications are being managed with support from one or more of the following
- [2022 MIPS Improvement Activity IA_PM_3: RHC, IHS or FQHC quality improvement activities](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_pm_3-rhc-ihs-or-fqhc-quality-improvement-activities/) - Activity Description Participating in a Rural Health Clinic (RHC), Indian Health Service Medium Management (IHS), or Federally Qualified Health Center in ongoing engagement activities that contribute to more formal quality reporting, and that include receiving quality data back for broader quality improvement and benchmarking improvement which will ultimately benefit patients. Participation in Indian Health Service,
- [2022 MIPS Improvement Activity IA_EPA_3: Collection and use of patient experience and satisfaction data on access](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_epa_3-collection-and-use-of-patient-experience-and-satisfaction-data-on-access/) - Activity Description Collection of patient experience and satisfaction data on access to care and development of an improvement plan, such as outlining steps for improving communications with patients to help understanding of urgent access needs. Activity ID Activity Weighting Sub-Category Name IA_EPA_3 Medium Expanded Practice Access Objective Develop an improvement plan informed by patient experience
- [2022 MIPS Improvement Activity IA_EPA_4: Additional improvements in access as a result of QIN/QIO TA](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_epa_4-additional-improvements-in-access-as-a-result-of-qin-qio-ta/) - Activity Description As a result of Quality Innovation Network-Quality Improvement Organization technical assistance, performance of additional activities that improve access to services or improve care coordination (for example, investment of on-site diabetes educator). Activity ID Activity Weighting Sub-Category Name IA_EPA_4 Medium Expanded Practice Access Objective Use learnings from engagement with Quality Innovation Network-Quality Improvement Organization
- [2022 MIPS Improvement Activity IA_EPA_5: Participation in User Testing of the Quality Payment Program Website (https://qpp.cms.gov/)](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_epa_5-participation-in-user-testing-of-the-quality-payment-program-website-https-qpp-cms-gov/) - Activity Description User participation in the Quality Payment Program website testing is an activity for eligible clinicians who have worked with CMS to provide substantive, timely, and responsive input to improve the CMS Quality Payment Program website through product user-testing that enhances system and program accessibility, readability and responsiveness as well as providing feedback for
- [2022 MIPS Improvement Activity IA_EPA_1: Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_epa_1-provide-24-7-access-to-mips-eligible-clinicians-or-groups-who-have-real-time-access-to-patients-medical-record/) - Activity Description Provide 24/7 access to MIPS eligible clinicians, groups, or care teams for advice about urgent care (e.g., MIPS eligible clinician and care team access to medical record, cross-coverage with access to medical record, or protocol-driven nurse line with access to medical record) that could include one or more of the following: Expanded hours
- [2022 MIPS Improvement Activity IA_EPA_2: Use of telehealth services that expand practice access](https://healthmonix.com/mips_ia/2022-mips-improvement-activity-ia_epa_2-use-of-telehealth-services-that-expand-practice-access/) - Activity Description Create and implement a standardized process for providing telehealth services to expand access to care. Activity ID Activity Weighting Sub-Category Name IA_EPA_2 Medium Expanded Practice Access Objective Improve health outcomes by expanding patient access to telehealth services that are delivered through standardized processes. Validation Evidence of the creation and implementation of standardized processes
- [2021 MIPS Improvement Activity IA_BMH_10: Completion of Collaborative Care Management Training Program](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_bmh_10-completion-of-collaborative-care-management-training-program/) - Activity Description To receive credit for this activity, MIPS eligible clinicians must complete a collaborative care management training program, such as the American Psychiatric Association (APA) Collaborative Care Model training program available to the public, in order to implement a collaborative care management approach that provides comprehensive training in the integration of behavioral health into
- [2021 MIPS Improvement Activity IA_PCMH: Electronic submission of Patient Centered Medical Home accreditation](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pcmh-electronic-submission-of-patient-centered-medical-home-accreditation/) - Activity Description Activity Description I attest that I am a Patient Centered Medical Home (PCMH) or Comparable Specialty Practice that has achieved certification from a national program, regional or state program, private payer, or other body that administers patient-centered medical home accreditation and should receive full credit for the Improvement Activities performance category. Activity ID
- [2021 MIPS Improvement Activity IA_BMH_7: Implementation of Integrated Patient Centered Behavioral Health Model](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_bmh_7-implementation-of-integrated-patient-centered-behavioral-health-model/) - Activity Description Offer integrated behavioral health services to support patients with behavioral health needs who also have conditions such as dementia or other poorly controlled chronic illnesses. The services could include one or more of the following: Use evidence-based treatment protocols and treatment to goal where appropriate; Use evidence-based screening and case finding strategies to
- [2021 MIPS Improvement Activity IA_BMH_8: Electronic Health Record Enhancements for BH data capture](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_bmh_8-electronic-health-record-enhancements-for-bh-data-capture/) - Activity Description Enhancements to an electronic health record to capture additional data on behavioral health (BH) populations and use that data for additional decision-making purposes (e.g., capture of additional BH data results in additional depression screening for at-risk patient not previously identified). Activity ID Activity Weighting Sub-Category Name IA_BMH_8 Medium Behavioral and Mental Health
- [2021 MIPS Improvement Activity IA_BMH_5: MDD prevention and treatment interventions](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_bmh_5-mdd-prevention-and-treatment-interventions/) - Activity Description Major depressive disorder: Regular engagement of MIPS eligible clinicians or groups in integrated prevention and treatment interventions, including suicide risk assessment (refer to NQF #0104) for mental health patients with co-occurring conditions of behavioral or mental health conditions. Activity ID Activity Weighting Sub-Category Name IA_BMH_5 Medium Behavioral and Mental Health
- [2021 MIPS Improvement Activity IA_BMH_6: Implementation of co-location PCP and MH services](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_bmh_6-implementation-of-co-location-pcp-and-mh-services/) - Activity Description Integration facilitation and promotion of the colocation of mental health and substance use disorder services in primary and/or non-primary clinical care settings. Activity ID Activity Weighting Sub-Category Name IA_BMH_6 High Behavioral and Mental Health
- [2021 MIPS Improvement Activity IA_BMH_1: Diabetes screening](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_bmh_1-diabetes-screening/) - Activity Description Diabetes screening for people with schizophrenia or bipolar disease who are using antipsychotic medication. Activity ID Activity Weighting Sub-Category Name IA_BMH_1 Medium Behavioral and Mental Health
- [2021 MIPS Improvement Activity IA_BMH_2: Tobacco use](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_bmh_2-tobacco-use/) - Activity Description Tobacco use: Regular engagement of MIPS eligible clinicians or groups in integrated prevention and treatment interventions, including tobacco use screening and cessation interventions (refer to NQF #0028) for patients with co-occurring conditions of behavioral or mental health and at risk factors for tobacco dependence. Activity ID Activity Weighting Sub-Category Name IA_BMH_2 Medium Behavioral
- [2021 MIPS Improvement Activity IA_BMH_4: Depression screening](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_bmh_4-depression-screening/) - Activity Description Depression screening and follow-up plan: Regular engagement of MIPS eligible clinicians or groups in integrated prevention and treatment interventions, including depression screening and follow-up plan (refer to NQF #0418) for patients with co-occurring conditions of behavioral or mental health conditions. Activity ID Activity Weighting Sub-Category Name IA_BMH_4 Medium Behavioral and Mental Health
- [2021 MIPS Improvement Activity IA_ERP_2: Participation in a 60-day or greater effort to support domestic or international humanitarian needs.](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_erp_2-participation-in-a-60-day-or-greater-effort-to-support-domestic-or-international-humanitarian-needs/) - Activity Description Participation in domestic or international humanitarian volunteer work. Activities that simply involve registration are not sufficient. MIPS eligible clinicians and groups attest to domestic or international humanitarian volunteer work for a period of a continuous 60 days or greater. Activity ID Activity Weighting Sub-Category Name IA_ERP_2 High Emergency Response And Preparedness
- [2021 MIPS Improvement Activity IA_ERP_3: COVID-19 Clinical Data Reporting with or without Clinical Trial](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_erp_3-covid-19-clinical-data-reporting-with-or-without-clinical-trial/) - Activity Description To receive credit for this improvement activity, a MIPS eligible clinician or group must: (1) participate in a COVID-19 clinical trial utilizing a drug or biological product to treat a patient with a COVID-19 infection and report their findings through a clinical data repository or clinical data registry for the duration of their
- [2021 MIPS Improvement Activity IA_AHE_6: Provide Education Opportunities for New Clinicians](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_ahe_6-provide-education-opportunities-for-new-clinicians/) - Activity Description MIPS eligible clinicians acting as a preceptor for clinicians-in-training (such as medical residents/fellows, medical students, physician assistants, nurse practitioners, or clinical nurse specialists) and accepting such clinicians for clinical rotations in community practices in small, underserved, or rural areas. Activity ID Activity Weighting Sub-Category Name IA_AHE_6 High Achieving Health Equity
- [2021 MIPS Improvement Activity IA_AHE_7: Comprehensive Eye Exams](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_ahe_7-comprehensive-eye-exams/) - Activity Description To receive credit for this activity, MIPS eligible clinicians must promote the importance of a comprehensive eye exam, which may be accomplished by any one or more of the following: providing literature, facilitating a conversation about this topic using resources such as the “Think About Your Eyes” campaign, referring patients to resources providing
- [2021 MIPS Improvement Activity IA_ERP_1: Participation on Disaster Medical Assistance Team, registered for 6 months](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_erp_1-participation-on-disaster-medical-assistance-team-registered-for-6-months/) - Activity Description Participation in Disaster Medical Assistance Teams, or Community Emergency Responder Teams. Activities that simply involve registration are not sufficient. MIPS eligible clinicians and MIPS eligible clinician groups must be registered for a minimum of 6 months as a volunteer for disaster or emergency response. Activity ID Activity Weighting Sub-Category Name IA_ERP_1 Medium Emergency
- [2021 MIPS Improvement Activity IA_AHE_3: Promote Use of Patient-Reported Outcome Tools](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_ahe_3-promote-use-of-patient-reported-outcome-tools/) - Activity Description Demonstrate performance of activities for employing patient-reported outcome (PRO) tools and corresponding collection of PRO data such as the use of PHQ-2 or PHQ-9, PROMIS instruments, patient reported Wound-Quality of Life (QoL), patient reported Wound Outcome, and patient reported Nutritional Screening. Activity ID Activity Weighting Sub-Category Name IA_AHE_3 High Achieving Health Equity
- [2021 MIPS Improvement Activity IA_AHE_5: MIPS Eligible Clinician Leadership in Clinical Trials or CBPR](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_ahe_5-mips-eligible-clinician-leadership-in-clinical-trials-or-cbpr/) - Activity Description MIPS eligible clinician leadership in clinical trials, research alliances or community-based participatory research (CBPR) that identify tools, research or processes that can focuses on minimizing disparities in healthcare access, care quality, affordability, or outcomes. Activity ID Activity Weighting Sub-Category Name IA_AHE_5 Medium Achieving Health Equity
- [2021 MIPS Improvement Activity IA_PSPA_31: Patient Medication Risk Education](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_31-patient-medication-risk-education/) - Activity Description In order to receive credit for this activity, MIPS eligible clinicians must provide both written and verbal education regarding the risks of concurrent opioid and benzodiazepine use for patients who are prescribed both benzodiazepines and opioids. Education must be completed for at least 75% of qualifying patients and occur: (1) at the time
- [2021 MIPS Improvement Activity IA_PSPA_32: Use of CDC Guideline for Clinical Decision Support to Prescribe Opioids for Chronic Pain via Clinical Decision Support](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_32-use-of-cdc-guideline-for-clinical-decision-support-to-prescribe-opioids-for-chronic-pain-via-clinical-decision-support/) - Activity Description In order to receive credit for this activity, MIPS eligible clinicians must utilize the Centers for Disease Control (CDC) Guideline for Prescribing Opioids for Chronic Pain via clinical decision support (CDS). For CDS to be most effective, it needs to be built directly into the clinician workflow and support decision making on a
- [2021 MIPS Improvement Activity IA_AHE_1: Engagement of New Medicaid Patients and Follow-up](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_ahe_1-engagement-of-new-medicaid-patients-and-follow-up/) - Activity Description Seeing new and follow-up Medicaid patients in a timely manner, including individuals dually eligible for Medicaid and Medicare. A timely manner is defined as within 10 business days for this activity. Activity ID Activity Weighting Sub-Category Name IA_AHE_1 High Achieving Health Equity
- [2021 MIPS Improvement Activity IA_PSPA_30: PCI Bleeding Campaign](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_30-pci-bleeding-campaign/) - Activity Description Participation in the PCI Bleeding Campaign which is a national quality improvement program that provides infrastructure for a learning network and offers evidence-based resources and tools to reduce avoidable bleeding associated with patients who receive a percutaneous coronary intervention (PCI). The program uses a patient-centered and team-based approach, leveraging evidence-based best practices to
- [2021 MIPS Improvement Activity IA_PSPA_27: Invasive Procedure or Surgery Anticoagulation Medication Management](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_27-invasive-procedure-or-surgery-anticoagulation-medication-management/) - Activity Description For an anticoagulated patient undergoing a planned invasive procedure for which interruption in anticoagulation is anticipated, including patients taking vitamin K antagonists (warfarin), target specific oral anticoagulants (such as apixaban, dabigatran, and rivaroxaban), and heparins/low molecular weight heparins, documentation, including through the use of electronic tools, that the plan for anticoagulation management in
- [2021 MIPS Improvement Activity IA_PSPA_28: Completion of an Accredited Safety or Quality Improvement Program](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_28-completion-of-an-accredited-safety-or-quality-improvement-program/) - Activity Description Completion of an accredited performance improvement continuing medical education (CME) program that addresses performance or quality improvement according to the following criteria: The activity must address a quality or safety gap that is supported by a needs assessment or problem analysis, or must support the completion of such a needs assessment as part
- [2021 MIPS Improvement Activity IA_PSPA_26: Communication of Unscheduled Visit for Adverse Drug Event and Nature of Event](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_26-communication-of-unscheduled-visit-for-adverse-drug-event-and-nature-of-event/) - Activity Description A MIPS eligible clinician providing unscheduled care (such as an emergency room, urgent care, or other unplanned encounter) attests that, for greater than 75 percent of case visits that result from a clinically significant adverse drug event, the MIPS eligible clinician provides information, including through the use of health IT to the patient’s
- [2021 MIPS Improvement Activity IA_PSPA_25: Cost Display for Laboratory and Radiographic Orders](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_25-cost-display-for-laboratory-and-radiographic-orders/) - Activity Description Implementation of a cost display for laboratory and radiographic orders, such as costs that can be obtained through the Medicare clinical laboratory fee schedule. Activity ID Activity Weighting Sub-Category Name IA_PSPA_25 Medium Patient Safety and Practice Assessment
- [2021 MIPS Improvement Activity IA_PSPA_21: Implementation of fall screening and assessment programs](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_21-implementation-of-fall-screening-and-assessment-programs/) - Activity Description Implementation of fall screening and assessment programs to identify patients at risk for falls and address modifiable risk factors (e.g., Clinical decision support/prompts in the electronic health record that help manage the use of medications, such as benzodiazepines, that increase fall risk). Activity ID Activity Weighting Sub-Category Name IA_PSPA_21 Medium Patient Safety and
- [2021 MIPS Improvement Activity IA_PSPA_22: CDC Training on CDC's Guideline for Prescribing Opioids for Chronic Pain](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_22-cdc-training-on-cdcs-guideline-for-prescribing-opioids-for-chronic-pain/) - Activity Description Completion of all the modules of the Centers for Disease Control and Prevention (CDC) course “Applying CDC’s Guideline for Prescribing Opioids” that reviews the 2016 “Guideline for Prescribing Opioids for Chronic Pain.” Note: This activity may be selected once every 4 years, to avoid duplicative information given that some of the modules may
- [2021 MIPS Improvement Activity IA_PSPA_23: Completion of CDC Training on Antibiotic Stewardship](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_23-completion-of-cdc-training-on-antibiotic-stewardship/) - Activity Description Completion of all modules of the Centers for Disease Control and Prevention antibiotic stewardship course. Note: This activity may be selected once every 4 years, to avoid duplicative information given that some of the modules may change on a year by year basis but over 4 years there would be a reasonable expectation
- [2021 MIPS Improvement Activity IA_PSPA_19: Implementation of formal quality improvement methods, practice changes, or other practice improvement processes](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_19-implementation-of-formal-quality-improvement-methods-practice-changes-or-other-practice-improvement-processes/) - Activity Description Adopt a formal model for quality improvement and create a culture in which all staff actively participates in improvement activities that could include one or more of the following, such as: Participation in multisource feedback; Train all staff in quality improvement methods; Integrate practice change/quality improvement into staff duties; Engage all staff in
- [2021 MIPS Improvement Activity IA_PSPA_20: Leadership engagement in regular guidance and demonstrated commitment for implementing practice improvement changes](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_20-leadership-engagement-in-regular-guidance-and-demonstrated-commitment-for-implementing-practice-improvement-changes/) - Activity Description Ensure full engagement of clinical and administrative leadership in practice improvement that could include one or more of the following: Make responsibility for guidance of practice change a component of clinical and administrative leadership roles; Allocate time for clinical and administrative leadership for practice improvement efforts, including participation in regular team meetings; and/or
- [2021 MIPS Improvement Activity IA_PSPA_16: Use of decision support and standardized treatment protocols](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_16-use-of-decision-support-and-standardized-treatment-protocols/) - Activity Description Use decision support and standardized treatment protocols to manage workflow in the team to meet patient needs. Activity ID Activity Weighting Sub-Category Name IA_PSPA_16 Medium Patient Safety and Practice Assessment
- [2021 MIPS Improvement Activity IA_PSPA_17: Implementation of analytic capabilities to manage total cost of care for practice population](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_17-implementation-of-analytic-capabilities-to-manage-total-cost-of-care-for-practice-population/) - Activity Description In order to receive credit for this activity, a MIPS eligible clinician must conduct or build the capacity to conduct analytic activities to manage total cost of care for the practice population. Examples of these activities could include: Train appropriate staff on interpretation of cost and utilization information; Use available data regularly to
- [2021 MIPS Improvement Activity IA_PSPA_18: Measurement and Improvement at the Practice and Panel Level](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_18-measurement-and-improvement-at-the-practice-and-panel-level/) - Activity Description Measure and improve quality at the practice and panel level, such as the American Board of Orthopaedic Surgery (ABOS) Physician Scorecards, that could include one or more of the following: Regularly review measures of quality, utilization, patient satisfaction and other measures that may be useful at the practice level and at the level
- [2021 MIPS Improvement Activity IA_PSPA_12: Participation in private payer CPIA](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_12-participation-in-private-payer-cpia/) - Activity Description Participation in designated private payer clinical practice improvement activities. Activity ID Activity Weighting Sub-Category Name IA_PSPA_12 Medium Patient Safety and Practice Assessment
- [2021 MIPS Improvement Activity IA_PSPA_13: Participation in Joint Commission Evaluation Initiative](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_13-participation-in-joint-commission-evaluation-initiative/) - Activity Description Participation in Joint Commission Ongoing Professional Practice Evaluation initiative. Activity ID Activity Weighting Sub-Category Name IA_PSPA_13 Medium Patient Safety and Practice Assessment
- [2021 MIPS Improvement Activity IA_PSPA_15: Implementation of an ASP](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_15-implementation-of-an-asp/) - Activity Description Leadership of an Antimicrobial Stewardship Program (ASP) that includes implementation of an ASP that measures the appropriate use of antibiotics for several different conditions (such as but not limited to upper respiratory infection treatment in children, diagnosis of pharyngitis, bronchitis treatment in adults) according to clinical guidelines for diagnostics and therapeutics. Specific activities
- [2021 MIPS Improvement Activity IA_PSPA_10: Completion of training and receipt of approved waiver for provision opioid medication-assisted treatments](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_10-completion-of-training-and-receipt-of-approved-waiver-for-provision-opioid-medication-assisted-treatments/) - Activity Description Completion of training and obtaining an approved waiver for provision of medication -assisted treatment of opioid use disorders using buprenorphine. Activity ID Activity Weighting Sub-Category Name IA_PSPA_10 Medium Patient Safety and Practice Assessment
- [2021 MIPS Improvement Activity IA_PSPA_11: Participation in CAHPS or other supplemental questionnaire](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_11-participation-in-cahps-or-other-supplemental-questionnaire/) - Activity Description Participation in the Consumer Assessment of Healthcare Providers and Systems Survey or other supplemental questionnaire items (e.g., Cultural Competence or Health Information Technology supplemental item sets). Activity ID Activity Weighting Sub-Category Name IA_PSPA_11 High Patient Safety and Practice Assessment
- [2021 MIPS Improvement Activity IA_PSPA_7: Use of QCDR data for ongoing practice assessment and improvements](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_7-use-of-qcdr-data-for-ongoing-practice-assessment-and-improvements/) - Activity Description Participation in a Qualified Clinical Data Registry (QCDR) and use of QCDR data for ongoing practice assessment and improvements in patient safety, including: Performance of activities that promote use of standard practices, tools and processes for quality improvement (for example, documented preventative screening and vaccinations that can be shared across MIPS eligible clinician
- [2021 MIPS Improvement Activity IA_PSPA_8: Use of Patient Safety Tools](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_8-use-of-patient-safety-tools/) - Activity Description In order to receive credit for this activity, a MIPS eligible clinician must use tools that assist specialty practices in tracking specific measures that are meaningful to their practice. Some examples of tools that could satisfy this activity are: a surgical risk calculator; evidence based protocols, such as Enhanced Recovery After Surgery (ERAS)
- [2021 MIPS Improvement Activity IA_PSPA_9: Completion of the AMA STEPS Forward program](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_9-completion-of-the-ama-steps-forward-program/) - Activity Description Completion of the American Medical Association’s STEPS Forward program. Activity ID Activity Weighting Sub-Category Name IA_PSPA_9 Medium Patient Safety and Practice Assessment
- [2021 MIPS Improvement Activity IA_PSPA_4: Administration of the AHRQ Survey of Patient Safety Culture](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_4-administration-of-the-ahrq-survey-of-patient-safety-culture/) - Activity Description Administration of the AHRQ Survey of Patient Safety Culture and submission of data to the comparative database (refer to AHRQ Survey of Patient Safety Culture website http://www.ahrq.gov/professionals/quality-patient-safety/patientsafetyculture/index.html). Note: This activity may be selected once every 4 years, to avoid duplicative information given that some of the modules may change on a year by
- [2021 MIPS Improvement Activity IA_PSPA_6: Consultation of the Prescription Drug Monitoring Program](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_6-consultation-of-the-prescription-drug-monitoring-program/) - Activity Description Clinicians would attest to reviewing the patients’ history of controlled substance prescription using state prescription drug monitoring program (PDMP) data prior to the issuance of a Controlled Substance Schedule II (CSII) opioid prescription lasting longer than 3 days. For the transition year, clinicians would attest to 60 percent review of applicable patient’s history.
- [2021 MIPS Improvement Activity IA_PSPA_3: Participate in IHI Training/Forum Event; National Academy of Medicine, AHRQ Team STEPPS® or Other Similar Activity](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_3-participate-in-ihi-training-forum-event-national-academy-of-medicine-ahrq-team-stepps-or-other-similar-activity/) - Activity Description For MIPS eligible clinicians not participating in Maintenance of Certification (MOC) Part IV, new engagement for MOC Part IV, such as the Institute for Healthcare Improvement (IHI) Training/Forum Event; National Academy of Medicine, Agency for Healthcare Research and Quality (AHRQ) Team STEPPS®, or the American Board of Family Medicine (ABFM) Performance in Practice
- [2021 MIPS Improvement Activity IA_PSPA_2: Participation in MOC Part IV](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_2-participation-in-moc-part-iv/) - Activity Description In order to receive credit for this activity, a MIPS eligible clinician must participate in Maintenance of Certification (MOC) Part IV. Maintenance of Certification (MOC) Part IV requires clinicians to perform monthly activities across practice to regularly assess performance by reviewing outcomes addressing identified areas for improvement and evaluating the results. Some examples
- [2021 MIPS Improvement Activity IA_BE_24: Financial Navigation Program](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_24-financial-navigation-program/) - Activity Description In order to receive credit for this activity, MIPS eligible clinicians must attest that their practice provides financial counseling to patients or their caregiver about costs of care and an exploration of different payment options. The MIPS eligible clinician may accomplish this by working with other members of their practice (for example, financial
- [2021 MIPS Improvement Activity IA_BE_25: Drug Cost Transparency](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_25-drug-cost-transparency/) - Activity Description To receive credit for this improvement activity, MIPS eligible clinicians must attest that their practice provides counseling to patients and/or their caregivers about the costs of drugs and the patients’ out-of-pocket costs for the drugs. If appropriate, the clinician must also explore with their patients the availability of alternative drugs and patients’ eligibility
- [2021 MIPS Improvement Activity IA_PSPA_1: Participation in an AHRQ-listed patient safety organization](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pspa_1-participation-in-an-ahrq-listed-patient-safety-organization/) - Activity Description Participation in an AHRQ-listed patient safety organization. Activity ID Activity Weighting Sub-Category Name IA_PSPA_1 Medium Patient Safety and Practice Assessment
- [2021 MIPS Improvement Activity IA_BE_22: Improved Practices that Engage Patients Pre-Visit](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_22-improved-practices-that-engage-patients-pre-visit/) - Activity Description Implementation of workflow changes that engage patients prior to the visit, such as a pre-visit development of a shared visit agenda with the patient, or targeted pre-visit laboratory testing that will be resulted and available to the MIPS eligible clinician to review and discuss during the patient’s appointment. Activity ID Activity Weighting Sub-Category
- [2021 MIPS Improvement Activity IA_BE_23: Integration of patient coaching practices between visits](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_23-integration-of-patient-coaching-practices-between-visits/) - Activity Description Provide coaching between visits with follow-up on care plan and goals. Activity ID Activity Weighting Sub-Category Name IA_BE_23 Medium Beneficiary Engagement
- [2021 MIPS Improvement Activity IA_BE_19: Use group visits for common chronic conditions (e.g., diabetes)](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_19-use-group-visits-for-common-chronic-conditions-e-g-diabetes/) - Activity Description Use group visits for common chronic conditions (e.g., diabetes). Activity ID Activity Weighting Sub-Category Name IA_BE_19 Medium Beneficiary Engagement
- [2021 MIPS Improvement Activity IA_BE_20: Implementation of condition-specific chronic disease self-management support programs](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_20-implementation-of-condition-specific-chronic-disease-self-management-support-programs/) - Activity Description Provide condition-specific chronic disease self-management support programs or coaching or link patients to those programs in the community. Activity ID Activity Weighting Sub-Category Name IA_BE_20 Medium Beneficiary Engagement
- [2021 MIPS Improvement Activity IA_BE_21: Improved Practices that Disseminate Appropriate Self-Management Materials](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_21-improved-practices-that-disseminate-appropriate-self-management-materials/) - Activity Description Provide self-management materials at an appropriate literacy level and in an appropriate language. Activity ID Activity Weighting Sub-Category Name IA_BE_21 Medium Beneficiary Engagement
- [2021 MIPS Improvement Activity IA_BE_17: Use of tools to assist patient self-management](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_17-use-of-tools-to-assist-patient-self-management/) - Activity Description Use tools to assist patients in assessing their need for support for self-management (e.g., the Patient Activation Measure or How’s My Health). Activity ID Activity Weighting Sub-Category Name IA_BE_17 Medium Beneficiary Engagement
- [2021 MIPS Improvement Activity IA_BE_18: Provide peer-led support for self-management.](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_18-provide-peer-led-support-for-self-management/) - Activity Description Provide peer-led support for self-management. Activity ID Activity Weighting Sub-Category Name IA_BE_18 Medium Beneficiary Engagement
- [2021 MIPS Improvement Activity IA_BE_15: Engagement of Patients, Family, and Caregivers in Developing a Plan of Care](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_15-engagement-of-patients-family-and-caregivers-in-developing-a-plan-of-care/) - Activity Description Engage patients, family, and caregivers in developing a plan of care and prioritizing their goals for action, documented in the electronic health record (EHR) technology. Activity ID Activity Weighting Sub-Category Name IA_BE_15 Medium Beneficiary Engagement
- [2021 MIPS Improvement Activity IA_BE_16: Evidenced-based techniques to promote self-management into usual care](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_16-evidenced-based-techniques-to-promote-self-management-into-usual-care/) - Activity Description Incorporate evidence-based techniques to promote self-management into usual care, using techniques such as goal setting with structured follow-up, Teach Back, action planning or motivational interviewing. Activity ID Activity Weighting Sub-Category Name IA_BE_16 Medium Beneficiary Engagement
- [2021 MIPS Improvement Activity IA_BE_13: Regularly assess the patient experience of care through surveys, advisory councils and/or other mechanisms](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_13-regularly-assess-the-patient-experience-of-care-through-surveys-advisory-councils-and-or-other-mechanisms/) - Activity Description Regularly assess the patient experience of care through surveys, advisory councils and/or other mechanisms. Activity ID Activity Weighting Sub-Category Name IA_BE_13 Medium Beneficiary Engagement
- [2021 MIPS Improvement Activity IA_BE_14: Engage Patients and Families to Guide Improvement in the System of Care](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_14-engage-patients-and-families-to-guide-improvement-in-the-system-of-care/) - Activity Description Engage patients and families to guide improvement in the system of care by leveraging digital tools for ongoing guidance and assessments outside the encounter, including the collection and use of patient data for return-to-work and patient quality of life improvement. Platforms and devices that collect patient-generated health data (PGHD) must do so with
- [2021 MIPS Improvement Activity IA_BE_7: Participation in a QCDR that promotes use of patient engagement tools](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_7-participation-in-a-qcdr-that-promotes-use-of-patient-engagement-tools/) - Activity Description Participation in a Qualified Clinical Data Registry (QCDR), that promotes patient engagement, including: Use of processes and tools that engage patients for adherence to treatment plans; Implementation of patient self-action plans; Implementation of shared clinical decision making capabilities; or Use of QCDR patient experience data to inform and advance improvements in beneficiary engagement.
- [2021 MIPS Improvement Activity IA_BE_8: Participation in a QCDR that promotes collaborative learning network opportunities that are interactive](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_8-participation-in-a-qcdr-that-promotes-collaborative-learning-network-opportunities-that-are-interactive/) - Activity Description Participation in a QCDR, that promotes collaborative learning network opportunities that are interactive. Activity ID Activity Weighting Sub-Category Name IA_BE_8 Medium Beneficiary Engagement
- [2021 MIPS Improvement Activity IA_BE_12: Use evidence-based decision aids to support shared decision-making](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_12-use-evidence-based-decision-aids-to-support-shared-decision-making/) - Activity Description Use evidence-based decision aids to support shared decision-making. Activity ID Activity Weighting Sub-Category Name IA_BE_12 Medium Beneficiary Engagement
- [2021 MIPS Improvement Activity IA_BE_5: Enhancements/regular updates to practice websites/tools that also include considerations for patients with cognitive disabilities](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_5-enhancements-regular-updates-to-practice-websites-tools-that-also-include-considerations-for-patients-with-cognitive-disabilities/) - Activity Description Enhancements and ongoing regular updates and use of websites/tools that include consideration for compliance with section 508 of the Rehabilitation Act of 1973 or for improved design for patients with cognitive disabilities. Refer to the CMS website on Section 508 of the Rehabilitation Act https://www.cms.gov/Research-Statistics-Data-and-Systems/CMS-Information-Technology/Section508/index.html?redirect=/InfoTechGenInfo/07_Section508.asp that requires that institutions receiving federal funds solicit,
- [2021 MIPS Improvement Activity IA_BE_6: Collection and follow-up on patient experience and satisfaction data on beneficiary engagement](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_6-collection-and-follow-up-on-patient-experience-and-satisfaction-data-on-beneficiary-engagement/) - Activity Description Collection and follow-up on patient experience and satisfaction data on beneficiary engagement, including development of improvement plan. Activity ID Activity Weighting Sub-Category Name IA_BE_6 High Beneficiary Engagement
- [2021 MIPS Improvement Activity IA_BE_1: Use of certified EHR to capture patient reported outcomes](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_1-use-of-certified-ehr-to-capture-patient-reported-outcomes/) - Activity Description In support of improving patient access, performing additional activities that enable capture of patient reported outcomes (e.g., home blood pressure, blood glucose logs, food diaries, at-risk health factors such as tobacco or alcohol use, etc.) or patient activation measures through use of certified EHR technology, containing this data in a separate queue for
- [2021 MIPS Improvement Activity IA_BE_3: Engagement with QIN-QIO to implement self-management training programs](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_3-engagement-with-qin-qio-to-implement-self-management-training-programs/) - Activity Description Engagement with a Quality Innovation Network-Quality Improvement Organization, which may include participation in self-management training programs such as diabetes. Activity ID Activity Weighting Sub-Category Name IA_BE_3 Medium Beneficiary Engagement
- [2021 MIPS Improvement Activity IA_BE_4: Engagement of patients through implementation of improvements in patient portal](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_be_4-engagement-of-patients-through-implementation-of-improvements-in-patient-portal/) - Activity Description To receive credit for this activity, MIPS eligible clinicians must provide access to an enhanced patient/caregiver portal that allows users (patients or caregivers and their clinicians) to engage in bidirectional information exchange. The primary use of this portal should be clinical and not administrative. Examples of the use of such a portal include,
- [2021 MIPS Improvement Activity IA_CC_18: Tracking of clinician’s relationship to and responsibility for a patient by reporting MACRA patient relationship codes](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_cc_18-tracking-of-clinicians-relationship-to-and-responsibility-for-a-patient-by-reporting-macra-patient-relationship-codes/) - Activity Description In order to receive credit for this activity, MIPS eligible clinicians must participate in a minimum of eight hours of training on relationship-centered care tenets such as making effective open-ended inquiries; eliciting patient stories and perspectives; listening and responding with empathy; using the ART (ask, respond, tell) communication technique to engage patients, and
- [2021 MIPS Improvement Activity IA_CC_15: PSH Care Coordination](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_cc_15-psh-care-coordination/) - Activity Description Participation in a Perioperative Surgical Home (PSH) that provides a patient-centered, physician-led, interdisciplinary, and team-based system of coordinated patient care, which coordinates care from pre-procedure assessment through the acute care episode, recovery, and post-acute care. This activity allows for reporting of strategies and processes related to care coordination of patients receiving surgical or
- [2021 MIPS Improvement Activity IA_CC_16: Primary Care Physician and Behavioral Health Bilateral Electronic Exchange of Information for Shared Patients](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_cc_16-primary-care-physician-and-behavioral-health-bilateral-electronic-exchange-of-information-for-shared-patients/) - Activity Description The primary care and behavioral health practices use the same electronic health record system for shared patients or have an established bidirectional flow of primary care and behavioral health records. Activity ID Activity Weighting Sub-Category Name IA_CC_16 Medium Care Coordination
- [2021 MIPS Improvement Activity IA_CC_17: Patient Navigator Program](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_cc_17-patient-navigator-program/) - Activity Description Implement a Patient Navigator Program that offers evidence-based resources and tools to reduce avoidable hospital readmissions, utilizing a patient-centered and team-based approach, leveraging evidence-based best practices to improve care for patients by making hospitalizations less stressful, and the recovery period more supportive by implementing quality improvement strategies. Activity ID Activity Weighting Sub-Category Name
- [2021 MIPS Improvement Activity IA_CC_13: Practice Improvements for Bilateral Exchange of Patient Information](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_cc_13-practice-improvements-for-bilateral-exchange-of-patient-information/) - Activity Description Ensure that there is bilateral exchange of necessary patient information to guide patient care, such as Open Notes, that could include one or more of the following: Participate in a Health Information Exchange if available; and/or Use structured referral notes. Activity ID Activity Weighting Sub-Category Name IA_CC_13 Medium Care Coordination
- [2021 MIPS Improvement Activity IA_CC_14: Practice Improvements that Engage Community Resources to Support Patient Health Goals](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_cc_14-practice-improvements-that-engage-community-resources-to-support-patient-health-goals/) - Activity Description Develop pathways to neighborhood/community-based resources to support patient health goals that could include one or more of the following: Maintain formal (referral) links to community-based chronic disease self-management support programs, exercise programs and other wellness resources with the potential for bidirectional flow of information; and provide a guide to available community resources. Including
- [2021 MIPS Improvement Activity IA_CC_10: Care transition documentation practice improvements](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_cc_10-care-transition-documentation-practice-improvements/) - Activity Description In order to receive credit for this activity, a MIPS eligible clinician must document practices/processes for care transition with documentation of how a MIPS eligible clinician or group carried out an action plan for the patient with the patient’s preferences in mind (that is, a “patient-centered” plan) during the first 30 days following
- [2021 MIPS Improvement Activity IA_CC_11: Care transition standard operational improvements](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_cc_11-care-transition-standard-operational-improvements/) - Activity Description Establish standard operations to manage transitions of care that could include one or more of the following: Establish formalized lines of communication with local settings in which empaneled patients receive care to ensure documented flow of information and seamless transitions in care; and/or Partner with community or hospital-based transitional care services. Activity ID
- [2021 MIPS Improvement Activity IA_CC_12: Care coordination agreements that promote improvements in patient tracking across settings](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_cc_12-care-coordination-agreements-that-promote-improvements-in-patient-tracking-across-settings/) - Activity Description Establish effective care coordination and active referral management that could include one or more of the following: Establish care coordination agreements with frequently used consultants that set expectations for documented flow of information and MIPS eligible clinician or MIPS eligible clinician group expectations between settings. Provide patients with information that sets their expectations
- [2021 MIPS Improvement Activity IA_CC_8: Implementation of documentation improvements for practice/process improvements](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_cc_8-implementation-of-documentation-improvements-for-practice-process-improvements/) - Activity Description Implementation of practices/processes that document care coordination activities (e.g., a documented care coordination encounter that tracks all clinical staff involved and communications from date patient is scheduled for outpatient procedure through day of procedure). Activity ID Activity Weighting Sub-Category Name IA_CC_8 Medium Care Coordination
- [2021 MIPS Improvement Activity IA_CC_9: Implementation of practices/processes for developing regular individual care plans](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_cc_9-implementation-of-practices-processes-for-developing-regular-individual-care-plans/) - Activity Description Implementation of practices/processes, including a discussion on care, to develop regularly updated individual care plans for at-risk patients that are shared with the beneficiary or caregiver(s). Individual care plans should include consideration of a patient’s goals and priorities, as well as desired outcomes of care. Activity ID Activity Weighting Sub-Category Name IA_CC_9 Medium
- [2021 MIPS Improvement Activity IA_CC_2: Implementation of improvements that contribute to more timely communication of test results](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_cc_2-implementation-of-improvements-that-contribute-to-more-timely-communication-of-test-results/) - Activity Description Timely communication of test results defined as timely identification of abnormal test results with timely follow-up. Activity ID Activity Weighting Sub-Category Name IA_CC_2-2021 Medium Care Coordination
- [2021 MIPS Improvement Activity IA_CC_7: Regular training in care coordination](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_cc_7-regular-training-in-care-coordination/) - Activity Description Implementation of regular care coordination training. Activity ID Activity Weighting Sub-Category Name IA_CC_7 Medium Care Coordination
- [2021 MIPS Improvement Activity IA_PM_21: Advance Care Planning](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pm_21-advance-care-planning/) - Activity Description Implementation of practices/processes to develop advance care planning that includes: documenting the advance care plan or living will within the medical record, educating clinicians about advance care planning motivating them to address advance care planning needs of their patients, and how these needs can translate into quality improvement, educating clinicians on approaches and
- [2021 MIPS Improvement Activity IA_CC_1: Implementation of Use of Specialist Reports Back to Referring Clinician or Group to Close Referral Loop](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_cc_1-implementation-of-use-of-specialist-reports-back-to-referring-clinician-or-group-to-close-referral-loop/) - Activity Description Performance of regular practices that include providing specialist reports back to the referring individual MIPS eligible clinician or group to close the referral loop or where the referring individual MIPS eligible clinician or group initiates regular inquiries to specialist for specialist reports which could be documented or noted in the EHR technology. Activity
- [2021 MIPS Improvement Activity IA_PM_17: Participation in Population Health Research](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pm_17-participation-in-population-health-research/) - Activity Description Participation in federally and/or privately funded research that identifies interventions, tools, or processes that can improve a targeted patient population. Activity ID Activity Weighting Sub-Category Name IA_PM_17 Medium Population Management
- [2021 MIPS Improvement Activity IA_PM_18: Provide Clinical-Community Linkages](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pm_18-provide-clinical-community-linkages/) - Activity Description Engaging community health workers to provide a comprehensive link to community resources through family-based services focusing on success in health, education, and self-sufficiency. This activity supports individual MIPS eligible clinicians or groups that coordinate with primary care and other clinicians, engage and support patients, use of health information technology, and employ quality measurement
- [2021 MIPS Improvement Activity IA_PM_14: Implementation of methodologies for improvements in longitudinal care management for high risk patients](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pm_14-implementation-of-methodologies-for-improvements-in-longitudinal-care-management-for-high-risk-patients/) - Activity Description Provide longitudinal care management to patients at high risk for adverse health outcome or harm that could include one or more of the following: Use a consistent method to assign and adjust global risk status for all empaneled patients to allow risk stratification into actionable risk cohorts. Monitor the risk-stratification method and refine
- [2021 MIPS Improvement Activity IA_PM_15: Implementation of episodic care management practice improvements](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pm_15-implementation-of-episodic-care-management-practice-improvements/) - Activity Description Provide episodic care management, including management across transitions and referrals that could include one or more of the following: Routine and timely follow-up to hospitalizations, ED visits and stays in other institutional settings, including symptom and disease management, and medication reconciliation and management; and/or Managing care intensively through new diagnoses, injuries and exacerbations
- [2021 MIPS Improvement Activity IA_PM_16: Implementation of medication management practice improvements](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pm_16-implementation-of-medication-management-practice-improvements/) - Activity Description Manage medications to maximize efficiency, effectiveness and safety that could include one or more of the following: Reconcile and coordinate medications and provide medication management across transitions of care settings and eligible clinicians or groups; Integrate a pharmacist into the care team; and/or Conduct periodic, structured medication reviews. Activity ID Activity Weighting Sub-Category
- [2021 MIPS Improvement Activity IA_PM_12: Population empanelment](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pm_12-population-empanelment/) - Activity Description Empanel (assign responsibility for) the total population, linking each patient to a MIPS eligible clinician or group or care team. Empanelment is a series of processes that assign each active patient to a MIPS eligible clinician or group and/or care team, confirm assignment with patients and clinicians, and use the resultant patient panels
- [2021 MIPS Improvement Activity IA_PM_13: Chronic Care and Preventative Care Management for Empaneled Patients](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pm_13-chronic-care-and-preventative-care-management-for-empaneled-patients/) - Activity Description In order to receive credit for this activity, a MIPS eligible clinician must manage chronic and preventive care for empaneled patients (that is, patients assigned to care teams for the purpose of population health management), which could include one or more of the following actions: Provide patients annually with an opportunity for development
- [2021 MIPS Improvement Activity IA_PM_6: Use of toolsets or other resources to close healthcare disparities across communities](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pm_6-use-of-toolsets-or-other-resources-to-close-healthcare-disparities-across-communities/) - Activity Description Take steps to improve healthcare disparities, such as Population Health Toolkit or other resources identified by CMS, the Learning and Action Network, Quality Innovation Network, or National Coordinating Center. Refer to the local Quality Improvement Organization (QIO) for additional steps to take for improving health status of communities as there are many steps
- [2021 MIPS Improvement Activity IA_PM_7: Use of QCDR for feedback reports that incorporate population health](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pm_7-use-of-qcdr-for-feedback-reports-that-incorporate-population-health/) - Activity Description Use of a QCDR to generate regular feedback reports that summarize local practice patterns and treatment outcomes, including for vulnerable populations. Activity ID Activity Weighting Sub-Category Name IA_PM_7 High Population Management
- [2021 MIPS Improvement Activity IA_PM_11: Regular Review Practices in Place on Targeted Patient Population Needs](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pm_11-regular-review-practices-in-place-on-targeted-patient-population-needs/) - Activity Description Implementation of regular reviews of targeted patient population needs, such as structured clinical case reviews, which includes access to reports that show unique characteristics of eligible clinician's patient population, identification of vulnerable patients, and how clinical treatment needs are being tailored, if necessary, to address unique needs and what resources in the community
- [2021 MIPS Improvement Activity IA_PM_4: Glycemic management services](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pm_4-glycemic-management-services/) - Activity Description For outpatient Medicare beneficiaries with diabetes and who are prescribed antidiabetic agents (e.g., insulin, sulfonylureas), MIPS eligible clinicians and groups must attest to having: For the first performance year, at least 60 percent of medical records with documentation of an individualized glycemic treatment goal that: Takes into account patient-specific factors, including, at least
- [2021 MIPS Improvement Activity IA_PM_5: Engagement of community for health status improvement](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pm_5-engagement-of-community-for-health-status-improvement/) - Activity Description Take steps to improve health status of communities, such as collaborating with key partners and stakeholders to implement evidenced-based practices to improve a specific chronic condition. Refer to the local Quality Improvement Organization (QIO) for additional steps to take for improving health status of communities as there are many steps to select from
- [2021 MIPS Improvement Activity IA_EPA_5: Participation in User Testing of the Quality Payment Program Website (https://qpp.cms.gov/)](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_epa_5-participation-in-user-testing-of-the-quality-payment-program-website-https-qpp-cms-gov/) - Activity Description User participation in the Quality Payment Program website testing is an activity for eligible clinicians who have worked with CMS to provide substantive, timely, and responsive input to improve the CMS Quality Payment Program website through product user-testing that enhances system and program accessibility, readability and responsiveness as well as providing feedback for
- [2021 MIPS Improvement Activity IA_PM_2: Anticoagulant Management Improvements](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pm_2-anticoagulant-management-improvements/) - Activity Description Individual MIPS eligible clinicians and groups who prescribe anti-coagulation medications (including, but not limited to oral Vitamin K antagonist therapy, including warfarin or other coagulation cascade inhibitors) must attest that for 75 percent of their ambulatory care patients receiving these medications are being managed with support from one or more of the following
- [2021 MIPS Improvement Activity IA_PM_3: RHC, IHS or FQHC quality improvement activities](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_pm_3-rhc-ihs-or-fqhc-quality-improvement-activities/) - Activity Description Participating in a Rural Health Clinic (RHC), Indian Health Service Medium Management (IHS), or Federally Qualified Health Center in ongoing engagement activities that contribute to more formal quality reporting, and that include receiving quality data back for broader quality improvement and benchmarking improvement which will ultimately benefit patients. Participation in Indian Health Service,
- [2021 MIPS Improvement Activity IA_EPA_3: Collection and use of patient experience and satisfaction data on access](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_epa_3-collection-and-use-of-patient-experience-and-satisfaction-data-on-access/) - Activity Description Collection of patient experience and satisfaction data on access to care and development of an improvement plan, such as outlining steps for improving communications with patients to help understanding of urgent access needs. Activity ID Activity Weighting Sub-Category Name IA_EPA_3 Medium Expanded Practice Access
- [2021 MIPS Improvement Activity IA_EPA_4: Additional improvements in access as a result of QIN/QIO TA](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_epa_4-additional-improvements-in-access-as-a-result-of-qin-qio-ta/) - Activity Description As a result of Quality Innovation Network-Quality Improvement Organization technical assistance, performance of additional activities that improve access to services or improve care coordination (for example, investment of on-site diabetes educator). Activity ID Activity Weighting Sub-Category Name IA_EPA_4 Medium Expanded Practice Access
- [2021 MIPS Improvement Activity IA_EPA_2: Use of telehealth services that expand practice access](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_epa_2-use-of-telehealth-services-that-expand-practice-access/) - Activity Description Use of telehealth services and analysis of data for quality improvement, such as participation in remote specialty care consults or teleaudiology pilots that assess ability to still deliver quality care to patients. Activity ID Activity Weighting Sub-Category Name IA_EPA_2 Medium Expanded Practice Access
- [2021 MIPS Improvement Activity IA_EPA_1: Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record](https://healthmonix.com/mips_ia/2021-mips-improvement-activity-ia_epa_1-provide-24-7-access-to-mips-eligible-clinicians-or-groups-who-have-real-time-access-to-patients-medical-record/) - Activity Description Provide 24/7 access to MIPS eligible clinicians, groups, or care teams for advice about urgent and emergent care (e.g., MIPS eligible clinician and care team access to medical record, cross-coverage with access to medical record, or protocol-driven nurse line with access to medical record) that could include one or more of the following:

## MIPS Specialty Recommendations

- [Women’s Health MIPS Quality Measure Recommendations – 2021](https://healthmonix.com/mips_by_specialty/womens-health-mips-quality-measure-recommendations-2021/) - Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you report do count towards the six
- [Allergy, Asthma, and Clinical Immunology MIPS Quality Measures and Improvement Activities – 2021](https://healthmonix.com/mips_by_specialty/allergy-asthma-and-clinical-immunology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Urology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/urology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Thoracic Surgery MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/thoracic-surgery-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Surgery MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/surgery-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Spine Specialists MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/spine-specialists-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Speech Therapy MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/speech-therapy-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Sleep Medicine MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/sleep-medicine-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Rheumatology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/rheumatology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Vascular Surgery MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/vascular-surgery-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Physical Medicine & Rehabilitation MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/physical-medicine-rehabilitation-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Plastic Surgery & Aesthetic Medicine MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/plastic-surgery-aesthetic-medicine-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Pediatrics MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/pediatrics-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Pathology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/pathology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Palliative Care MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/palliative-care-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Pain Management MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/pain-management-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Otolaryngology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/otolaryngology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Orthopedics MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/orthopedics-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Orthopedic Surgery MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/orthopedic-surgery-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Oral/Maxillofacial Surgery MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/oral-maxillofacial-surgery-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Physical Medicine MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/physical-medicine-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Physical Therapy MIPS Quality Measures and Improvement Activities – 2021](https://healthmonix.com/mips_by_specialty/physical-therapy-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Plastic Surgery MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/plastic-surgery-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Podiatry MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/podiatry-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Preventive Medicine MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/preventive-medicine-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Psychiatry & Mental Health MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/psychiatry-mental-health-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Psychology MIPS Quality Measures and Improvement Activities – 2021](https://healthmonix.com/mips_by_specialty/psychology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Pulmonary Medicine MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/pulmonary-medicine-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Radiation Oncology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/radiation-oncology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Radiology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/radiology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Optometry MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/optometry-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Ophthalmology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/ophthalmology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Occupational Therapy MIPS Quality Measures and Improvement Activities – 2021](https://healthmonix.com/mips_by_specialty/occupational-therapy-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Obstetrics/Gynecology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/obstetrics-gynecology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Nuclear Medicine MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/nuclear-medicine-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Neurosurgery MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/neurosurgery-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [OB/GYN And Women’s Health MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/ob-gyn-and-womens-health-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Geriatrics / Gerontology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/geriatrics-gerontology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Gynecology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/gynecology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Hand Surgery MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/hand-surgery-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Hematology-Oncology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/hematology-oncology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Hospitalist / Critical Care MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/hospitalist-critical-care-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Hospitalist MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/hospitalist-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Infectious Disease MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/infectious-disease-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Internal Medicine MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/internal-medicine-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Interventional Radiology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/interventional-radiology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Lab Medicine MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/lab-medicine-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Mental/Behavioral Health MIPS Quality Measures and Improvement Activities – 2021](https://healthmonix.com/mips_by_specialty/mental-behavioral-health-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Nephrology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/nephrology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Neurology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/neurology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Anesthesiology MIPS Quality Measures and Improvement Activities – 2021](https://healthmonix.com/mips_by_specialty/anesthesiology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Audiology MIPS Quality Measures and Improvement Activities – 2021](https://healthmonix.com/mips_by_specialty/audiology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Cardiac Arrhythmia MIPS Quality Measures and Improvement Activities – 2021](https://healthmonix.com/mips_by_specialty/cardiac-arrhythmia-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Cardiology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/cardiology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Chiropractic MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/chiropractic-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Colon & Rectal Surgery MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/colon-rectal-surgery-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Critical Care / Hospitalist MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/critical-care-hospitalist-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Dermatology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/dermatology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Diabetes & Endocrinology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/diabetes-endocrinology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Diagnostic Radiology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/diagnostic-radiology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Electrophysiology Cardiac Specialist MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/electrophysiology-cardiac-specialist-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Emergency Medicine MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/emergency-medicine-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [ENT/Otolaryngology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/ent-otolaryngology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Family Medicine MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/family-medicine-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [Gastroenterology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/gastroenterology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [General Medicine MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/general-medicine-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [General Oncology MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/general-oncology-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [General Practice/Family Medicine MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/general-practice-family-medicine-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you
- [General Surgery MIPS Quality Measures and Improvement Activities - 2021](https://healthmonix.com/mips_by_specialty/general-surgery-mips-quality-measures-and-improvement-activities-2021/) - How to Select MIPS Quality Measures Step 1 : Select At Least 1 Outcome Measure For the MIPS Quality Performance Category, you must report at least one outcome measure. If no outcome measures are applicable to your patient population, then you must select at least one high-priority measure (see Step 2). The outcome measures you

## Specialty Measure Sets

- [Speech Language Pathology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/speech-language-pathology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Audiology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/audiology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Clinical Social Work MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/clinical-social-work-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Chiropractic Medicine MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/chiropractic-medicine-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Pulmonology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/pulmonology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Vascular Surgery MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/vascular-surgery-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Diagnostic Radiology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/diagnostic-radiology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Nephrology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/nephrology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [General Surgery MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/general-surgery-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Thoracic Surgery MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/thoracic-surgery-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Urology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/urology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [General Oncology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/general-oncology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Radiation Oncology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/radiation-oncology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Infectious Disease MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/infectious-disease-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Neurosurgical MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/neurosurgical-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Hospitalists MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/hospitalists-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Nutrition/Dietician MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/nutrition-dietician-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Endocrinology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/endocrinology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Skilled Nursing Facility MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/skilled-nursing-facility-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Podiatry MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/podiatry-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Urgent Care MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/urgent-care-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Geriatrics MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/geriatrics-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Physical Therapy/Occupational Therapy MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/physical-therapy-occupational-therapy-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Dentistry MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/dentistry-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Rheumatology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/rheumatology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Anesthesiology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/anesthesiology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Cardiology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/cardiology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Electro-physiology Cardiac Specialist MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/electro-physiology-cardiac-specialist-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Gastro-enterology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/gastro-enterology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Dermatology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/dermatology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Family Medicine MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/family-medicine-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Internal Medicine MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/internal-medicine-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Emergency Medicine MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/emergency-medicine-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Obstetrics / Gynecology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/obstetrics-gynecology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Ophthalmology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/ophthalmology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Orthopedic Surgery MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/orthopedic-surgery-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Otolaryngology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/otolaryngology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Pathology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/pathology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Pediatrics MIPS Specialty Measure Set (2022](https://healthmonix.com/mips_measure_set/pediatrics-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Physical Medicine MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/physical-medicine-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Plastic Surgery MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/plastic-surgery-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Preventive Medicine MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/preventive-medicine-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Neurology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/neurology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Mental / Behavioral Health MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/mental-behavioral-health-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Allergy/ Immunology MIPS Specialty Measure Set (2022)](https://healthmonix.com/mips_measure_set/allergy-immunology-mips-specialty-measure-set-2022/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Speech Language Pathology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/speech-language-pathology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Audiology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/audiology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Clinical Social Work MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/clinical-social-work-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Chiropractic Medicine MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/chiropractic-medicine-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Pulmonology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/pulmonology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Vascular Surgery MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/vascular-surgery-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Diagnostic Radiology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/diagnostic-radiology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Nephrology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/nephrology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [General Surgery MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/general-surgery-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Thoracic Surgery MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/thoracic-surgery-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Urology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/urology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [General Oncology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/general-oncology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Radiation Oncology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/radiation-oncology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Infectious Disease MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/infectious-disease-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Neurosurgical MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/neurosurgical-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Hospitalists MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/hospitalists-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Nutrition/Dietician MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/nutrition-dietician-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Endocrinology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/endocrinology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Skilled Nursing Facility MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/skilled-nursing-facility-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Podiatry MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/podiatry-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Urgent Care MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/urgent-care-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Geriatrics MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/geriatrics-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Physical Therapy/Occupational Therapy MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/physical-therapy-occupational-therapy-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Dentistry MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/dentistry-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Rheumatology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/rheumatology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Anesthesiology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/anesthesiology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Cardiology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/cardiology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Electro-physiology Cardiac Specialist MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/electro-physiology-cardiac-specialist-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Gastro-enterology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/gastro-enterology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Dermatology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/dermatology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Family Medicine MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/family-medicine-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Internal Medicine MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/internal-medicine-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Emergency Medicine MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/emergency-medicine-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Obstetrics / Gynecology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/obstetrics-gynecology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Ophthalmology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/ophthalmology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Orthopedic Surgery MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/orthopedic-surgery-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Otolaryngology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/otolaryngology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Pathology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/pathology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Pediatrics MIPS Specialty Measure Set (2021](https://healthmonix.com/mips_measure_set/pediatrics-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Physical Medicine MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/physical-medicine-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Plastic Surgery MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/plastic-surgery-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Preventive Medicine MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/preventive-medicine-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Neurology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/neurology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Mental / Behavioral Health MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/mental-behavioral-health-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their
- [Allergy/ Immunology MIPS Specialty Measure Set (2021)](https://healthmonix.com/mips_measure_set/allergy-immunology-mips-specialty-measure-set-2021/) - CMS specialty measure sets may be reported as an alternative to reporting 6 separate quality measures. If a measure set has less than 6 measures, eligible groups and clinicians must report all measures in the set. However, if a set has more than 6 measures, participants may choose the 6 measures that best fit their

## Promoting Interoperability Measures

- [High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides](https://healthmonix.com/mips_pi_measures/high-priority-practices-guide-of-the-safety-assurance-factors-for-ehr-resilience-safer-guides/) - Measure description Conduct an annual assessment of the High Priority Practices Guide SAFER Guides beginning with the 2024 performance period. Objective Measure Maximum points Protect Patient Health Information High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides 0 points* * This measure must be reported, but can be reported with
- [Query of Prescription Drug Monitoring Program (PDMP)](https://healthmonix.com/mips_pi_measures/query-of-prescription-drug-monitoring-program-pdmp/) - Measure description For at least one Schedule II opioid electronically prescribed using CEHRT during the performance period, the MIPS eligible clinician uses data from CEHRT to conduct a query of a PDMP for prescription drug history, except where prohibited and in accordance with applicable law. Objective Measure Maximum Points Electronic Prescribing Query of Prescription Drug
- [High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER)  Guides](https://healthmonix.com/mips_pi_measures/high-priority-practices-guide-of-the-safety-assurance-factors-for-ehr-resilience-safer-guides-2/) - Measure description Conduct an annual assessment of the High Priority Practices Guide SAFER Guide. Objective Measure Maximum Points Protect Patient Health Information High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides 0 Points Definition of Terms N/A The MIPS eligible clinician must attest YES to conducting a query of a
- [Query of Prescription Drug Monitoring Program (PDMP)](https://healthmonix.com/mips_pi_measures/2025query-of-prescription-drug-monitoring-program-pdmp/) - Measure description For at least one Schedule II opioid or Schedule III or IV drug electronically prescribed using certified electronic health record technology (CEHRT) during the performance period, the MIPS eligible clinician uses data from CEHRT to conduct a query of a PDMP for prescription drug history. Objective Measure Maximum Points e-Prescribing Query of Prescription
- [Security Risk Analysis](https://healthmonix.com/mips_pi_measures/security-risk-analysis/) - Measure description Conduct or review a security risk analysis in accordance with the requirements in 45 CFR 164.308(a)(1), including addressing the security (to include encryption) of ePHI data created or maintained by certified electronic health record technology (CEHRT) in accordance with requirements in 45 CFR 164.312(a)(2)(iv) and 45 CFR 164.306(d)(3), implement security updates as necessary,
- [Clinical Data Registry (CDR) Reporting](https://healthmonix.com/mips_pi_measures/clinical-data-registry-cdr-reporting/) - Measure description The MIPS eligible clinician is in active engagement to submit data to a clinical data registry. Objective Measure Maximum points Public Health and Clinical Data Exchange Clinical Data Registry Reporting 5 points* * Any of the three PHCDRR measures of Syndromic Surveillance Reporting, Public Health Registry Reporting, Clinical Data Registry (CDR) Reporting can
- [Public Health Registry Reporting](https://healthmonix.com/mips_pi_measures/public-health-registry-reporting/) - Measure description The MIPS eligible clinician is in active engagement with a public health agency (PHA) to submit data to public health registries. Objective Measure Maximum points Public Health and Clinical Data Exchange Public Health Registry Reporting 5 points* * Any of the three PHCDRR measures of Syndromic Surveillance Reporting, Public Health Registry Reporting, Clinical
- [Electronic Case Reporting | MIPS PI Measures for 2023 Reporting](https://healthmonix.com/mips_pi_measures/electronic-case-reporting-mips-pi-measures-for-2023-reporting/) - Measure description The MIPS eligible clinician is in active engagement with a public health agency (PHA) to electronically submit case reporting of reportable conditions. Objective Measure Maximum points Public Health and Clinical Data Exchange Electronic Case Reporting 12.5 points* *For 2023, the Immunization Registry Reporting measure and the Electronic Case Reporting measure are required. If
- [Syndromic Surveillance Reporting](https://healthmonix.com/mips_pi_measures/syndromic-surveillance-reporting/) - Measure description The MIPS eligible clinician is in active engagement with a public health agency (PHA) to submit syndromic surveillance data from an urgent care setting. Objective Measure Maximum point value Public Health and Clinical Data Exchange Syndromic Surveillance Reporting 5 points * * Any of the three PHCDRR measures of Syndromic Surveillance Reporting, Public
- [Immunization Registry Reporting | MIPS PI Measures](https://healthmonix.com/mips_pi_measures/immunization-registry-reporting-mips-pi-measures-for-2023-reporting/) - Measure description The MIPS eligible clinician is in active engagement with a public health agency (PHA) to submit immunization data and receive immunization forecasts and histories from the public health immunization registry/immunization information system (IIS). Objective Measure Maximum points Public Health and Clinical Data Exchange Immunization Registry Reporting 12.5 points * *For 2023, the Immunization
- [Provide Patients Electronic Access to Their Health Information](https://healthmonix.com/mips_pi_measures/provide-patients-electronic-access-to-their-health-information-mips-pi-measures-for-2023-reporting/) - Measure description For at least one unique patient seen by the MIPS eligible clinician: (1) The patient (or the patient-authorized representative) is provided timely access to view online, download, and transmit his or her health information; and (2) The MIPS eligible clinician ensures the patient’s health information is available for the patient (or patient-authorized representative)
- [Enabling Exchange Under the Trusted Exchange Framework and Common Agreement (TEFCA)](https://healthmonix.com/mips_pi_measures/enabling-exchange-under-the-trusted-exchange-framework-and-common-agreement-tefca-mips-pi-measures-for-2023-reporting/) - Measure description The MIPS eligible clinician or group must attest that they engage in bi-directional exchange with an HIE to support transitions of care. Objective Measure Maximum points Health Information Exchange Enabling Exchange Under the Trusted Exchange Framework and Common Agreement (TEFCA) 30 points* * This measure is an additional alternative to the Support Electronic
- [Health Information Exchange (HIE) Bi-Directional Exchange](https://healthmonix.com/mips_pi_measures/health-information-exchange-hie-bi-directional-exchange-mips-pi-measures-for-2023-reporting/) - Measure description The MIPS eligible clinician or group must attest that they engage in bi-directional exchange with an HIE to support transitions of care. Objective Measure Maximum points Health Information Exchange Health Information Exchange (HIE) Bi-Directional Exchange 30 points* * This measure is an additional alternative to the Support Electronic Referral Loops by Sending Health
- [Support Electronic Referral Loops by Receiving and Incorporating Health Information](https://healthmonix.com/mips_pi_measures/support-electronic-referral-loops-by-receiving-and-incorporating-health-information/) - Measure description For at least one electronic summary of care record received for patient encounters during the performance period for which a MIPS eligible clinician was the receiving party of a transition of care or referral, or for patient encounters during the performance period in which the MIPS eligible clinician has never before encountered the
- [Support Electronic Referral Loops by Sending Health Information](https://healthmonix.com/mips_pi_measures/support-electronic-referral-loops-by-sending-health-information-mips-pi-measures-for-2023-reporting/) - Measure description For at least one transition of care or referral, the MIPS eligible clinician that transitions or refers their patient to another setting of care or health care provider — (1) creates a summary of care record using certified electronic health record technology (CEHRT); and (2) electronically exchanges the summary of care record. *
- [E-Prescribing](https://healthmonix.com/mips_pi_measures/e-prescribing-mips-pi-measures-for-2023-reporting/) - Measure description At least one permissible prescription written by the MIPS eligible clinician is queried for a drug formulary and transmitted electronically using certified electronic health record technology (CEHRT). Measure Exclusion: Any MIPS eligible clinician who writes fewer than 100 permissible prescriptions during the performance period. Objective Measure Maximum Points Electronic Prescribing Electronic Prescribing 10
- [Query of Prescription Drug Monitoring Program (PDMP) | MIPS PI Measures for 2022 Reporting](https://healthmonix.com/mips_pi_measures/query-of-prescription-drug-monitoring-program-pdmp-mips-pi-measures-for-2022-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description For at least one Schedule II opioid or Schedule III or IV drug electronically prescribed using certified electronic health record technology (CEHRT) during the performance period, the MIPS eligible clinician uses data from CEHRT to conduct a query of a PDMP for prescription drug
- [E-Prescribing | MIPS PI Measures for 2022 Reporting](https://healthmonix.com/mips_pi_measures/e-prescribing-mips-pi-measures-for-2022-reporting/) - "For use with CEHRT certified to the 2015 edition. Measure Description At least one permissible prescription written by the MIPS eligible clinician is queried for a drug formulary and transmitted electronically using certified electronic health record technology (CEHRT). Measure Exclusion: Any MIPS eligible clinician who writes fewer than 100 permissible prescriptions during the performance period.
- [Clinical Data Registry (CDR) Reporting | MIPS PI Measures for 2022 Reporting](https://healthmonix.com/mips_pi_measures/clinical-data-registry-cdr-reporting-mips-pi-measures-for-2022-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description The MIPS eligible clinician is in active engagement to submit data to a clinical data registry. Objective Measure Maximum Points Public Health and Clinical Data Exchange Clinical Data Registry Reporting 5 points* * Any of the three PHCDRR measures of Syndromic Surveillance Reporting,
- [High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides | MIPS PI Measures for 2022 Reporting](https://healthmonix.com/mips_pi_measures/high-priority-practices-guide-of-the-safety-assurance-factors-for-ehr-resilience-safer-guides-mips-pi-measures-for-2022-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description Conduct an annual assessment of the High Priority Practices Guide SAFER Guides beginning with the 2022 performance period. Objective Measure Maximum Points Protect Patient Health Information High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides 0 points* * This
- [Health Information Exchange (HIE) Bi-Directional Exchange | MIPS PI Measures for 2022 Reporting](https://healthmonix.com/mips_pi_measures/health-information-exchange-hie-bi-directional-exchange-mips-pi-measures-for-2022-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description The MIPS eligible clinician or group must attest that they engage in bi-directional exchange with an HIE to support transitions of care. Objective Measure Maximum Points Health Information Exchange Health Information Exchange (HIE) Bi-Directional Exchange 40 points* * This measure is an alternative to
- [Support Electronic Referral Loops by Sending Health Information | MIPS PI Measures for 2022 Reporting](https://healthmonix.com/mips_pi_measures/support-electronic-referral-loops-by-sending-health-information-mips-pi-measures-for-2022-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description For at least one transition of care or referral, the MIPS eligible clinician that transitions or refers their patient to another setting of care or health care provider — (1) creates a summary of care record using certified electronic health record technology (CEHRT); and
- [Provide Patients Electronic Access to Their Health Information | MIPS PI Measures for 2022 Reporting](https://healthmonix.com/mips_pi_measures/provide-patients-electronic-access-to-their-health-information-mips-pi-measures-for-2022-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description For at least one unique patient seen by the MIPS eligible clinician: (1) The patient (or the patient-authorized representative) is provided timely access to view online, download, and transmit his or her health information; and (2) The MIPS eligible clinician ensures the patient's health
- [Immunization Registry Reporting | MIPS PI Measures for 2022 Reporting](https://healthmonix.com/mips_pi_measures/immunization-registry-reporting-mips-pi-measures-for-2022-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description The MIPS eligible clinician is in active engagement with a public health agency (PHA) to submit immunization data and receive immunization forecasts and histories from the public health immunization registry/immunization information system (IIS). Objective Measure Maximum points Public Health and Clinical Data Exchange Immunization
- [Syndromic Surveillance Reporting | MIPS PI Measures for 2022 Reporting](https://healthmonix.com/mips_pi_measures/syndromic-surveillance-reporting-mips-pi-measures-for-2022-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description The MIPS eligible clinician is in active engagement with a public health agency (PHA) to submit syndromic surveillance data from an urgent care setting. Objective Measure Maximum Point Value Public Health and Clinical Data Exchange Syndromic Surveillance Reporting 5 points* * Any of the
- [Electronic Case Reporting | MIPS PI Measures for 2022 Reporting](https://healthmonix.com/mips_pi_measures/electronic-case-reporting-mips-pi-measures-for-2022-reporting/) - "For use with CEHRT certified to the 2015 edition. Measure Description The MIPS eligible clinician is in active engagement with a public health agency (PHA) to electronically submit case reporting of reportable conditions. Objective Measure Maximum Points Public Health and Clinical Data Exchange Electronic Case Reporting 10 points* *For 2022, the Immunization Registry Reporting measure
- [Public Health Registry Reporting | MIPS PI Measures for 2022 Reporting](https://healthmonix.com/mips_pi_measures/public-health-registry-reporting-mips-pi-measures-for-2022-reporting/) - "For use with CEHRT certified to the 2015 edition. Measure Description The MIPS eligible clinician is in active engagement with a public health agency (PHA) to submit data to public health registries. Objective Measure Maximum Points Public Health and Clinical Data Exchange Public Health Registry Reporting 5 points* * Any of the three PHCDRR measures
- [Security Risk Analysis | MIPS PI Measures for 2022 Reporting](https://healthmonix.com/mips_pi_measures/security-risk-analysis-mips-pi-measures-for-2022-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description Conduct or review a security risk analysis in accordance with the requirements in 45 CFR 164.308(a)(1), including addressing the security (to include encryption) of ePHI data created or maintained by certified electronic health record technology (CEHRT) in accordance with requirements in 45 CFR 164.312(a)(2)(iv)
- [Support Electronic Referral Loops by Receiving and Incorporating Health Information | MIPS PI Measures for 2022 Reporting](https://healthmonix.com/mips_pi_measures/support-electronic-referral-loops-by-receiving-and-incorporating-health-information-mips-pi-measures-for-2022-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description For at least one electronic summary of care record received for patient encounters during the performance period for which a MIPS eligible clinician was the receiving party of a transition of care or referral, or for patient encounters during the performance period in which
- [E-Prescribing | MIPS PI Measures for 2021 Reporting](https://healthmonix.com/mips_pi_measures/e-prescribing-mips-pi-measures-for-2021-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description At least one permissible prescription written by the MIPS eligible clinician and transmitted electronically using certified electronic health record technology (CEHRT). Measure Exclusion: Any MIPS eligible clinician who writes fewer than 100 permissible prescriptions during the performance period. Objective Measure Maximum Points Electronic
- [Security Risk Analysis | MIPS PI Measures for 2021 Reporting](https://healthmonix.com/mips_pi_measures/security-risk-analysis-mips-pi-measures-for-2021-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description Conduct or review a security risk analysis in accordance with the requirements in 45 CFR 164.308(a)(1), including addressing the security (to include encryption) of ePHI data created or maintained by certified electronic health record technology (CEHRT) in accordance with requirements in 45 CFR 164.312(a)(2)(iv)
- [Clinical Data Registry (CDR) Reporting | MIPS PI Measures for 2021 Reporting](https://healthmonix.com/mips_pi_measures/clinical-data-registry-cdr-reporting-mips-pi-measures-for-2021-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description The MIPS eligible clinician is in active engagement to submit data to a clinical data registry. Objective Measure Maximum Points Public Health and Clinical Data Exchange Clinical Data Registry Reporting 5 points* *A MIPS eligible clinician is required to submit at least
- [Public Health Registry Reporting | MIPS PI Measures for 2021 Reporting](https://healthmonix.com/mips_pi_measures/public-health-registry-reporting-mips-pi-measures-for-2021-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description The MIPS eligible clinician is in active engagement with a public health agency (PHA) to submit data to public health registries. Objective Measure Maximum Points Public Health and Clinical Data Exchange Public Health Registry Reporting 5 points* *A MIPS eligible clinician
- [Electronic Case Reporting | MIPS PI Measures for 2021 Reporting](https://healthmonix.com/mips_pi_measures/electronic-case-reporting-mips-pi-measures-for-2021-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description The MIPS eligible clinician is in active engagement with a public health agency (PHA) to electronically submit case reporting of reportable conditions. Objective Measure Maximum Points Public Health and Clinical Data Exchange Electronic Case Reporting 5 points* *A MIPS eligible clinician
- [Syndromic Surveillance Reporting | MIPS PI Measures for 2021 Reporting](https://healthmonix.com/mips_pi_measures/syndromic-surveillance-reporting-mips-pi-measures-for-2021-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description The MIPS eligible clinician is in active engagement with a public health agency (PHA) to submit syndromic surveillance data from an urgent care setting. Objective Measure Maximum Point Value Public Health and Clinical Data Exchange Syndromic Surveillance Reporting 5 points* *A
- [Immunization Registry Reporting | MIPS PI Measures for 2021 Reporting](https://healthmonix.com/mips_pi_measures/immunization-registry-reporting-mips-pi-measures-for-2021-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description The MIPS eligible clinician is in active engagement with a public health agency (PHA) to submit immunization data and receive immunization forecasts and histories from the public health immunization registry/immunization information system (IIS). Objective Measure Maximum points Public Health and Clinical Data
- [Provide Patients Electronic Access to Their Health Information | MIPS PI Measures for 2021 Reporting](https://healthmonix.com/mips_pi_measures/provide-patients-electronic-access-to-their-health-information-mips-pi-measures-for-2021-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description For at least one unique patient seen by the MIPS eligible clinician: (1) The patient (or the patient-authorized representative) is provided timely access to view online, download, and transmit his or her health information; and (2) The MIPS eligible clinician ensures the patient’s health
- [Support Electronic Referral Loops by Sending Health Information | MIPS PI Measures for 2021 Reporting](https://healthmonix.com/mips_pi_measures/support-electronic-referral-loops-by-sending-health-information-mips-pi-measures-for-2021-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description For at least one transition of care or referral, the MIPS eligible clinician that transitions or refers their patient to another setting of care or health care provider — (1) creates a summary of care record using certified electronichealth record technology (CEHRT); and (2)
- [Query of Prescription Drug Monitoring Program (PDMP) | MIPS PI Measures for 2021 Reporting](https://healthmonix.com/mips_pi_measures/query-of-prescription-drug-monitoring-program-pdmp-mips-pi-measures-for-2021-reporting/) - For use with CEHRT certified to the 2015 edition. Measure Description For at least one Schedule II opioid electronically prescribed using CEHRT during the performance period, the MIPS eligible clinician uses data from CEHRT to conduct a query of a PDMP for prescription drug history, except where prohibited and in accordance with applicable law. Objective

## MIPS Cost Measures

- [2021 COST Measure #020: Acute Kidney Injury Requiring New Inpatient Dialysis](https://healthmonix.com/mips_cost_measures/2021-cost-measure-020-acute-kidney-injury-requiring-new-inpatient-dialysis/) - Introduction This document details the methodology for the Acute Kidney Injury Requiring New Inpatient Dialysis measure and should be reviewed along with the Acute Kidney Injury Requiring New Inpatient Dialysis Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to Medicare for
- [2021 COST Measure #019: Elective Primary Hip Arthroplasty](https://healthmonix.com/mips_cost_measures/2021-cost-measure-019-elective-primary-hip-arthroplasty/) - Introduction This document details the methodology for the Elective Primary Hip Arthroplasty measure and should be reviewed along with the Elective Primary Hip Arthroplasty Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to Medicare for the items and services provided to
- [2021 COST Measure #018: Femoral or Inguinal Hernia Repair](https://healthmonix.com/mips_cost_measures/2021-cost-measure-018-femoral-or-inguinal-hernia-repair/) - Introduction This document details the methodology for the Femoral or Inguinal Hernia Repair measure and should be reviewed along with the Femoral or Inguinal Hernia Repair Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to Medicare for the items and services
- [2021 COST Measure #017: Hemodialysis Access Creation](https://healthmonix.com/mips_cost_measures/2021-cost-measure-017-hemodialysis-access-creation/) - Introduction This document details the methodology for the Hemodialysis Access Creation measure and should be reviewed along with the Hemodialysis Access Creation Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to Medicare for the items and services provided to a patient
- [2021 COST Measure #016: Inpatient Chronic Obstructive Pulmonary Disease (COPD) Exacerbation](https://healthmonix.com/mips_cost_measures/2021-cost-measure-016-inpatient-chronic-obstructive-pulmonary-disease-copd-exacerbation/) - Introduction This document details the methodology for the Inpatient Chronic Obstructive Pulmonary Disease (COPD) Exacerbation measure and should be reviewed along with the Inpatient Chronic Obstructive Pulmonary Disease (COPD) Exacerbation Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to Medicare for
- [2021 COST Measure #015: Lumbar Spine Fusion for Degenerative Disease, 1-3 Levels](https://healthmonix.com/mips_cost_measures/2021-cost-measure-015-lumbar-spine-fusion-for-degenerative-disease-1-3-levels/) - Introduction This document details the methodology for the Lumbar Spine Fusion for Degenerative Disease, 1-3 Levels measure and should be reviewed along with the Lumbar Spine Fusion for Degenerative Disease, 1-3 Levels Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to
- [2021 COST Measure #014: Lower Gastrointestinal Hemorrhage Measure Cost Measure](https://healthmonix.com/mips_cost_measures/2021-cost-measure-014-lower-gastrointestinal-hemorrhage-measure-cost-measure/) - Introduction This document details the methodology for the Lower Gastrointestinal Hemorrhage measure and should be reviewed along with the Lower Gastrointestinal Hemorrhage Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to Medicare for the items and services provided to a patient
- [2021 COST Measure #013: Lumpectomy, Partial Mastectomy, Simple Mastectomy](https://healthmonix.com/mips_cost_measures/2021-cost-measure-013-lumpectomy-partial-mastectomy-simple-mastectomy/) - Introduction This document details the methodology for the Lumpectomy, Partial Mastectomy, Simple Mastectomy measure and should be reviewed along with the Lumpectomy, Partial Mastectomy, Simple Mastectomy Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to Medicare for the items and services
- [2021 COST Measure #012: Non-Emergent Coronary Artery Bypass Graft (CABG)](https://healthmonix.com/mips_cost_measures/2021-cost-measure-012-non-emergent-coronary-artery-bypass-graft-cabg/) - Introduction This document details the methodology for the Non-Emergent Coronary Artery Bypass Graft (CABG) measure and should be reviewed along with the Non-Emergent Coronary Artery Bypass Graft (CABG) Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to Medicare for the items
- [2021 COST Measure #011: Renal or Ureteral Stone Surgical Treatment](https://healthmonix.com/mips_cost_measures/2021-cost-measure-011-renal-or-ureteral-stone-surgical-treatment/) - Introduction This document details the methodology for the Renal or Ureteral Stone Surgical Treatment measure and should be reviewed along with the Renal or Ureteral Stone Surgical Treatment Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to Medicare for the items
- [2021 COST Measure #010: ST-Elevation Myocardial Infarction (STEMI) with Percutaneous Coronary Intervention (PCI)](https://healthmonix.com/mips_cost_measures/2021-cost-measure-010-st-elevation-myocardial-infarction-stemi-with-percutaneous-coronary-intervention-pci/) - Introduction This document details the methodology for the ST-Elevation Myocardial Infarction (STEMI) with Percutaneous Coronary Intervention (PCI) measure and should be reviewed along with the ST-Elevation Myocardial Infarction (STEMI) with Percutaneous Coronary Intervention (PCI) Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the
- [2021 COST Measure #009: Screening/Surveillance Colonoscopy](https://healthmonix.com/mips_cost_measures/2021-cost-measure-009-screening-surveillance-colonoscopy/) - Introduction This document details the methodology for the Screening/Surveillance Colonoscopy measure and should be reviewed along with the Screening/Surveillance Colonoscopy Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to Medicare for the items and services provided to a patient during an
- [2021 COST Measure #008: Revascularization for Lower Extremity Chronic Critical Limb Ischemia](https://healthmonix.com/mips_cost_measures/2021-cost-measure-008-revascularization-for-lower-extremity-chronic-critical-limb-ischemia/) - Introduction This document details the methodology for the Revascularization for Lower Extremity Chronic Critical Limb Ischemia measure and should be reviewed along with the Revascularization for Lower Extremity Chronic Critical Limb Ischemia Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to
- [2021 COST Measure #007: Simple Pneumonia with Hospitalization](https://healthmonix.com/mips_cost_measures/2021-cost-measure-007-simple-pneumonia-with-hospitalization/) - Introduction This document details the methodology for the Simple Pneumonia with Hospitalization measure and should be reviewed along with the Simple Pneumonia with Hospitalization Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to Medicare for the items and services provided to
- [2021 COST Measure #006: Elective Outpatient Percutaneous Coronary Intervention (PCI)](https://healthmonix.com/mips_cost_measures/2021-cost-measure-006-elective-outpatient-percutaneous-coronary-intervention-pci/) - Introduction This document details the methodology for the Elective Outpatient Percutaneous Coronary Intervention (PCI) measure and should be reviewed along with the Elective Outpatient Percutaneous Coronary Intervention (PCI) Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to Medicare for the items
- [2021 COST Measure #005: Knee Arthroplasty](https://healthmonix.com/mips_cost_measures/2021-cost-measure-005-knee-arthroplasty/) - Introduction This document details the methodology for the Knee Arthroplasty measure and should be reviewed along with the Knee Arthroplasty Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to Medicare for the items and services provided to a patient during an
- [2021 COST Measure #004: Intracranial Hemorrhage or Cerebral Infarction](https://healthmonix.com/mips_cost_measures/2021-cost-measure-004-intracranial-hemorrhage-or-cerebral-infarction/) - Introduction This document details the methodology for the Intracranial Hemorrhage or Cerebral Infarction measure and should be reviewed along with the Intracranial Hemorrhage or Cerebral Infarction Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to Medicare for the items and services
- [2021 COST Measure #003: Routine Cataract Removal with Intraocular Lens (IOL) Implantation](https://healthmonix.com/mips_cost_measures/2021-cost-measure-003-routine-cataract-removal-with-intraocular-lens-iol-implantation/) - Introduction This document details the methodology for the Routine Cataract Removal with Intraocular Lens (IOL) Implantation measure and should be reviewed along with the Routine Cataract Removal with Intraocular Lens (IOL) Implantation Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description Episode-based cost measures represent the cost to
- [2021 COST Measure #002: Total Per Capita Costs (TPCC)](https://healthmonix.com/mips_cost_measures/2021-cost-measure-002-total-per-capita-costs-tpcc/) - Introduction This document details the methodology for the revised Total Per Capita Cost (TPCC) measure. The methodology should be reviewed along with the Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description The revised TPCC measures the overall cost of care delivered to a beneficiary with a focus
- [2021 COST Measure #001: Medicare Spending Per Beneficiary (MSPB)](https://healthmonix.com/mips_cost_measures/2021-cost-measure-001-medicare-spending-per-beneficiary-mspb/) - Introduction This document details the methodology for the revised Medicare Spending Per Beneficiary (MSPB) clinician measure and should be reviewed along with the Measure Codes List file, which contains the medical codes used in constructing the measure. Measure Description The revised MSPB clinician measure assesses the cost to Medicare of services provided to a beneficiary

## Thrive Lightboxes

- [MIPS Pro Dashboard](https://healthmonix.com/?tcb_lightbox=mips-pro-dashboard)
- [Product & Services Interest Request Form](https://healthmonix.com/?tcb_lightbox=product-services-interest-request-form)
- [Lightbox – Data Integration Services | MIPSPRO-8](https://healthmonix.com/?tcb_lightbox=lightbox-data-integration-services-mipspro-8)
- [MIPS Revenue Estimator](https://healthmonix.com/?tcb_lightbox=mips-revenue-estimator)
- [Public Health and Clinical Data Registry Reporting](https://healthmonix.com/?tcb_lightbox=public-health-and-clinical-data-registry-reporting)
- [Health Information Exchange](https://healthmonix.com/?tcb_lightbox=health-information-exchange)
- [Coordination of Care through Patient Engagement](https://healthmonix.com/?tcb_lightbox=coordination-of-care-through-patient-engagement)
- [Patient Electronic Access](https://healthmonix.com/?tcb_lightbox=patient-electronic-access)
- [Electronic Prescribing](https://healthmonix.com/?tcb_lightbox=electronic-prescribing)
- [Protect Patient Health Information](https://healthmonix.com/?tcb_lightbox=lightbox-advancing-care-information-performance-category-1)

## Sliders

- [test](https://healthmonix.com/?carousels=test)

## Categories

- [Uncategorized](https://healthmonix.com/category/uncategorized/)
- [outcome](https://healthmonix.com/category/outcome/)
- [High-Priority](https://healthmonix.com/category/high-priority/)
- [2021](https://healthmonix.com/category/2021/)
- [2024 CQM](https://healthmonix.com/category/2024-cqm/)
- [2025 CQMS](https://healthmonix.com/category/2025-cqms/)
- [News](https://healthmonix.com/category/news/)
- [ecqm-2026](https://healthmonix.com/category/ecqm-2026/)

## Tags

- [Emergency Medicine](https://healthmonix.com/tag/emergency-medicine/)
- [Otolaryngology](https://healthmonix.com/tag/otolaryngology/)
- [General Practice/Family Medicine](https://healthmonix.com/tag/general-practicefamily-medicine/)
- [Pediatrics](https://healthmonix.com/tag/pediatrics/)
- [Ophthalmology](https://healthmonix.com/tag/ophthalmology/)
- [Internal Medicine](https://healthmonix.com/tag/internal-medicine/)
- [Diagnostic Radiology](https://healthmonix.com/tag/diagnostic-radiology/)
- [Obstetrics/Gynecology](https://healthmonix.com/tag/obstetricsgynecology/)
- [Pathology](https://healthmonix.com/tag/pathology/)
- [Urology](https://healthmonix.com/tag/urology/)
- [Preventive Medicine](https://healthmonix.com/tag/preventive-medicine/)
- [Physical Medicine](https://healthmonix.com/tag/physical-medicine/)
- [Geriatrics / Gerontology](https://healthmonix.com/tag/geriatrics-gerontology/)
- [Optometry](https://healthmonix.com/tag/optometry/)
- [Hematology-Oncology](https://healthmonix.com/tag/hematology-oncology/)
- [Orthopedics](https://healthmonix.com/tag/orthopedics/)
- [Spine Specialists](https://healthmonix.com/tag/spine-specialists/)
- [Neuromusculoskeletal Medicine](https://healthmonix.com/tag/neuromusculoskeletal-medicine/)
- [Pain Management](https://healthmonix.com/tag/pain-management/)
- [Physical Therapy](https://healthmonix.com/tag/physical-therapy/)
- [Nephrology](https://healthmonix.com/tag/nephrology/)
- [Occupational Therapy](https://healthmonix.com/tag/occupational-therapy/)
- [Podiatry](https://healthmonix.com/tag/podiatry/)
- [Palliative Care](https://healthmonix.com/tag/palliative-care/)
- [Pulmonary Medicine](https://healthmonix.com/tag/pulmonary-medicine/)
- [Sleep Medicine](https://healthmonix.com/tag/sleep-medicine/)
- [Infectious Disease](https://healthmonix.com/tag/infectious-disease/)
- [Endocrinology](https://healthmonix.com/tag/endocrinology/)
- [Audiology](https://healthmonix.com/tag/audiology/)
- [Chiropractic](https://healthmonix.com/tag/chiropractic/)
- [Psychiatry & Mental Health](https://healthmonix.com/tag/psychiatry-mental-health/)
- [Speech Therapy](https://healthmonix.com/tag/speech-therapy/)
- [EHR only](https://healthmonix.com/tag/ehr-only/)
- [Quality_2017](https://healthmonix.com/tag/quality_2017/)
- [CardiologyDiagnostic Radiology](https://healthmonix.com/tag/cardiologydiagnostic-radiology/)
- [Anesthesiology-20](https://healthmonix.com/tag/anesthesiology-20/)
- [GeriatricsGerontology](https://healthmonix.com/tag/geriatricsgerontology/)
- [General-Practice-Family Medicine](https://healthmonix.com/tag/general-practice-family-medicine/)
- [CMS-Endocrinology-2021](https://healthmonix.com/tag/cms-endocrinology-2021/)
- [CMS-Family-Medicine-2021](https://healthmonix.com/tag/cms-family-medicine-2021/)
- [CMS-Internal-Medicine-2021](https://healthmonix.com/tag/cms-internal-medicine-2021/)
- [CMS-Nephrology-2021](https://healthmonix.com/tag/cms-nephrology-2021/)
- [CMS-Nutrition-Dietician-2021](https://healthmonix.com/tag/cms-nutrition-dietician-2021/)
- [CMS-Preventive-Medicine-2021](https://healthmonix.com/tag/cms-preventive-medicine-2021/)
- [Emergency Medicine-2021](https://healthmonix.com/tag/emergency-medicine-2021/)
- [Endocrinology-2021](https://healthmonix.com/tag/endocrinology-2021/)
- [General Practice/Family Medicine-2021](https://healthmonix.com/tag/general-practice-family-medicine-2021/)
- [Geriatrics / Gerontology-2021](https://healthmonix.com/tag/geriatrics-gerontology-2021/)
- [Hospitalists-2021](https://healthmonix.com/tag/hospitalists-2021/)
- [Infectious Disease-2021](https://healthmonix.com/tag/infectious-disease-2021/)
- [Internal Medicine-2021](https://healthmonix.com/tag/internal-medicine-2021/)
- [Lab Medicine-2021](https://healthmonix.com/tag/lab-medicine-2021/)
- [Nephrology-2021](https://healthmonix.com/tag/nephrology-2021/)
- [Ophthalmology-2021](https://healthmonix.com/tag/ophthalmology-2021/)
- [Optometry-2021](https://healthmonix.com/tag/optometry-2021/)
- [Palliative Care-2021](https://healthmonix.com/tag/palliative-care-2021/)
- [Podiatry-2021](https://healthmonix.com/tag/podiatry-2021/)
- [Preventive Medicine-2021](https://healthmonix.com/tag/preventive-medicine-2021/)
- [Quality-2021](https://healthmonix.com/tag/quality-2021/)
- [Telehealth-2021](https://healthmonix.com/tag/telehealth-2021/)
- [Cardiology-2021](https://healthmonix.com/tag/cardiology-2021/)
- [CMS-Cardiology-2021](https://healthmonix.com/tag/cms-cardiology-2021/)
- [CMS-Hospitalists-2021](https://healthmonix.com/tag/cms-hospitalists-2021/)
- [NonTelehealth-2021](https://healthmonix.com/tag/nontelehealth-2021/)
- [CMS-Skilled-Nursing-Facility-2021](https://healthmonix.com/tag/cms-skilled-nursing-facility-2021/)
- [Topped-Quality-2021](https://healthmonix.com/tag/topped-quality-2021/)
- [CMS-Mental-Behavioral-Health-2021](https://healthmonix.com/tag/cms-mental-behavioral-health-2021/)
- [Psychiatry & Mental Health-2021](https://healthmonix.com/tag/psychiatry-mental-health-2021/)
- [CMS-Opthalmology-2021](https://healthmonix.com/tag/cms-opthalmology-2021/)
- [Topped-claims-Quality-2021](https://healthmonix.com/tag/topped-claims-quality-2021/)
- [Cardiac Arrhythmia-2021](https://healthmonix.com/tag/cardiac-arrhythmia-2021/)
- [CMS-General-Surgery-2021](https://healthmonix.com/tag/cms-general-surgery-2021/)
- [CMS-Neurosurgical-2021](https://healthmonix.com/tag/cms-neurosurgical-2021/)
- [CMS-Orthopedic-Surgery-2021](https://healthmonix.com/tag/cms-orthopedic-surgery-2021/)
- [CMS-Otolaryngology-2021](https://healthmonix.com/tag/cms-otolaryngology-2021/)
- [CMS-Plastic-Surgery-2021](https://healthmonix.com/tag/cms-plastic-surgery-2021/)
- [CMS-Thoracic-Surgery-2021](https://healthmonix.com/tag/cms-thoracic-surgery-2021/)
- [CMS-Vascular-Surgery-2021](https://healthmonix.com/tag/cms-vascular-surgery-2021/)
- [Colon & Rectal Surgery-2021](https://healthmonix.com/tag/colon-rectal-surgery-2021/)
- [ENT/Otolaryngology-2021](https://healthmonix.com/tag/ent-otolaryngology-2021/)
- [General Oncology-2021](https://healthmonix.com/tag/general-oncology-2021/)
- [General Surgery-2021](https://healthmonix.com/tag/general-surgery-2021/)
- [Hand Surgery-2021](https://healthmonix.com/tag/hand-surgery-2021/)
- [Hematology-Oncology-2021](https://healthmonix.com/tag/hematology-oncology-2021/)
- [Interventional Radiology-2021](https://healthmonix.com/tag/interventional-radiology-2021/)
- [Neurosurgery-2021](https://healthmonix.com/tag/neurosurgery-2021/)
- [Nuclear Medicine-2021](https://healthmonix.com/tag/nuclear-medicine-2021/)
- [Obstetrics/Gynecology-2021](https://healthmonix.com/tag/obstetrics-gynecology-2021/)
- [Oral/Maxillofacial Surgery-2021](https://healthmonix.com/tag/oral-maxillofacial-surgery-2021/)
- [Orthopedic Surgery-2021](https://healthmonix.com/tag/orthopedic-surgery-2021/)
- [Orthopedics-2021](https://healthmonix.com/tag/orthopedics-2021/)
- [Physical Medicine-2021](https://healthmonix.com/tag/physical-medicine-2021/)
- [Plastic Surgery-2021](https://healthmonix.com/tag/plastic-surgery-2021/)
- [Spine Specialists-2021](https://healthmonix.com/tag/spine-specialists-2021/)
- [Thoracic Surgery-2021](https://healthmonix.com/tag/thoracic-surgery-2021/)
- [Urology-2021](https://healthmonix.com/tag/urology-2021/)
- [Vascular Surgery-2021](https://healthmonix.com/tag/vascular-surgery-2021/)
- [CMS-Urology-2021](https://healthmonix.com/tag/cms-urology-2021/)
- [CMS-Rheumatology-2021](https://healthmonix.com/tag/cms-rheumatology-2021/)
- [Neuromusculoskeletal Medicine-2021](https://healthmonix.com/tag/neuromusculoskeletal-medicine-2021/)
- [Pain Management-2021](https://healthmonix.com/tag/pain-management-2021/)
- [Physical Therapy-2021](https://healthmonix.com/tag/physical-therapy-2021/)
- [Radiology-2021](https://healthmonix.com/tag/radiology-2021/)
- [Rheumatology-2021](https://healthmonix.com/tag/rheumatology-2021/)
- [CMS-Geriatrics-2021](https://healthmonix.com/tag/cms-geriatrics-2021/)
- [Occupational Therapy-2021](https://healthmonix.com/tag/occupational-therapy-2021/)
- [Anesthesiology-2021](https://healthmonix.com/tag/anesthesiology-2021/)
- [CMS-Anesthesiology-2021](https://healthmonix.com/tag/cms-anesthesiology-2021/)
- [Chiropractic-2021](https://healthmonix.com/tag/chiropractic-2021/)
- [CMS-Gastro-enterology-2021](https://healthmonix.com/tag/cms-gastro-enterology-2021/)
- [CMS-Neurology-2021](https://healthmonix.com/tag/cms-neurology-2021/)
- [CMS-Obstetrics-Gynecology-2021](https://healthmonix.com/tag/cms-obstetrics-gynecology-2021/)
- [CMS-Oncology-2021](https://healthmonix.com/tag/cms-oncology-2021/)
- [CMS-Physical-Medicine-2021](https://healthmonix.com/tag/cms-physical-medicine-2021/)
- [CMS-Pulmonology-2021](https://healthmonix.com/tag/cms-pulmonology-2021/)
- [Dermatology-2021](https://healthmonix.com/tag/dermatology-2021/)
- [Gastroenterology-2021](https://healthmonix.com/tag/gastroenterology-2021/)
- [LCSW-2021](https://healthmonix.com/tag/lcsw-2021/)
- [Mental/Behavioral Health-2021](https://healthmonix.com/tag/mental-behavioral-health-2021/)
- [Neurology-2021](https://healthmonix.com/tag/neurology-2021/)
- [Psychology-2021](https://healthmonix.com/tag/psychology-2021/)
- [Pulmonary Medicine-2021](https://healthmonix.com/tag/pulmonary-medicine-2021/)
- [Radiation Oncology-2021](https://healthmonix.com/tag/radiation-oncology-2021/)
- [Sleep Medicine-2021](https://healthmonix.com/tag/sleep-medicine-2021/)
- [AllergyImmunology-2021](https://healthmonix.com/tag/allergyimmunology-2021/)
- [CMS-Pediatrics-2021](https://healthmonix.com/tag/cms-pediatrics-2021/)
- [CMS-Urgent-Care-2021](https://healthmonix.com/tag/cms-urgent-care-2021/)
- [Pediatrics-2021](https://healthmonix.com/tag/pediatrics-2021/)
- [CMS-Emergency-Medicine-2021](https://healthmonix.com/tag/cms-emergency-medicine-2021/)
- [CMS-Interventional-Radiology-2021](https://healthmonix.com/tag/cms-interventional-radiology-2021/)
- [CMS-Radiation-Oncology-2021](https://healthmonix.com/tag/cms-radiation-oncology-2021/)
- [CMS-Allergy-Immunology-2021](https://healthmonix.com/tag/cms-allergy-immunology-2021/)
- [CMS-Infectious-Disease-2021](https://healthmonix.com/tag/cms-infectious-disease-2021/)
- [CardiologyGeneral Practice/Family Medicine-2021](https://healthmonix.com/tag/cardiologygeneral-practice-family-medicine-2021/)
- [CMS-Physical-Therapy-Occupational-Therapy-2021](https://healthmonix.com/tag/cms-physical-therapy-occupational-therapy-2021/)
- [CMS-Podiatry-2021](https://healthmonix.com/tag/cms-podiatry-2021/)
- [Audiology-2021](https://healthmonix.com/tag/audiology-2021/)
- [CMS-Audiology-2021](https://healthmonix.com/tag/cms-audiology-2021/)
- [CMS-Clinical-Social-Work-2021](https://healthmonix.com/tag/cms-clinical-social-work-2021/)
- [CMS-Dermatology-2021](https://healthmonix.com/tag/cms-dermatology-2021/)
- [CMS-Speech-Language-Pathology-2021](https://healthmonix.com/tag/cms-speech-language-pathology-2021/)
- [Speech Therapy-2021](https://healthmonix.com/tag/speech-therapy-2021/)
- [Topped-eCQM-Quality-2021](https://healthmonix.com/tag/topped-ecqm-quality-2021/)
- [CMS-Diagnostic-Radiology-2021](https://healthmonix.com/tag/cms-diagnostic-radiology-2021/)
- [CMS-Chiropractic-Medicine-2021](https://healthmonix.com/tag/cms-chiropractic-medicine-2021/)
- [CardiologyColon & Rectal Surgery-2021](https://healthmonix.com/tag/cardiologycolon-rectal-surgery-2021/)
- [CMS-Pathology-2021](https://healthmonix.com/tag/cms-pathology-2021/)
- [Electrophysiology Cardiac Specialist-2021](https://healthmonix.com/tag/electrophysiology-cardiac-specialist-2021/)
- [Diagnostic Radiology-2021](https://healthmonix.com/tag/diagnostic-radiology-2021/)
- [CMS-Dentistry-2021](https://healthmonix.com/tag/cms-dentistry-2021/)
- [QCDR-2021](https://healthmonix.com/tag/qcdr-2021/)
- [HMX_Specialty_2021](https://healthmonix.com/tag/hmx_specialty_2021/)
- [CMS-2021](https://healthmonix.com/tag/cms-2021/)
- [QCDR-EACCR-2021](https://healthmonix.com/tag/qcdr-eaccr-2021/)
- [QCDR-Quality-2021](https://healthmonix.com/tag/qcdr-quality-2021/)
- [Physical Therapy QCDR Quality Measures-2021](https://healthmonix.com/tag/physical-therapy-qcdr-quality-measures-2021/)
- [Occupational Therapy QCDR Quality Measures-2021](https://healthmonix.com/tag/occupational-therapy-qcdr-quality-measures-2021/)
- [Orthopedics QCDR Quality Measures-2021](https://healthmonix.com/tag/orthopedics-qcdr-quality-measures-2021/)
- [Audiology-QCDR-2021](https://healthmonix.com/tag/audiology-qcdr-2021/)
- [MBHR-2021](https://healthmonix.com/tag/mbhr-2021/)
- [IA_2021](https://healthmonix.com/tag/ia_2021/)
- [Pathology-2021](https://healthmonix.com/tag/pathology-2021/)
- [COST-2021](https://healthmonix.com/tag/cost-2021/)
- [PI_2021](https://healthmonix.com/tag/pi_2021/)
- [Audiology-QCDR-Audiologists-2021](https://healthmonix.com/tag/audiology-qcdr-audiologists-2021/)
- [APP-2021](https://healthmonix.com/tag/app-2021/)
- [ecqm-2022](https://healthmonix.com/tag/ecqm-2022/)
- [Audiology-QCDR-2022](https://healthmonix.com/tag/audiology-qcdr-2022/)
- [Audiology-QCDR-Audiologists-2022](https://healthmonix.com/tag/audiology-qcdr-audiologists-2022/)
- [MBHR-2022](https://healthmonix.com/tag/mbhr-2022/)
- [QCDR-2022](https://healthmonix.com/tag/qcdr-2022/)
- [QCDR-EACCR-2022](https://healthmonix.com/tag/qcdr-eaccr-2022/)
- [Quality-2022](https://healthmonix.com/tag/quality-2022/)
- [IA_2022](https://healthmonix.com/tag/ia_2022/)
- [PI_2022](https://healthmonix.com/tag/pi_2022/)
- [CMS-Endocrinology-2022](https://healthmonix.com/tag/cms-endocrinology-2022/)
- [CMS-Family-Medicine-2022](https://healthmonix.com/tag/cms-family-medicine-2022/)
- [CMS-Internal-Medicine-2022](https://healthmonix.com/tag/cms-internal-medicine-2022/)
- [CMS-Nephrology-2022](https://healthmonix.com/tag/cms-nephrology-2022/)
- [CMS-Preventive-Medicine-2022](https://healthmonix.com/tag/cms-preventive-medicine-2022/)
- [CMS-Cardiology-2022](https://healthmonix.com/tag/cms-cardiology-2022/)
- [CMS-Hospitalists-2022](https://healthmonix.com/tag/cms-hospitalists-2022/)
- [CMS-Skilled-Nursing-Facility-2022](https://healthmonix.com/tag/cms-skilled-nursing-facility-2022/)
- [Neurology-2022](https://healthmonix.com/tag/neurology-2022/)
- [APP-2022](https://healthmonix.com/tag/app-2022/)
- [CMS-Nutrition-Dietician-2022](https://healthmonix.com/tag/cms-nutrition-dietician-2022/)
- [Emergency Medicine-2022](https://healthmonix.com/tag/emergency-medicine-2022/)
- [Endocrinology-2022](https://healthmonix.com/tag/endocrinology-2022/)
- [General Practice/Family Medicine-2022](https://healthmonix.com/tag/general-practice-family-medicine-2022/)
- [Geriatrics / Gerontology-2022](https://healthmonix.com/tag/geriatrics-gerontology-2022/)
- [Hospitalists-2022](https://healthmonix.com/tag/hospitalists-2022/)
- [Infectious Disease-2022](https://healthmonix.com/tag/infectious-disease-2022/)
- [Internal Medicine-2022](https://healthmonix.com/tag/internal-medicine-2022/)
- [Lab Medicine-2022](https://healthmonix.com/tag/lab-medicine-2022/)
- [Nephrology-2022](https://healthmonix.com/tag/nephrology-2022/)
- [Ophthalmology-2022](https://healthmonix.com/tag/ophthalmology-2022/)
- [Optometry-2022](https://healthmonix.com/tag/optometry-2022/)
- [Palliative Care-2022](https://healthmonix.com/tag/palliative-care-2022/)
- [Podiatry-2022](https://healthmonix.com/tag/podiatry-2022/)
- [Preventive Medicine-2022](https://healthmonix.com/tag/preventive-medicine-2022/)
- [CMS-Neurology-2022](https://healthmonix.com/tag/cms-neurology-2022/)
- [NonTelehealth-2022](https://healthmonix.com/tag/nontelehealth-2022/)
- [Topped-Quality-2022](https://healthmonix.com/tag/topped-quality-2022/)
- [Cardiology-2022](https://healthmonix.com/tag/cardiology-2022/)
- [CMS-Pediatrics-2022](https://healthmonix.com/tag/cms-pediatrics-2022/)
- [CMS-Obstetrics-Gynecology-2022](https://healthmonix.com/tag/cms-obstetrics-gynecology-2022/)
- [CMS-Gastro-enterology-2022](https://healthmonix.com/tag/cms-gastro-enterology-2022/)
- [Colon & Rectal Surgery-2022](https://healthmonix.com/tag/colon-rectal-surgery-2022/)
- [Gastroenterology-2022](https://healthmonix.com/tag/gastroenterology-2022/)
- [Topped-claims-Quality-2022](https://healthmonix.com/tag/topped-claims-quality-2022/)
- [Interventional Radiology-2022](https://healthmonix.com/tag/interventional-radiology-2022/)
- [Nuclear Medicine-2022](https://healthmonix.com/tag/nuclear-medicine-2022/)
- [Radiation Oncology-2022](https://healthmonix.com/tag/radiation-oncology-2022/)
- [Radiology-2022](https://healthmonix.com/tag/radiology-2022/)
- [Cardiac Arrhythmia-2022](https://healthmonix.com/tag/cardiac-arrhythmia-2022/)
- [General Surgery-2022](https://healthmonix.com/tag/general-surgery-2022/)
- [AllergyImmunology-2022](https://healthmonix.com/tag/allergyimmunology-2022/)
- [CMS-Emergency-Medicine-2022](https://healthmonix.com/tag/cms-emergency-medicine-2022/)
- [CMS-Otolaryngology-2022](https://healthmonix.com/tag/cms-otolaryngology-2022/)
- [CMS-Urgent-Care-2022](https://healthmonix.com/tag/cms-urgent-care-2022/)
- [ENT/Otolaryngology-2022](https://healthmonix.com/tag/ent-otolaryngology-2022/)
- [Obstetrics/Gynecology-2022](https://healthmonix.com/tag/obstetrics-gynecology-2022/)
- [Pediatrics-2022](https://healthmonix.com/tag/pediatrics-2022/)
- [CMS-Orthopedic-Surgery-2022](https://healthmonix.com/tag/cms-orthopedic-surgery-2022/)
- [CMS-Rheumatology-2022](https://healthmonix.com/tag/cms-rheumatology-2022/)
- [Hand Surgery-2022](https://healthmonix.com/tag/hand-surgery-2022/)
- [Neuromusculoskeletal Medicine-2022](https://healthmonix.com/tag/neuromusculoskeletal-medicine-2022/)
- [Neurosurgery-2022](https://healthmonix.com/tag/neurosurgery-2022/)
- [Orthopedics-2022](https://healthmonix.com/tag/orthopedics-2022/)
- [Pain Management-2022](https://healthmonix.com/tag/pain-management-2022/)
- [Physical Medicine-2022](https://healthmonix.com/tag/physical-medicine-2022/)
- [Physical Therapy-2022](https://healthmonix.com/tag/physical-therapy-2022/)
- [Rheumatology-2022](https://healthmonix.com/tag/rheumatology-2022/)
- [Spine Specialists-2022](https://healthmonix.com/tag/spine-specialists-2022/)
- [Telehealth-2022](https://healthmonix.com/tag/telehealth-2022/)
- [CMS-Allergy-Immunology-2022](https://healthmonix.com/tag/cms-allergy-immunology-2022/)
- [CMS-Infectious-Disease-2022](https://healthmonix.com/tag/cms-infectious-disease-2022/)
- [CMS-Vascular-Surgery-2022](https://healthmonix.com/tag/cms-vascular-surgery-2022/)
- [Vascular Surgery-2022](https://healthmonix.com/tag/vascular-surgery-2022/)
- [Orthopedic Surgery-2022](https://healthmonix.com/tag/orthopedic-surgery-2022/)
- [CMS-General-Surgery-2022](https://healthmonix.com/tag/cms-general-surgery-2022/)
- [CMS-Plastic-Surgery-2022](https://healthmonix.com/tag/cms-plastic-surgery-2022/)
- [Plastic Surgery-2022](https://healthmonix.com/tag/plastic-surgery-2022/)
- [Anesthesiology-2022](https://healthmonix.com/tag/anesthesiology-2022/)
- [CMS-Thoracic-Surgery-2022](https://healthmonix.com/tag/cms-thoracic-surgery-2022/)
- [CMS-Urology-2022](https://healthmonix.com/tag/cms-urology-2022/)
- [Dermatology-2022](https://healthmonix.com/tag/dermatology-2022/)
- [General Oncology-2022](https://healthmonix.com/tag/general-oncology-2022/)
- [Oral/Maxillofacial Surgery-2022](https://healthmonix.com/tag/oral-maxillofacial-surgery-2022/)
- [Thoracic Surgery-2022](https://healthmonix.com/tag/thoracic-surgery-2022/)
- [Urology-2022](https://healthmonix.com/tag/urology-2022/)
- [CMS-Geriatrics-2022](https://healthmonix.com/tag/cms-geriatrics-2022/)
- [Occupational Therapy-2022](https://healthmonix.com/tag/occupational-therapy-2022/)
- [CMS-Diagnostic-Radiology-2022](https://healthmonix.com/tag/cms-diagnostic-radiology-2022/)
- [Diagnostic Radiology-2022](https://healthmonix.com/tag/diagnostic-radiology-2022/)
- [Chiropractic-2022](https://healthmonix.com/tag/chiropractic-2022/)
- [CMS-Oncology-2022](https://healthmonix.com/tag/cms-oncology-2022/)
- [CMS-Physical-Medicine-2022](https://healthmonix.com/tag/cms-physical-medicine-2022/)
- [CMS-Pulmonology-2022](https://healthmonix.com/tag/cms-pulmonology-2022/)
- [Hematology-Oncology-2022](https://healthmonix.com/tag/hematology-oncology-2022/)
- [LCSW-2022](https://healthmonix.com/tag/lcsw-2022/)
- [Mental/Behavioral Health-2022](https://healthmonix.com/tag/mental-behavioral-health-2022/)
- [Psychiatry & Mental Health-2022](https://healthmonix.com/tag/psychiatry-mental-health-2022/)
- [Psychology-2022](https://healthmonix.com/tag/psychology-2022/)
- [Pulmonary Medicine-2022](https://healthmonix.com/tag/pulmonary-medicine-2022/)
- [Sleep Medicine-2022](https://healthmonix.com/tag/sleep-medicine-2022/)
- [CMS-Clinical-Social-Work-2022](https://healthmonix.com/tag/cms-clinical-social-work-2022/)
- [CMS-Mental-Behavioral-Health-2022](https://healthmonix.com/tag/cms-mental-behavioral-health-2022/)
- [CMS-Dermatology-2022](https://healthmonix.com/tag/cms-dermatology-2022/)
- [CMS-Interventional-Radiology-2022](https://healthmonix.com/tag/cms-interventional-radiology-2022/)
- [CMS-Opthalmology-2022](https://healthmonix.com/tag/cms-opthalmology-2022/)
- [CMS-Electro-physiology-Cardiac-Specialist-2022](https://healthmonix.com/tag/cms-electro-physiology-cardiac-specialist-2022/)
- [Electrophysiology Cardiac Specialist-2022](https://healthmonix.com/tag/electrophysiology-cardiac-specialist-2022/)
- [CMS-Pathology-2022](https://healthmonix.com/tag/cms-pathology-2022/)
- [Speech Therapy-2022](https://healthmonix.com/tag/speech-therapy-2022/)
- [CMS-Anesthesiology-2022](https://healthmonix.com/tag/cms-anesthesiology-2022/)
- [CMS-Neurosurgical-2022](https://healthmonix.com/tag/cms-neurosurgical-2022/)
- [CMS-Certified-Nurse-Midwife-2022](https://healthmonix.com/tag/cms-certified-nurse-midwife-2022/)
- [Audiology-2022](https://healthmonix.com/tag/audiology-2022/)
- [CMS-Radiation-Oncology-2022](https://healthmonix.com/tag/cms-radiation-oncology-2022/)
- [CMS-Skilled-Nursing-Facility](https://healthmonix.com/tag/cms-skilled-nursing-facility/)
- [CardiologyGeneral Practice/Family Medicine-2022](https://healthmonix.com/tag/cardiologygeneral-practice-family-medicine-2022/)
- [CMS-Physical-Therapy-Occupational-Therapy-2022](https://healthmonix.com/tag/cms-physical-therapy-occupational-therapy-2022/)
- [CMS-Podiatry-2022](https://healthmonix.com/tag/cms-podiatry-2022/)
- [Occupational Therapy QCDR Quality Measures-2022](https://healthmonix.com/tag/occupational-therapy-qcdr-quality-measures-2022/)
- [Orthopedics QCDR Quality Measures-2022](https://healthmonix.com/tag/orthopedics-qcdr-quality-measures-2022/)
- [Physical Therapy QCDR Quality Measures-2022](https://healthmonix.com/tag/physical-therapy-qcdr-quality-measures-2022/)
- [CMS-Audiology-2022](https://healthmonix.com/tag/cms-audiology-2022/)
- [CMS-Speech-Language-Pathology-2022](https://healthmonix.com/tag/cms-speech-language-pathology-2022/)
- [Topped-eCQM-Quality-2022](https://healthmonix.com/tag/topped-ecqm-quality-2022/)
- [CMS-Chiropractic-Medicine-2022](https://healthmonix.com/tag/cms-chiropractic-medicine-2022/)
- [CardiologyColon & Rectal Surgery-2022](https://healthmonix.com/tag/cardiologycolon-rectal-surgery-2022/)
- [CMS-Dentistry-2022](https://healthmonix.com/tag/cms-dentistry-2022/)
- [CMS-2022](https://healthmonix.com/tag/cms-2022/)
- [QCDR-EACCR-2023](https://healthmonix.com/tag/qcdr-eaccr-2023/)
- [MBHR-2023](https://healthmonix.com/tag/mbhr-2023/)
- [QCDR-2023](https://healthmonix.com/tag/qcdr-2023/)
- [CQM-2023](https://healthmonix.com/tag/cqm-2023/)
- [ecqm-2023](https://healthmonix.com/tag/ecqm-2023/)
- [MVP-2023](https://healthmonix.com/tag/mvp-2023/)
- [CQM-eCQM-2023](https://healthmonix.com/tag/cqm-ecqm-2023/)
- [CQM-eCQM-MVP-2023](https://healthmonix.com/tag/cqm-ecqm-mvp-2023/)
- [CQM-MVP-2023](https://healthmonix.com/tag/cqm-mvp-2023/)
- [Pop-Health-2023](https://healthmonix.com/tag/pop-health-2023/)
- [Allergy/Immunology-2023](https://healthmonix.com/tag/allergy-immunology-2023/)
- [Anesthesiology-2023](https://healthmonix.com/tag/anesthesiology-2023/)
- [Audiology-2023](https://healthmonix.com/tag/audiology-2023/)
- [Cardiology-2023](https://healthmonix.com/tag/cardiology-2023/)
- [pi-2023](https://healthmonix.com/tag/pi-2023/)
- [IA-2023](https://healthmonix.com/tag/ia-2023/)
- [APP-2023](https://healthmonix.com/tag/app-2023/)
- [QCDR-2024](https://healthmonix.com/tag/qcdr-2024/)
- [2024-CQM](https://healthmonix.com/tag/2024-cqm/)
- [2025-CQMS](https://healthmonix.com/tag/2025-cqms/)
- [pi-2025](https://healthmonix.com/tag/pi-2025/)
- [pi-2024](https://healthmonix.com/tag/pi-2024/)
- [ecqm-2026](https://healthmonix.com/tag/ecqm-2026/)

## Specialty Measure Sets

- [AllergyImmunology](https://healthmonix.com/mips_quality_measure-spms/allergyimmunology/)
- [Anesthesiology](https://healthmonix.com/mips_quality_measure-spms/anesthesiology/)

## Webinar Categories

- [MIPS Webinars](https://healthmonix.com/webinar-category/mips-webinars/)
- [MIPS COST ANALYTICS](https://healthmonix.com/webinar-category/mips-cost-analytics/)
- [APP WEBINARS](https://healthmonix.com/webinar-category/app-webinars/)

## specialty measure sets

- [Allergy/Immunology](https://healthmonix.com/specialty_measure_sets/allergy-immunology/)
- [Test term 2](https://healthmonix.com/specialty_measure_sets/test-term-2/)
- [Family Medicine](https://healthmonix.com/specialty_measure_sets/family-medicine/)
- [Anesthesiology](https://healthmonix.com/specialty_measure_sets/anesthesiology/)
- [Audiology](https://healthmonix.com/specialty_measure_sets/audiology/)
- [Cardiology](https://healthmonix.com/specialty_measure_sets/cardiology/)
- [Electrophysiology Cardiac Specialist](https://healthmonix.com/specialty_measure_sets/electrophysiology-cardiac-specialist/)
- [Clinical Social Work](https://healthmonix.com/specialty_measure_sets/clinical-social-work/)
- [Dentistry](https://healthmonix.com/specialty_measure_sets/dentistry/)
- [Dermatology](https://healthmonix.com/specialty_measure_sets/dermatology/)
- [Diagnostic Radiology](https://healthmonix.com/specialty_measure_sets/diagnostic-radiology/)
- [Emergency Medicine](https://healthmonix.com/specialty_measure_sets/emergency-medicine/)
- [Endocrinology](https://healthmonix.com/specialty_measure_sets/endocrinology/)
- [Gastroenterology](https://healthmonix.com/specialty_measure_sets/gastroenterology/)
- [General Surgery](https://healthmonix.com/specialty_measure_sets/general-surgery/)
- [Geriatrics](https://healthmonix.com/specialty_measure_sets/geriatrics/)
- [Hospitalists](https://healthmonix.com/specialty_measure_sets/hospitalists/)
- [Infectious Disease](https://healthmonix.com/specialty_measure_sets/infectious-disease/)
- [Internal Medicine](https://healthmonix.com/specialty_measure_sets/internal-medicine/)
- [Interventional Radiology](https://healthmonix.com/specialty_measure_sets/interventional-radiology/)
- [Mental/Behavioral Health and Psychiatry](https://healthmonix.com/specialty_measure_sets/mental-behavioral-health-and-psychiatry/)
- [Nephrology](https://healthmonix.com/specialty_measure_sets/nephrology/)
- [Neurology](https://healthmonix.com/specialty_measure_sets/neurology/)
- [Neurosurgical](https://healthmonix.com/specialty_measure_sets/neurosurgical/)
- [Nutrition/Dietician](https://healthmonix.com/specialty_measure_sets/nutrition-dietician/)
- [Obstetrics/Gynecology](https://healthmonix.com/specialty_measure_sets/obstetrics-gynecology/)
- [Oncology/Hematology](https://healthmonix.com/specialty_measure_sets/oncology-hematology/)
- [Radiation Oncology](https://healthmonix.com/specialty_measure_sets/radiation-oncology/)
- [Ophthalmology/Optometry](https://healthmonix.com/specialty_measure_sets/ophthalmology-optometry/)
- [Orthopedic Surgery](https://healthmonix.com/specialty_measure_sets/orthopedic-surgery/)
- [Otolaryngology](https://healthmonix.com/specialty_measure_sets/otolaryngology/)
- [Pathology](https://healthmonix.com/specialty_measure_sets/pathology/)
- [Pediatrics](https://healthmonix.com/specialty_measure_sets/pediatrics/)
- [Physical Medicine](https://healthmonix.com/specialty_measure_sets/physical-medicine/)
- [Physical Therapy/Occupational Therapy](https://healthmonix.com/specialty_measure_sets/physical-therapy-occupational-therapy/)
- [Plastic Surgery](https://healthmonix.com/specialty_measure_sets/plastic-surgery/)
- [Podiatry](https://healthmonix.com/specialty_measure_sets/podiatry/)
- [Preventive Medicine](https://healthmonix.com/specialty_measure_sets/preventive-medicine/)
- [Pulmonology](https://healthmonix.com/specialty_measure_sets/pulmonology/)
- [Rheumatology](https://healthmonix.com/specialty_measure_sets/rheumatology/)
- [Skilled Nursing Facility](https://healthmonix.com/specialty_measure_sets/skilled-nursing-facility/)
- [Speech Language Pathology](https://healthmonix.com/specialty_measure_sets/speech-language-pathology/)
- [Thoracic Surgery](https://healthmonix.com/specialty_measure_sets/thoracic-surgery/)
- [Urgent Care](https://healthmonix.com/specialty_measure_sets/urgent-care/)
- [Urology](https://healthmonix.com/specialty_measure_sets/urology/)
- [Vascular Surgery](https://healthmonix.com/specialty_measure_sets/vascular-surgery/)

## collection types

- [CQM/MVP](https://healthmonix.com/collection_types/cqm-mvp/)
- [CQM](https://healthmonix.com/collection_types/cqm/)
- [eCQM](https://healthmonix.com/collection_types/ecqm/)
- [MVP](https://healthmonix.com/collection_types/mvp/)
- [CQM/eCQM/MVP](https://healthmonix.com/collection_types/cqm-ecqm-mvp/)
- [QCDR](https://healthmonix.com/collection_types/qcdr/)
- [CQM/eCQM](https://healthmonix.com/collection_types/cqm-ecqm/)
- [eCQM/MVP](https://healthmonix.com/collection_types/ecqm-mvp/)
- [QCDR/MVP](https://healthmonix.com/collection_types/qcdr-mvp/)
- [MIPS/CQM](https://healthmonix.com/collection_types/mips-cqm-2/)
- [CQMS](https://healthmonix.com/collection_types/cqms/)

## Symbols

- [Headers](https://healthmonix.com/tcb_symbol/headers/)
- [Footers](https://healthmonix.com/tcb_symbol/footers/)